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CHAPTER 1 GENERAL INTRODUCTION 
1. THE NEED FOR STABILIZATION 
For more than 30 years biologicals like proteins, peptides, and hormones gain increas-
ing importance for the treatment of human diseases. Due to the enormous potential of 
biologicals to act as very specific and high potency pharmaceutical substances, enormous 
efforts are put in developing such new molecules to function against severe illness. While 
those molecules persuade by their unique potency as pharmaceutical substances, they 
usually exhibit weak stability during processing into a final drug [1]. Minor thermody-
namic stability as well as miscellaneous degradation pathways are characteristic of many 
biological (macro-) molecules. Hence, the need to protect these molecules during pro-
cessing and over the entire shelf life against various stress vectors is most important. 
For many small molecules, the way of administration is the oral route, which is a very 
comfortable way to administer a drug. However, the gastro-intestinal system in mam-
mals was built to take large molecules like proteins to pieces. Moreover, molecules larger 
than 500-600 Da are not able to overcome the intestinal barriers of the biological mem-
branes [2]. For this reason, biopharmaceutical drugs are usually administered via the par-
enteral route as a liquid formulation [3]. Consequently, those molecules need to be for-
mulated as solutions or suspensions. Quite a number of biopharmaceutical drugs on the 
market are in fact available as liquid formulations [4]; however, many molecules cannot 
be stabilized in a solution throughout the whole shelf life of usually 24 months. Mono-
clonal antibodies, the most important class of biopharmaceutical molecules [5], are often 
susceptible to degradation in liquid environment. In order to be able to distribute the 
biopharmaceutical drugs to patients, the sensitive molecules need to be stabilized in a 
thermodynamically less active system. Although storage could theoretically be realized 
as a frozen solution, which would represent a thermodynamically less active system, for 
practical reasons storage and distribution at frozen condition is not feasible. Storing val-
uable biopharmaceuticals in the dried state therefore has become the method of choice 
already decades ago [6]. Most of the biological molecules to be stabilized are sensitive 
against temperatures above the body temperature of mammals. Thus, drying must be 
operated at low temperatures compared to other industrial drying processes. To reach 
reasonable drying rates at low temperatures (i.e. low vapor pressure of the solvent), low-
ering of the surrounding pressure is mandatory. However, pharmaceutical formulations 
that are only dried by applying vacuum, result in products that are often not easy to re-
dissolve [7]. At that point “lyophilization” (or synonymously “freeze-drying”) bears cru-
cial advantage. A solution is frozen to a system consisting of solvent crystals (most often 
ice) and a concentrated and therefore solidified interstitial matrix composed of the solutes 
of the initial solution. The crystallized solvent is subsequently removed by sublimation 
at low temperature. As soon as all of the solvent has been removed, the interstitial matrix 
forms a highly porous structure, which can easily be dissolved again. Embedded in those 
solid matrices sensitive biomolecules it can be stabilized successfully for the intended 
shelf lives.  
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In order to successfully stabilize a sensitive biomolecule within a freeze-dried prod-
uct, a combination of necessary excipients and accurate control of the freeze-drying pro-
cess is essential. Excipients are used to stabilize the molecule of interest against stress 
vectors arising during processing and subsequent storage. In the course of freeze-drying 
excipients generally need to provide protection against freezing-, drying-, and interfacial 
stresses [8]. Additional excipients are used to adjust the tonicity, maintain pH level, and 
provide a rigid structure to support the interstitial matrix after removing the solvent by 
sublimation. 
The most important goal of a freeze-drying process is to conserve critical quality at-
tributes of the product. In order to avoid deterioration of the quality of an embedded 
molecule of interest, during a freeze-drying process the temperature of the product needs 
to be kept below a critical temperature [9]. In order to control the product temperature, a 
controlled (low) pressure and energy (heat) input for a defined period is necessary. Most 
often, the so-called collapse temperature is considered as maximally allowable product 
temperature, as above the collapse temperature the interstitial matrix softens [10]. A col-
lapsed product is regarded as failure of the process, particularly because of the corrupted 
macroscopic pharmaceutical elegance [11], but also as some data from literature report, 
an adverse effect of collapse on the stability of the embedded molecule of interest [12, 13]. 
Moreover, important physical parameters as for example residual water content [14] or 
dissolution time [15] are reported to be negatively affected in collapsed products, too. 
On the contrary, having a closer look to stability data of collapsed lyophilizates, in 
several cases collapsed material did not perform worse than non-collapsed material re-
garding stabilization of embedded molecules. In a systematic study it was recently 
shown, that collapsed freeze-dried formulations are able to stabilize a number of sensitive 
proteins – in same cases even better than non-collapsed lyophilizates [16, 17]. This report 
is even more remarkably as the results apply to classical freeze-drying formulations (con-
taining sugars and bulking agents) without further optimization. Collapsed products 
were achieved by increasing the product temperature above the collapse temperature by 
means of an aggressive freeze-drying cycle. This cycle, running at high shelf tempera-
tures and high chamber pressures aimed at high energy input into the drying product. 
As already 1 °C increase in product temperature cause a decrease of 13% in primary dry-
ing time [11], high drying rates, and therefore short freeze-drying processes can be 
achieved. Shortening of freeze-drying cycles is of major interest in industry. Several pa-
tents and patent applications aim on shortening freeze-drying cycles by increasing prod-
uct temperatures close to or above the collapse temperature [18-20]. 
The aggressive cycle, proposed by Schersch et al., seems to be promising in terms of 
short freeze-drying processes whilst the most critical product attributes (stability/activ-
ity, rehydration time) were at least comparable to conventional freeze-drying. However, 
in contrast to conventional freeze-drying essential knowledge is missing so far to estab-
lish aggressive freeze-drying as a reliable alternative to conventional freeze-drying. To 
fill that gap, this work presents systematic investigations of variations of process param-
eters and formulation designs and their influence on product quality. Moreover, robust-
ness and reproducibility of aggressive collapse cycles as well as the applicability to dif-
ferent freeze-driers is studied. 
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2. FREEZE-DRYING PROCESS 
Freeze-Drying, or interchangeably lyophilization, is a 3-step unit operation to remove 
a solvent from a material in order to improve stability of that material [21]. In contrast to 
many conventional drying techniques that use evaporation as drying mechanism, during 
freeze-drying the solvent (usually water [22]) is first solidified (step 1: freezing) and sub-
sequently removed from the system via sublimation (step 2: primary drying). To reach 
the desired residual solvent levels a further step utilizing desorption is normally added 
(step 3: secondary drying). [6, 21, 23]  
A major reason for this elaborate and time consuming drying operation is in most 
cases the heat sensitive nature of the material to be dried, often food or pharmaceutical 
products [24].  
Since removing a solvent by sublimation is the major step in freeze-drying, the pro-
cess needs to be controlled according to the phase transition behavior of the solvent, 
which is represented by a phase diagram. Figure 1.1 exemplarily shows a phase diagram 
of water schematically including the phase transitions during freeze-drying. 
 
Figure 1.1: Schematic phase diagram of pure water (figure modified from [25]) including characteristic phase 
transitions during freeze-drying: 1:freezing, 2:primary drying, 3: secondary drying (pressure is displayed in 
mmHg=Torr, 760mmHg=1,013bar, 4,579mmHg =6,117mbar) 
To realize the necessary steps given by the phase diagram, temperature as well as 
pressure needs to be controlled in the course of the drying process. A typical freeze-dry-
ing process is for that reason divided in the already mentioned three steps: Firstly, the 
solvent needs to be forced from the liquid to the solid state what is realized by cooling 
the system down. Secondly, the pressure needs to be reduced below the triple point fol-
lowed by a distinct increase of temperature which forces the solid to pass the sublimation 
curve and be sublimated. Thirdly, to dry the material to the desired final solvent content, 
more energy is supplied via a further increase in temperature (while the pressure is main-
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tained low). An example of a freeze-drying process is shown in Figure 1.2, also highlight-
ing the three major steps during freeze-drying. In this case, an optional annealing step is 
included, which can become necessary for some excipients or sometimes bears ad-
vantages regarding drying rates. Annealing during the freezing step as well as a general 
description of the three major steps of a freeze-drying cycle are delineated in the next 
paragraph with focus on freeze-drying of aqueous pharmaceutical formulations. 
 
Figure 1.2: Schematic illustration of a typical freeze-drying cycle for pharmaceutical solutions. Numbers depict 
typical steps; 1: freezing (with optional annealing step 1b), 2: primary drying, 3: secondary drying. 
2.1 FREEZING STEP 
During the freezing step the temperature of a material is lowered to an extent that 
solvent(s) (hereafter “solvent” is replaced by water, as water is the most prominent sol-
vent in freeze-drying [22]) as well as solute(s) are completely solidified to crystalline or 
amorphous solids [26]. Since the (micro-) structure formed by both, the ice crystals and 
the solidified solute determines characteristics like primary and secondary drying rate, 
product crystallinity, surface area, and protein stability, ice nucleation plays a major role 
in freeze-drying [27, 28]. The characteristics of ice nucleation depend directly on the de-
gree of supercooling, which in turn depends on solution properties as well as process 
conditions [29]. A higher degree of supercooling results in faster ice nucleation and faster 
effective freezing and therefore smaller ice crystals, while a lower degree of supercooling 
result in slower freezing, allowing the ice crystals enough time to grow [14, 27]. Although 
the degree of supercooling plays a dominant role for the later morphology of the lyophi-
lizates, that particular parameter is difficult to control, especially during scale-up of 
freeze-drying from laboratory (more impurities) to production scale in clean room areas 
[30]. However, also in laboratory freeze-drying intra-batch heterogeneity is reported [27, 
28, 31], resulting from stochastic ice nucleation (meaning different degree of supercooling 
for each vial).  
While freezing progresses, water is separated from the supercooled solution in the 
form of growing ice crystals, resulting in a continually concentration (“cryoconcentra-
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tion” [32]) of the solutes within the remaining solution up to a 20-fold increase of concen-
tration [33]. This removal of water from the solution is sometimes considered the main 
drying mechanism [33]. Depending on the nature of the solutes they either crystallize to 
an eutectic mixture, or remain in an amorphous state [23]. In the latter case, at a certain 
concentration 𝑐𝑔′ or weight fraction 𝑤𝑔′ and temperature 𝑇𝑔′ the viscosity of the concen-
trated solution reaches a critical value (around 1012 Pa s [34]) and the now maximally 
freeze-concentrated solution undergoes a vitrification. Figure 1.3 shows both, a phase di-
agram of a sucrose water mixture as well as a phase diagram of a salt water mixture 
complemented by a typical behavior of a sucrose solution or a salt solution during freeze-
drying (see description for details). 
 
Figure 1.3: Left: Solid–liquid phase diagram of a sucrose–water mixture. As an example the route of a 5%wt so-
lution of sucrose during freeze-drying is marked with arrows [33] (A  supercooling, ice nucleation and freez-
ing of pure water  passing 𝑇𝑒 without crystallization  forming a glass at 𝑇𝑔
′  being dried towards 𝑇𝑔). 
Right: Solid–liquid phase diagram of a salt–water mixture, whereby the salt can be considered to represent also 
crystalline bulking agents. The route of a crystallizing solution is depicted in letters A to F [35] (A  cooling to B 
 supercooling and freezing of water to C and D  eutectic crystallization at E  eutectic mixture at F).  
As already mentioned above, uniform ice nucleation is difficult to control within a 
batch of, for example, glass vials. In order to reduce inter-vial heterogeneity, a modified 
freezing step is suggested to change the micro-structure of the frozen product [36]. This 
method, called “annealing”, recommends to increase the temperature of the frozen prod-
uct after complete solidification (e.g. at -50°C) above the glass transition temperature of 
the interstitial matrix (e.g. to -20°C) for a certain amount of time [29]. This increase in 
temperature results in a re-softening of the interstitial matrix and allows (further) crys-
tallization of solutes (e.g. crystalline bulking agents like mannitol)[37]. Moreover, due to 
the systems tendency to reduce the overall energy, Ostwald ripening increases larger ice 
crystals to the account of smaller ones. Consequently, the primary drying kinetics are 
improved (as larger ice crystals result in larger pores an therefore less resistance to water 
vapor) [32]. On the downside, the increases in pore size by annealing decreases the abso-
lute number of pores and therefore decreases specific surface area [38] and thus slows 
down secondary drying kinetics. Moreover, during annealing the solutes are again in a 
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highly concentrated rubbery state, which is not a preferable situation especially for sen-
sitive APIs and can lead to instabilities of those molecules.  
Controlled ice nucleation seems to be an elegant way to optimize freeze-dried prod-
ucts regarding reduction of vial-to-vial heterogeneity (a particular problem in produc-
tion-scale freeze-driers) and shortening freeze-drying cycles by increased primary drying 
rates [39]. Recently, different techniques were developed that aim for a better/complete 
control of ice nucleation during the freezing step [29, 40]. Controlled nucleation systems 
are already available for lab and pilot scale freeze-driers from different vendors (Con-
troLyoTM, SP Scientific/Praxair; FreezeBoosterTM, Millrock Technology; VERISEQ©Nucle-
ation, Linde AG/Ima Life). For large-scale production freeze-driers this technology is un-
der development. 
2.2 PRIMARY DRYING STEP 
The primary drying step during freeze-drying serves to remove the frozen solvent 
from the product by sublimation. In order to force a phase transition from solid to vapor 
state, conditions have to be set to a pressure and temperature below the triple point of 
the solvent (for the most common solvent water cf. Figure 1.1, p<6.11 mbar, T<0.0098 °C). 
Although, it would also be possible to achieve sublimation at atmospheric pressure (if 
the partial pressure of water is kept below the triple point) enormous technical effort like 
immense volume flows of cold and dry drying gas had to be realized [41]. 
To achieve sublimation, the necessary sublimation enthalpy needs to be provided by 
supplying energy in form of heat. Since freeze-drying products contain an interstitial ma-
trix besides ice, and the mass rate to remove water vapor is technically restricted, the heat 
input has to be accurately controlled in order not to increase the product temperature 
above the critical temperature of the product [26]. As long as the heat input is controlled 
below that critical level at a certain product temperature, the provided heat is transduced 
into the sublimation of ice in a quasi-steady state until all ice is sublimated [42]. This 
situation can be expressed as coupled heat and mass transfer (cf. equation (1.1); 𝑑𝑄/𝑑𝑡 
represents the heat flow into the product, ∆𝐻𝑆 the sublimation enthalpy, 𝑑𝑚/𝑑𝑡 the mass 
flow of water vapor, 𝑚cp𝜕𝑇/𝜕𝑡 the change of the product temperature). However, as the 
change in product temperature is small compared to the heat flow due to sublimation, 
the second part of equation (1.1) can usually be neglected. [43] 
 
𝑑𝑄
𝑑𝑡
= ∆𝐻𝑆
𝑑𝑚
𝑑𝑡
+ 𝑚𝑐𝑝
𝜕𝑇
𝜕𝑡
(1.1) 
 
The necessary heat input into the product is generally realized by temperature con-
trolled (i.e. heated) surfaces that are in direct contact with the product or, more common, 
a primary packing material containing the material to be freeze-dried is placed on those 
surfaces. The most common method for pharmaceuticals is to fill a solution into glass 
vials and place them onto shelves within a freeze-drier. In this case, the heat flow into the 
product can be expressed as equation (1.2) (𝑑𝑄/𝑑𝑡 heat flow into the product; A𝑉 cross-
section area of the vial; K𝑉 heat transfer coefficient of the vial; T𝑆 shelf temperature; T𝑃 
product temperature) [42].  
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𝑑𝑄
𝑑𝑡
= 𝐴𝑉𝐾𝑉(𝑇𝑆 − 𝑇𝑃) (1.2) 
 
The overall heat flow is composed of three components: conduction between shelf 
and vial/product (K𝑐), thermal radiation (K𝑟), and heat transfer via gas convection (K𝑔) 
[44]. While heat transfer coefficients for conduction and radiation are independent from 
pressure, K𝑔 is proportionally related to pressure [42]. Since at higher chamber pressures 
heat transfer is more efficient, shelf temperatures can be reduce to some extent, reducing 
the risk of melt back at the bottom (due to a temperature gradient within the sample) [26]. 
Driving force for sublimation of ice from an ice surface is the difference between water 
vapor pressure at the ice surface and partial water vapor pressure in the surrounding of 
the ice surface [45]. If there is no difference, no sublimation occurs. Usually, the partial 
water vapor pressure in the surrounding (i.e. product chamber) is decreased by a surface 
that is cooled down to lower temperatures than the actual product temperature (i.e. a so-
called condenser). In common freeze-drying equipment and primary packaging material, 
there is a certain resistance to free water vapor transport [26]. More importantly, the 
freeze-drying product itself restricts the free transport of water molecules from the sub-
limation site to the condenser (so called product resistance). This so called “product re-
sistance” is a function of dry layer thickness and increases with increasing layer thickness, 
which in turn increases with increasing drying time [46]. Summarizing, the sublimation 
rate 𝑑𝑚/𝑑𝑡 can be expressed as a combination of driving and hindering forces of subli-
mation (cf. equation (1.3), p0: vapor pressure of ice at the sublimation front; p𝐶𝑑: conden-
ser pressure; R𝑡𝑜𝑡𝑎𝑙: Resistance to water vapor flow, consisting of product resistance R𝑃, 
resistance of primary packaging material R𝑆, and resistance of the chamber R𝐶) [45].  
 
𝑑𝑚
𝑑𝑡
=
𝑝0 − 𝑝𝐶𝑑
𝑅𝑃 + 𝑅𝑆 + 𝑅𝐶
=
𝑝0 − 𝑝𝐶𝑑
𝑅𝑡𝑜𝑡𝑎𝑙
(1.3) 
 
𝑙𝑛(𝑝0) = 24.01849 −
6144.96
𝑇𝑃
(1.4) 
 
As the vapor pressure of ice is dependent on the product temperature (equation (1.4)) 
[43], an increase in product temperature results in an increase of sublimation rate and 
therefore in shorter primary drying times. Experimental data underline the strong de-
pendence of product temperature and primary drying time (cf. Figure 1.4 and Figure 1.5) 
[47]. For an increase of 1 K in product temperature a decrease of more than 10% in drying 
time is reported [11]. However, since product temperature needs to be maintained below 
the critical product temperature to avoid product collapse, an approach to increase dry-
ing rates due to higher product temperatures is limited, especially for amorphous prod-
ucts.  
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Figure 1.4: Effect of product temperature on primary drying time of 5% (v/v) solutions of KCL (dots) and PVP 
(triangles); filling height 1cm; from [47]  
 
Figure 1.5: Effect of chamber pressure on sublimation rate (0.18; methylprednisolone sodium succinate, approx. 
0.8 cm filling height, 45°C shelf temperature; modified from [47]) 
During progression of primary drying, the dry layer thickness increases, the more ice 
is removed by sublimation, resulting in increasing product resistance [43] and therefore 
decreased sublimation rate. If the reduced sublimation is not taken into account and the 
heat input is maintained at the same level (although less energy is required for sublima-
tion), the product will warm up. Therefore, particularly freeze-drying processes that are 
optimized regarding product temperatures close to the critical product temperature, 
need to be carefully controlled and monitored. On the other hand, some degree of local 
collapse (also called microscopic or small scale collapse) can enhance primary drying 
rates, since due to increased pore size product resistance is remarkably reduced in micro-
collapsed material [48].  
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2.3 SECONDARY DRYING STEP 
After completion of primary drying, unfrozen water has to be removed via a second-
ary drying step by desorption [23] to reach residual moistures that are able to provide 
stabilization throughout an intended period of storage time [49] (most commonly 0.5 - 
1%). During freezing, not the entire water is transformed into ice, but is distributed within 
the amorphous matrix formed by the solutes (most common situation for pharmaceuti-
cals). Up to 30% of this interstitial matrix is composed of unfrozen water [36, 50]. In rare 
cases of pure crystalline products, unfrozen water is adsorbed to the surfaces of the crys-
talline matrix [51]. 
Since more energy is required to overcome the activation energy of desorption, more 
heat is provided to the product (via higher shelf temperatures, e.g. 25°C). Attention needs 
to be paid to the heating ramp rate of the shelf temperatures, as at the beginning of sec-
ondary drying the glass transition temperature of the product is low (due to high residual 
moisture) [50]. Because drying rates are not influenced by chamber pressure, no further 
adjustment needs to be realized compared to chamber pressure of the primary drying. 
Dependent on the temperature and specific surface area of the matrix, after a certain 
amount of time a plateau level of residual water is reached. [51]  
Concerning the influence of secondary drying on stability, for heat sensitive biophar-
maceuticals temperature and time of secondary drying need to be chosen carefully [52]. 
So called “over-drying”, i.e. reducing the residual water content to very low amounts, 
can cause severe instabilities. [53, 54] Especially for proteins, a certain amount of remain-
ing water in the matrix is of importance, as those molecules rely on the preservation of 
their native state, which is closely connected to water. Additionally, uneven distribution 
of residual water inside the product matrix, which is a highly probable scenario, can re-
sult in instability [55]. 
3. FREEZE-DRYING OF PROTEIN FORMULATIONS 
The most convenient way to handle a protein pharmaceutical throughout production 
until administration is a liquid formulation. However, most proteins do not show suffi-
cient stability in solution, as water serves as an excellent reaction partner or medium for 
hydrolysis, cross-linking, deamidation, oxidation, aggregation, disulfide rearrange-
ments, etc. [33, 56]. Those degradation pathways in the majority of cases result in loss of 
activity. In addition, other severe consequences like immune response caused by aggre-
gated protein species upon administration to patients are a serious concern. [57]. Hence, 
a cautious stabilization of protein pharmaceuticals is indispensable. 
By reducing the amount of water (i.e. drying) degradation usually can be decelerated 
to an extend that sufficient stability is provided to store such products over extended 
periods of time (18-24 months) [49]. On the other hand, however, the proper activity of 
proteins is dependent on their native structure that is generally inevitable connected to 
the presence of surrounding water molecules [58]. Consequently, the preservation of the 
native structure at very low water presence plays a major role in stabilization of proteins. 
In order to achieve that, in freeze-drying of proteins excipients need to be employed. 
Most often a combination of cryo- and lyo-protectants, a surfactant and buffer agents is 
included in a freeze-drying formulation [49]. To account for further requirements also 
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crystalline bulking agents, tonicifiers, antioxidants, and/or preservatives can be part of 
the mixture [8, 59].  
3.1 STABILIZATION OF PROTEINS DURING FREEZE-DRYING AND STORAGE 
Although freeze-drying is the method of choice for long-term preservation of product 
quality, the process itself entails several risks for sensitive molecules like protein phar-
maceuticals [33]. In which way proteins in aqueous solution can be affected by freezing- 
and drying-stress, and how they can be successfully stabilized against those stress vec-
tors, will be discussed in the following. 
3.1.1 FREEZING STEP 
3.1.1.1 Stress vectors 
As a first step in freeze-drying, by lowering the temperature of the solution, water has 
to be transferred into ice. Since the free energy of unfolding shows a temperature depend-
ent parabolic profile, above and below certain temperatures (<10°C and >50-100°C, re-
spectively) a denaturation is thermodynamically favored [60]. At low temperatures the 
solubility of hydrophobic parts of a protein molecule increases, resulting in a decrease of 
intra-molecular hydrophobic interactions that are responsible for the three-dimensional 
native structure of the molecule [61-63]. Hence, the native conformation is changed due 
to the low temperature, which is referred to cold denaturation.  
As soon as the water is transferred to ice crystals, new interfaces are formed within 
the mixture. As proteins are surface active molecules they can adsorb to that solid-liquid 
interfaces, which can result in surface-induced denaturation [64-66].  
Due to the removal of water in the form of ice, the remaining solution is concentrated. 
Thus, two effects can be observed that have an effect on protein stability: Firstly, every 
solute can reach levels of a more than 20 fold higher concentration compared to the initial 
concentration [67]. Regarding ionic strength, this dramatic increase can cause destabili-
zation of the native conformation of a protein [60]. Moreover, the presence of reactive 
species (e.g. oxygen) in high concentrations can accelerate protein degradation [8]. Sec-
ondly, at high concentrations excipients can be separated from the protein to be stabilized 
[68, 69]. Due to selective crystallization of for example buffer salt, the pH value can 
change dramatically [70, 71]. Moreover, if cryo-/lyo-protectants crystallize during freez-
ing, they are no longer able to ensure stabilization during freeze-drying [72]. But also non 
crystallizing excipients can exhibit phase separation from the protein to be stabilized [73].  
 
3.1.1.2 Stabilization 
Cryoprotectants are able to stabilize sensitive proteins during freezing successfully. It 
has been shown, that postulated mechanisms that account for stabilization of proteins in 
aqueous solution are also valid for cryoprotection [74]. In brief, the addition of a stabiliz-
ing excipient to an aqueous protein solution results in a preferential hydration of the sur-
face of the protein due to thermodynamically favored interaction of the protein with the 
solvent. Consequently, the excipient is preferentially excluded from the protein domain, 
increasing the free energy of the system and therefore resulting in stabilization as the 
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unfolded state of the proteins is less favored. [75-78]. As preferential exclusion is not a 
direct interaction between excipient and protein, quite a number of substances can be 
used as cryoprotectans (sugars, polyols, amino acids, polymers, etc.) [79]. Most often sug-
ars are employed as they do not show phase separation or crystallization (they are even 
able to suppress crystallization of other excipients [80]) as it is reported for other excipi-
ents that are used [72]. To protect proteins from denaturation at interfaces, non-ionic sur-
factants can be added to the formulation [65].  
 
3.1.2 DRYING STEP 
3.1.2.1 Stress vectors 
During the drying step of freeze-drying, the environment of the protein is further al-
tered compared to the situation during or after freezing. After freezing, the protein is 
distributed in an amorphous glassy matrix (if a suitable formulation has been chosen). 
This matrix contains a substantial amount of unfrozen water, which assists to keep the 
native conformation of the protein. However, as already during freezing, a major part of 
water is removed from the solution, “drying stress” already appears at that stage. In so-
lution 1 g of fully hydrated protein contains 0.3-0.35 g water [81, 82], while during drying 
the residual water is reduced at least to one third of that [8]. Nevertheless, at which state 
of freeze-drying it occurs, dehydration of the protein environment usually results in de-
naturation [83, 84].  
 
3.1.2.2 Stabilization 
Stabilization of proteins against dehydration-induced stress is generally based on an 
amorphous matrix that encloses the protein as a sort of a solid dispersion. Good stabili-
zation properties of the amorphous matrix are generally attributed to two major mecha-
nisms, namely the vitrification in a rigid matrix and the replacement of water by solutes, 
respectively [85]. 
Vitrification Theory 
The formation of an amorphous glass (“vitrification”) is considered as the first major 
mechanism to stabilize a protein in a freeze-dried product [86-88]. This mechanism is 
termed “glass dynamics mechanism” by some researchers [89]. A precondition for a suc-
cessful stabilization is a molecular dispersion of the protein within the glass. As amor-
phous glasses in terms of their structure are more comparable to liquids than to (crystal-
line) solids [90], they can also be considered as “solid solutions” with extremely increased 
viscosity (around 1012 Pa s [91]) [86]. To achieve the formation of an amorphous glass, 
which contains the dispersed protein, usually excipients like sugars or polymers are uti-
lized. By cooling of such (aqueous) solutions during the freezing step of freeze-drying, 
the excipient/protein mixture undergoes a glass transition at the glass transition temper-
ature of the maximally freeze-concentrated solution (Tg’). Due to the glassy state of the 
matrix, diffusion, which is the prerequisite for chemical and conformational degradation 
reactions, is kinetically slowed down dramatically [79]. The glassy structure that is 
formed during freezing is maintained throughout the entire freeze-drying process. Due 
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to the removal of water from the amorphous glass, the glass transition temperature is 
continuously increased during the freeze-drying process. For a successful stabilization of 
the protein in the final freeze-dried product, the glassy matrix needs to be stored below 
their glass transition temperature Tg [92] in order to maintain kinetic hindrance of degra-
dation. Glasses formed by different substances can be characterized regarding their 
change in viscosity for a certain temperature change [91]. So-called fragile glasses exhibit 
a higher increase in viscosity for a particular temperature drop compared to so called 
strong glasses [91]. Therefore, excipients forming fragile glasses (like sucrose or treha-
lose) are preferable for protein stabilization [93] 
Water Replacement Theory 
A second major prerequisite for successful stabilization of a protein is to maintain the 
native conformation throughout processing and storage [83]. The native structure of pro-
teins is adapted to aqueous environment including the formation of hydrogen bonds to 
surrounding water molecules. As water is removed during drying, the function of water 
needs to be replaced by an excipient (water replacement hypothesis) [94-97]. Hydrogen 
bonds between protein and specific excipients, like saccharides, preserve the native struc-
ture of the protein in the solid state and therefore act as water substituent [58, 98, 99].  
 
Since the postulation of both theories, a number of studies have been evaluated to 
show the applicability to experimental results. Some findings show that their results fit 
better to the preservation of the native conformation by water replacement [85, 89, 99, 
100], while other researchers rather confirmed kinetic stabilization [101-103]. Most prob-
able a synergistic effect of both mechanism contribute to stability (as for example sug-
gested by Yoshioka et al. [104, 105]). 
 
3.1.3 LONG-TERM STABILIZATION OF DRIED PROTEINS 
Beyond stabilization of proteins just during a freeze-drying process, the ultimate goal 
of (freeze-) drying is still a preservation of product quality for an extended period of time 
(e.g. compared to stability in solution). Although, remaining water within a freeze-dried 
product is reduced to low amounts, causing stabilization in situ, during storage and ship-
ping, degradation still can occur [100, 106, 107]. As pharmaceutical quality is diminished 
by both, chemical and physical degradation, in the following no distinction is made be-
tween instability arising from either of those mechanisms. Anyway, they are known to 
foster each other [108] resulting in deterioration of quality.  
3.1.4 FACTORS AFFECTING LONG-TERM STABILIZATION 
While the mechanisms to keep a protein stable in a freeze-dried product (“vitrifica-
tion” and “water replacement”) are known at least since the early 1990s, the connection 
between properties of the stabilizing matrix and stability of the proteins during storage 
is still somewhat ambiguous [109]. A tool that is able to predict precisely the long-term 
storage stability based on material characteristics is still lacking. However, in the last dec-
ade more and more studies point in the direction of the importance of molecular mobility 
or relaxation behavior respectively [101, 105, 110-116]. Since it is beyond the scope of this 
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work to review the mechanisms of molecular mobility in detail, in the following sub 
chapter an overview of factors affecting long-term stabilization in general is given. 
3.1.4.1 Glassy dynamics 
The dispersion within an amorphous matrix is a major requirement for most pharma-
ceutical proteins to achieve stabilization for long-term storage at reasonable temperatures 
[117]. Typical amorphous solids to protect proteins are composed of disaccharides which 
exist after freeze-drying in a glassy solid state, characterized by both, lacking long-range 
order compared to crystalline material and undergoing a glass transition (which is the 
general definition of a glass [118]). Inherently, glasses are thermodynamically not stable 
due to a non-equilibrium state, which is expressed as an excess in enthalpy [118] com-
pared to an equilibrium solid state (=crystal). Figure 1.6 schematically depicts the differ-
ence between the enthalpy of an amorphous glass compared to a crystal of the same ma-
terial.  
In contrast to a crystal, which is spontaneously formed at the melting temperature Tm 
upon cooling, a glass is formed first by supercooling and then a glass transition at Tg. If a 
supercooled liquid is further cooled down, viscosity is increased and therefore a reduced 
mobility of the molecules is enforced. These molecules generally are prone to rearrange 
towards equilibrium like in the liquid state. However, below a certain temperature (glass 
transition temperature Tg) the molecules are not able to rearrange due to high viscosity, 
finally resulting in the formation of a non-equilibrium highly viscous state: a glass is 
formed, characterized by timescales (well) above 100 s for molecular rearrangements. 
[119]  
Major prerequisite for glass transition is rapid cooling [120] and a comparable high 
viscosity around Tm, since otherwise the liquid will spontaneously crystallize at Tm. As 
the system is thermodynamically not in an equilibrium state, the molecules are driven by 
thermodynamic forces (reduction of enthalpy) to relax towards that equilibrium state 
[119]. In other words, there is still mobility inside a glass. 
The enthalpy of a glass is dependent on the way of formation, for example rapid cool-
ing results in higher enthalpy. However, the enthalpy of glass can be reduced by treat-
ment of the glass at temperatures close to the glass transition temperature (e.g. 16 K below 
Tg) [121]. This intended or non-intended change in enthalpy (and therefore mobility/re-
laxation) is named “annealing” or “aging” [119].  
 
Figure 1.6: Schematic description of temperature dependent enthalpy of amorphous (glass) versus crystalline 
material (Tk=Kauzmanm temperature; Tg=glass transition temperature; Tm=melting temperature) from [120] 
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Molecular mobility and protein stability 
Thinking back to the concept of stabilizing a sensitive protein inside the glassy matrix, 
mobility inside the glassy matrix seems to be unfavorable as every degradation reaction 
necessarily involves some degree of mobility [85]. The Kauzmann temperature TK (theo-
retical intersection of enthalpy of a supercooled liquid and the crystalline state, for de-
tailed description see e.g. [122]), lying about 50 K below Tg, is sometimes referred to as 
the temperature of zero configurational entropy [121]. Thus, some authors suggest best 
stability of a protein within a glass during storage at a storage temperature 50 K below 
Tg. In turn, they try to reach high glass transition temperatures by selecting appropriate 
excipients allowing storage at higher temperatures [49, 123, 124]. 
Having a closer look at the connection between stability on the one hand and charac-
teristics of the amorphous glassy matrix on the other hand, there is more which needs to 
be considered than “just” a glass transition temperature [116]. As already outlined above, 
the amorphous matrix, which incorporates the protein, features a complex number of 
relaxation processes [125]. Depending on the scale of their occurrence they are classified 
in global and local dynamics, while global mobility (or α-relaxation) is connected to glass 
transition (and relaxation times of around 100s, local mobility (or β-relaxation) is con-
nected to vibrational motions at temperatures below the glass transition (and relaxation 
times of picoseconds to microseconds [126]) [116, 127].  
Several authors have shown, that stability against physical degradation [102, 128] 
and/or against chemical degradation [102, 129] can be explained by global mobility. In 
addition, a connection between higher glass transition temperatures and increased stor-
age stability could be shown [130-132]. On the other hand, global mobility is not neces-
sarily connected to storage stability in every case [92, 133].  
Regarding the influence of local mobility on storage stability, some authors stated a 
more significant relevance of that phenomenon [89, 134-136]. A correlation between local 
mobility and stability against chemical and physical degradation was reported by some 
authors [137, 138]. Interestingly, adding a plasticizer to an excipient mixture and there-
fore increasing global mobility, resulted in a decrease in local mobility (expressed as in-
creased relaxation time) and an increase in storage stability [126, 134]. Based on their 
findings, Cicerone and coworkers proposed to adapt the vitrification hypothesis regard-
ing superior importance of β-relaxation compared to α-relaxation [126]. 
Beside the choice of appropriate anti-plasticizers, a modification in relaxation times 
can also be achieved via additional steps during or after freeze-drying. Treatment of 
(freeze-) dried amorphous glasses by high temperatures (below Tg) result in relaxation of 
the glass towards equilibrium [110]. Consequently, relaxation times are decreased. Since 
an increase in relaxation time is generally assigned to an increase in protein stabilization, 
additional annealing, or aging of amorphous glasses is advised to improve storage sta-
bility. [111, 139-142] 
3.1.4.2 Residual water 
The content of water remaining in the product after freeze-drying has a significant 
influence on the stability of a protein during storage. For freeze-drying of proteins with-
out excipients, a certain level of water have to be maintained in order not to compromise 
the hydration shell of the protein resulting in instability [53]. However, as water can be 
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directly involved in degradation reaction as reactant, reaction medium and/or solvent 
[108, 143], sufficient low residual water content is mandatory.  
Since in freeze-dried products protein pharmaceuticals are stabilized in glassy matri-
ces, the amount of water in the amorphous phase plays a major role. Since water act as 
plasticizer of the amorphous matrix, molecular mobility is affected directly by water con-
tent, which is often reported as a decrease in glass transition temperatures as consequence 
of an increase in water content [54, 89]. The same situation can also be described by in-
creasing water content, resulting in increasing mobility (α- and β-dynamics [144]) and 
therefore increasing reaction rates that are coupled to mobility [143].  
3.1.4.3 Hydrogen ion and hydroxide ion activity 
Although from a classical point of view there is no definition of pH in the solid state, 
hydrogen ions as well as hydroxide ions can influence degradation of proteins in the 
dried state (e.g. β-elimination) [107, 145-147]. This phenomenon can be explained as sort 
of a “pH memory” of proteins in the freeze-dried state. Depending on the pH in aqueous 
solution prior to lyophilization, the ionogenic groups preserve their ionization state in 
the dried state [148]. In order to access solid state “pH” recently new pH sensors were 
developed [149].  
3.1.4.4 Temperature 
As molecular mobility as well as chemical reactions in general are dependent on tem-
perature (as described by the Arrhenius equation), this is an important factor for stabili-
zation. Exposure of freeze-dried protein formulations to elevated temperatures therefore 
result in decreased stability, especially chemical degradation reactions are increased 
[107]. As some degradation reactions did not show a Arrhenius like temperature depend-
ence [150], results from accelerated storage stability studies at elevated temperatures 
have to be judged carefully.  
3.1.4.5 Crystallization of amorphous excipients  
Crystallization of stabilizing amorphous excipients during storage causes a separa-
tion of the regarding excipient from the amorphous mixture. Consequently, the crystal-
lized proportion of the excipient is no longer able to fulfill its task to stabilize the protein. 
[68, 151] Several examples have shown that crystallization of excipients deteriorates pro-
tein stabilization during storage and thus needs to be avoided [72, 152, 153]. In pharma-
ceutical freeze-drying, one widely used excipient that is prone to crystallization during 
storage, is mannitol [154, 155]. 
 
3.1.4.6 Specific surface area 
As already outlined above, during freeze-drying new interfaces are generated during 
the freezing of solutions to be freeze-dried (cf. page 10). Once ice crystals are removed by 
sublimation, the character of these interfaces change from (interstitial amorphous) 
solid/ice to solid/void, however, they persist throughout the whole period of storage. 
Hence, a potential degradation of proteins at those interfaces can occur during an ex-
tended period. Consequently, the specific surface area of a freeze-dried product can play 
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an important role for storage stability. Higher specific surface area is equal to more pro-
tein molecules exposed at the surface of the dried solid (provided that the coverage of the 
surface by protein molecules is constant).  
Generally, a uniform distribution of protein molecules inside the stabilizing amor-
phous matrix is thought to be essential for good protein stabilization [156]. However, due 
to their amphiphilic nature, proteins tend to accumulate at interfaces. Recently it was 
shown that in freeze-dried and spray-(freeze-)dried mixtures of proteins and sugars ac-
cumulation of protein at the surface of the dried matrix can be detected [157-159]. While 
spray-(freeze-)dried products show a significantly higher accumulation compared to 
freeze-dried products, the addition of a surfactants like polysorbate was able to depress 
the accumulation of protein at the surface [158-160]. As expected, also the storage stability 
of the incorporated protein was increased [159, 161].  
Besides the observation that protein instability in dried products can generally be cor-
related to accumulation of protein at surfaces, a correlation between stability and the spe-
cific surface area of the product seems to be more feasible [139]. Abdul-Fattah et al. pro-
posed that the “total protein surface accumulation”, representing the total amount of pro-
tein that is exposed to the surface (in percentage of all protein present), is more precise to 
correlate possible instability to surface degradation [139]. For example, if the product ex-
hibits a high protein accumulation but a low specific surface area, less protein could be 
present at the surface compared to low surface accumulation and high specific surface 
area.  
Although they had no evidence for surface accumulation of the protein, Hsu and 
coworkers found that the formation of non-soluble aggregates of t-PA in freeze-dried and 
subsequently stored lyophilizates, linearly correlates with the specific surface area of a 
freeze-dried product. Since there was now instability in freeze-thawed samples, and all 
physical characteristics of the products except the SSA were identically, they conclude 
that instability necessarily arose from degradation at the solid/void interface [162]. 
3.2 SELECTION OF THE RIGHT EXCIPIENTS 
There is a tremendous number of publications in literature that report effects of add-
ing various substances to freeze-drying products in order to improve product quality. It 
is beyond the scope of this section to review all of them in detail. Therefore, the most 
important classes of excipients for freeze-drying of protein formulations are briefly intro-
duced in the following. For further information the interested reader is referred to the 
detailed paper of Wang [8], where also a list of suitable formulations for different proteins 
can be found (see also [163] and for marketed products [164]). 
As already noted above, a protein that needs to be dried, has to be stabilized against 
a number of stress vectors that arise during freeze-drying and storage (cf. pages 10 and 
11). This is done mostly by adding one or more excipients of the following groups to the 
protein solution prior to freeze-drying: cryo- and lyo-protectant (carbohydrate, polymer, 
protein, or amino acid), pH buffer agent (salts, amino acids), bulking agent (sugar alco-
hols, amino acids, polymers), tonicity modifier (salts), surfactant (non-ionic), antimicro-
bial preservative. 
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Cryo- and lyo-protectants  
The mechanism of cryo-protection is mainly based on the preferential exclusion of 
excipients from the protein surface, which in turn is preferentially hydrated [58]. As pref-
erential exclusion is mediated by non-specific interactions, quite a number of excipients 
are able to act as cryo-protectants: sugars, polyols, certain amino acids (and derivatives), 
salts, polymers (e.g. proteins, PEG) [8, 76, 79]. However, most of those excipients fail as 
stabilizers during the drying step of freeze-drying as they do not provide either a glassy 
matrix or specific interaction or they lack both [79].  
Amongst all stabilizers that were investigated for their use as stabilizers of proteins, 
non-reducing disaccharides (sucrose, trehalose) have shown a superior potential to keep 
proteins active during freeze-drying and subsequent storage [49, 79]. Besides their ability 
to act as cryo-protectants, major advantage of those sugars is their capability to stabilize 
a protein (1) kinetically in an amorphous glass (vitrification) [88] and (2) thermodynami-
cally via direct interaction with the protein (water replacement) [94, 95]. Carpenter et al. 
recommend a minimal weigh-to-weight ratio of 5:1 between stabilizer and protein as a 
rule of thumb [49]. However, the most proper ratio needs to be reexamined from case to 
case. 
Reducing sugars (like glucose, fructose, galactose, maltose, lactose) are also able to 
provide an amorphous matrix and interact with the protein; however, they are also likely 
to react with the protein via their reducing entity, especially during storage [8]. Also basic 
amino acids like arginine have been shown to form amorphous glasses and stabilize pro-
teins during storage [165]. However, for sufficient residual water content and high glass 
transition temperatures they need to be combined with crystalline bulking agents [166].  
Although they do not contribute to a direct stabilization due to lacking of specific 
interactions [49], sometimes the use of high molecular weight carbohydrates or polymers 
(PVP, dextran, HES) additionally to disaccharides as main stabilizers, is suggested in or-
der to increase the glass transition of the dried mixture [8, 164].  
Buffering agents 
The first step to choose a proper buffer agent is to select the appropriate pH value for 
the best stabilization of the protein – in solution and in the dry state. Not necessarily the 
optimum pH in solution is the optimum pH for storage in the dried state [103]. In princi-
ple, most of the well-known buffer systems can be used (phosphate, acetate, citrate, gly-
cine, histidine, TRIS, etc). However, sodium phosphates tend to selective crystallization 
of the basic salt during the freezing step resulting in enormous pH shifts of up to four pH 
values [167]. Instead of sodium phosphate potassium phosphate is recommended as suit-
able buffer system besides citrate, histidine, and Tris [49, 67]. Although the risk of selec-
tive buffer crystallization can be minimized by glass forming excipients [168], using the 
minimal buffer concentration, which is necessary to keep the pH stable, is recommended 
[49, 169]. 10mM to 20mM can be considered as a suitable starting point for optimization. 
Bulking agents 
In order to improve the formation of a mechanically strong cake, which also has an 
elegant appearance, an excipient that crystallizes during freezing can be utilized [8, 49]. 
Due to their crystalline structure these so called bulking agents do not contribute to the 
direct stabilization of proteins [72, 83]. However, even for proteins that are stable without 
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amorphous stabilizer, bulking agents can be necessary to hinder the (low concentrated) 
protein to be lost from the vial by being blown out by the water vapor stream [151]. Most 
frequently mannitol and glycine are used as crystalline bulking agents [164]. However, 
other amino acids also showed their potential to fulfill that role due to their crystallization 
propensity [7, 166]. Generally, bulking agents are used in excess to amorphous stabilizers 
regarding weight to weight ratios [164].  
As the mixture of bulking agents with amorphous glass forming excipients signifi-
cantly impacts (decreases) the crystallization behavior, accurate care needs to be taken to 
fully crystallize the bulking agent during the freezing step [170]. Remaining amorphous 
bulking agent is likely to crystallize during storage and therefore decrease stability of 
proteins [72]. Full crystallization can be achieved by annealing during freezing [154]. 
Moreover, the polymorphic form of the crystallized bulking agent needs to be considered 
as critical factor, as a later change during storage, for example from hydrate crystal to 
anhydrous crystal, can decrease protein stability [171].  
Besides crystalline bulking agents like mannitol or glycine also the use of polymers 
like dextran (in amorphous state) can improve drying behavior by increasing the formu-
lations glass transition temperature in the frozen state (Tg’) and therefore allows to apply 
higher drying temperatures [49]. 
Surfactants 
One of the major stress vectors for proteins during freeze-drying results from different 
interfaces present during the process: container-solution interface, air-solution interface, 
ice-solution interface, void-solid interface [124]. However, proteins can be stabilized 
against denaturation and aggregation at these interfaces by adding surfactants (usually 
non-ionic species) to the formulation [49]. These surfactants compete with the protein for 
adsorption at the interfaces [172, 173] or directly interact with the protein molecules pre-
venting aggregation [174]. The addition of surfactants to the rehydration diluent can sup-
port stabilization, too [8, 65].  
Quite a number of surfactants have been shown to be effective stabilizers against ag-
gregation during freeze-thaw experiments (Tween 20, Tween 80, Brij 35, Brij 30, Triton X-
10, Pluronic F127, SDS) [124]. Most often the polysorbates Tween 20 and 80 are used in 
freeze-dried products [164], due to their low critical micelle concentration (CMC) they 
are effective already at low concentrations [8](i.e. at concentrations not far above the 
CMC, e.g. 0.5mg/ml or 0.05%). 
Although their overall beneficial properties for protein stabilization, especially poly-
sorbates are prone to a number of chemical degradation reactions like auto-oxidation an 
therefore formation of peroxides, which can destabilize proteins [175].  
Further formulation excipients 
Parenteral protein formulations generally should be isotonic solutions. If a solution, 
after choosing appropriate stabilizers, still is hypotonic, a tonicity modifier has to be 
added. Carpenter and coworkers suggest glycine or mannitol instead of sodium chloride 
[49]. However, also sugars can be added [79], which are usually already present as stabi-
lizers. In this case, just the amount of sugar needs to be increased (isotonic solution of 
sucrose approx. 8.7%, mannitol approx. 5.2%). 
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Although microbiological growth is per se inhibited in dried matter, one could think 
of a multi-dose freeze-dried biopharmaceutical, which for example is administered in a 
multiple way after reconstitution. In that case, an antimicrobial preservative would be 
necessary to be included into the formulation. However, from studies on liquid protein 
formulations it is known that antimicrobial preservatives often have a strong destabiliz-
ing effect on proteins [176].  
4. COLLAPSE OF FREEZE-DRYING PRODUCTS 
4.1 THE COLLAPSE PHENOMENON 
Structural change of a frozen sample upon freeze-drying is a well-known phenome-
non already for more than a hundred years, when Shackell described shrinkage of differ-
ent foodstuffs if they are dried under vacuum without complete solidification by freezing 
[177] (which also is regarded as first documented use of sublimation as drying mecha-
nism [178]). In general, collapse can be described as microscopic or macroscopic struc-
tural changes due to (intentionally or unintentionally) applied drying conditions [179]. 
Those changes occur, when the temperature of the product exceeds a critical value, which 
is usually termed “collapse temperature” [180]. Concerning aqueous solutions (e.g. pro-
tein formulations) collapse can be regarded as loss in the highly porous cake structure 
that is formed during freezing [181].  
4.1.1 MACROSCOPIC COLLAPSE 
As already the first descriptions of collapse lines out, shrinkage of the material during 
freeze-drying is an immediately visible sign of structural collapse [177]. This reduction of 
the volume of the dried product compared to the frozen product can also be observed in 
freeze-drying of aqueous solutions in glass vials [10, 23]. However, macroscopic collapse 
usually is rather described as bubbling, formation of cavitations, fenestration, foaming, 
spattering, etc. [10, 179]. Figure 1.7 exemplarily shows macroscopic appearance of col-
lapsed vs. non-collapsed lyophilizates. 
 
Figure 1.7: Macroscopic appearance of non-collapsed (left) as well as collapsed (right) lyophilizate (freeze-dried 
from 5% wt/wt aqueous sucrose solution) 
4.1.2 MICROSCOPIC COLLAPSE 
On a microscopic scale, collapse is characterized by a reduction of the average pore 
size (i.e. porosity) and an increase in bulk density, respectively [181, 182]. Since certain 
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changes on the microscopic scale show no or just minor changes on the macroscopic ap-
pearance of the product, this phenomenon is also regarded as “modified” or “limited” 
collapse [10]. Figure 1.8 shows microscopic pictures (SEM) exhibiting small holes in the 
amorphous sugar structure, which were formed by micro-collapse during freeze-drying 
[48]. Some authors also consider a slightly reduced cake volume (i.e. shrinkage) as col-
lapse on the microscopic level and use “shrinkage” as a synonym for micro-collapse [183, 
184].  
Especially if mixtures of excipients are used, that form a partly crystalline and partly 
amorphous interstitial matrix, no signs of collapse can be observed macroscopically, even 
if micro-collapse occurs. In this case the crystalline fraction forms a supporting matrix for 
the collapsing amorphous fraction [10, 13, 183] (same mechanism also reported for vac-
uum drying without freezing [7]).  
  
Figure 1.8: Scanning electron microscope pictures of sucrose based (left) as well as trehalose based (right) freeze-
dried placebo formulation showing small pores (2-20µm) as visible sign of micro-collapse. (45mg/mL respective 
sugar, 0.1 mg/mL polysorbate 20, and 5 mM histidine, pH 6.0) (white scale bars represent 100µm) [48]  
4.2 THE CAUSE OF COLLAPSE 
Collapse during freeze-drying is caused by a reduction in viscosity due to rewarming 
of the previously solidified product above the critical product temperature (i.e. collapse 
temperature) followed by viscous flow caused by gravity and surface tension [10, 180, 
183]. More precisely, on the microscopic scale collapse can be defined as viscous flow 
over the finite distance of a pore diameter during the timescale of freeze drying [185]. 
While first it was thought that viscous flow occurs due to the force to gravity [10], some 
authors outline the importance of surface tension as driving force for viscous flow [180, 
185]. In case of a fully amorphous interstitial matrix, collapse is connected to the glass 
transition. For crystalline systems collapse can be observed at the eutectic temperature 
[186].  
 
4.2.1 VISCOSITY AND VISCOUS FLOW 
In order to find a way to describe collapse behavior in more quantitative terms, Bel-
lows and King proposed a simple equation from the energy balance between surface en-
ergy decrease and viscous dissipation (equation (1.5), 𝑡 represents the time necessary for 
collapse, 𝛾  the surface tension, 𝜂 the viscosity of the amorphous phase, and 𝑅 the pore 
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radius) [180]. Pikal and Shah formulated a similar description for a dynamic process de-
pendent on temperature and measurement time (equation (1.6)), where 𝑥 represents the 
distance of flow (e.g. pore radius for full collapse), 𝑡 represents the time, 𝛾  the surface 
tension, 𝜂 the viscosity of the amorphous phase, 𝑇 the temperature [185].  
 
𝑡 =
𝜂𝑅
2𝛾
(1.5) 
 
𝑑𝑥 = 2𝛾 ∫
𝑑𝑡
𝜂(𝑇, 𝑡)
𝑡
0
(1.6) 
 
Both equations highlight the importance of viscosity on the collapse. The authors rea-
sonably assume a constant surface tension in the region of interest as well as a constant 
pore size and time of observation. Therefore, they were able to calculate critical viscosities 
necessary for collapse, which are in the order of 107 – 1010 cPoise [180] or around 108 Poise 
[185]. However, as these viscosities equal 104 – 107 Pas, which is at least five orders of 
magnitude lower than the viscosity usually attributed to glass transition (1012 Pas [34]), 
an explanation of this gap is missing at the moment. Possible explanations include a de-
viation of glass transition viscosities of sugar based glasses from generally proposed vis-
cosity of glass forming liquids [187] as well as deviations due to measurement setup (e.g. 
measurement time).  
Nonetheless, viscosity is strongly dependent on temperature as illustrated in Figure 
1.9 for aqueous solutions (25 wt %) of some low molecular sugars.  
 
Figure 1.9: Relationship between equilibrium viscosity and (collapse) temperature of aqueous sugar soltuions 
(initial solute concentration 25 wt % ). From [180] 
The connection of viscosity η and temperature T in vicinity of the glass transition 
(characterized by the viscosity ηg and temperature Tg) can be expresses by the Williams-
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Landel-Ferry equation (1.7). For many glass forming polymers the constants c1 and c2 for 
temperatures above Tg are similar and can by estimated as c1=17.4 and c2=51.6. [188]. 
 
𝑙𝑜𝑔 (
𝜂
𝜂𝑔
) =
−𝑐1(𝑇 − 𝑇𝑔)
𝑐2 + (𝑇 − 𝑇𝑔)
(1.7) 
 
If the temperature of the material is further increased, at a certain temperature ice 
melts and dilutes the (already viscous and collapsing) interstitial matrix resulting in fur-
ther decrease of viscosity [179, 189]. 
4.2.2 COLLAPSE TEMPERATURE  
As outlined above viscosity is strongly coupled to temperature. Therefore, in order 
not to fall below the critical viscosity causing structural collapse, a certain temperature 
should not be exceeded during freeze-drying. This temperature is referred to as collapse 
temperature Tc [179, 180]. In general, the collapse temperature depends on the composi-
tion of the interstitial phase (molecular weight and structure, mixtures of solutes) be-
tween the ice crystals [10].  
For low molecular sugars, collapse temperatures range about 1-5 K above glass tran-
sition temperatures detected by differential scanning calorimetry [8, 10, 190]. Collapse 
temperatures of sucrose and trehalose, the most prominent excipients for freeze-drying 
of pharmaceutical proteins, range around -30 °C. Adding higher molecular weight excip-
ients (e.g. proteins) or cells to the mixture causes an increase in divergence between T’g 
and Tc of up to 10 K [191, 192]. For fully amorphous mixtures, the divergence between Tg 
and Tc can be attributed to the fact, that either temperature is detected at slightly different 
states of the system. During measurement of Tg the interstitial matrix is in contact with 
ice and exhibits a certain non-frozen water amount, while during the measurement of Tc 
the ice has been removed as well as some of the non-frozen water has already been evap-
orated [185]. As water acts as plasticizer of the amorphous phase [193, 194], removing 
water increases the collapse temperature. 
It is well known that higher product temperatures result in faster drying and therefore 
shorter processes. As the collapse temperature represents the upper limit of product tem-
peratures allowing freeze-drying to a non-collapsed product, a considerable interest has 
been drawn to detect collapse temperatures [185]. On the other hand, detection of col-
lapse temperatures is an analytical challenge. While the glass transition temperatures of 
the maximally freeze-concentrated solution Tg’ can be determined via a number of meth-
ods (differential thermal analysis DTA, thermal mechanical analysis TMA, electrical ther-
mal analysis ETA, or most commonly differential scanning calorimetry DSC)[168, 195, 
196], the detection of Tc is limited by using a specialized microscope [197, 198]. These 
microscopes are equipped with a small temperature and pressure controlled chamber, 
where freeze-drying of a small amount of solution (2 – 10 µl) is operated between two 
cover slips and therefore can be optically monitored. Although there is a progress in well-
engineered freeze-drying microscopes [199], every measurement inherently bears subjec-
tive judgment of the operator. Moreover, the collapse temperature determined by FDM 
might not represent the situation in a glass vial, since in the FDM just a thin layer of e.g. 
25 µm [200] instead of a larger three-dimensional matrix is analyzed. Additionally, the 
detection of collapse at a certain temperature depends on the duration of the analytical 
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determination, where prolonged measurement time lead to observation of collapse at 
(slightly) lower temperatures [185]. Consequently, some caution needs to be exercised for 
designing freeze-drying cycles based on collapse temperature measurement. If observa-
tion times during Tc measurements are short, possibly artificially high collapse tempera-
tures are detected, which in turn do not correspond to the actual temperature at which 
the sample collapses in a real freeze-drying cycle [181, 185].  
Nevertheless, FDM is the most often applied technique to asses collapse temperatures 
of freeze-drying solutions [200]. Usually, two different temperatures can be read out from 
the microscopic determination, 𝑇𝑐
𝑚𝑖𝑐𝑟𝑜 represents the temperatures, at which the very first 
visible signs of collapse (thin cracks or tiny holes, also referred to as 𝑇𝑐
𝑜𝑛𝑠𝑒𝑡) are apparent, 
while 𝑇𝑐
𝑚𝑎𝑐𝑟𝑜 corresponds to the temperature at which a complete loss of structure is vis-
ible (also referred to as 𝑇𝑐
𝑐𝑜𝑚𝑝𝑙𝑒𝑡𝑒) [48, 191, 192]. 
Recently, optical coherence tomography-based freeze-drying microscopy was pro-
posed as the more accurate technique to determine collapse temperatures directly in a 
vial during a real freeze-drying run. Comparing temperature measured by a thermocou-
ple and optical collapse behavior according to the special microscope, collapse tempera-
tures can be determined with a setting closer to the situation of the product during a 
freeze-drying run [201]. 
4.3 MANIPULATION OF COLLAPSE BEHAVIOR 
As already outlined above, a higher product temperature during (freeze-) drying 
saves time. Hence, especially from a manufacturing perspective it is of high interest to 
increase the maximum allowable product temperatures of products to be freeze-dried as 
far as possible without risking a loss in product quality.  
Having a look back to the determinants of collapse (cf. equations (1.5) and (1.6)), 
namely viscosity, temperature, pore radius, surface tension, and time, it becomes explicit 
that some of these parameters can be hardly influenced. Since the time that is necessary 
for collapse to occur lays in the magnitude of minutes and freeze-drying processes took 
at least hours, time cannot be influenced in a useful way. In addition, surface tension is 
difficult to be influenced directly. However, viscosity, temperature, and pore size can be 
influenced by adjusting process parameters and formulation composition, whereas 
changing viscosity by formulation composition plays a major role. 
Following an experimental observation, that higher initial solute concentrations result 
in higher collapse temperatures, Tsourouflis et al concluded that during freezing of 
higher concentrated solutions less ice is formed, and therefore the system contains less 
void per volume after drying, which can be expressed as a lower inner surface. Further, 
lower inner surface reduces the surface tension, and therefore the system collapses at 
higher temperatures [179]. However, as the authors detected an inconsistent influence of 
freezing rate on collapse temperature for similar disaccharides, it is doubtful, if the mod-
ification of pore size by modification of freezing (e.g. by controlled nucleation) affects 
collapse temperatures considerably. In contrast to the observation of Tsourouflis et al, 
MacKenzie stated that the collapse temperature is independent from initial solute con-
centration as well as from freezing rate [10]. In a recent study, Meister and coworkers 
report a dependence of collapse temperature on both, initial solute concentration as well 
as nucleation temperature [202]. However, the authors also point out the difficulties to 
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determine reliable data, since the control of nucleation temperature is difficult in a freeze-
drying microscope and the observation of collapse can be challenging for both, quite high 
as well as quite low solute concentrations.  
Contrary to freeze-drying of food products, which exhibit collapse according to their 
structure and composition defined by nature, protein formulations can be compounded 
of numbers of different excipients. As described above, an amorphous matrix is necessary 
for successful stabilization of most proteins. Excellent stabilization can be achieved by 
low molecular weight sugars, especially non-reducing disaccharides (sucrose, trehalose). 
Unfortunately, these sugars exhibit low collapse temperatures (cf. Table 1.1).  
Table 1.1: Collapse temperatures (Tc) and glass transition temperatures of the maximally freeze-concentrated 
solution (Tg‘) of a number of freeze-drying excipients. 
excipient Tc [°C] reference Tg’ [°C] reference 
Arginine -34 Ito [203]   
Dextran 2000 -9 Mackenzie [10]   
Dextran 70kDa -11 Adams and Ramsay [204] -10 Her et al [210] 
Fructose -48 Mackenzie [10]   
Glucose -40 Mackenzie [10]   
Glycine   -37 Chang and Fischer [205] 
Hp-beta-CD -9.2a Meister et al [202]   
Lactose -31 Mackenzie [10] -27 Her et al [210] 
Mannitol -2 (eutectic melt) Johnson et al [206] -27 Lueckel et al [154] 
Phenylalanine   -10.5 own observations 
PVP 40kDa -24, -17.3 
Adams and Ramsey [204], 
Meister et al [202] 
-20 Her et al [210] 
Sorbitol -54 Adams and Ramsey [204]   
Sucrose -32 Meister et al [202], Ito [203] -32 Kasraian et al [198] 
Trehalose -29 
Meister et al [202], Adams 
and Ramsey [204] 
-30 Levine and Slade [207] 
 
Viscosity of an amorphous mixture is strongly dependent on its composition, with 
higher molecular weight components, exhibiting higher viscosity and therefore higher 
collapse temperature [180, 208]. It was shown, that the addition of polysaccharides like 
starch [179], maltodextrins [179, 208], dextran [209], PVP, Ficoll [210], and proteins [211] 
distinctly increase glass transition temperatures. Since collapse temperatures are inher-
ently linked to glass transition temperatures, above mentioned findings that excipients 
influence glass transition temperatures can be attributed to collapse temperatures, too. 
Moreover, the addition of protein in high concentrations (> 60 mg/ml) has elucidated an 
even more pronounced increase in collapse temperatures compared to glass transition 
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temperatures [212]. On the other hand, low molecular weight excipients like sodium chlo-
ride, glycerol, as well as glycine, decrease glass transition temperatures of amorphous 
mixtures [10, 15, 179, 198]. 
The correlation between the composition of an amorphous mixture and the resulting 
glass transition temperature can be characterized by the Gordon-Taylor equation or in a 
simplified form by the Fox equation [211, 213]. Based on their experimental data, To and 
Flink proposed the usability of the same correlation for collapse temperatures (cf. equa-
tion (1.8)) [208]. 𝑇𝑐,𝑚𝑖𝑥 represents the collapse temperature of the mixture, 𝑇𝑐,1 and 𝑇𝑐,2 the 
collapse temperatures of the solutes, 𝑤1 and 𝑤2 the weight fraction of the corresponding 
solutes. The factor 𝐵 is difficult to detect and basically based on free volume theory. As-
suming, according to Duddu and coworkers [211], the same simplification for 𝐵 (namely 
to describe 𝐵 as a constant), prediction of collapse temperature of a binary mixture from 
collapse temperatures of the pure components should hypothetically be possible accord-
ing to equation (1.9) (modified Fox equation).  
 
1
𝑇𝑐,𝑚𝑖𝑥
=
𝑤1
𝑇𝑐,1
+
𝑤2𝐵
𝑇𝑐,2
𝑤1 + 𝑤2𝐵
(1.8) 
 
1
𝑇𝑐,𝑚𝑖𝑥
=
𝑤1
𝑇𝑐,1
+
𝑤2
𝑇𝑐,2
(1.9) 
 
Based on considerations about glass transition temperatures of frozen aqueous bio-
logical media (4 solutes plus water), Fonseca and coworkers proposed a simple linear 
equation to calculated Tg’ as well as Tc based on properties of the single components in 
aqueous solution (determined experimentally or taken from literature sources) [192, 214]. 
Equation (1.10) shows the proposed correlation, 𝑇𝑐,𝑚𝑖𝑥 represents the collapse tempera-
ture of the mixture, 𝑇𝑐,𝑖 the collapse temperature of solute 𝑖, and 𝑐𝑖 denotes the concentra-
tion in % wt/wt of solute 𝑖 in the multicomponent aqueous mixture. 
 
𝑇𝑐,𝑚𝑖𝑥 =
∑ 𝑇𝑐,𝑖𝑖 𝑐𝑖
∑ 𝑐𝑖𝑖
(1.10) 
 
In order to achieve mechanically stable and elegant product cakes, it is a common 
strategy during development of freeze-drying formulations, to include a solute into the 
mixture, which crystallizes during freezing and is therefore termed crystalline bulking 
agent [8]. By admixing sufficient amounts of a crystalline bulking agent to a formulation 
the macroscopic collapse temperature can be markedly increased [208], for example an 
18 K increase for mannitol sucrose mixture is reported [192]. Hence, such formulations 
can be freeze-dried at high product temperatures without visible signs of collapse [206], 
since the crystalline bulking agent provides sufficient cake stability. On the microscopic 
scale, however, collapse of the amorphous phase towards the crystalline matrix occurs 
[10, 208]. 
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4.4 DETECTION OF COLLAPSE 
Collapse as macroscopic change of product structure has already been qualitatively 
described by Shakell in 1909 [177]. Although collapse was an often observed event during 
freeze-drying, the description of the structure of the freeze-dried product was based on 
macroscopic appearance and limited to non-collapsed, partially collapsed and com-
pletely collapsed for some decades [195].  
Several microscopic techniques were applied to characterize the structure of freeze-
dried products. While scanning electron microscopy has been used at least since the 1970s 
[10], fluorescence microscopy [48] and Micro-X-Ray Computed Tomography [215] are 
more recent technologies to qualitatively illustrate freeze-dried material. Although from 
the latter technique some quantitative facts can be calculated, microscopic methods are 
rather suitable for qualitatively illustrating cake structures. 
On the other hand, several authors describe techniques to detect alterations in product 
structure associated with collapse in a more quantitative way. For example, a decrease in 
volume was assessed by simple determination of height and diameter of samples [216]. 
Levi and Karel used a method (previously described by Hwang and Harakawa), where 
specific volumes of freeze-dried samples were determined by a glass beads displacement 
method [181]. To assess changes in the true density due to collapse of freeze-dried sam-
ples also helium pycnometry can be utilized [182, 217]. Rambhatla et al made use of mer-
cury intrusion porosimetry to detect different degree of shrinkage [183]. These authors 
also used Brunauer-Emmett-Teller (BET) gas adsorption to quantify specific surface area 
of shrunken cakes.  
Despite the fact that collapse is a serious issue for freeze-dried pharmaceuticals, a 
sound investigation of the applicability of the different techniques for a reliable quanti-
tative description of degree of collapse was lacking for a long time. However, recently 
Schersch investigated several techniques (helium pycnometry, mercury porosimetry, 
specific volume determination, density measurements, and BET SSA analysis) with the 
aid of lyophilizates exhibiting different degrees of collapse. Although “pore diameter and 
volume, the specific volume, the density and the apparent porosity all show some degree 
of correlation to the macroscopically determined degree of collapse”, the determination 
of the specific surface area showed up as most sensitive tool to characterizes small differ-
ences in degree of collapse, also micro-collapse could clearly be detected [190]. 
4.5 IMPACT OF COLLAPSE 
Based on a long history, most publications dealing with freeze-drying of sensitive 
goods point out that collapse is an unwanted event during freeze-drying. Also most re-
views, which serve as sort of entry literature in the field of freeze-drying for young sci-
entists, underline the importance to avoid product collapse [23, 36, 49, 169]. Therefore, 
there is a strong persuasion of scientists as well as responsible people from the industry 
that (at least macroscopic) collapse has to be avoided by all means, resulting for example 
in rejection of whole batches of freeze-dried products as far as collapse was observed 
[192]. In the following section, the documented impact of collapse on product character-
istics shall be examined from relevant available literature emphasizing pharmaceutical 
freeze-drying. 
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4.5.1 IMPACT ON PHYSICAL CHARACTERISTICS 
One of the most immediate signs of collapse is loss of structure, described in many 
variations, e.g. “bubbling, swelling, foaming, cavitation, fenestration, gross collapse, re-
traction and beading” [10]. Altogether, due to their loss in structure collapsed pharma-
ceutical products are described to lack a pharmaceutical elegance [14, 218].  
On the other hand, a number of product properties are potentially affected by the 
structural changes during collapse occurs or in the final collapse material. MacKenzie as 
well as Tsourouflius et al already delineate the closure of pores as a result of viscous flow 
during collapse as dramatic limitation for water vapor transport from the proceeding 
sublimation front [10, 179]. They noticed that drying is reduced to ineffective evaporative 
mechanisms [179] or more generally that drying is drastically hampered [10]. The in-
creased (product) resistance to water vapor flow is thought of leading to decreased sub-
limation rates and therefore a retarded primary drying [219]. In addition, due to reduced 
porosity (i.e. reduced specific surface area), desorptive drying during secondary drying 
becomes less effective resulting in high residual water contents [14, 15, 220].  
Since the highly porous structure of freeze-dried products generally allows for a fast 
rehydration of such products, a reduced porosity is also considered to worsen the rehy-
dration behavior of collapsed products [10, 15].  
Darcy and Buckton report an increased tendency of spray-dried and subsequently 
collapsed lactose to undergo crystallization [221]. Obviously, the increased water content 
of the collapsed samples resulted in an increased tendency toward crystallization due to 
an increased mobility of the amorphous phase. Izutsu and coworkers showed that stor-
age at elevated temperatures of inositol based lyophilizates caused collapse and crystal-
lization [152], potentially resulting from increased mobility due to higher storage tem-
peratures, too.  
4.5.2 IMPACT ON PROTEIN STABILITY / PRODUCT QUALITY 
Based on the serious influence of collapse on the morphology and physical character-
istics of freeze-dried products, there are general concerns about adequate preservation of 
product qualities in collapsed material [10, 23, 218]. Especially for the production of 
freeze-dried pharmaceutical, the importance of a mechanically stable, non-collapsed 
caked is outlined [8, 185].  
On the other hand, several approaches have shown that for a successful stabilization 
of pharmaceutical molecules a porous cake is not the only possible way. Particularly 
spray drying has been established as a beneficial tool to stabilize proteins [160, 222-224]. 
However, also vacuum drying, foam drying as well as supercritical fluid drying have 
shown their potential to stabilize embedded molecules without generation of porous 
cakes [7, 161, 166, 217, 225, 226].  
Although there is the widespread opinion that product collapse needs to be avoided 
during freeze-drying, data confirming a clear negative effect of collapse on the stability 
of molecules to be stabilized are rather rare.  
Lueckel et al observed a dramatic increase in IL-6 aggregation, if collapsed samples 
were stored at elevated temperatures, though right after freeze-drying there was no dif-
ference between collapsed and non-collapse samples. However, due to their high resid-
ual water content, collapsed samples exhibited low glass transition temperature, which 
laid below the respective storage temperatures. Therefore, degradation by a Maillard-ike 
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reaction was fostered due to high molecular mobility. Moreover, also non-collapse sam-
ples, if they exhibited high residual water content, showed similar increase in aggrega-
tion [227]. 
Passot and coworkers observed markedly decreased storage stability for toxins for-
mulated in PVP-sucrose and mannitol-PVP mixtures, if those were freeze-dried above 
their glass transition temperature Tg’. These observations were independent from the 
macroscopic collapse, as PVP-sucrose showed macroscopic collapse while mannitol-PVP 
did not show a difference in macroscopic appearance compared to samples freeze-dried 
below Tg’. Therefore, micro-collapse seems to be the main cause for decrease of storage 
stability. In samples that were freeze-dried below their corresponding Tg’, no loss of toxin 
activity could be detected [13]. 
Schneid et al operated a robustness testing for a model vaccine formulation (live bac-
teria, sucrose, buffer; quantities not specified), where they employed different freeze-dry-
ing protocols in order to achieve different product temperatures during primary drying, 
below and above the collapse temperature of the formulation. Although they did not 
identify a difference in stability right after freeze-drying, collapsed samples showed an 
increased degradation behavior compared to non-collapsed samples. However, also in 
this study, the collapsed and non-collapsed samples exhibit different residual water con-
tents as well as different glass transition temperatures, i.e. collapsed samples show lower 
glass transition temperature and therefore higher mobility during storage at equal tem-
peratures compared to non-collapsed samples [228]. 
Jiang and Nail directly assed the influence of process conditions on the protein stabil-
ity during freeze-drying from solutions containing no excipients but buffers. By the var-
iation of product temperature (due to variation of process parameters) they generated 
collapsed and non-collapsed samples. Comparing the recovery of protein activity, col-
lapsed samples showed less activity recovery compared to non-collapsed samples, most 
pronounced for LDH samples. Also for non-collapsed samples, the authors observed a 
faster loss of activity during primary drying for higher product temperatures. However, 
since the authors outline a strong decrease in activity recovery at residual water contents 
below approx. 10%, a decrease in recovery during freeze-drying could also be attributed 
to the decrease in water content, as for higher product temperatures a faster decrease in 
water is expected. Moreover, the authors emphasized the importance of the freezing 
method, protein concentration as well as the use of stabilizers on the recovery of activity 
in general [12]. 
Adams and Iron reported no loss in enzyme activity (Erwinia L-Asparaginase) due to 
collapse, although their products exhibited complete structural collapse in lactose-so-
dium chloride mixtures [15]. In a further study, Adams and Ramsay also described that 
structural collapse of glucose based formulation did not hamper successful stabilization 
of the enzyme, whereas non-collapsed samples, based on mannitol, showed a poor en-
zyme activity [204]. 
Izutsu and coworkers freeze-dried β-galactosidase in increasing amounts of inositol 
and subjected these samples to storage at elevated temperatures. While right after freeze-
drying all samples showed a non-collapsed appearance, by storing them at 60°C and 70°C 
for up to seven days they observed structural collapse during storage. Concurrently they 
noticed a decrease in recovery of enzyme activity. However, collapse was accompanied 
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by crystallization of the previously amorphous inositol. In turn, if crystallization was im-
peded by addition of polymers to the formulations, collapsed but not crystallized sam-
ples preserved activity equally well as non-collapsed samples, which were stored at 
lower temperatures [152]. 
Stimulated by the finding of Lueckel, Jiang, and Izutsu Wang et al designed a study 
to investigate the influence of structural collapse on the stability of α-amylase as well as 
recombinant Factor VIII (rFVIII) formulated in a glycine-sucrose mixture. By omitting the 
annealing step during freezing, they avoid crystallization of glycine resulting in low col-
lapse temperature. In turn, annealing caused glycine crystallization followed by an in-
crease in collapse temperature. Hence, both species dried by the same freeze-drying pro-
tocol resulted either in collapsed or non-collapsed samples. Though, the samples showed 
different residual water contents (collapsed as expected higher), the authors did not de-
tect a difference in stability for both proteins between non-collapsed and collapsed sam-
ples, neither right after freeze-drying, nor after storage of 18 months. Even a slightly bet-
ter preservation of activity was reported for 40°C storage of collapsed rFVIII samples 
[219]. 
Chatterjee et al subjected formulations composed of LDH and a mixture of raffinose 
or trehalose and glycine in different ratios to a freeze-drying protocol ensuring a product 
temperature 10 K above the glass transition temperature. Formulations at low glycine 
contents showed structural collapse, while increasing amounts of glycine result in mac-
roscopically non-collapsed samples due to formation of a crystalline glycine matrix. For 
comparison, all formulations are freeze-dried at low product temperature according a 
conventional freeze-drying protocol, which ensures that samples did not exceed the col-
lapse temperature during drying. Regarding preservation of LDH activity, no significant 
differences could be detected comparing low and high glycine amounts from the aggres-
sive cycle, former collapsed latter not. Moreover, comparing collapsed samples from the 
aggressive cycle to non-collapsed samples from the conventional cycle, an equally well 
preservation of activity was detected [220]. 
Although the intention of their study was not an investigation of the influence of col-
lapse on the activity preservation of incorporated bacteriophages, Puapermpoonsiri et al 
detected a better stabilization of bacteriophages in collapsed sucrose and PEG samples 
compared to non-collapsed samples after a storage period of 30 days. The authors attrib-
ute this surprising finding to higher residual water contents of the collapsed samples. 
Nevertheless, collapsed sucrose and PEG samples seem to be superior to non-collapsed 
samples [229]. 
During evaluation, whether primary or secondary drying step during freeze-drying 
is more critical for the stability of am model protein (LDH), Luthra and coworkers dis-
covered that collapse during primary drying has no influence on recovery of LDH activ-
ity – even without lyo-protectant. Moreover, they found no difference between collapsed 
and non-collapsed samples after secondary drying (0.5% and 5% sucrose). In collapsed 
samples that contain 5% sucrose actually a full recovery of LDH activity was recorded 
[52]. 
In a two-section study Schersch et al investigated the direct influence of collapse on 
the stability of three model proteins (IgG1, LDH, and “PA01”), formulated in typical 
amorphous or partially crystalline formulations and freeze-dried to collapsed or non-col-
lapsed lyophilizates by choosing a conventional or an aggressive freeze-drying cycle. To 
General Introduction 
30 
act as amorphous stabilizers sucrose, trehalose (IgG1 LDH) or arginine (PA01) was em-
ployed, for partially crystalline mixtures PEG3350 was utilized (LDH). The authors ap-
plied quite a number of techniques to detect differences in protein aggregation, confor-
mational stability, as well as activity recovery between collapsed and non-collapsed sam-
ples. Altogether, after freeze-drying they observed an excellent stability of IgG1 as well 
as PA01 independent from structural collapse of the samples. LDH samples showed in-
creased levels of insoluble protein aggregates (detected by light obscuration), however, 
there were no differences between both species collapsed and non-collapsed. Regardless 
of the higher amounts of aggregates, the activity of LDH was preserved equally well 
(around 100%) in both collapsed and non-collapsed samples. The authors concluded that 
there is not necessarily a detrimental effect of structural collapse on protein stability [16].
  
In addition to investigations on the stability of proteins in collapsed lyophilizates right 
after freeze-drying Schersch and coworkers studied the influence of collapse on the stor-
age stability of the lyophilizates that have been mentioned already above (IgG1, LDH, 
PA01). To accelerate potential degradation they stored samples at up to 50°C for up to 26 
weeks. They found a comparable stability throughout the whole storage period for the 
potentially most sensitive model protein LDH, expressed in comparable aggregation, 
conformation, and activity recovery. For IgG1 as well as for PA01 collapsed samples ex-
hibited even a slightly better stabilization, as especially at high storage temperatures col-
lapsed samples showed less aggregation or less decrease in catalytic activity to some ex-
tent. Moreover, also partially collapsed samples performed worse than completely col-
lapsed samples [17]. 
4.6 INTENTIONAL USE OF COLLAPSE 
Growing evidence showed that collapse during freeze-drying does not necessarily 
damage the molecule to be stabilized. Thus, several companies/inventors filed patent ap-
plications dealing with freeze-drying using protocols that causes (micro-) collapse. Some 
applications explicitly claim freeze-drying processes (and formulations) resulting in 
product temperatures above the glass transition temperature Tg’ but below the collapse 
temperature Tc consequently resulting in micro-collapsed products, but retaining the 
macroscopic structure [18, 230]. The reduction of porosity by micro-collapse decreases 
the dry layer resistance. Therefore, during primary drying at a certain product tempera-
ture, drying rates are increased, as water vapor can more easily pass the dry layer [48, 
171, 186]. Applying those high product temperatures result in short freeze-drying pro-
cesses as already outlined by several authors [36, 48, 206, 220]. Moreover, recently also 
Tchessalov and coworkers filed a patent application using high product temperatures 
during primary drying, too. In contrast to former mentioned applications, Tchessalov et 
al also apply product temperatures above the collapse temperature in order to decrease 
process time as much as possible [20]. 
Besides protein stability, also residual water content as well as reconstitution time 
belongs to the often mentioned concerns for collapsed products. However, for example 
Schersch et al as well as Tchessalov et al demonstrated that despite fully collapsed struc-
ture the samples can be dried to adequate residual water contents. Furthermore, recon-
stitution times are in the range of non-collapsed samples [16, 20]. 
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5. SPECIFIC CONSIDERATIONS FOR AGGRESSIVE FREEZE-DRYING 
Condensing the knowledge about collapse during freeze-drying and its effect on crit-
ical product qualities by now, a further development of “collapse-drying” [16] or aggres-
sive freeze-drying towards a new freeze-drying technique promises to be valuable. The 
potential capability to manufacture products in considerably less time to at least the same 
quality, as already delineated by recent findings [16, 17, 20], renders a further investiga-
tion highly attractive. In order to develop aggressive freeze-drying towards a reliably 
technical option, some points needs to be considered. 
Generally, a freeze-drying process has to produce high quality products in a repro-
ducible way. Generating and maintaining of a precise low vacuum as well as precise con-
trol of the heat input into the product is a technical challenge. Therefore, a freeze-drying 
process also needs to be robust against small variations in process controlling factors 
(pressure, temperature).  
In order to implement a new technique for (pharmaceutical) freeze-drying, a fast suc-
cess would be more realistic if these techniques would be executable on already available 
technical equipment. Independent from structural collapse, freeze-drying at high prod-
uct temperatures can unveil some new challenges for the technical equipment. For exam-
ple especially during primary drying a larger amount of water vapor is generated per 
time compared to conventional freeze-drying cycles, that needs to be removed from the 
surrounding of the product. In laboratory as well as in pilot and production scale freeze-
driers, this is usually realized by a combination of a condenser for water vapor and a 
vacuum system for non-condensable gases. Maintaining a certain precise chamber pres-
sure is an inevitable prerequisite for successful freeze-drying. Hence, the condenser and 
vacuum machinery have to be capable to remove water vapor in the quantities that were 
generated by sublimation. Furthermore, if the connection between product chamber and 
condenser is constructed in a way that water vapor flow is restricted to a certain degree, 
the velocity of water vapor could potentially reach the speed of sound, resulting in 
choked flow and finally in loss of chamber vacuum [231]. Aggressive freeze-drying pro-
cesses result in higher amounts of water vapor per time compared to conventional freeze-
drying, therefore the condenser temperatures as well as the maintenance of chamber 
pressure has to be monitored carefully. Moreover, the system controlling the energy in-
put into the product (usually in form of temperature controlled shelves) has to be able to 
supply more energy per time compared to conventional freeze-drying cycles. 
For a better understanding – and a sound process design – of aggressive freeze-dry-
ing, the kinetic of primary and secondary drying is of high interest. It is widely accepted 
that freeze-drying at higher product temperatures result in a reduction of freeze-drying 
time as proposed by Pikal [11]. However, the drying kinetics of freeze-drying cycles at 
higher product temperatures are barely investigated so far. Generally, primary drying 
kinetics of aggressive freeze-drying cycles are expected to differ profoundly due to high 
energy input as well as due to micro- or structural collapse. It is known that secondary 
drying kinetics strongly depend on the microscopic structure [51], therefore, for collapsed 
products a distinction to conventional freeze-dried product has to be expected.  
Contrary to the widespread opinion that reduced porosity, or better reduced specific 
surface area, solely bears corrupted product quality regarding achievable residual water 
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contents and rehydration behavior, Schersch and coworkers have shown a superior stor-
age stability of collapsed samples with low specific surface area [17]. Observations of Hsu 
et al as well as of Abdul-Fattah et al (foam-dried material) also point in the direction of 
slightly better stability of products with lower specific surface area [162, 217]. Moreover, 
residual water content as well as reconstitution time of samples of a number of quite 
different formulations have not shown significant or stability influencing differences be-
tween collapsed and non-collapse material [16, 20]. However, bearing reports of deterio-
rated residual water content as well as reconstitution time in mind, it is important to keep 
an eye on those important product qualities.   
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CHAPTER 2 OBJECTIVES 
 
Many therapeutic proteins are not stable in liquid solutions. Freeze-drying is therefore 
the process of choice when it comes to stabilization. Over the last decades, pharmaceuti-
cal freeze-drying was established as a reliable technique to stabilize sensitive molecules. 
Already in the beginnings, the importance to avoid collapse of the product during drying 
and storage was highlighted [1]. Collapsed samples are regarded as irregular, unaccepta-
ble products, which exhibit higher water content, slower reconstitution and compro-
mised protein stability.  
In a recent, systematic investigation, however, it was shown that collapse during 
freeze-drying did not affect the stability of a sensitive model protein and two therapeutic 
proteins [2]. Moreover, compared to conventionally freeze-dried, non-collapsed lyophi-
lizates the collapsed samples revealed superior stability during storage at elevated tem-
peratures [3]. The collapsed lyophilizates were mainly produced by an aggressive freeze-
drying cycle that increased the product temperature above the collapse temperature. 
Hence, the proven fact that aggressive freeze-drying does not affect the protein stability 
was taken as a starting point for the actual work. 
The major aim of this thesis was to generate a foundation for the intended use of ag-
gressive freeze-drying for stabilization of protein pharmaceuticals. Controllable and re-
producible production of lyophilizates by aggressive freeze-drying was considered as 
fundamental requirement to facilitate aggressive freeze-drying as suitable alternative to 
conventional freeze-drying. Thus, the first part of the studies was focused on controlla-
bility of aggressive freeze-drying.  
Aiming for definition of a design space for controllable and reproducible production 
of lyophilizates by aggressive freeze-drying, the influence of process parameters on prod-
uct characteristics was evaluated. For a sound understanding of how to perform and po-
tentially optimize aggressive freeze-drying, the drying kinetics of samples during aggres-
sive freeze-drying were monitored. To gain understating how the formulation composi-
tion affects the drying behavior, the most common formulation strategies were taken into 
consideration. Disaccharide based formulations without bulking agent were compared 
to formulations of low and high bulking agent content. Beyond drying behavior, the final 
lyophilizate characteristics resulting from different process parameters were of utmost 
interest. Key lyophilizate qualities (e.g. water content, crystallinity) were determined and 
judged regarding the potential to ensure protein stabilization based on the concepts of 
water replacement and vitrification. Preserving the protein stability was regarded as a 
major determinant for successful use of aggressive freeze-drying within the studied de-
sign space.  
The second major aim of the thesis was to shorten drying times of aggressive freeze-
drying and maintain the superior protein stabilization. In previous work [4], collapsed 
samples have shown slow secondary drying due to the low specific surface area. As col-
lapsed samples concurrently revealed preferable stabilization, it was aimed to develop a 
formulation strategy that result in collapsed samples, which can be dried within less than 
24 h to < 1% residual water content.  
Summarizing, the aims of the thesis were:  
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 Evaluation on how the variation of process parameters influences the drying 
kinetics, physico-chemical characteristics, and protein stabilization of aggres-
sively freeze-dried lyophilizates in order to define a design space for aggres-
sive freeze-drying (Chapter 4). 
 
 Investigation of the influence of bulking agents, solid concentration, and pro-
tein concentration to identify formulation strategies that are able to achieve 
preferable physico-chemical characteristics of aggressively freeze-dried lyoph-
ilizates (Chapter 5). 
 
 Characterization of the influence of bulking agents, solid concentration, and 
protein concentration on the ability to stabilize incorporated proteins during 
aggressive freeze-drying and subsequent storage in order to verify broad ap-
plicability or isolate the most promising formulation strategy (Chapter 6). 
 
 Evaluation of the applicability of aggressive freeze-drying to further proteins 
in order to examine a potentially universal use of aggressive freeze-drying for 
the stabilization of proteins (Chapter 7).  
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CHAPTER 3 MATERIALS AND METHODS 
1. MATERIALS 
1.1 MODEL PROTEINS 
1.1.1 MONOCLONAL ANTIBODY MAB_T1 
In order to represent the most important class of therapeutic antibodies [1] an IgG1 
monoclonal antibody has been selected as model protein. Immunoglobulins like IgG (IgG 
= immunoglobulin subtype G) belong to the group of immunological active glycopro-
teins, which bind highly specific to an explicit epitope of a cell or the like. This makes 
them very effective therapeutics.  
Like all antibodies, IgG molecules consist of each, two heavy and two light chains, 
forming a Y-shaped three-dimensional structure of around 150kDa. Enzymatic cleavage 
by papain results in two Fab-fragments (Fab = antibody binding fragment) as well as one 
Fc-fragment (Fc = crystallizable fragment). While the Fab-parts are associated with anti-
gen binding, the Fc-part facilitates effector functions of the antibody [2].  
Mab_T1 was available as bulk solution at a concentration of approx. 17 mg/ml in a 
phosphate buffer at 10.5 mM at pH of 6.4. Prior to use, the bulk was filtered using a sy-
ringe filter (PVDF membrane, 0.2µm pore diameter; PALL Lifesciences, Dreieich, Ger-
many) in a laminar airflow bench (Herasafe, Heraeus Instruments GmbH, Hanau, Ger-
many). After filtration, the exact concentration of mab_T1 was determined by UV absorp-
tion (UV 280nm, ε=1.499 ml mg-1 cm-1) at a wavelength of 280 nm using a NanoDrop 2000 
photometer (Thermo Fischer Scientific, Schwerte, Germany). For freeze-drying experi-
ments, the protein concentration was adjusted to the desired value by mixing the filtered 
bulk solution with 10mM potassium phosphate buffer (pH=6.4) and various amounts of 
excipients. 
1.1.2 MONOCLONAL ANTIBODY MAB_T2 
In order to account for the prominent status of monoclonal antibodies in the thera-
peutic treatment, a second monoclonal antibody (mab_T2, IgG1) was utilized for freeze-
drying investigations. Mab_T2 was available at a concentration of approx. 40 mg/ml as 
bulk solution containing histidine, trehalose, as well as polysorbate (pH=5.4).  
Prior to use, the bulk solution was dialyzed overnight at 5°C (exchange of buffer me-
dium after 2 and 4 hours) against a 10mM sodium citrate buffer (pH=5.4) using Pierce 
Slide-A-Lyzer® dialysis cassettes (cutoff 10 kDa, 12 ml; Thermo Fisher Scientific, Bonn, 
Germany). After dialysis, the solution was filtered using a syringe filter (PVDF mem-
brane, 0.2µm pore diameter; PALL Lifesciences, Dreieich, Germany). The exact concen-
tration of mab_T2 after filtration was determined by UV absorption (UV 280nm, 
ε=1.55  ml mg-1 cm-1) at a wavelength of 280 nm using a NanoDrop 2000 photometer 
(Thermo Fischer Scientific, Schwerte, Germany). For freeze-drying experiments the pro-
tein concentration was adjusted to the desired value by mixing the mab_T2 solution with 
10mM sodium citrate buffer (pH=5.4) and various amounts of excipients. 
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1.1.3 L-LACTATE DEHYDROGENASE (LDH) 
Although L-lactate dehydrogenase is not employed as therapeutic protein, it is often 
used to reveal destabilizing stress vectors during freeze-drying [3-14], spray-drying [15, 
16], vacuum drying [17, 18], or supercritical fluid drying [19]. Due to its sensitivity to 
freezing as well as drying stresses, if not proper stabilized by suitable cryo- and lyo-pro-
tectants, LDH is also reported to be a suitable model to investigate the effect of product 
collapse on the protein stability [20, 21]. 
LDH is an enzyme (oxidoreductase; EC 1.1.1.27) that catalyze the oxidation of lactic 
acid to pyruvate and concurrent the reduction of the oxidized form of nicotinamide ade-
nine dinucleotide (NAD+) to the reduced form (NADH) and vice versa. LDH is present 
in a wide variety of animals and plants. For freeze-drying LDH from rabbit muscle fre-
quently is utilized, which consists of four subunits forming a tetramer of 140 kDa molec-
ular weight [22]. 
L-lactic dehydrogenase type II from rabbit muscle was acquired as aqueous suspen-
sion (approx. 12 mg/ml LDH, 800-1,200 units/mg protein, 3.2 M ammonium sulfate, 
pH=6.0; Sigma-Aldrich, Steinheim, Germany). Immediately before use, the suspension 
was dialyzed 24 hours at 5°C (exchange of buffer medium after 3 and 6 hours) against a 
10mM sodium phosphate buffer (pH=7.5) using Pierce Slide-A-Lyzer® dialysis cassettes 
(cutoff 20 kDa, 0.3 – 5 ml; Thermo Fisher Scientific, Bonn, Germany). After dialysis the 
exact concentration of LDH was determined by UV absorption (UV 280nm, ε=1.49  ml mg-
1 cm-1) at a wavelength of 280 nm using a NanoDrop 2000 photometer (Thermo Fischer 
Scientific, Schwerte, Germany). For freeze-drying experiments the protein concentration 
was adjusted to the desired value by mixing the LDH solution with 10mM sodium phos-
phate buffer (pH=7.5) and various amounts of excipients. 
1.1.4 RECOMBINANT PLASMINOGEN ACTIVATOR (RPA) 
To broaden knowledge about aggressive freeze-drying and also to different classes of 
protein drugs, formulations of recombinant plasminogen activator  (rPA) available at a 
concentration of 3.0 mg/ml formulated with 0.5M arginine and 0.25M phosphate (pH=7.2) 
were used. RPA is a modified form of human tissue plasminogen activator containing 
355 amino acids (62.9 kDa) produced in E.coli and therefore present as non-glycosylated 
modification. After thawing rPA bulk was filtered using a syringe filter (PVDF mem-
brane, 0.2µm pore diameter; PALL Lifesciences, Dreieich, Germany). Following filtration 
the exact concentration of rPA was determined by UV absorption (UV 280nm, 
ε=1.74  ml mg-1 cm-1) at a wavelength of 280 nm using a NanoDrop 2000 photometer 
(Thermo Fischer Scientific, Schwerte, Germany). For freeze-drying experiments, the pro-
tein concentration was adjusted to the desired value by mixing the rPA solution with 
highly purified water and various amounts of excipients.  
1.1.5 GRANULOCYTE COLONY-STIMULATING FACTOR (GCSF) 
To complete the set of model proteins GCSF was chosen representing another thera-
peutic protein (treatment of neutropenia [23]). GCSF is a monomeric cytokine of 19kDa 
molecular weight, which is most stable at pH of 4.0 and exhibits poor stability upon 
freeze-drying without proper stabilization by excipients [24]. GCSF was available as fro-
zen bulk solution containing 5%wt sorbitol and 0.004% polysorbate 80 in a 10mM sodium 
acetate buffer (pH=4.0).  
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Prior to use, the bulk solution was dialyzed overnight at 5°C (exchange of buffer me-
dium after 2 and 4 hours) against a 10mM sodium citrate buffer (pH=4.0) using a Spec-
tra/Por® dialysis membrane (cutoff 6-8 kDa, Spectrum Laboratories, Rancho Dominguez, 
CA, USA). After dialysis, the solution was filtered using a syringe filter (PVDF mem-
brane, 0.2µm pore diameter; PALL Lifesciences, Dreieich, Germany). The exact concen-
tration of GCSF after filtration was determined by UV absorption (UV 280nm, 
ε=0.815 ml mg-1 cm-1) at a wavelength of 280 nm using a NanoDrop 2000 photometer 
(Thermo Fischer Scientific, Schwerte, Germany). For freeze-drying experiments the pro-
tein concentration was adjusted to the desired value by mixing the GCSF solution with 
10mM sodium citrate buffer (pH=4.0) and various amounts of excipients.  
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1.2 FREEZE-DRYING EXCIPIENTS 
Table 3.1 lists the excipients that were used in this work. 
Table 3.1: List of excipients used in this thesis 
excipient specification supplier 
Citric acid monohydrate Ph.Eur.  Jungbunzlauer (Ladenburg, Germany) 
hp-β-cyclodextrin (Cavasol W 
7 HP Pharma) 
 Wacker Chemie (Munich, Germany) 
K2HPO4 p.A. Applichem (Darmstadt, Germany) 
KH2PO4 p.A. Applichem (Darmstadt, Germany) 
L-arginine Emprove® Ph.Eur., 
USP 
Merck KGaA (Darmstadt, Germany) 
L-Glycine >99% Sigma Aldrich Chemie (Steinheim, Germany) 
L-Glycine Ph.Eur., USP Merck KGaA (Darmstadt, Germany) 
L-histidine Emprove® Ph.Eur., 
USP 
Merck KGaA (Darmstadt, Germany) 
L-isoleucine BioUltra, ≥99.5% Fluka Analytical (Sigma Aldrich Chemie, Steinheim, 
Germany) 
L-leucine For biochemistry Merck KGaA (Darmstadt, Germany) 
L-methionine Emprove® Ph.Eur., 
USP 
Merck KGaA (Darmstadt, Germany) 
L-Phenylalanine >99% Sigma Aldrich Chemie (Steinheim, Germany) 
L-tryptophan reagent grade,  
≥98% 
Sigma Aldrich Chemie (Steinheim, Germany) 
Mannitol Ph.Eur. Cerestar (Cargill Europe BVBA, Mechelen, Belgium) 
Na2HPO4 x 2 H2O p.A. Applichem (Darmstadt, Germany) 
NaCl p.A. VWR (Darmstadt, Germany) 
NaH2PO4 x 2 H2O p.A. Sigma Aldrich Chemie (Steinheim, Germany) 
NaOH 1M  Applichem (Darmstadt, Germany) 
Na-Succinate * 6 H2O p.A. Dr.Paul Lohmann (Emmerthal, Germany) 
Polysorbate 20 Ph.Eur. Fluka Analytical (Sigma Aldrich Chemie, Steinheim, 
Germany) 
Polysorbate 80 J.T. Baker®, Ph Eur., 
BP, JP 
VWR (Darmstadt, Germany) 
Sucrose p.A. Suedzucker (Mannheim, Germany) 
Trehalose  British Sugar (Peterborough, England) 
α,α-Trehalose dihydrate high purity, low en-
dotoxin 
Ferro Pfanstiehl Lab., Inc.(Waukegan, IL, USA) 
α,α-Trehalose dihydrate For Biochemistry VWR (Darmstadt, Germany) 
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1.3 CHEMICALS AND REAGENTS 
The chemicals and reagents used in this work are listed in Table 3.2. 
Table 3.2: List of chemicals and reagents used in this thesis 
substance specification supplier 
Bovine Serum Albumine (BSA) ≥ 98% Sigma Aldrich Chemie (Steinheim, Germany) 
Hydranal® water standard 0.1 0.01% water Fluka Analytical  
(Sigma Aldrich Chemie, Steinheim, Germany) 
Hydranal® water standard 1.0 0.1% water Fluka Analytical  
(Sigma Aldrich Chemie, Steinheim, Germany) 
Hydranal® water standard 1.0 1.0% water Fluka Analytical  
(Sigma Aldrich Chemie, Steinheim, Germany) 
Hydranal®-Methanol dry <0.01% water Fluka Analytical  
(Sigma Aldrich Chemie, Steinheim, Germany) 
Hydrochloric acid 1M  Applichem (Darmstadt, Germany) 
L-arginine Emprove® Ph.Eur., 
USP 
Merck KGaA (Darmstadt, Germany) 
Na2HPO4 x 2 H2O p.A. Applichem (Darmstadt, Germany) 
NaCl p.A. VWR (Darmstadt, Germany) 
NaH2PO4 x 2 H2O p.A. Sigma Aldrich Chemie (Steinheim, Germany) 
Na-Pyruvat 99% Sigma Aldrich Chemie (Steinheim, Germany) 
β – NADH 98% Sigma Aldrich Chemie (Steinheim, Germany) 
Phohspohric acid 85% BioReagent Sigma Aldrich Chemie (Steinheim, Germany) 
S-2288TM (H-D-Isoleucyl-L-
prolyl-L-arginine-p-nitroan-
iline dihydrochloride) 
 Chromogenix (Milano, Italy) 
 
Trizma® base BioUltra Sigma Aldrich Chemie (Steinheim, Germany) 
 
2. METHODS 
2.1 FREEZE-DRYING 
1 ml of the formulations to be freeze-dried was filled into pre-washed (HPW) DIN 2R 
glass vials (glass type I, “Fiolax” quality) from Schott (Schott, Mainz, Germany). This 
combination resulted in a filling height of approx. 1 cm. After filling, lyophilization stop-
pers (WESTAR® RS with FluroTec coating; West Pharmaceutical Services , Eschweiler, 
Germany) were placed in position 1 allowing water vapor to escape during freeze-drying. 
Especially for storage stability, investigation vials as well as stoppers were sterilized prior 
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to use. According to the Ph. Eur. vials were heat sterilized (160°C, 120 min), while stop-
pers were autoclaved (121°C, 15 min) and subsequently dried at 80°C over night assisted 
by vacuum. 
Freeze-drying was performed utilizing one of the freeze-driers specified in Table 3.3. 
Vials were placed directly on the shelves surrounded by a metal frame. In order to mini-
mize edge effects due to radiation from non-temperature controlled parts of the freeze-
drier (chamber walls, door), in every experimental run at least two rows of vials filled 
with 5% wt. sucrose solution were placed at each side of the frame (“shielding” vials).  
Table 3.3: Overview of freeze-driers used in this thesis 
Type FTS LyoStar II FTS LyoStar III Christ Epsilon 2-12D 
spezial 
Christ Epsilon 2-6D 
Manufacturer SP Scientific, Stone 
Ridge, NY, USA 
SP Scientific, Stone 
Ridge, NY, USA 
Martin Christ,  
Osterode am Harz, 
Germany 
Martin Christ,  
Osterode am Harz, 
Germany 
Number of shelves 3 3 3 3 
Shelf area 0.43 m² 0.43 m² 0.47 m² 0.21 m² 
inner diameter con-
nection chamber/con-
denser 
9.9 cm 9.9 cm 30 cm 12 cm 
Ice capacity 30 l 30 l 12 kg 6 kg 
Number of tempera-
ture sensors  
16 16 6 6 
Pressure gauge 1 Capacitance Capacitance Pirani Pirani 
Pressure gauge 2 Pirani Pirani - - 
 
Freeze-drying was operated according to the freeze-drying cycles described below. 
After finishing the freeze-drying cycle, the freeze-drier was vented by nitrogen gas (qual-
ity 5.0) to 800 mbar and the vials were closed by lowering the shelves of the freeze-drier. 
Finally, the vials were crimped with aluminum flip-off caps (West Pharmaceutical Ser-
vices, Eschweiler, Germany). 
2.1.1 COMPOUNDING OF FREEZE-DRYING FORMULATIONS 
Formulations to be freeze-dried were prepared by mixing precise amounts of excipi-
ent stock solutions (excipient dissolved in formulation buffer), formulation buffer, and 
finally adding the protein bulk solution. For homogeneous mixture, the container was 
gently rotated. Finally, the formulations were filtered using a syringe filter (PVDF mem-
brane, 0.2µm pore diameter; PALL Lifesciences, Dreieich, Germany). In order to assess 
the characteristics of the initial formulation, an aliquot of each sample was analyzed with-
out being freeze-dried. 
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2.1.2 FREEZE-DRYING CYCLES 
2.1.2.1 Aggressive cycles 
Based on the work of Schersch [25] two basic aggressive cycles were chosen that were 
used throughout the work if not stated otherwise in the respective section. Basically, 
freezing of products was performed by lowering the shelf temperature from 20°C to -
50°C at a rate of 0.8 K/min. To ensure complete solidification, -50°C was held for at least 
120 minutes. In order to provide sufficient refrigeration power to the condenser, the shelf 
temperature was increased up to -40°C prior to applying vacuum. 
For aggressive freeze-drying, a chamber pressure of 1 mbar is applied and the shelf 
temperature is increased to 45°C at a rate of 0.7 K/min. Primary and secondary drying is 
operated at 1 mbar and 45°C. See Table 3.4 for aggressive cycle 1, aggressive cycle 2 can 
be found in Table 3.5. Cycle 2 was derived from cycle 1 after it was recognized that for 
certain formulations much shorter drying cycles are suitable to generate lyophilizates of 
sufficiently low residual moistures, too. In order to evaluate a design space for aggressive 
freeze-drying shelf temperature as well as chamber pressure were varied in a dedicated 
study (cf. CHAPTER 4, section 2). Generally, the chamber pressure was controlled by 
nitrogen-injections via the gas injection valve of the freeze-driers. 
Table 3.4: Aggressive freeze-drying cycle 1 (long cycle) 
 
ramp 
shelf 
temperature 
chamber 
pressure hold time 
summed up 
process time 
 [K/min] [°C] [mbar] [min] [hh:mm] [min] [hh:mm] 
loading  20 atm.     
freezing 0.78 -50 atm.   90 01:30 
  -50 atm. 120 02:00 210 03:30 
 0.33 -40 atm.   240 04:00 
drying  -40 1 20 00:20 260 04:20 
 0.71 45 1   380 06:20 
  45 1 1440 24:00 1820 30:20 
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Table 3.5: Aggressive freeze-drying cycle 2 (short cycle) 
 
ramp 
shelf 
temperature 
chamber 
pressure hold time 
summed up 
process time 
 [K/min] [°C] [mbar] [min] [hh:mm] [min] [hh:mm] 
loading  20 atm.     
freezing 0.78 -50 atm.   90 01:30 
  -50 atm. 120 02:00 210 03:30 
 0.33 -40 atm.   240 04:00 
drying  -40 1 20 00:20 260 04:20 
 0.71 45 1   380 06:20 
  45 1 360 06:00 740 12:20 
 
 
 
2.1.2.2 Conventional cycles 
In order to benchmark the result of samples from aggressive freeze-drying cycles, 
conventional freeze-drying cycles were applied for selected formulations (cf. Table 3.6, 
Table 3.7, and Table 3.8, respectively). These gentle freeze-drying protocols ensured 
product temperatures below the collapse temperature of respective formulations. 
Table 3.6: Conventional freeze-drying cycle 1, applied for placebo studies with 5% sucrose formulation 
 
ramp 
shelf 
temperature 
chamber 
pressure hold time 
summed up 
process time 
 [K/min] [°C] [mbar] [min] [hh:mm] [min] [hh:mm] 
loading  20 atm.     
freezing 0.78 -50 atm.   90 01:30 
  -50 atm. 120 02:00 210 03:30 
 0.33 -40 atm.   240 04:00 
primary 
drying 
 -40 0.09 20 00:20 260 04:20 
0.67 -20 0.09   290 04:50 
 -20 0.09 1800 30:00 2090 34:50 
secondary 
drying 
0.2 5 0.09   2215 36:55 
 5 0.09 420 07:00 2635 43:55 
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Table 3.7: Conventional freeze-drying cycle 2, applied for formulations containing LDH 
 
ramp 
shelf 
temperature 
chamber 
pressure hold time 
summed up 
process time 
 [K/min] [°C] [mbar] [min] [hh:mm] [min] [hh:mm] 
loading  20 atm.     
freezing 0.78 -50 atm.   90 01:30 
  -50 atm. 200 03:20 290 04:50 
 0.33 -40 atm.   320 05:20 
primary 
drying 
 -40 0.04 1830 30:30 2150 35:50 
0.1 -20 0.04   2350 39:10 
 -20 0.04 1200 20:00 3550 59:10 
secondary 
drying 
0.2 10 0.04   3700 61:40 
 10 0.04 600 10:00 4300 71:45 
 
 
Table 3.8: Conventional freeze-drying cycle 3, applied for formulations containing mab_T1 
 
ramp 
shelf 
temperature 
chamber 
pressure hold time 
summed up 
process time 
 [K/min] [°C] [mbar] [min] [hh:mm] [min] [hh:mm] 
loading  20 atm.     
freezing 0.9 2 atm.   20 00:20 
  2 atm. 60 01:00 80 01:20 
 0.8 -50 atm.   145 02:25 
  -50 atm. 120 02:00 265 04:25 
 0.33 -40 atm.   295 04:55 
  -40 atm. 30 00:30 325 05:25 
primary 
drying 
 -40 0.07 30 00:30 355 05:55 
0.33 -30 0.07   385 06:25 
 -30 0.07 3600 60:00 3985 66:25 
secondary 
drying 
0.1 10 0.07   4385 73:05 
 10 0.07 600 10:00 4985 83:05 
 
 
2.1.3 PROCESS MONITORING 
During freeze-drying especially the temperature of the drying product is of interest. 
To monitor product temperatures thermocouples (FTS LyoStar II) or resistance tempera-
ture, detectors (RTDs; Christ freeze-driers) were used. The measuring head was placed 
in a centered position slightly above the bottom of the glass vial. During early primary 
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drying, the product temperature is significantly below the shelf temperature due to sub-
limative self-cooling. The end of sublimation (or more specifically the end of primary 
drying according to the definition of primary drying as drying by sublimation) is indi-
cated by an increase in product temperature, finally approaching the shelf temperature. 
In addition, the end of primary drying can be monitored by comparing pressure reading 
from a capacitance and a Pirani pressure gauge (end of primary drying indicated by ap-
proaching pressure readings). Since only the FTS LyoStar II freeze-drier was equipped 
by a capacitance as well as a Pirani pressure gauge (cf. Table 3.3) this method could just 
be applied to freeze-drying cycles in that machine. 
In order to evaluate primary drying kinetics during aggressive freeze-drying by 
weight loss, a Christ CWS-40 freeze-drying balance (Martin Christ, Osterode am Harz, 
Germany) was employed in selected freeze-drying cycles. Additionally, a sample thief 
was used to draw samples from the running process during primary as well as secondary 
drying. Based on either determining weight loss or residual water content, primary and 
secondary drying kinetics were calculated. 
 
2.2 CHARACTERIZATION OF PROTEIN STABILITY 
2.2.1 HIGH PERFORMANCE SIZE-EXCLUSION CHROMATOGRAPHY (HP-SEC) 
Protein aggregation of samples prior and after freeze-drying was monitored via HP-
SEC. Befor injection, samples were filtered or centrifuged in order to remove insoluble 
aggregates. From each species at least two samples were analyzed and each sample was 
injected twice. The chromatograms were integrated manually using the Chromeleon Soft-
ware from Dionex (Dionex, Idstein, Germany). The integrated chromatograms were an-
alyzed regarding percentage content of fragments, monomers, dimers, and high molecu-
lar weight species by dividing the partial area under the curve (AUC) of each species by 
the total AUC. Additionally, the recovery of monomer was calculated. To allow for com-
parison of results from different runs, standard calibration curves were collected from 
known concentrations of 0.25 to 1.0 mg/ml. Samples were analyzed undiluted. 
mab_T1 and mab_T2 
A Gynkotek HPLC system was used (Gynkotek, Germering, Germany) equipped 
with a TSKgel G3000SWxl column from Tosoh (Tosoh Bioscience, Stuttgart, Germany). 
An aqueous buffer containing 50 mM sodium phosphate and 300 mM sodium chloride 
(pH=7.0) was used as mobile phase at a flow rate of 0.5 ml/min. 50µl of sample were 
injected and absorbance was measured photometrically at λ=280 nm and recorded by the 
connected Chromeleon software. 
LDH 
A Gynkotek HPLC system was used (Gynkotek, Germering, Germany) equipped 
with a TSKgel G3000SWxl column from Tosoh (Tosoh Bioscience, Stuttgart, Germany). 
An aqueous buffer containing 10 mM sodium phosphate and 150 mM sodium chloride 
(pH=6.9) was used as mobile phase at a flow rate of 0.8 ml/min. 50µl of sample were 
injected and absorbance was measured photometrically at λ=280 nm and recorded by the 
connected Chromeleon software. 
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GCSF 
A Dionex Ultimate 3000 HPLC system was used (Dionex, Idstein, Germany) equipped 
with a YMC-Pack Diol 120 DL 12S05 – 3008 WT column from YMC Europe (YMC Europe, 
Dinslaken, Germany). An aqueous buffer containing 50 mM sodium phosphate and 
300 mM sodium chloride (pH=7.0) was used as mobile phase at a flow rate of 0.8 ml/min. 
30µl of sample were injected and absorbance was measured photometrically at λ=215 nm 
and recorded by the connected Chromeleon software. 
 
RPA 
A Gynkotek HPLC system was used (Gynkotek, Germering, Germany) equipped 
with a TSKgel G3000SWxl column from Tosoh (Tosoh Bioscience, Stuttgart, Germany). 
An aqueous buffer containing 0.5 M arginine and 0.25 M phosphate (pH=7.5) was used 
as mobile phase at a flow rate of 0.5 ml/min. 50µl of sample were injected and the eluate 
was monitored by fluorescence (extinction λ=280 nm, emission λ=344nm) and recorded 
by the connected Chromeleon software. 
 
2.2.2 LIGHT OBSCURATION (LO) 
Light obscuration was used in addition to HP-SEC to characterize samples prior to 
and after freeze-drying regarding protein aggregation. Via LO the concentration of sub-
visible particles (svp) in the range of 1 to 200 µm was determined using a PAMAS SVSS-
C40 device (PAMAS, Rutesheim, Germany). The system was calibrated annually. Ahead 
of use, the device was rinsed with HPW (0.2µm filtered) until control measurement 
showed a particle count of less than 100 particles > 1 µm per ml. To gain the necessary 
volume of 1.3 ml for one sample cycle (0.4 ml sample pre-rinse, 3 measurements each 
consuming 0.3 ml) two lyophilizates were reconstituted and pooled. At least two sample 
cycles were measured (i.e. four lyophilizates). To evaluate protein aggregation the mean 
svp count per ml of particles >1 µm, >10 µm, and >25µm were calculated. 
 
2.2.3 NEPHELOMETRY (TURBIDITY) 
To assess insoluble protein aggregates also in the range below 1 µm turbidity of sam-
ples prior and after freeze-drying was determined via nephelometry. The turbidity was 
measured by static light scattering at 90° (λ = 860 nm) using a NEPHLA turbidimeter (Dr. 
Lange, Düsseldorf, Germany) and recorded in formazine nephelometric units (FNU). At 
least a duplicate of 2 ml of pre-lyophilization solutions or 2 pooled vials of reconstituted 
lyophilizate, respectively was analyzed and the mean values are calculated. 
2.2.4 FOURIER TRANSFORM INFRARED (FTIR) SPECTROSCOPY  
The secondary structure of proteins prior to freeze-drying and after reconstitution of 
the freeze-dried products were investigated using Fourier Transform Infrared (FTIR) 
spectroscopy. A Tensor 27 FTIR spectrometer (Bruker Optics, Ettlingen, Germany) 
equipped with a temperature controlled (20°C) calcium fluoride flow through cell (Aqua 
Spec Flow Cell AS 1100 BM, path length 6.5 µm, Bruker Optics, Ettlingen, Germany) and 
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a nitrogen cooled mercury-cadmium-telluride (MCT) detector was utilized. Each spec-
trum was generated by 120 scans (LDH formulations: 240 scans) from 4000 to 850 cm-1 
with a resolution of 4 cm-1. In order to evaluate pure protein spectra, placebo excipient 
solutions were measured, which represented the exact composition of the respective for-
mulation but without protein content. Either these placebo solutions were directly used 
as background spectra or they were subtracted by the OPUS software (OPUS 6.5, Bruker 
Optics, Ettlingen, Germany) prior to analyzing the measurement data. To evaluate sec-
ondary structure elements of proteins, the amide I region of the spectra (1720 – 1580 cm-
1) was vector normalized (i.e. area normalized) and the second derivative was calculated 
(with 17 smoothing points according to the Savitzky-Golay algorithm). At least two sam-
ples of each species were injected in duplicate. The mean spectra were calculated and 
samples before freeze-drying were visually compared to reconstituted freeze-dried sam-
ples. Beyond visual comparison for selected samples, a correlation coefficient of the spec-
tra was calculated according to Prestrelski et al [26] (cf. Equation (3.1)), where 𝑟 repre-
sents the correlation coefficient (𝑟 = 1 for identically spectra) whereas 𝑥𝑖 and 𝑦𝑖 represent 
the spectral absorbance values of the two spectra that should be compared. For calcula-
tion the range between 1720 and 1610 cm-1 was evaluated. 
 
𝑟 =
∑ 𝑥𝑖𝑦𝑖
√∑ 𝑥𝑖
2 ∑ 𝑦𝑖
2
(3.1) 
 
For heat stress spectra measurement of mab_T1, mab_T2, and GCSF a Bio ATR cell II 
(Bruker Optics, Ettlingen, Germany) was used. A temperature ramp was accomplished 
from 30°C to 90°C recording a spectrum every 10 minute. Initially, background spectra 
of the placebo solution were taken and subsequently the protein solution of about 
10 mg/ml in the same buffer was measured. Second derivative spectra were calculated 
and standardized. 
2.2.5 CATALYTIC ACTIVITY 
LDH 
The enzymatic activity of LDH was evaluated by monitoring the decrease of absorp-
tion at 340 nm using the enzyme assay provided by Sigma-Aldrich (Sigma-Aldrich, Stein-
heim, Germany). 100 mM phosphate buffer pH 7.5 was prepared by dissolving 0.842 g 
monosodium phosphate dihydrate and 2.580 g disodium hydrogen phosphate dihydrate 
in 200 ml HPW. 23.05 mg β-NADH was dissolved in 5.0 ml 100 mM phosphate buffer 
and further diluted 1:50 with 100 mM phosphate buffer (final concentration 0.13 mM). 
75.92 mg sodium pyruvate was dissolved in 1.0 ml 100 mM phosphate buffer and further 
diluted 1:10 with 100 mM phosphate buffer (final concentration 0.69 mM). For dilution of 
LDH samples (in order to inhibit adsorption of LDH to cuvettes etc.) a 1.0% (w/v) solution 
of bovine serum albumine (BSA) was prepared by dissolving 200.0 mg BSA in 20 mL 
100 mM phosphate buffer. LDH samples were diluted to a final LDH concentration of 0.5 
μg/mL (approx. 0.46 units/mL) with 1%(w/v) BSA solution (to minimize dilution errors 
a two-step dilution scheme was applied). Before measurement, the β-NADH and the py-
ruvate solution were equilibrated at 37°C. To start the measurement, a Poly (methyl 
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methacrylate) (PMMA) was placed in an Agilent 8453 UV-visible Spectrophotometer 
(Agilent Technologies, Waldbronn, Germany) temperature controlled at 37°C. 2.8 ml β-
NADH solution was pipetted into the cuvette and 100 μl pyruvate solution was added. 
Finally, 100 μl sample solution was added and a 1000 μL Eppendorf pipette was used to 
mix the solution gently. Immediately after mixing the UV absorption (λ = 340 nm) it was 
measured for at least 120 seconds. The activity was calculated using equation (3.2) based 
on a linear slope (∆𝐴340𝑛𝑚
𝑠𝑎𝑚𝑝𝑙𝑒) obtained by regression. 3 (ml) represents the total volume of 
the assay, 𝑓 is the dilution factor, 6.22 is the millimolar extinction co-efficient of β-NADH 
at 340 nm and 0.1 (ml) is the volume of the enzyme solution added to the assay. Finally, 
the activity in units per mg protein was calculated by equation (3.3). 
 
𝑎𝑐𝑡𝑖𝑣𝑖𝑡𝑦 [
𝑈
𝑚𝑙𝑒𝑛𝑧𝑦𝑚𝑒
] =
(∆𝐴340𝑛𝑚
𝑠𝑎𝑚𝑝𝑙𝑒
− ∆𝐴340𝑛𝑚
𝑏𝑙𝑎𝑛𝑘 )3𝑓
(6.22)(0.1)
(3.2) 
𝑎𝑐𝑡𝑖𝑣𝑖𝑡𝑦 [
𝑈
𝑚𝑔𝑝𝑟𝑜𝑡𝑒𝑖𝑛
] =
𝑎𝑐𝑡𝑖𝑣𝑖𝑡𝑦 [
𝑈
𝑚𝑙𝑒𝑛𝑧𝑦𝑚𝑒
]
𝑚𝑔𝑝𝑟𝑜𝑡𝑒𝑖𝑛
𝑚𝑙𝑒𝑛𝑧𝑦𝑚𝑒
(3.3) 
 
In order to correct day-to-day variations of the assay, a standard LDH solution was 
included in the daily measurements. This standard solution was prepared by directly 
diluting 83.3 µl of LDH suspension as purchased from Sigma-Aldrich with 916.6 µl 1% 
(w/v) BSA solution to a final concentration of 0.5 μg/ml.  
RPA 
The plasminogenolytic activity of rPA was analyzed by a method based on an assay 
described by Kohnert et al. [27]. Samples to be analyzed were diluted to a rPA concentra-
tion of 10 µg/ml with a 100 mM TRIS buffer (pH=7.5). The temperature of the diluted 
sample and of a 12 mM solution of S-2288TM was adjusted to 37 °C in a water bath. S-
2288TM (H-D-Isoleucyl-L-prolyl-L-arginine-p-nitroaniline dihydrochloride) is an artificial 
substrate of rPA. Cleavage of S-2288TM at the amide group results in the formation of p-
nitroaniline.  
To start the enzymatic reaction, 50 µl of diluted sample was mixed with 50 µl of the 
12 mM S-2288TM solution in a pre-warmed (37 °C) quartz well plate. The concentration of 
p-nitroaniline was detected by UV absorption at 405 nm (extinction coefficient 9750 l mol-
1  cm-1) using a BMG Fluostar Omega at 37 °C (BMG Labtech, Offenburg, Germany) over 
10 minutes. The activity of rPa was calculated from the linear fit (i.e. slope) of the first 120 
data points (i.e. 120 s) of the measurement.  
2.3 PHYSICAL CHARACTERISTICS OF LYOPHILIZATES 
2.3.1 MACROSCOPIC APPEARANCE 
Each species of lyophilizates was visually inspected regarding the macroscopic ap-
pearance. Characteristics like cracks, shrinkage, foaming, spattering, etc. were taken into 
consideration. In order to document the macroscopic appearance, pictures of at least two 
samples of each species were taken.  
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2.3.2 KARL-FISCHER (KF) 
The residual water content of lyophilizates was analyzed by coulometric Karl-Fischer 
titration employing a 737 KF Coulometer (Metrohm, Filderstadt Germany). Prior to 
measurement, the calibration of the device was checked by water standards (Hydranal® 
water standard 1.0 and 0.1, Riedel-de-Haën, Sigma-Aldrich, Steinheim, Germany). For 
analysis of lyophilizates, 3 mL of dry methanol (Hydranal® -Methanol dry, Fluka, Sigma-
Aldrich, Steinheim, Germany; kept dry by a molecular sieve, UOP Type 3A, Fluka, 
Sigma-Aldrich, Steinheim, Germany) was added to the sealed lyophilizate by injection. 
To allow for a complete extraction of water from the dispersed lyophilizate, the sample 
was placed in an ultrasonic bath for 10 minutes. After extraction, 1 ml of the methanol 
was injected into the reaction vessel and the amount of water was determined (maximum 
allowed start drift 10 µg/min). To correct for water content of the methanol, each time 
three blank measurements were performed at the beginning and at the end of each meas-
urement series. Each lyophilizate species was measured at least in triplicate. The residual 
water content in percentage was calculated based on the weight of the lyophilizate (cal-
culated from filling volume and solid content of the formulation). 
2.3.3 DIFFERENTIAL SCANNING CALORIMETRY (DSC) 
Differential Scanning Calorimetry was used to characterize the formulations before 
freeze-drying and the freeze-dried (and stored) samples, respectively. A DSC 204 Phoe-
nix (Netzsch, Selb, Germany) system was used, which was annually calibrated by an in-
dium standard.  
Glass transition of the maximally freeze-concentrated solution (Tg’) 
For analyzing Tg’ 20 µl solution it was pipetted to aluminum crucibles that where 
subsequently closed by an aluminum lid and cold welded. As reference, an empty cruci-
ble was used (also sealed by a lid). To determine Tg’ the samples were cooled down to -
70°C at a cooling rate of 10 K/min and subsequently heated up to 20°C at a heating rate 
of 10 K/min. The midpoint of an endothermic shift of the baseline during the heating scan 
was regarded as Tg’. Samples were analyzed in triplicates. 
Glass transition of the freeze-dried samples (Tg) 
In order not to compromise the glass transition temperatures by exposure to air hu-
midity, the preparation of samples were accomplished in an isolator flushed by dry ni-
trogen gas. About 5 to 15 mg of a freeze-dried sample was homogenized within the vial 
by a spatula and accurately weighted into aluminum crucibles and sealed by an alumi-
num lid. As reference, an empty crucible sealed under nitrogenwas used too. To deter-
mine Tg, samples were cooled to 0°C at a cooling rate of 10 K/min, then heated to 100 – 
120°C (depending on the excipients used) at 10 K/min, again cooled to 0° at 10 K/min, 
and finally heated up to 160 - 200°C (depending on the excipients used) at a heating rate 
of 10 K/min. The first heating step was included in order to remove artifacts and not used 
for analysis. From the second heating scan the midpoint of endothermic shifts were re-
garded as glass transitions. Moreover, further endo- and exothermic events were as-
signed to melting or crystallization of sample compounds. 
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2.3.4 FREEZE-DRYING MICROSCOPY (FDM) 
The collapse temperatures of certain formulations were analyzed by Freeze-Drying 
Microscopy (FDM). A Linkham FDCS 196 freeze-drying stage (Linkham Scientific Instru-
ments, Surrey, UK) with a liquid nitrogen cooling system, a programmable temperature 
controller, and a vacuum pump (TRIVAC, Oerlikon Leybold Vacuum, Köln, Germany) 
were used in combination with a Zeiss Axio Imager Zm1 microscope (Zeiss, Göttingen, 
Germany) and set up with a Pixelink digital camera (Linkham Scientific Instruments, 
Surrey, UK). Utilizing a Zeiss LD Epiplan 20x lens (Zeiss, Göttingen, Germany) a 200-fold 
magnification was used. Pressure was monitored with a Pirani sensor and controlled by 
a proportional bleeding valve. Temperature was determined via a thermocouple 
mounted in the oven, used to control the sample temperature. For analysis, a droplet of 
2 µl was placed on a glass cover slide, which was positioned on top of the oven of the 
freeze-drying stage (for better thermal contact a thin film of silicon oil is applied between 
oven and cover slide). A precision cut spacer of 25µm thickness was used to ensure a 
constant thickness of the layer to be analyzed. Finally, a second glass cover slide was 
placed on top. Samples were frozen at a cooling rate of 1 K/min to -50°C. After reaching 
-50°C a vacuum of 0.02mbar was applied. In the next step, the sample was heated at a 
heating rate of 1 K/min and pictures were taken every second. Characteristic changes in 
the structure of the already dried material (behind the progressing sublimation front) 
were attributed to micro-collapse, macro-collapse, and meltback. 
2.3.5 X-RAY POWDER DIFFRACTION (XRD) 
To characterize the molecular structure of freeze-dried samples X-Ray Powder Dif-
fraction (XRD) was utilized. Around 100 mg of sample was grinded to powder in the 
freeze-drying vial by a spatula and subsequently placed on a copper sample holder in a 
flat layer. Analyses were carried out using a Seifert XRD 3000 TT diffractometer (GE Sens-
ing & Inspection Technologies, Ahrensburg, Germany) with a Bragg-Brentano theta-theta 
geometry and equipped with a copper anode (40 kV, 30 mA, CuKα at λ=0.15417nm). 
Samples were analyzed from 5° to 45° 2-θ with a step size of 0.05° 2-θ and a hold time of 
2 seconds per angle. The resulting diffractograms were evaluated regarding diffraction 
peaks. Detected diffraction peaks were compared to reference diffraction patterns of the 
International Centre for Diffraction Data (ICDD) (formerly JCPDS) database. If no dif-
fraction peaks were present in the diffractogram, the sample was regarded as fully amor-
phous. 
 
2.3.6 SCANNING ELECTRON MICROSCOPY (SEM) 
To get an insight into the morphology of the lyophilizate scanning electron micros-
copy was applied. Small pieces of a sample were extracted carefully from the vial and 
put to a double-sided adhesive carbon tape (Bal-tec GmbH, Witten, Germany) on top of 
an aluminum sample holder. In order to enhance electrical conductivity, samples were 
prepared by low-vacuum sputter coating using carbon. For microscopy, a Jeol JSM-6500F 
(Jeol, Ebersberg, Germany) at magnifications of up to 10,000 was used. 
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2.3.7 DETERMINATION OF SPECIFIC SURFACE AREA (SSA) 
Krypton gas adsorption according to the Brunauer Emmett Teller (BET) method was 
used to determine the specific surface area (SSA) of lyophilizates. Measurements were 
performed by using an Autosorb-1 (Quantachrome Instruments, Odelzhausen, Ger-
many) purged with Krypton 4.8. Two to five lyophilizates were pooled to reach a volume 
of about 1 cm3 and weighted into a special glass tube. Subsequently, samples were de-
gassed for at least two hours by vacuum at room temperature (by the Autosorb-1 degas-
sing feature). For analysis, krypton adsorption at 77 K over a relative pressure range of 
0.05 – 0.3 was accomplished and the Brunauer Emmett and Teller (BET) equation was 
used to fit the data employing at least 5 measurement points and calculate the SSA. Ac-
cording to the European Pharmacopeia the correlation coefficient of the fit was at least 
0.9975 (r2=0.995) [1]. 
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CHAPTER 4 INVESTIGATIONS ON THE AGGRESSIVE FREEZE-
DRYING PROCESS  
1. INTRODUCTION 
A number of textbooks (e.g. [1-4]) and publications (e.g. [5-8]) are available concerning 
the proper performance of freeze-drying with respect to conventional strategy and re-
sulting product qualities. More recently it was shown that also the application of compa-
rably harsh conditions in terms of freeze-drying process parameters, resulted in freeze-
dried products of admirable stability of the incorporated proteins – although they exhib-
ited a collapsed appearance [9]. The proper stabilization which was reported not only for 
the stability of mentioned “collapse-dried” products right after drying, but also during 
accelerated storage stability studies [10], stimulates to reconsider the conventional ap-
proach of freeze-drying of pharmaceutical formulations. Most recently it was shown that, 
compared to conventionally freeze-dried (=elegant) lyophilizates, the collapsed lyophi-
lizates are less susceptible to changes during storage at elevated temperatures [11]. 
Conventional freeze-drying ever since is known as a time-consuming production step. 
Throughout research and development the application of product temperatures as high 
as possible is strived for [12-15]. Bearing now the findings of Schersch et al [9, 10] in mind, 
the application of aggressive conditions for freeze-drying appears as an encouraging pos-
sibility to save time and therefore resources without compromising key product qualities, 
i.e. stability of the molecule to be stabilized. Therefore, an investigation of the robustness 
and potentially universal use of aggressive freeze-drying to different types of protein for-
mulations is of high interest. 
In contrast to conventional freeze-drying, for the quite new field of aggressive freeze-
drying little is known concerning major topics like relation between variations of process 
or formulations parameters and later product characteristics by now. Regarding a poten-
tial evolution of aggressive freeze-drying from an unwanted aberration of conventional 
freeze-drying towards a competitive alternative, there is the utmost need to gain more 
knowledge about the relation of controllable process parameters and final product char-
acteristics. In addition, the applicability of aggressive freeze-drying to different freeze-
drier designs would be a prerequisite for successful establishment of aggressive freeze-
drying as a reliable drying technology. As final product qualities inherently depend on 
the initial solution, and quite a number of different formulations are reported to be con-
ventionally freeze-dried [6, 8], also the suitability of aggressive freeze-drying for a broad 
range of formulations is a topic of high interest, which is outlined in Chapter 5 of this 
thesis.  
In addition to the relationship between process parameter variations and final prod-
uct qualities, kinetics of primary and secondary drying mechanisms of aggressive freeze-
drying were investigated. As a third topic, the use of different freeze-drier designs for 
aggressive freeze-drying were studied.  
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Important physicochemical characteristics of aggressive freeze-dried products like re-
sidual water content and glass transition temperature were determined. To gain further 
insight in the qualities of those products, a set of techniques (e.g. specific surface area 
analysis, X-Ray powder diffraction) were applied. Besides the importance of basic phys-
icochemical characteristics, also the impact of different process conditions on the stability 
of incorporated proteins was evaluated. In order to cover a significant range of marketed 
biopharmaceutical proteins [16], an IgG1 antibody (mab_T1) was used as main model 
protein. Due to its susceptibility to freezing and drying stresses, mab_T1 is not stored in 
a lyophilized form, but as refridgerated liquid bulk solution. Upon freeze-drying without 
addition of appropriate cryo- and lyo-protectants or by using improper freeze-drying 
protocols, mab_T1 undergoes remarkable instability expressed as pronounced aggregate 
formation. Therefore, this sensitive molecule is regarded as ideal model to reveal even 
slightly non-ideal conditions that possibly can occur during aggressive freeze-drying. In 
order to compare the results from aggressively freeze-dried samples to the state of the art 
technique, selected samples were also freeze-dried according to conventional freeze-dry-
ing protocols. As the main instability pathway of mab_T1 is of aggregative nature, the 
investigation of protein stability was focused on analytical tools, which account for solu-
ble and non-soluble protein aggregates.  
2. VARIATION OF PROCESS CONDITIONS 
To dry a product, or more specific a pharmaceutical formulation at gentle conditions, 
the temperature of the material needs to be controlled at low values. In common freeze-
driers, the product temperature during freeze-drying is controlled by temperature con-
trolled shelves, where the product is placed on (e.g. in a vial). After lowering the product 
temperature to values below temperature of complete solidification of all components 
(for pharmaceutical formulations represented by Tg’) sublimative drying is fostered by 
applying vacuum. The necessary energy input for solid to gaseous phase transition (i.e. 
from ice to water vapor) is provided via controlling the temperature of the shelves in a 
way that ensures the desired product temperature at the given vacuum. After sublima-
tion is completed, in a secondary drying phase the temperature of the shelves is increased 
to higher values to remove non-frozen water via desorption from the product to reach 
desired residual water content. Summing up, the freeze-drying process is operated by 
the control of (shelf) temperature and vacuum (also denoted as chamber pressure).  
While for conventional freeze-drying people have a good understanding of the limits 
on how the process can be controlled to reach desired product temperatures and final 
product characteristics (e.g. [17]), for aggressive freeze-drying this information has never 
been determined so far. The following section presents the results of studies about the 
influence of different combinations of process parameters (shelf temperature, chamber 
pressure, time) on final product characteristics (physical and protein stability) and drying 
kinetics of primary and secondary drying step. In order to keep the focus on the influence 
of process parameters, a straightforward number of formulations has been chosen repre-
senting both, purely amorphous as well as partially crystalline products. 
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2.1 INFLUENCE OF PROCESS VARIATIONS ON PHYSICAL CHARACTERISTICS 
The influence of applied shelf temperature and chamber pressure were evaluated in 
a two-step study. As a first step, based on the collapse-drying process of Schersch [18] 
(originally adapted from [19]), the dependence of collapse behavior from applied cham-
ber pressure was studied, using a purely amorphous product (5% wt/wt sucrose solu-
tion). As it was already shown by Schersch, purely amorphous sugar solutions result in 
sort of a foamed product upon freeze-drying by the collapse-drying protocol. However, 
the formation of foam from the initially micro-porous structure of the frozen product 
implied a tremendous change in structure, that raised the question whether this process 
is well controllable or not. Especially spattering of the low viscous collapsing matrix 
within the vial or even out of the vial seems to be a highly probable scenario, which would 
be unacceptable keeping in mind the use of such a freeze-drying technology for produc-
tion of biopharmaceuticals.  
2.1.1 SUCROSE-BASED LYOPHILIZATES 
The behavior of collapsing material regarding spattering or other uncontrollable be-
havior during aggressive freeze-drying was investigated. A 5% (wt/wt) sucrose solution 
(in 10mM sodium succinate buffer pH 5.5; 2R glass vials, 1 ml fill) was subjected to a 
number of different aggressive freeze-drying protocols based on variations of aggressive 
freeze-drying cycle 1 (cf. Table 3.4, page 55) and using a FTS LyoStarII freeze-drier. In 
order to simulate at least a medium load of the freeze-drier, one of the three shelves of 
the freeze-drier was loaded with filled vials (594 vials). To avoid a bias in resulting char-
acteristics due to edge effects, the outmost two rows of vials were not used for analysis. 
As it was known that chamber pressure plays a major role for drying behavior, only this 
parameter was adjusted to different levels in the first study (cf. Table 4.1).  
Table 4.1: Parameters used for aggressive freeze-drying of 5% (wt/wt) sucrose and resulting product tempera-
tures during primary drying (PD) 
ID chamber pressure shelf temperature drying time product temp. PD 
 mbar °C hours °C 
0.5 0.5 45 24 -24.3 
1 1 45 24 -17.2 
2 2 45 24 -11.5 
4 4 45 24 -0.7 
 
As expected, the different drying protocols resulted in products of different macro-
scopic appearance. Pictures of representative samples can be found in Figure 4.1.  
 
Investigations on the aggressive freeze-drying process 
70 
 
Figure 4.1: Macroscopic appearance of collapsed lyophilizates produced at different chamber pressures (initial 
solution 5% (wt/wt) sucrose in 10mM sodium succinate buffer; numbers indicate applied chamber pressure in 
mbar; 4A – 4C: 4 mbar, due to inconsistent appearance 3 vials shown) 
Chamber pressures of 0.5 mbar and 1 mbar resulted in foamed products, neither 
showing spattered material at the inner walls of the vial, nor at the stopper (throughout 
the whole batch, >50 vials visually inspected). Samples dried at higher chamber pressure 
of 2 mbar and above consistently showed spattered material all over the inner wall of the 
vial and at the inside of the stopper. Whereas at 4 mbar chamber pressure, the material 
even splashed out of the stopper during drying and the single vials of the batch showed 
inconsistent appearance throughout the batch. Characteristic product temperature data 
of 5% (wt/wt) sucrose subjected to aggressive freeze-drying at different chamber pres-
sures are shown in Figure 4.2. The product temperature during primary drying is char-
acterized by a plateau, significantly lower than the applied shelf temperature during the 
first few hours of drying (due to so called self-cooling of the material as a result of subli-
mation: phase transition from solid to liquid “consumes” the energy provided by the 
shelves). If there is no more ice to be sublimed, the product temperature increases to a 
level close to the shelf temperature. Depending on the applied chamber pressure, subli-
mation took place at different product temperatures. Low chamber pressure resulted in 
comparable low product temperature, while higher chamber pressure resulted in higher 
product temperatures (cf. Table 4.1 and Figure 4.2). Compared to conventional freeze-
drying, where sublimation is completed within around 30 hours for the identical setting 
(data not shown), the time needed to remove ice by sublimation is extremely short. 
Counting from the start of drying (indicated by vacuum pull-down and start of the heat-
ing ramp), sublimation is completed within maximum 6 hours.  
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Figure 4.2: Product temperatures 5% (wt/wt) sucrose solution (in 10mM sodium succinate buffer pH 5.5; 2R 
glass vials, 1 ml fill) aggressive freeze-dried at different chamber pressures. Upper graph shows the complete 
process, lower graph shows enlarged detail of product temperatures during early part of aggressive freeze-dry-
ing 
Most reasonable, the different product temperatures, which result from the different 
chamber pressures (cf. Table 4.1), directly influence the viscosity of the collapsing mate-
rial. Higher chamber pressures result in higher product temperatures and therefore de-
creased viscosity. Using equation (1.7) (see page 20) and assuming the applicability also 
to viscous material around 30 K above the glass transition temperature, for a chamber 
pressure of 4 mbar – and therefore product temperature of -0.7 °C – the viscosity of the 
collapsing sucrose is roughly 3.7 million times lower than at the glass transition. Even for 
a product temperature of -24.3 °C (chamber pressure of 0.5 mbar) the viscosity is about 
180 times lower than at the glass transition. As there is a high flow of water vapor from 
the product at lower viscosity, the chance for the product to be carried off to the inner 
vial wall or even through the stopper is increased compared to lower viscosities (i.e. 
lower product temperatures as a result of lower chamber pressures). 
 
Residual moisture data (cf. Figure 4.3) show that for a chamber pressure of 0.5 mbar 
up to 2 mbar there is residual water content of about 2.2% and no significant difference 
in residual water content. On the contrary, a chamber pressure of 4 mbar resulted in 
higher residual water content of 3.3%. Obviously, the non-controlled spattering of the 
vials during drying hinders effective removal of residual water. Additionally, the stand-
ard deviation between three analyzed vials was consistently higher for samples that 
showed spattering of material (2 mbar and 4 mbar chamber pressure). This is taken as an 
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indication for inhomogeneous drying behavior of single vials within one batch for cycles 
that apply higher chamber pressures. Consequently, the application of chamber pressure 
of 0.5 mbar as well as 1 mbar resulted in lyophilizates that dry controllable (i.e. no spat-
tering or other uncontrollable drying behavior) and homogeneously throughout the 
batch.  
 
Figure 4.3: Residual water content of aggressively freeze-dried 5% (wt/wt) sucrose (in 10mM sodium succinate 
buffer pH 5.5; 2R glass vials, 1 ml fill; n=3).  
From a more general perspective, also the residual water content of samples from cy-
cles utilizing chamber pressures of 0.5 and 1 mbar are comparably high for a freeze-dried 
pharmaceutical formulation. Especially, if the high drying temperature of 45 °C and the 
comparably long time of about 18 hours at product temperatures close to 45 °C (cf. upper 
part of Figure 4.2) are taken into consideration. Although the target residual water con-
tent for pharmaceutical protein formulations has to be determined for every product sep-
arately, an often recommended aim is a residual water content of below 2% [6]. Due to 
controllable drying behavior and lowest residual moisture content, from this study a 
chamber pressure of 1 mbar (at 45 °C shelf temperature) seems to be most feasible for 
aggressive freeze-drying of 5% sugar solution.  
 
2.1.2 TREHALOSE-BASED LYOPHILIZATES 
The knowledge gained from the experimental series using 5% (wt/wt) sucrose solu-
tion was used as a starting point for a second study that was initiated to investigate the 
influence of chamber pressure, shelf temperature and process time on the physical char-
acteristics of resulting lyophilizates. In order to maximize the knowledge on a design 
space for aggressive freeze-drying towards formulations containing a bulking agent, be-
sides 5% (wt/wt) trehalose two formulations containing phenylalanine as bulking agent 
were included (cf. Table 4.2). Trehalose was chosen instead of sucrose to extend the study 
to the second of the mainly used amorphous stabilizers in freeze-dried pharmaceutical 
products [8].  
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Table 4.2: Formulations used to characterize the influence of process conditions on the resulting characteristics 
of aggressively freeze-dried model formulations 
ID trehalose phenylalanine potassium 
phosphates 
mab_T1 
 mg/ml mg/ml mg/ml mg/ml 
tre 50  2.4 1.0 
tre:phe 10:0.5 47.6 2.4 2.4 1.0 
tre:phe 10:3 38.5 11.5 2.4 1.0 
 
Formulation tre:phe 10:0.5 exemplifies a formulation at 5% (wt/wt) solid content, con-
taining a low amount of bulking agent, while formulation tre:phe 10:3 represents a for-
mulation at a high content of bulking agent. Preliminary tests have shown that 
tre:phe 10:3 can be considered as similar to a formulation of trehalose and mannitol at a 
ratio of 1:3 regarding physico-chemical characteristics like residual moisture, glass tran-
sition temperature and specific surface area (compare section 3 of CHAPTER 5, page 
113pp.). To concurrently investigate the influence of different cycle conditions on the sta-
bility of an incorporated protein, mab_T1 was added in a concentration of 1 mg/ml. Re-
sults referring to the stability of mab_T1 are shown in section 2.3 of this chapter. 
For this study, samples were freeze-dried in a Christ 2-12D freeze-drier (at approx. 
1/2 load) utilizing the different freeze-drying protocols shown in Table 4.3.  
Table 4.3: Cycles used for aggressive freeze-drying of 5% (wt/wt) trehalose, tre:phe 10:0.5, and tre:phe 10:3 
ID chamber pressure shelf temperature drying time 
 mbar °C hours 
0.1_30_8 0.1 30 8 
0.1_30_24 0.1 30 24 
0.1_60_8 0.1 60 8 
0.1_60_24 0.1 60 24 
1_45_8 1 45 8 
1_45_24 1 45 24 
2_45_15 2 45 15 
2_45_24 2 45 24 
4_30_8 4 30 8 
4_30_24 4 30 24 
4_60_8 4 60 8 
4_60_24 4 60 24 
 
The range of chamber pressure was set from 0.1 mbar, representing a pressure fre-
quently used for conventional freeze-drying, to 6 mbar representing the theoretical upper 
limit of sublimation (triple point of water). However, during preliminary tests a stepwise 
reduction of chamber pressure set point to 4 mbar was necessary, due to the fact that 
above 4 mbar the samples showed meltback right after start of the heating ramp indicat-
ing product temperatures exceeding the melting temperature of the formulation (around 
0 °C). 
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Shelf temperature was varied from 30 °C, regarded as low shelf temperature for ag-
gressive freeze-drying, up to 60 °C, representing the maximum shelf temperature the uti-
lized freeze-drier is capable. As it was known that primary drying of 5% (wt/wt) trehalose 
solution is completed within maximum 6 hours (comparable to 5% (wt/wt) sucrose solu-
tion, data not shown) 8 hours were set as lower limit for drying time. The upper limit of 
drying time was set to 24 hours considering the idea that aggressive freeze-drying should 
represent a fast freeze-drying process compared to conventional freeze-drying. In order 
to reduce the number of necessary freeze-drying runs, samples of 8 and 24 hours drying 
time were produced within one freeze-drying cycle. To remove samples after 8 hours 
drying time, the freeze-drier was vented with nitr ogen, samples were removed and the 
freeze-drier was evacuated again to complete the 24 hours drying for the remaining sam-
ples. As primary drying was completed for all samples after 8 hours, indicated by prod-
uct temperatures close to the shelf temperature, the final structures of the lyophilizates 
were already settled.  
Product temperature 
Table 4.4 shows the product temperatures of the three different formulations during 
primary drying. While product temperatures approach the shelf temperature after fin-
ishing sublimation, during sublimation (i.e. primary drying) of aggressive freeze-drying 
the product temperatures resides from 33.4 K up to 87.9 K below the shelf temperature 
(difference between Ts and Tp).  
Table 4.4: Product temperatures during primary drying of 5% (wt/wt) trehalose, tre:phe 10:0.5, and tre:phe 10:3 
ID 5% (wt/wt) trehalose tre:phe 10:0.5 tre:phe 10:3 
 °C °C °C 
0.1_30 -28.8 -26.7 -27.7 
0.1_60 -27.9 -26.8 -20.7 
1_45 -17.7 -16.4 -12.3 
2_45 -11.5 -8.4 -7.5 
4_30 -3.7 -4.1 -3.4 
4_60 -3.7 -2.5 -1.7 
 
Regarding the influence of shelf temperature and chamber pressure on the product 
temperature, an interesting trend could be shown. Although there is a difference of 30 K 
(30 °C versus 60 °C) between the shelf temperatures applied in different cycles, neither 
for low chamber pressure (0.1 mbar) nor for high chamber pressure (4 mbar) trehalose as 
well as tre:phe 10:0.5 did show a considerable difference in resulting product tempera-
tures. On the other hand, comparing product temperatures of samples from aggressive 
freeze-drying cycles applying identical shelf temperatures of e.g. 30 °C but different 
chamber pressures, it was shown that a low chamber pressure resulted in low product 
temperatures, while a high chamber pressure resulted in high product temperatures. For 
example at a chamber pressure of 0.1 mbar the product temperature of 5% (wt/wt) treha-
lose exhibits -28.8 °C while at the same shelf temperature but with 4 mbar chamber pres-
sure the product temperature reaches -3.7 °C. The same clear trend holds true for both, 
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the low as well as high bulking agent containing formulation. However, while the low 
bulking agent containing formulation exhibits product temperatures very similar to the 
formulation containing no bulking agent, tre:phe 10:3 exhibits a slightly higher product 
temperature especially at 0.1 as well as 1 mbar chamber pressure. This particular formu-
lation contains phenylalanine (=bulking agent) in an amount, preventing the macroscopic 
collapse of the lyophilizate (compare also Figure 4.4) as well as resulting in higher specific 
surface area (compare also Figure 4.5) and therefore indicating a higher resistance of the 
already dried layer against the passing water vapor (i.e. product resistance R𝑃; compare 
equation (1.3)). By a higher product resistance the local pressure at the sublimation front 
is increased and consequently the product temperature increased. 
Generally, it can be stated that the product temperature during sublimation (i.e. pri-
mary drying) of aggressive freeze-drying is mainly determined by the applied chamber 
pressure as it is the case in conventional freeze-drying, too. 
 
Macroscopic appearance 
Having a look at the products from the different formulations and aggressive freeze-
drying cycles it revealed quite different macrosopic appearance of the samples (cf. Figure 
4.4). The appearance of the samples exhibits a broad range from no visuable sings of 
collapse to completely collapsed with spattering through the stopper. While 5% (wt/wt) 
trehalose and tre:phe 10:0.5 showed a very similar appearance for all applied cycles, the 
higher content of phenylalanine in formulation tre:phe 10:3 rendered this formulation 
more resistively against macroscopic collapse. 
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Figure 4.4: Macroscopic appearance of samples subjected to different aggressive freeze-drying protocols (24 
hours drying time). A: 5 % (wt/wt) trehalose, B: tre:phe 10:0.5, C: tre:phe 10:3; I: 0.1 mbar_30 °C, II: 4 mbar_30 °C, 
III: 1 mbar_45 °C, IV: 2 mbar_45 °C, V: 0.1 mbar_60 °C, VI: 4 mbar_60 °C 
As expected for the aggressive conditions of the applied freeze-drying cycles, the 
samples containing no or a low amount of bulking agent (tre, tre:phe 10:0.5) showed 
macroscopic detectable collapse for all of the applied shelf temperatures and chamber 
pressures. While for chamber pressures of 1 mbar and above, there could be observed 
fully collapsed appearance for 5% (wt/wt) trehalose (foam-like appearance) and 
tre:phe 10:0.5 (sponge-like appearance), a chamber pressure of 0.1 mbar resulted in 
samples that showed only slight shrinkage. At that chamber pressure, even the 
application of shelf temperature of 60 °C was not able to increase the product 
temperatures to an extent that would cause fully collapsed lyophilizates. To gain data 
about the critical product temperature of the utilized formulations, the glass transition 
temperature of the maximally freeze-concentrated solution (Tg’) was determined by DSC 
analysis. Moreover, also the collapse temperatures of the formulations were determined 
using freeze-drying microscopy (FDM). Table 4.5 shows the corresponding results. Both 
5% (wt/wt) trehalose and tre:phe 10:0.5 showed comparable glass transition and collapse 
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temperatures. Comparing product temperatures of both formulations Tg’ and 𝑇𝑐
𝑚𝑖𝑐𝑟𝑜 it 
becomes apparent that for a chamber pressure of 0.1 mbar the product temperatures are 
in the range of those critical product temperatures. Therefore, the viscosity of the samples 
is not low enough to cause full collapse, but some degree of micro-collapse resulting in 
apparent shrinkage. For increasing chamber pressures of 1 mbar and 2 mbar, also the 
product temperature increases to values considerably higher than Tg’ and 𝑇𝑐
𝑚𝑎𝑐𝑟𝑜, 
consequently resulting in fully collapsed products. At a chamber pressure of 4 mbar all 
formulations showed macroscopic collapse, tre and tre:phe 10:05 even foamed out of the 
stopper as already observed for aggressive freeze-drying of 5% (wt/wt) sucrose at 4 mbar 
(see above). The higher content of phenylalanin in tre:phe 10:3 resulted in an appearance 
indicating collapse at a late stage of primary drying as a considerable piece of already 
dried cake was elevated by material collapsing at the bottom of the vial.  
Table 4.5: Glass transition temperature of the maximally freeze-concentrated solution (Tg’) as well as collapse 
temperatures (𝑇𝑐
𝑚𝑖𝑐𝑟𝑜, 𝑇𝑐
𝑚𝑎𝑐𝑟𝑜) of 5% (wt/wt) trehalose, tre:phe 10:0.5, and tre:phe 10:3 
Formulation Tg’ 𝑇𝑐
𝑚𝑖𝑐𝑟𝑜 𝑇𝑐
𝑚𝑎𝑐𝑟𝑜 
 °C °C °C 
5% (wt/wt) trehalose -30.8 -30.5 -28.2 
tre:phe 10:0.5 -30.5 -30.0 -28.5 
tre:phe 10:3 -29.3 -20.3 -10.2 
 
 
In contrast to the formulations containing no or a low amount of phenylalanine as 
bulking agent (tre, tre:phe 10:0.5), up to chamber pressures of 2 mbar, tre:phe 10:03 
resulted in macroscopically elegant cakes independent from shelf temperature. 
Comparing again the critical temperatures Tg’, 𝑇𝑐
𝑚𝑖𝑐𝑟𝑜, and 𝑇𝑐
𝑚𝑎𝑐𝑟𝑜 with the product 
temperatures of tre:phe 10:3 at the different chamber pressure from the different cycles, 
it becomes apparent that up to a chamber pressure of 2 mbar the product temperature is 
below or in the vicinity of 𝑇𝑐
𝑚𝑎𝑐𝑟𝑜. Contrary to the formulations tre and tre:phe 10:0.5 the 
amount of phenylalanine contained in tre:phe 10:3 result in a remarkable difference of 
10.1 K between 𝑇𝑐
𝑚𝑖𝑐𝑟𝑜 and 𝑇𝑐
𝑚𝑎𝑐𝑟𝑜 according to FDM. Moreover 𝑇𝑐
𝑚𝑖𝑐𝑟𝑜 is 9 K higher than 
Tg’ .This phenomenon can be attributed to the formation of a crystalline phenylalanine 
dominated matrix within the product, which is able to withstand higher temperatures 
and to which amorphous sugar is thought to collapse on (compare also [20]). So while the 
product temperature exceed Tg’ and/or 𝑇𝑐
𝑚𝑖𝑐𝑟𝑜, 𝑇𝑐
𝑚𝑎𝑐𝑟𝑜 is not exceeded to a degreee 
causing macroscopically detectable collapse.  
Specific Surface Area (SSA) 
To confirm the observation from assesment of macroscopic appearance of the 
aggressive freeze-dried samples, also the specific surface area (SSA) was evaluated. As 
shown by Schersch [18], the determination of the SSA is a sensitive and valuable tool to 
detect even slight changes in the structure of a product that is not discenarbly visible. 
Especially the occurance of micro-collapse in aggressive freeze-dried products can be 
determined by reduced SSA compared to products that are freeze-dried conventionally. 
SSA of freeze-dried samples was determined by BET gas adsorption (cf. Figure 4.5). For 
Investigations on the aggressive freeze-drying process 
78 
comparison to non-collapsed products, also conventionally freeze-dried samples were 
analyzed (freeze-dried according to cycle 3, shown in Table 3.8 on page 57). 
Comparing the SSA of sample from aggressive freeze-drying to conventionally freeze-
dried ones (cf. Figure 4.5), the formulation with high bulking agent content (tre:phe 10:3) 
showed a significant reduction of SSA from 3.3 m²/g (conventional) to at most 2.2 m²/g 
(aggressive, 0.1 mbar, 30°C). Increasing chamber pressure – and therefore increasing 
product temperature – resulted in decreasing SSA down to 1.1 m²/g (2 mbar, 45°C), 
although the macroscopic appearance showed no visible signs of collapse. These data 
confirm the assumption that micro-collapse occurred during aggressive freeze-drying. 
Micro-collapse was caused by product temperatures above Tg’ and 𝑇𝑐
𝑚𝑖𝑐𝑟𝑜. For samples 
of tre:phe 10:3 that showed macroscopic collapse, the SSA is further reduced to around 
0.4 m²/g.  
Regarding SSA, formulations containing no or a low amount of phenylalanine are 
comparable. Obviously, the low amount of bulking agent does not influence the drying 
behavior regarding SSA. Comparing the slightly shrunken samples aggressively freeze-
dried at 0.1 mbar with conventionally freeze-dried samples, a reduction from 2.1 m²/g to 
about 1.0 m²/g could be noticed, indicating micro-collapse of that products. Fully 
collapsed samples of tre and tre:phe 10:5 exhibits SSA of 0.2 m²/g and below. 
According to macroscopic appearance and specific surface area data, no change in 
structure of product occurred during the period between 8 hours and 24 hours drying 
time (data not shown). Therefore, the additional drying time can be regarded as domi-
nated by secondary drying mechanisms. 
 
Figure 4.5: Specific surface area of samples subjected to different aggressive freeze-drying protocols (24 hours 
drying time). 
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Reconstitution time 
Since the highly porous structure of freeze-dried products generally allows for a fast 
rehydration of such products, a reduced porosity is also considered to worsen the rehy-
dration behavior of collapsed products [21, 22]. The products from aggressive freeze-dry-
ing of the three different formulations were rehydrated with water and the time until 
complete dissolution was determined (cf. Figure 4.6). Despite collapsed structure of the 
samples freeze-dried at higher chamber pressures, all samples were completely rehy-
drated within below 50 seconds, independently from formulation composition or process 
parameters applied. Having a closer look at the samples that showed extreme collapse, 
including spattering out of the vials (i.e. freeze-dried at 4 mbar), the reconstitution time 
of both formulations containing phenylalanine seems to be slightly prolonged compared 
to the samples showing no gross collapse (i.e. freeze-dried at 0.1 mbar). However, the 
formulation containing no phenylalanine (5% (wt/wt) trehalose) did also show full col-
lapse with spattering out of the vial, if subjected to aggressive freeze-drying at high cham-
ber pressures, but rehydrates within 14 seconds. Based on the specific surface area as 
quantitative method for the degree of collapse, no correlation between degree of collapse 
and reconstitution time could be established. Furthermore, no influence of shelf temper-
atures on the reconstitution time could be detected. In addition, the reconstitution times 
after 8 hours drying time are comparable to those determined after 24 hours drying time. 
The only parameter that has a slight influence on the reconstitution time is the applied 
chamber pressure during aggressive freeze-drying. However, the small increase in recon-
stitution time is potentially a side effect of the collapse behavior of those samples, which 
is partly accompanied by spattering of the material within the complete interior surface 
of the vial as well as out of the vial. 
 
Figure 4.6: Reconstitution time of aggressive freeze-dried samples (24 hours drying time) 
 
Residual water content 
The residual water content of the lyophilizates is summarized in Figure 4.7. Samples 
aggressively freeze-dried from 5% (wt/wt) trehalose at a (low) chamber pressure of 
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0.1 mbar exhibited a residual water content of 1.6% (Ts=30 °C) or 0.7% (Ts=60 °C), respec-
tively, after only 8 hours drying. After 24 hours drying, these sample species ended up at 
0.3% (Ts = 60 °C) or 0.6% (Ts = 30 °C) water content. As outlined above, these samples 
exhibited only micro-collapse as they were aggressively freeze-dried at 0.1 mbar. On the 
other hand, high chamber pressure of 4 mbar resulted in higher residual water content. 
As expected, higher shelf temperature (60 °C, 2.1%) resulted in lower water content com-
pared to lower shelf temperature (30 °C, 7.3%). Even after 24 h drying, the fully collapsed 
samples exhibit residual water contents of up to 4.1% (4 mbar, 30 °C). It was shown above 
that drying at high chamber pressures results in full collapse and drastically reduced 
SSA. Nevertheless, by applying a shelf temperature of 45 °C also the collapsed samples 
could be dried to below 2% within 24 h. By a shelf temperature of 60 °C, the collapsed 
trehalose samples even achieved 1.1% water content. Summarizing the findings for tre-
halose, a residual water content of well below 2% can be achieved within 24 h by high 
shelf temperature (e.g. 60 °C). If a low chamber pressure (e.g. 0.1 mbar) is utilized, after 
8 h drying a water content of below 2% can be reached, even with comparably low shelf 
temperature of 30 °C. 
 
Figure 4.7: Residual water content of aggressive freeze-dried 5% (wt/wt) trehalose, tre:phe 10:0.5, and tre:phe 3 
formulation. Upper graph after 8 hours drying time, lower graph after 24 hours drying time (n=3). 
As a second model, a formulation containing a low amount of bulking agent 
(tre:phe 10:0.5) was investigated (results cf. Figure 4.7). Using chamber pressures up to 
2 mbar, already after 8 h drying time, low residual water contents of below 1% were 
achieved. For a chamber pressure of 4 mbar, the residual moisture was highly dependent 
on the shelf temperature. While a shelf temperature of 60 °C resulted in 1.3% residual 
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water, for Ts = 30 °C 6.4% residual water was determined.   
After a drying time of 24 h, overall low residual water contents of 0.5% and below were 
determined for almost all tre:phe 10:0.5 products. Only the samples freeze-dried at 
4 mbar, exhibited 1.1% residual water. Obviously, a shelf temperature of 30 °C was too 
low to reach lower residual water content in that fully collapsed material. Like already 
observed for the trehalose samples, higher shelf temperature result in lower residual wa-
ter content.   
Comparing the water content of tre:phe 10:0.5 and trehalose samples, the samples with a 
low amount of bulking agent exhibited drastically reduced water content regardless of 
the the collapsed structure. If shelf temperatures of 45 °C and higher were applied, the 
lyophilizates could be dried to below 1.3% within 8 h. As will be shown below (cf. page 
85pp.), this improvement of drying behavior was achieved without the formation of of 
crystalline (non-collapsed) cake strucutre. The collapsed tre:phe 10:0.5 lyophilizates re-
mained fully amorphous.  
Finally, also a formulation containing a high amount of bulking agent (i.e. phenylala-
nine, tre:phe 10:3) was studied. The same trends as for the formulation containing a low 
amount of phenylalanine could be noticed (cf. Figure 4.7): up to a chamber pressure of 
2 mbar, very low residual water contents of 0.3% and below were achieved already after 
8 h drying. While for a chamber pressure of 4 mbar and Ts = 60 °C a low residual water 
content of 0.3% was determined, too, pc = 4 mbar and a shelf temperature of 30 °C re-
sulted in 4.6% residual water.  
After 24 h drying, all products exhibit residual water contents of 0.6% and below. Inter-
estingly, the collapsed samples from aggressive freeze-drying at 4 mbar and 60 °C exhib-
its slightly lower residual water content (0.1%) compared to the macroscopic elegant sam-
ples aggressively freeze-dried at 0.1 mbar and 60 °C (0.2%). A possible explanation for 
this difference could be a small difference in product temperature during secondary dry-
ing. Chamber pressure plays an important role for the heat transport into the product via 
convection, while higher chamber pressures provide more convective heat transport. For 
a chamber pressure of 4 mbar an average product temperature of 56.3 °C was recorded 
during drying between 8 and 24 hours, while for a chamber pressure of 0.1 mbar a prod-
uct temperature of 51.4 °C was recorded. 
 
Summing up the findings on the residual water content, for all three types of formu-
lation at a certain chamber pressure (0.1 or 4 mbar) a significantly lower residual water 
content is achieved for higher shelf temperatures. In addition, a considerable influence of 
the SSA on the residual water content was detected, which is already known for conven-
tionally freeze-dried lyophilizates [23]. While products exhibiting a higher specific sur-
face area can be dried fast to low residual moisture (i.e. within a drying time of 8 hours), 
collapsed samples, naturally exhibiting a lower SSA, needed more time to reach low re-
sidual water contents. If aggressively freeze-dried under conditions that causes collapse 
(i.e. chamber pressure at or above 1 mbar), the formulation containing no bulking agent 
(5% (wt/wt) trehalose) could be dried only to 1.1%. As the level of chamber pressure plays 
an important role for the formation of the structure of the lyophilizate during aggressive 
freeze-drying, besides the shelf temperature and the drying time in contrast to conven-
tional freeze-drying, also chamber pressure plays a major role for the level of residual 
water content in the final product. 
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Glass transition temperature 
All aggressively freeze-dried samples revealed a detectable glass transition, charac-
terized by a shift of the baseline in the heat signal obtained by differential scanning calo-
rimetry (DSC, example curves of samples aggressively freeze-dried at 2 mbar and 45 °C 
shown in Figure 4.8). Therefore, it can be concluded that amorphous material is present 
in the dried products. The glass transition temperatures are shown in Figure 4.9.  
The use of a (low) chamber pressure of 0.1 mbar resulted in high glass transition tem-
peratures of samples from all formulations (no / low / high bulking agent content). After 
only 8 h drying at Ts=30 °C, Tgs of 84.4 °C (5% (wt/wt) trehalose) up to 100.2 °C 
(tre:phe 10:3) were achieved. Applying a shelf temperature of 60 °C, Tgs of 93.8 °C to 
106.1 °C were reached, respectively. Using higher chamber pressures (≥ 1 mbar), samples 
of 5% (wt/wt) trehalose showed comparably low glass transition temperatures of for ex-
ample 31.2 °C for 4 mbar and 30 °C. Also Tgs of samples that contain bulking agent were 
slightly affected by a chamber pressure of 4 mbar, but exhibited high values for 1 mbar 
and 2 mbar. As the residual water content of all samples is lower after a drying time of 
24 hours, the corresponding glass transition temperatures are consequently higher.  
However, although the glass transition temperatures of the collapsed trehalose sam-
ples are significantly lower compared to the formulations containing a low or high 
amount of bulking agent, after 24 hours drying time they show values higher than 50 °C. 
At the same time, formulations containing bulking agent (phenylalanine) exhibit consid-
erably high glass transition temperatures already at a low concentration and already after 
a drying time of 8 hours.  
 
Figure 4.8: DSC example curves of aggressive freeze-dried 5% (wt/wt) trehalose, tre:phe 10:0.5, and tre:phe3 for-
mulation (process parameters: 2 mbar chamber pressure, 45 °C shelf temperature, 24 hours drying time). 
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Figure 4.9: Glass transition temperatures of aggressive freeze-dried 5% (wt/wt) trehalose, tre:phe 10:0.5, and 
tre:phe3 formulation. Upper graph after 8 hours drying time, lower graph after 24 hours drying time (n=3). 
In general, increased storage stability is attributed to higher glass transition tempera-
ture [24-26]. Since the Kauzmann temperature TK (theoretical intersection of enthalpy of 
a supercooled liquid and the crystalline state (for detailed description see e.g. [27]), lies 
about 50 K below Tg, it is suggested by some authors to aim for a glass transition tem-
perature of 50 K above the planned storage temperature [5, 28, 29]. Usually, a difference 
of 30 K between the intended storage temperature and the glass transition temperature 
is regarded as sufficient to achieve stability during storage. Since (aggressive) freeze-dry-
ing aims for products that are storable at ambient conditions (25 °C), a glass transition of 
at least 55 °C needs to be achieved.  
As water acts as plasticizer of an amorphous matrix [30], the glass transition temper-
ature is inversely proportional to residual water content. Consequently, aggressively 
freeze-dried samples of higher water content exhibit glass transition at lower tempera-
ture. Figure 4.10 shows the correlation of glass transition temperature and residual water 
content of the aggressively freeze-dried samples. A linear regression of data from all for-
mulations revealed a slope of -11.0 K %-1 (R²=0.92). These data imply that with a decrease 
of 1% in water content an increase of about 11 K in the glass transition temperature is to 
be expected. Interpolation according to the regression revealed that for achieving a Tg of 
55 °C a water content of 4.4% is necessary. To achieve a Tg of 75 °C a water content of 
about 2.6% needs to be reached.  
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Figure 4.10: Comparison of glass transition temperatures and residual water content of aggressively freeze-dried 
5% (wt/wt) trehalose, tre:phe 10:0.5, and tre:phe 10:3 formulation. Data of 8 h and 24 h drying are included. The 
dotted line represents a linear regression of Tg vs. water content of sample from all three formulations.  
Table 4.6 gives an overview of process conditions that are able to produce lyophi-
lizates, potentially offering storage stability at room temperature (i.e. 25 °C, Tg ≥ 55 °C 
or even Tg ≥ 75 °C).  
Besides aggressive freeze-drying at 4 mbar chamber pressure and 30 °C shelf temper-
ature, all investigated process conditions were able to produce lyophilizates of Tg ≥ 55 °C 
within 8 hours drying time – independent from the amount of added bulking agent (no, 
low, high). Most of the samples even reached glass transition temperatures of ≥ 75 °C, 
which is most remarkably for collapsed tre:phe 10:0.5 samples. Despite the collapsed 
structure, these lyophilizates could be dried within 8 hours drying time to Tgs of ≥ 75 °C 
if shelf temperatures ≥ 45 °C were used. 
Table 4.6: Overview of process conditions of aggressive freeze-drying that are able to produce samples with a 
glass transition temperatures of ≥ 55 °C or ≥ 75 °C (pc = chamber pressure, Ts = shelf temperature; collapsed 
samples are marked by an asterisk) 
ID pc Ts trehalose tre:phe 10:0.5 tre:phe 10:3 
 mbar °C 8 h  
drying 
24 h 
drying 
8 h  
drying 
24 h 
drying 
8 h  
drying 
24 h 
drying 
   Tg 
≥55 °
C 
Tg 
≥75 °
C 
Tg 
≥55 °
C 
Tg 
≥75 °
C 
Tg 
≥55 °
C 
Tg 
≥75 °
C 
Tg 
≥55 °
C 
Tg 
≥75 °
C 
Tg 
≥55 °
C 
Tg 
≥75 °
C 
Tg 
≥55 °
C 
Tg 
≥75 °
C 
0.1_30 0.1 30 yes yes yes yes yes yes yes yes yes yes yes yes 
0.1_60 0.1 60 yes yes yes yes yes yes yes yes yes yes yes yes 
1_45 1 45 no* no* yes* no* yes* yes* yes* yes* yes yes yes yes 
2_45 2 45 yes* no* yes* yes* yes* yes* yes* yes* yes yes yes yes 
4_30 4 30 no* no* no* no* no* no* yes* yes* yes* no* yes* yes* 
4_60 4 60 yes* no* yes* yes* yes* yes* yes* yes* yes* yes* yes* yes* 
*collapsed samples 
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Crystallinity 
As already outlined above, DSC data showed that all aggressively freeze-dried sam-
ples indicated substantial amounts of amorphous material, most probably dominated by 
amorphous trehalose. To have a closer look on the molecular structure, X-Ray powder 
diffraction (XRD) was used to characterize the influence of chamber pressure, shelf tem-
perature, and drying time on the dried products. Especially potential crystallization of 
trehalose or phenylalanine during aggressive freeze-drying was monitored, as the crys-
tallization of excipients in freeze-dried product is considered as potentially harmful for 
the incorporated molecules of interest [31, 32]. Distinct peaks in the diffractograms from 
XRD analysis were regarded as attributes of a crystalline structure. Figure 4.11 shows 
diffractograms of freeze-dried samples of the three formulations according to the differ-
ent aggressive freeze-drying protocols (drying time of 24 hours). In addition, samples 
after 8 hours drying were analyzed as well. Since they exhibit comparable XRD patterns 
to samples after 24 hours drying time, those data are not shown. All lyophilizates are 
regarded as fully amorphous as no peaks were detectable in samples of 5% (wt/wt) tre-
halose. Obviously, no crystallization occurred during collapsing of the samples, although 
the mobility is high according to low viscosity. Having a closer look to the formulation 
containing a high amount of phenylalanine (tre:phe 10:3), several distinct peaks are dis-
cernible for all applied process conditions.  
 
 
Figure 4.11: X-Ray Powder diffraction patterns of samples subjected to aggressive freeze-drying at different con-
ditions. Top: 5% (wt/wt) trehalose, middle: tre:phe 10:0.5, bottom: tre:phe 10:3. 
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According to the International Centre for Diffraction Data (ICDD) database, the de-
tected characteristic peaks at 6.4°, 14.7°, 17.4°, and 21.3° 2-theta can be attributed to crys-
talline L-phenylalanine hydrate. Although XRD was used as qualitative method, slight 
differences can be detected comparing the diffractograms of products from different ag-
gressive freeze-drying cycles, especially for samples freeze-dried from formulations con-
taining a high amount of phenylalanine. At low chamber pressure of 0.1 mbar, the inten-
sity of all characteristic peaks is less pronounced compared to samples from cycles ap-
plying a high chamber pressure of 4 mbar. An intermediate chamber pressure of 2 mbar 
seem to result in intensities comparable to 4 mbar chamber pressure. Taking the macro-
scopic appearance of the product from high chamber pressure into consideration, there 
seems to be a connection between complete collapse and a higher degree of crystalliza-
tion. Most probably, during aggressive freeze-drying at high chamber pressure, there is 
sufficient mobility in the system allowing molecular rearrangement resulting in crystal-
lization of phenylalanine hydrate. This trend seems to be also valid for the formulation 
containing a low amount of phenylalanine (tre:phe 10:0.5), as only the samples subjected 
to higher chamber pressure (and which were therefore collapsed) showed a small peak 
at 6.4 °2-theta indicating a minute amount of crystalline phenylalanine in the respective 
products. Comparing the intensity of the peak at 6.4 °2-theta to the specific heat of an 
endothermic event detected by DSC around 140 °C (cf. right graph of Figure 4.12), this 
endothermic event can be probably assigned to the melt of phenylalanine hydrate.  
 
Figure 4.12: Enlarged XRD patterns (left) and DSC curves of the respective samples (right) of samples of aggres-
sively freeze-dried tre:phe 10:0.5 formulation using different drying protocols (arrows highlight an endothermic 
event assigned to phenylalanine hydrate melting). 
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Figure 4.13: Comparison of specific heat of phenylalanine hydrate melting (n=3) and intensity of the XRD inten-
sity at 6.4 ° 2-theta for the formulation containing low amount of phenylalanine (tre:phe 10:0.5). 
Confirming the results of the XRD measurements, no endothermic event could be ob-
served from the DSC curves of samples aggressively freeze-dried at low chamber pres-
sure. These products are regarded as fully amorphous. Relating the intensity of the XRD 
peak at 6.4 °2-theta to the amount of specific heat of melting of phenylalanine hydrate 
determined by DSC (cf. Figure 4.13), it was noticed that the occurrence of a detectable 
XRD peak is accompanied by a detectable DSC event. Comparing the samples freeze-
dried at high chamber pressure, for a shelf temperature of 60 °C, slightly higher peak 
intensity (XRD) as well as a slightly higher specific heat was detected compared to freeze-
dried at 30 °C shelf temperature, suggesting a somewhat higher amount of phenylalanine 
hydrate present in the sample. However, the correlation of peak intensity from XRD 
measurement and the amount of specific heat from DSC analysis seems not to be feasible 
in every case, as the melting endotherm of the formulation containing a high amount of 
phenylalanine did not show a higher specific heat, although the intensity of the XRD peak 
at 6.4 ° 2-theta is increased more than 4-fold (data not shown). As the amount of specific 
heat for a potential melting of phenylalanine hydrate is small and therefore susceptible 
to integration error, the presence or absence of characteristic peaks in a XRD diffracto-
gram are considered as more representative for the presence or absence of crystalline 
material in a sample than a DSC scan. 
2.1.3 CONCLUSIONS 
The influence of process parameters on the physico-chemical characteristics of aggres-
sively freeze-dried products were outlined in the section above. Aggressive freeze-drying 
aims to generate dry lyophilizates, which exhibit product characteristics allowing storage 
at room temperature. For most of the molecules to be stabilized in a lyophilizate a (partly) 
amorphous matrix is inevitable for stabilization. Therefore, glass transition temperatures 
play a major role. Moreover, a low specific surface area improves the storage stability of 
e.g. embedded proteins, as recently shown by some authors [10, 33, 34].  
Trehalose-based formulations (5% wt/wt) that contain no bulking agent exhibited a 
collapsed appearance with low specific surface area upon freeze-drying at a chamber 
pressure of ≥ 1 mbar. Due to the low specific surface area, the collapsed samples could 
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not be dried to below 2% residual water content within 8 h drying time, not even by 
applying a high shelf temperature of 60 °C. After 24 h at 60 °C, the collapsed trehalose 
lyophilizates reached a water content of below 2% (namely 1.1%). A shelf temperature of 
30 °C or 45 °C was not sufficient to decrease the water content below 2% within 24 hours. 
On the other hand, also the lyophilizates exhibiting a water content slightly above 2% 
showed high glass transition temperatures. Based on an intended storage temperature of 
25 °C, a glass transition temperature of 55 °C is considered as benchmark to be met. Col-
lapsed trehalose lyophilizates can be dried to a Tg > 55 °C within either 8 h drying at 
60 °C shelf temperature, or 15 h at 45 °C. Drying at 30 °C shelf temperature did not result 
in sufficiently high glass transition. Overall, the samples produced at 4 mbar chamber 
pressure showed promising physico-chemical characteristics. However, collapsing mate-
rial spattered out of the vials during drying. Spattering is regarded as uncontrollable dry-
ing behavior. Hence, aggressive freeze-drying of disaccharide formulations, at least for 
the applied solid content (5% wt/wt), is not feasible at a chamber pressure of 4 mbar. 
Although shelf temperatures of 30 °C or 60 °C were utilized, aggressive freeze-drying 
of trehalose at a chamber pressure of 0.1 mbar did not result in collapse, but slightly 
shrinked appearance. The non-collapsed microstructure is also reflected in comparably 
high specific surface area of these samples. These lyophilizates exhibited low water con-
tent and high glass transition after 8 h drying at 60 °C and 30 °C, which is attributed to 
effective desorption of water from the large surface area during the secondary drying 
phase.  
Generally, high Tg at rather high water content can be attributed to the inherently 
high glass transition temperature of trehalose. For formulations based on other disaccha-
rides (e.g. sucrose) of inherently lower Tg than trehalose, low residual water content is a 
necessary prerequisite to achieve high glass transition temperatures. To realize storable 
collapsed lyophilizates of disaccharide formulations by aggressive freeze-drying, me-
dium chamber pressure (1-2 mbar), high shelf temperatures (≥ 45 °C) and drying times 
of ≥ 24 h are recommended. If one aims for production of non-collapsed lyophilizates 
within 8 h drying time, the use of low chamber pressure (≤ 0.1 mbar) and high shelf tem-
perature (e.g. 60 °C) is advised. 
 
From a general perspective, the amorphous state is preferable for successful stabiliza-
tion of e.g. therapeutic proteins. As shown above, collapsed sugar lyophilizates retain 
their amorphous structure independent from process conditions. However, these col-
lapsed samples are difficult to dry to low residual water content within the intended short 
drying times of aggressive freeze-drying. For improvement of drying, still maintaining 
the fully amorphous structure, the addition of a small quantity of phenylalanine (i.e. a 
bulking agent) was evaluated (tre:phe 10: 0.5). XRD analysis of aggressively freeze-dried 
lyophilizates revealed that the use of a higher chamber pressure of ≥ 2 mbar results in 
small crystalline fractions in the lyophilizates, which were not observed in samples pro-
duced at lower chamber pressure (≤ 1 mbar). Consequently, for producing fully amor-
phous lyophilizates of the sugar:phenylylanine formulation, a chamber pressure of 
≤ 1 mbar is recommendable.  
Although phenylalanine was added, aggressive freeze-drying resulted in similar ap-
pearance and specific surface area for the different freeze-drying conditions as for pure 
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trehalose lyophilizates. The samples dried at low chamber pressure exhibited a non-col-
lapse structure. These samples were dried to ≤ 1% water content and a Tg of ≥ 85 °C 
within 8 h drying time at shelf temperatures of ≥ 30 °C. On the other hand, the use of a 
chamber pressure of 1 mbar resulted in collapsed lyophilizates. In contrast to the treha-
lose samples, those collapsed lyophilizates reached a water content of ≤ 1% within 8 h 
drying time (Ts=45 °C). Hence, by the addition of a small quantity of phenylalanine to 
the sugar-based formulation collapsed, dry, and fully amorphous lyophilizates could 
be achieved within 8 h drying time.  
 
A common strategy in formulation design is the addition of substantial amounts of 
bulking agents to freeze-drying formulations. Bulking agents are intended to crystallize 
during the freezing step. Hence, at least partially crystalline lyophilizates result from 
freeze-drying of formulations containing a bulking agent. In this study, trehalose was 
combined with phenylalanine at a ratio of 10:3 (overall 5% solid content) to generate a 
partly crystalline system. 
XRD analysis of the aggressively freeze-dried samples showed the presence of crys-
talline L-phenylalanine hydrate independent from process parameters used. The pres-
ence of crystalline material is reflected in the appearance of the lyophilizates after drying. 
For chamber pressures of 0.1 mbar to 2 mbar, the aggressively freeze-dried samples ex-
hibited a non-collapsed appearance and also large specific surface areas. The use of 
4 mbar chamber pressure resulted in sort of collapse (elevation of the already dried cake 
by collapsing material at the bottom of the cake). But also for these samples comparably 
large SSA was detected.  
Because of the large SSA, the partly crystalline lyophilizates were dried rapidly. Al-
ready after 8 h drying time the lyophilizates exhibited residual water contents of <0.5%. 
Only the lyophilizates dried at 4 mbar and 30 °C could not be dried to such low water 
content within 8 h (4.6%). As indicated by DSC, a substantial amount of amorphous ma-
terial (mainly trehalose) is present in all samples. Due to the low water content of the 
samples, the glass transition temperatures of all lyophilizates (besides 4 mbar, 30 °C) 
ranged above 95 °C.  
Overall, partly crystalline formulations can be aggressively freeze-dried to low water 
content and high Tg by using chamber pressures of 0.1 – 2 mbar and shelf temperatures 
of 30-60 °C within 8 h drying time. 
 
2.2 INFLUENCE OF PROCESS VARIATIONS ON DRYING KINETICS 
To gain more information about the kinetics of water loss during aggressive freeze-
drying, a number of experiments were conducted utilizing a sample thief to extract sam-
ples from a running freeze-drying run. In a first experimental series at several time points, 
pre-weighted samples were extracted and the loss of mass (i.e. water by sublimation) 
and/or residual water content was determined. As during primary drying phase weight 
loss over time showed a sigmoidal shape, data were fitted using a Boltzman function1 
and the first derivative was calculated representing the sublimation rate (in g/h). 
                                                 
1 Boltzman function: y=
𝐴1−𝐴2
1+𝑒(𝑥−𝑥0) 𝑑𝑥⁄
+ 𝐴2 
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In order to compare the kinetics of primary (i.e. sublimative) drying of aggressive to 
conventional freeze-drying, two cycles were operated employing 5% sucrose (in 10 mM 
sodium succinate buffer pH 5.5; filling volume 1 ml, glass type 1 DIN 2R vials). Aggres-
sive freeze-drying was operated at 1 mbar chamber pressure and 45 °C shelf temperature 
for 24 h of drying time (compare cycle 1_45 from Table 4.3) resulting in fully collapsed 
products. For conventional freeze-drying of the same samples 0.09 mbar chamber pres-
sure and -20 °C shelf temperature were applied for primary drying for 30 h. An additional 
secondary drying step at 5 °C shelf temperature and 0.09 mbar (7 h) was included. Con-
ventional freeze-drying resulted in elegant lyophilizates. Contrary to the water loss pro-
file of aggressive freeze-drying, water loss of conventional freeze-drying followed a less 
pronounced sigmoidal profile, which was fitted by a sigmoidal logistic function (type 3)2. 
Sublimation rate was calculated by the first derivative of the fitted data and expressed in 
g/h. Comparing now weight loss profiles and sublimation rates of aggressive vs conven-
tional freeze-drying (cf. Figure 4.14), it becomes obvious that aggressive freeze-drying 
showed a dramatically faster weight loss compared to conventional freeze-drying. While 
for aggressive freeze-drying sublimation is completed within 4 h of drying time, indi-
cated by weight loss reaching a plateau level, for conventional freeze-drying 30 h of dry-
ing time were needed to complete sublimation. Expressed in sublimation rates (cf. Figure 
4.14), during aggressive freeze-drying water loss by sublimation reached a maximum of 
0.67 g/h, against a maximum of 0.047 g/h for conventional freeze-drying.  
 
Figure 4.14: Weight loss data as well as calculated sublimation rates of either aggressively or conventionally 
freeze-dried 50mg/ml sucrose solution (left: overview, right: first 6 h of drying phase enlarged). 
To confirm the weight loss data and sublimation rates of the samples extracted by a 
sample thief, both cycles were additionally featured by a freeze-balance (Martin Christ, 
Osterode am Harz, Germany). Basically, the freeze-drying balance showed comparable 
but slightly faster weight loss profiles (data not shown). Due to construction of the bal-
ance, only one vial without further shielding against heat input by radiation was 
weighted. Thus, the sublimation behavior (i.e. weight loss) of the vials extracted by the 
sample thief from a shelf completely covered with filled vials are regarded as more rep-
resentative for all vials. 
                                                 
2 Slogistic3 function: y=
a
1+𝑏𝑒−𝑘𝑥
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As mentioned above, during secondary phase of both drying cycles further samples 
were extracted using a sample thief and the residual water content was determined. Fig-
ure 4.15 shows the respective data. Secondary drying is governed by desorptive drying 
of the already settled material structure. The sample extracted from the aggressive freeze-
drying cycle showed sort of an asymptotic decrease of residual water content over drying 
time. While within about 7 h the sample could be dried from 7.0% to 2.0% residual water 
content, further 16 h resulted in a decrease of just 0.5% to a final residual water content 
of 1.5% – although the product temperature was comparably high (above 40 °C). As be-
sides the applied temperature, the specific surface area available for desorption plays a 
major role for secondary drying [35], the secondary drying behavior of the fully collapsed 
samples from aggressive freeze-drying can be attributed to their low specific surface area 
of below 0.1 m²/g. On the other hand, conventional freeze-drying at 5 °C shelf tempera-
ture resulted in a decrease from 8.9% to 2.2% residual water content within 15.8 h. Alt-
hough there are not enough data available to conclude a profound drying kinetic curve 
for conventionally freeze-drying, the secondary drying kinetic of conventional freeze-
drying is known to follow an asymptotic behavior as well [35]. An overlay of water loss 
of aggressively and conventionally freeze-dried samples (cf. right graph in Figure 4.15) 
suggest that secondary drying of both species follows a similar profile. However, it needs 
to be mentioned that aggressive freeze-drying utilized 45 °C shelf temperature, while SD 
of conventionally freeze-drying was accomplished at 5 °C. 
  
Figure 4.15: Secondary drying kinetic expressed as residual water content over time of either aggressively or 
conventionally freeze-dried 5% sucrose (left: residual water content over drying time; right: overlay of residual 
water content over time). 
In order to evaluate the influence of process parameters on the drying kinetics for 
further characteristic model formulations, the formulations according to Table 4.2 were 
used, representing a formulation containing no bulking agent (5% (wt/wt) trehalose), a 
low amount of bulking agent (tre:phe 10:0.5), as well as a high amount of bulking agent 
(tre:phe 10:3).  
To get an idea, whether the addition of bulking agent changes the drying kinetics 
dramatically, in a first step the three model formulations were subjected to aggressive 
freeze-drying at 1 mbar chamber pressure and 45 °C shelf temperature for 24 h of drying 
time (compare cycle 1_45 from Table 4.3). During the cycle samples were extracted by a 
sample thief. As shown in Figure 4.16, weight loss during primary drying of 5% (wt/wt) 
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trehalose is comparable to 5% (wt/wt) sucrose. Moreover, the addition of a low amount 
of phenylalanine as bulking agent (formulation tre:phe 10:0.5) showed no influence on 
primary drying kinetic, too. The addition of a high amount of phenylalanine (tre:phe 10:3) 
however, resulted in a slight shift of the weight loss profile indicating a slightly slower 
primary drying kinetic. Taking also the slightly higher product temperature into consid-
eration (cf. Table 4.4), the slower primary drying can be attributed to the higher product 
resistance of the cakes.  
 
 
Figure 4.16: Primary drying kinetics of aggressive freeze-drying. Primary drying kinetics are expressed as 
weight loss (upper graph) and sublimation rate (lower graph) (process 1mbar, 45 °C, 24h). 
As already outlined above, samples containing a high amount of bulking agent did 
not show macro-collapse under the applied process conditions. Regarding secondary 
drying kinetics, the effect of bulking agent on the drying kinetics is significantly more 
pronounced (cf. Figure 4.17). All formulations showed an asymptotic progress of second-
ary drying. The initial steep decrease of residual moisture after finishing the primary 
drying is more pronounced for higher amounts of phenylalanine. 5% (wt/wt) trehalose 
showed a similar progress of drying like 5% (wt/wt) sucrose at overall slightly higher 
residual water content.  
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Figure 4.17: Secondary drying kinetics of aggressive freeze-drying expressed as residual water content (different 
formulations, process 1mbar, 45 °C, 24 h). 
To reduce the experimental effort for the different cycles, primary drying kinetics 
were determined as average values. For this purpose, the endpoint of sublimation was 
determined by the product temperature, reaching shelf temperature and the average sub-
limation rate was calculated. Independent from formulation, within every single aggres-
sive freeze-drying cycle, the product temperature reached the level of the shelf tempera-
ture within a narrow timeframe (less than 30 minutes) indicating a comparable primary 
drying behavior of all three formulations (data not shown) as already observed from 
weight loss data (see above). Although resulting in collapsed (5% (wt/wt) trehalose and 
tre:phe 10:0.5) or non-collapsed (tre:phe 10:3) products, the primary drying behavior dif-
fers only slightly. Therefore, in order to elucidate the influence of shelf temperature and 
chamber pressure on the primary drying kinetics, the product temperature data of the 
three formulations were averaged. Hence, the average sublimation rates displayed in Fig-
ure 4.18 represent also an average of the three formulations. For comparison, the average 
sublimation rate of a conventionally freeze-dried 5% trehalose sample is shown in Figure 
4.18, too.  
Compared to the conventional cycle, a drastic increase of the sublimation rate was 
noticed for each of the aggressive cycles. According to the correlation between product 
temperature and sublimation rate [35], an increase in chamber pressure (i.e. higher prod-
uct temperature, cf. Table 4.4) results in higher sublimation rate as expected. However, a 
further increase of chamber pressure to above 1 mbar did not result in a further increase 
of sublimation rate, although the product temperatures still increase. Overall, the highest 
sublimation rates were noticed for chamber pressures of 1 mbar and 2 mbar. As expected, 
the sublimation rate at a distinct chamber pressure (low and high) was influenced by the 
shelf temperature, with higher sublimation rates for higher shelf temperatures.  
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Figure 4.18: Averaged sublimation rates of trehalose-based samples subjected to different aggressive freeze-dry-
ing conditions. For comparison, the sublimation rate of conventional freeze-drying is displayed, too. 
The drying behavior during secondary drying is mainly influenced by the structure 
formed during primary drying. As shown above, the samples resulting from the different 
formulations exhibited different secondary drying kinetics (cf. Figure 4.15), which de-
pend on the specific surface area of the lyophilizates. Larger surface enables a better de-
sorption of water from the lyophilizate. Since the temperature has a major influence on 
desorption, too, for higher shelf temperatures faster drying is to be expected. Figure 4.19 
displays the residual water content over drying time. In this study, no sample thief was 
used to extract samples. Therefore, only a small number of data points are available. Nev-
ertheless, this rough description of secondary drying showed that higher temperature 
result in faster drying as it was expected. The effect of low chamber pressure (0.1 mbar), 
which also seems to enhance secondary drying, is accounted to the larger SSA of the sam-
ples produced at a chamber pressure of 0.1 mbar. This assumption is underlined by in-
vestigations on the influence of chamber pressure on the drying kinetics of convention-
ally freeze-dried lyophilizates [23]. 
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Figure 4.19: Secondary drying kinetics of aggressive freeze-drying expressed as residual water content (5% treha-
lose at different process parameters; a residual water content of 10% is estimated as entry value for secondary 
drying). 
2.3 INFLUENCE OF PROCESS VARIATIONS ON PROTEIN STABILITY 
The ability to stabilize a sensitive molecule is the major interest of freeze-drying. To 
evaluate the influence of variations of process parameters on the stabilization of a sensi-
tive molecule, the recombinant monoclonal human IgG1 antibody mab_T1 was selected 
as a suitable model. Own observations during a pre-test to select a proper model revealed 
its susceptibility freeze-drying stress. To investigate the influence of shelf temperature, 
chamber pressure, and drying time on the stability of mab_T1, the formulations shown 
in Table 4.7 were subjected to the aggressive freeze-drying cycles displayed in Table 4.3 
(page 73, except the cycle at 1 mbar, which was not included). The three different formu-
lations can be regarded as representative for typical disaccharide based freeze-drying 
formulations containing (i) no bulking agent (5% (wt/wt) trehalose), (ii) a low amount of 
phenylalanine as bulking agent (tre:phe 10:0.5), or (iii) a high amount of phenylalanine 
as bulking agent (tre:phe 10:3).  
Table 4.7: Formulations used to characterize the influence of process conditions on the stability of mab_T1 in 
aggressively freeze-dried lyophilizates. 
ID mab_T1 trehalose phenylalanine potassium 
phosphates 
 mg/ml mg/ml mg/ml mg/ml 
tre 1.0 50  2.4 
tre:phe 10:0.5 1.0 47.6 2.4 2.4 
tre:phe 10:3 1.0 38.5 11.5 2.4 
 
Since mab_T1 is especially prone to aggregation if not proper stabilized, the aggrega-
tion behavior was investigated by HP-SEC, subvisible particle count (by light obscuration 
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LO), and turbidity. While HP-SEC is utilized to analyze samples regarding soluble pro-
tein aggregates, subvisible particle counts and turbidity was employed to detect non-sol-
uble protein aggregates. 
2.3.1 NO BULKING AGENT 
Figure 4.20 shows the influence of shelf temperature, chamber pressure, and drying 
time on the formation of subvisible particles ≥ 1 µm during aggressive freeze-drying of 
1 mg/ml mab_T1 in a 5% (wt/wt) trehalose formulation. Overall, low amounts of subvi-
sible particles ≥1 µm were detected for the collapsed lyophilizates. Neither an impact of 
the different chamber pressures (2 mbar or 4 mbar), nor the different shelf temperatures 
(30 °C, 45 °C, 60 °C) were noticed. For a shelf temperature of 30 °C and 45 °C a minor 
tendency of increased svp counts for increasing drying time was observed.  
 
Figure 4.20: Sub-visible particle counts of particles ≥1 µm of samples aggressively freeze-dried from 5% (wt/wt) 
trehalose formulation containing 1 mg/ml mab_T1 (analyzed by LO; svp counts before freeze-drying around 
1,000 particles ≥1 µm per ml; n=3). 
Although the samples freeze-dried at Ts=30 °C and pc=0.1 mbar exhibited a non-col-
lapses appearance, the highest amount of insoluble aggregates (i.e. svp) was detected. 
Since mab_T1 is susceptible to surface stress, the higher specific surface area of non-col-
lapsed samples offers an explanation for more pronounced aggregation. As shown in 
Figure 4.5, the non-collapsed samples exhibit a SSA of about 1 m²/g, while the collapsed 
samples range below 0.15m²/g. Interestingly, the lowest amount of svp was detected in 
non-collapsed samples freeze-dried at pc=0.1 mbar and Ts=60° C for 8 h. These samples 
had a large SSA, too. Obviously, the high shelf temperature result in a better stabilization 
of mab_T1 despite the large SSA. An annealing effect, which would reduce molecular 
mobility [36], is suggested as potential explanation. The increase of svp in those samples 
after 24 h drying suggest that high temperatures should be used only for short drying 
cycles of non-collapsed lyophilizates. 
The overall trends regarding aggregation detected by subvisible particle formation 
were underlined by comparable trends in turbidity data (cf. Figure 4.21). Since turbidity 
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is also sensitive for particles smaller than 1 µm, obviously aggregates in the size range 
below 1 µm were formed during aggressive freeze-drying. 
 
Figure 4.21: Turbidity of samples aggressively freeze-dried from 5% (wt/wt) trehalose formulation containing 
1 mg/ml mab_T1 (analyzed by nephelometry; turbidity before freeze-drying around 0.7 FNU; n=3). 
Table 4.8 shows the HP-SEC results. Throughout all analyzed samples, no decrease in 
monomer content was detected, indicating no formation of soluble aggregates (dimer or 
higher molecular weight species) or fragmentation of monomer. Comparing aggressively 
freeze-dried samples to a sample prior to freeze-drying, a slight tendency of lower mon-
omer recovery for higher shelf temperatures seems to exist. However, because of over-
lapping standard deviations the differences between the species are regarded negligible.  
Table 4.8: Monomer content and monomer recovery of mab_T1 (c=1mg/ml) in lyophilizates aggressively freeze-
dried from a 5% (wt/wt) trehalose formulation using various conditions (analyzed by HP-SEC; monomer con-
tent prior to freeze-drying 97.5%; n=3). 
process parameters monomer content monomer recovery 
chamber 
pressure 
shelf  
temperature 
drying time mean SD mean SD 
mbar °C hours % % % % 
0.1 30 8 98.3 0.3 98.9 1.9 
  24 97.9 0.3 99.5 2.6 
 60 8 97.7 0.1 97.3 0.9 
  24 97.8 0.0 96.5 1.0 
2 45 8 97.9 0.0 98.3 0.9 
  24 97.9 0.1 97.0 0.8 
4 30 8 97.9 0.0 100.4 0.7 
  24 98.0 0.0 98.2 0.9 
 60 8 97.9 0.0 96.7 0.9 
  24 98.0 0.0 99.2 1.4 
 
Investigations on the aggressive freeze-drying process 
98 
To assess the mab_T1 stability data also in the light of the physico-chemical charac-
teristics of the lyophilizates aggressively freeze-dried from 5% (wt/wt) trehalose formu-
lation, the data shown in section 2.1.2 are taken into consideration.  
Although the samples showed some differences in physico-chemical characteristics, 
overall a good stabilization of mab_T1 was observed. After 24 h drying, collapsed sam-
ples (freeze-dried at 2 or 4 mbar chamber pressure) showed slightly less aggregation than 
non-collapsed lyophilizates (freeze-dried at 0.1 mbar chamber pressure). Besides differ-
ent appearance and SSA, also a range of residual water contents and glass transition tem-
peratures were observed for samples aggressively freeze-dried using different process 
parameters. Nevertheless, no impact on the stabilization of mab_T1 could be noticed. It 
is concluded that a broad range of aggressive freeze-drying process parameters can be 
used to generate lyophilizates of 5% (wt/wt) trehalose that can successfully stabilize a 
sensitive molecule like mab_T1.  
 
2.3.2 LOW AMOUNT OF PHENYLALANINE (TRE:PHE 10:0.5) 
The stability of mab_T1 in the aggressively freeze-dried products based on the formu-
lation containing a low amount of phenylalanine as bulking agent (tre:phe 10:0.5) was 
evaluated. For products aggressively freeze-dried at 0.1 mbar chamber pressure a very 
low amount of subvisible particles ≥1µm was detected independent from shelf tempera-
ture (cf. Figure 4.22). Higher chamber pressures of 4 mbar resulted in slightly higher 
amounts of subvisible particles. Additionally, for higher chamber pressure a tendency to 
higher svp counts for longer drying times was detected.  
 
Figure 4.22: Sub-visible particle counts of particles ≥1 µm of samples aggressively freeze-dried from 
tre:phe 10:0.5 formulation, representing a formulation containing a low amount of bulking agent, using various 
conditions (analyzed by LO; svp counts before freeze-drying around 1000 particles ≥1 µm per ml; n=3). 
Figure 4.23 shows the turbidity of the analyzed lyophilizates. An increase of turbidity 
with increasing drying time could also be observed for the samples freeze-dried at low 
chamber pressure. Also the lyophilizates freeze-dried at 4 mbar and 30 °C exhibited a 
substantial increase. As increasing svp counts as well as turbidity indicate an increase in 
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non-soluble particles, increasing drying time seems to be connected to increasing aggre-
gation of mab_T1. While overall the majority of the samples exhibit comparable low svp 
counts as well as low turbidity, samples freeze-dried applying 4 mbar chamber pressure 
and 30 °C shelf temperature showed remarkable formation of non-soluble aggregates of 
mab_T1. 
 
Figure 4.23: Turbidity of samples aggressively freeze-dried using various conditions from formulation contain-
ing trehalose and a low amount of phenylalanine as bulking agent (tre:phe 10:0.5 ) (analyzed by nephelometry; 
turbidity before freeze-drying around 0.7 FNU; n=3). 
Regarding the formation of soluble aggregates, HP-SEC data revealed no decrease in 
monomer content (cf. Table 4.9) indicating no formation of soluble aggregates. Having a 
look at monomer recovery of the samples aggressively freeze-dried compared to the for-
mulation prior to freeze-drying, no clear trend could be observed. While for low chamber 
pressure (0.1 mbar) a higher shelf temperature resulted in decreased monomer recovery, 
for high chamber pressure (4 mbar) a higher shelf temperature led to higher monomer 
recovery. As there is no extensive formation of aggregates, neither soluble nor non-solu-
ble, the cause for fluctuating recoveries remained unclear.  
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Table 4.9: Monomer content and monomer recovery of samples aggressively freeze-dried from tre:phe 10:0.5 
formulation using various conditions (analyzed by HP-SEC; monomer content prior to freeze-drying 97.4%; 
n=3). 
process parameters monomer content monomer recovery 
chamber 
pressure 
shelf  
temperature 
drying time mean SD mean SD 
mbar °C hours % % % % 
0.1 30 8 97.9 0.0 98.1 2.2 
  24 97.8 0.1 99.7 1.8 
 60 8 97.8 0.1 95.7 2.2 
  24 97.7 0.1 94.2 1.9 
2 45 8 97.8 0.1 98.7 2.1 
  24 97.9 0.1 96.8 2.1 
4 30 8 97.8 0.1 98.1 2.0 
  24 98.0 0.2 95.6 2.2 
 60 8 98.0 0.1 102.0 2.4 
    24 98.0 0.1 101.4 2.1 
 
2.3.3  HIGH AMOUNT OF PHENYLALANINE (TRE:PHE 10:3) 
To complete the picture, in addition to the formulations containing no bulking agent 
or a low amount of phenylalanine as bulking agent, also a formulation containing a high 
amount of phenylalanine (tre:phe10:3) was investigated regarding the influence of pro-
cess parameters on the stability of incorporated mab_T1. As already outlined above, this 
formulation can be regarded as comparable to a formulation containing for example tre-
halose and mannitol at a ratio of 1:2 (at 5% solid content) concerning physico-chemical 
characteristics during and after aggressive freeze-drying. 
The subvisible particle counts, representing non-soluble particles, are shown in Figure 
4.24. Samples freeze-dried at low chamber pressure (0.1 mbar) exhibited a slight tendency 
that a higher shelf temperature of 60 °C resulted in less aggregation compared to 30 °C 
shelf temperature. This trend is even more pronounced after a drying time of 24 h. Con-
trary to this tendency, at high chamber pressure of 4 mbar higher shelf temperature re-
sulted in increased aggregation compared to 30 °C shelf temperature. Overall, high cham-
ber pressure resulted in more aggregation. Samples from the process that applied me-
dium chamber pressure of 2 mbar and medium shelf temperature of 45 °C, however, did 
not show aggregation of mab_T1.  
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Figure 4.24: Sub-visible particle counts of particles ≥1 µm of samples aggressively freeze-dried from tre:phe 10:3 
formulation, representing a formulation containing a high amount of bulking agent, using various conditions 
(analyzed by LO; svp counts before freeze-drying around 1000 particles ≥1 µm per ml; n=3). 
In addition, turbidity of that product did not show increased values compared to the 
formulation prior to freeze-drying (cf Figure 4.25). Interestingly, the samples aggressively 
freeze-dried at low chamber pressure, which showed lower svp counts as lyophilizates 
dried at high chamber pressures, exhibited higher turbidity values. Considering the 
physico-chemical characteristics, the difference in specific surface area (cf. Figure 4.5, 
page 78) is thought to foster different aggregation mechanisms leading to different sized 
aggregates (turbidity also accounts for aggregates smaller than 1 µm). 
 
Figure 4.25: Turbidity of samples aggressively freeze-dried using various conditions from formulation contain-
ing trehalose and a high amount of phenylalanine as bulking agent (tre:phe 10:3 ) (analyzed by nephelometry; 
turbidity before freeze-drying around 0.7 FNU; n=3). 
 
The monomer content of the aggressively freeze-dried samples remained unchanged 
compared to the formulation prior to freeze-drying (cf. Table 4.10). None of the analyzed 
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products did show aggregation to soluble aggregates, the monomer content remained 
unchanged after aggressive freeze-drying. A decreased recovery was noticed only for the 
samples freeze-dried at 0.1 mbar chamber pressure and 60 °C shelf temperature suggest-
ing a degradation of mab_T1.  
 
Table 4.10: Monomer content and monomer recovery of samples aggressively freeze-dried from tre:phe 10:3 for-
mulation using various conditions (analyzed by HP-SEC; monomer content prior to freeze-drying 97.5%; n=3). 
process parameters monomer content monomer recovery 
chamber 
pressure 
shelf  
temperature 
drying time mean SD mean SD 
mbar °C hours % % % % 
0.1 30 8 98.0 0.4 99.0 3.2 
  24 98.0 0.2 102.0 3.2 
 60 8 97.8 0.0 96.2 3.4 
  24 97.8 0.0 93.7 2.9 
2 45 8 98.1 0.0 98.8 2.9 
  24 98.0 0.0 97.6 3.1 
4 30 8 97.8 0.0 98.1 3.6 
  24 97.7 0.0 98.4 3.1 
 60 8 97.9 0.1 98.1 3.5 
    24 97.8 0.1 97.5 2.7 
 
2.3.4 CONLCUSIONS 
Aggressive freeze-drying of the formulation containing no bulking agent (5% (wt/wt) 
trehalose) at high chamber pressure and high shelf temperature resulted in excellent sta-
bilization of mab_T1 in collapsed lyophilizates. The non-collapsed lyophilizates that re-
sult from low chamber pressure exhibited aggregation of the incorporated mab_T1, es-
pecially if long drying times were used.  
Formulations that contain a low amount phenylalanine as bulking agent 
(tre:phe 10:0.5) showed best stabilization of mab_T1 in collapsed lyophilizates that result 
from medium chamber pressure and medium shelf temperature. Lyophilizates freeze-
dried at 60 °C shelf temperature provided sound stabilization, too, if the drying time is 
kept short. Thereby, no difference between non-collapsed and collapsed samples was no-
ticed. 
Aggressive freeze-drying of the formulation with the high bulking agent content 
(tre:phe 10:3) is accompanied by a worse stabilization of mab_T1. Non-collapsed (dried 
at low pc) and collapsed samples (dried at high pc) showed aggregation of mab_T1 indi-
cated by increased concentrations of subvisible particles. In addition, a clear trend of in-
creased aggregation for prolonged drying time was noticed. The poor stabilization of 
mab_T1 in lyophilizates containing a high content of bulking agent is attributed to the 
high specific surface area of these products (compare section 2.1.2).  
 
Overall, the chamber pressure indirectly influences the stability of mab_T1, mainly by 
the resulting structure of the lyophilizates (collapsed=low specific surface area, non-
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collpased=high specific surface area). Short drying time is preferable in every case, but 
with respect to low residual water content only applicable to formulations that contain a 
bulking agent. The applied shelf temperature seems to play a two-sided role for stabili-
zation of mab_T1. For non-collapsed samples (due to high bulking agent content or low 
chamber pressure), high shelf temperatures resulted in less aggregation than low shelf 
temperatures. Since these lyophilizates have a comparable large specific surface area, a 
negative effect of higher temperatures would have been expected. Although the specific 
surface area plays a major role for stabilization, a correlation between SSA, shelf temper-
ature, and stability of mab_T1 cannot be stated. Probably, high shelf temperature resulted 
in relaxation of the amorphous part in the lyophilizates.  
 
Independent from drying time for all formulations a medium chamber pressure of 
2 mbar and a medium shelf temperature of 45 °C resulted in good preservation of 
mab_T1. These settings seem to be preferable regarding protein stabilization during ag-
gressive freeze-drying. 
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3. SUMMARY AND CONCLUSIONS 
In this chapter, the influence of different settings for aggressive freeze-drying on the 
final product characteristics as well as on the drying kinetics were studied. Furthermore, 
the implications for the stabilization of an incorporated model protein (mab_T1, mono-
clonal IgG antibody) was evaluated. In order to get an idea, in which range the process 
parameters need to be controlled for successful operation of aggressive freeze-drying, 
typical freeze-drying formulations that contain an amorphous stabilizer (sucrose or tre-
halose) were aggressively freeze-dried. The main process parameters (shelf temperature, 
chamber pressure, and process time) were controlled at different levels. To account for 
the common strategy to add bulking agents to freeze-drying formulations, two formula-
tions that contain phenylalanine were included in the studies. 
In a first step, the chamber pressure was varied between 0.5 and 4 mbar and the dry-
ing behavior as well as final product characteristics of a 5% sucrose solution were deter-
mined. The variation of chamber pressure imposed a considerable influence on the prod-
uct temperature during sublimation. In all of the applied cycles, the product temperature 
of the sucrose samples was above the collapse temperature. While low chamber pressure 
resulted in comparably low product temperatures, high chamber pressure caused high 
product temperatures as expected. The collapsed sugar formulation spattered out of the 
vials as one major consequence of high product temperatures. It is concluded that at 
4 mbar chamber pressure the drying behavior is not controllable. Samples generated at 
lower chamber pressure (up to 1 mbar) did not experience this phenomenon. Therefore, 
for sucrose formulations (without bulking agent) a maximal chamber pressure of 1 mbar 
is advised. 
The difference in collapse behavior did not influence the extremely fast sublimation 
of water during the primary drying step. Already after 6 h drying, the frozen ice was 
sublimated and the primary drying completed. As usual in freeze-drying, the water con-
tent was reduced by a secondary drying step (in this case 18 h). Except for the lyophi-
lizates freeze-dried at 4 mbar, after secondary drying an overall comparable residual wa-
ter content was detected. The water content was at a comparably high level (around 
2.2%), known for collapsed samples based on pure sugar formulations. In order to gen-
erate lyophilizates of lower water content, the use of additional excipients is regarded 
inevitable (unless the drying time is drastically prolonged). 
In the second step of the study, in addition to varying the chamber pressure, the shelf 
temperature and process time were altered, too. The utilized formulations were based on 
trehalose and complemented by two formulations, containing phenylalanine as bulking 
agent. In order to evaluate the capability of the lyophilizates produced with the different 
aggressive freeze-drying processes to stabilize proteins, a monoclonal IgG1 antibody 
(mab_T1) was included in the formulations. 
While in the first step of the study the chamber pressure was varied between 0.5 mbar 
and 4 mbar, the range was expanded down to 0.1 mbar for the trehalose based formula-
tions. As expected, for medium and high chamber pressure (above 1 mbar) also the tre-
halose based lyophilizates collapsed during aggressive freeze-drying. The formulations, 
which comprise no or a low amount of bulking agent, spattered out of the vial. On the 
other hand, if freeze-dried at 0.1mbar, even the formulations containing no bulking agent 
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exhibited a slightly shrunken but overall acceptable appearance - despite high shelf tem-
peratures of up to 60 °C. The marked differences for different chamber pressure can be 
explained by the influence of the chamber pressure on the product temperature. The 
chamber pressure is the major determinant for the product temperature and therefore 
collapse behavior and final structure. Moreover, it was noticed that the sublimation is 
faster for higher chamber pressures due to the higher product temperatures. Because of 
the major influence on the collapse behavior, the chamber pressure strongly influences 
the physico-chemical characteristics of the lyophilizates regarding e.g. specific surface 
area, water content, or glass transition temperatures. The evaluation of mab_T1 stability 
in the collapsed and non-collapsed samples, which were produced at the different cham-
ber pressures, revealed that a medium to high pressure is preferable for stabilization. 
Most probably, the low specific surface area of these lyophilizates offered best stabiliza-
tion to mab_T1. 
The influence of shelf temperature was investigated in the range of 30 °C to 60 °C. The 
variation of the shelf temperature revealed higher sublimation rates for higher shelf tem-
perature. The effect was less pronounced than expected, however, it can be explained by 
the low influence of the shelf temperature on the product temperature. Although the shelf 
temperature varied in a range of 30 K, the product temperature remained almost un-
changed. In contrast to the minor influence of shelf temperature on the sublimation, a 
variation of the shelf temperature affected the effectiveness of secondary drying. Both, 
the residual water content and glass transition temperature were influenced. A higher 
shelf temperature resulted in lower water content and higher Tg. Regarding the influence 
of shelf temperature on the stability of the incorporated antibody mab_T1, an interesting 
phenomenon was observed. High shelf temperature resulted in less aggregation than low 
shelf temperature.  
Drying time was varied between 8 h and 24 h. While appearance, crystallinity, and 
specific surface area remained unchanged, increased drying time resulted in considera-
bly reduced residual water content and higher Tg as expected. Concerning the stability 
of the embedded antibody mab_T1, the data showed that pro-longed drying time in-
creased aggregation.  
Summarizing the data on the influence of variation of process conditions on the re-
sulting products from aggressive freeze-drying, an overall good to excellent stabilization 
of mab_T1 can be stated. An optimum level of stabilization was achieved by samples of 
low specific surface area (< 0.5 m²/g) and fully amorphous structure. Although lyophi-
lizates of very different physico-chemical characteristics were generated by the different 
shelf temperatures, chamber pressures, and drying times, at least sufficient stabilizations 
of the sensitive model protein could be ensured. Therefore, it is concluded that aggressive 
freeze-drying can be performed in a wide range of shelf temperatures (30 °C – 60 °C) and 
chamber pressures (0.1 mbar – 4 mbar). Since increased drying times result in decreasing 
stabilization, short cycles (8 hours drying time) are preferable in terms of protein stabili-
zation. To produce lyophilizates of sufficiently low residual water content and low spe-
cific surface area by short drying cycles, the addition of low amounts of phenylalanine to 
sugar-based formulations (ratio 10:0.5, e.g. tre:phe 10:0.5) was the key to success. Due to 
on the one hand excellent preservation of mab_T1 and on the other hand sound physico-
chemical characteristics, medium chamber pressure of 1 to 2 mbar and medium shelf 
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temperature of 45 °C is advised for aggressive freeze-drying of sugar-based protein for-
mulations.   
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CHAPTER 5 THE INFLUENCE OF FORMULATION COMPOSITION ON 
PHYSICO-CHEMICAL CHARACTERISTICS OF AGGRESSIVELY 
FREEZE-DRIED LYOPHILIZATES  
1. INTRODUCTION 
The systematic study about the influence of structural collapse on the stability of phar-
maceutical proteins by Schersch and coworkers has undoubtedly shown that even a se-
vere change in product structure (referred to as complete structural collapse) does not 
necessarily result in instability of incorporated proteins [1]. Even more remarkably, they 
have shown that proteins in collapsed formulations showed an at least comparable or 
even a superior stability during storage at rather harsh conditions (50 °C for 6 months) 
compared to samples freeze-dried conventionally [2, 3]. Based on those findings, and the 
overall growing interest in applying high product temperatures during freeze-drying [4-
7], and in order to save time and resources, the investigation of the robustness and po-
tentially universal use of aggressive freeze-drying to different types of protein formula-
tions is of high interest. In chapter 4 of this thesis it could be shown that aggressive freeze-
drying is a well controllable and reproducible technique to achieve products of suitable 
characteristics for protein stabilization. 
To extend the knowledge about the influence of formulation design on physico-chem-
ical characteristics of aggressively freeze-dried lyophilizates, in this chapter the range of 
selected freeze-drying formulations was extended. As already outlined in the general in-
troduction (cf. pages 11 and 12), for most pharmaceutical formulations, the use of an 
amorphous excipient is obligatory for the stabilization of incorporated sensitive mole-
cules. Amorphous excipients act as water replacement in the dry state [8-11] and provide 
a vitrified glassy matrix of reduced mobility [12-14]. In order to increase the mechanic 
strength of the resulting dry product cake, crystalline components are added frequently 
(see e.g. [15]). Taking that into consideration, all formulations evaluated in in this chapter 
are based on a considerable amount of an amorphous excipient (e.g. a disaccharide). Since 
formulation strategy for freeze-drying formulations emphasizes the importance of bulk-
ing agents [16], the utilization of bulking agents for aggressive freeze-drying was scruti-
nized closely. Due to a number of circumstances (e.g. necessary dose), the protein con-
centration in a biopharmaceutical drug can cover a considerable range [17]. Therefore, 
the effect of protein concentration on resulting physico-chemical characteristics was eval-
uated, too. Beyond different protein concentrations, freeze-drying formulations exhibit 
also an overall different content of dissolved solids, usually in form of stabilizing excipi-
ents. To account for the effect of different solid contents on resulting product character-
istics, formulations covering a range of solid contents were aggressively freeze-dried and 
investigated. 
The aggressively freeze-dried products were evaluated with respect to key product 
qualities. Major physico-chemical characteristics of aggressive freeze-dried products like 
residual water content and glass transition temperature were determined. Furthermore, 
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important characteristics like specific surface area analysis and crystallinity were moni-
tored.  
2. TYPE OF DISACCHARIDE 
As already outlined in more detail in the general introduction, both sucrose and tre-
halose are the most prominent stabilizers used to protect valuable molecules in freeze-
dried products [17]. Therefore, it is of major interest to evaluate the influence of sugar 
selection on the physico-chemical characteristics of products from aggressive freeze-dry-
ing. For this purpose, 5% (wt/wt) solutions of sucrose as well as trehalose were aggres-
sively freeze-dried in 2R vials with 1ml fill using the protocol shown in Table 3.4 (page 
55) in an FTS LyoStar II freeze-drier. Aggressive freeze-dried samples were analyzed re-
garding appearance, residual water content, glass transition temperature, specific surface 
area, as well as molecular structure (crystallinity).  
 
     
Figure 5.1: Macroscopic appearance of products aggressively freeze-dried samples from 5% (wt/wt) sugar solu-
tions (process settings: pc=1 mbar, Ts=45 °C). Left picture shows sucrose based samples, right picture trehalose 
based. 
Figure 5.1 shows the macroscopic appearance of aggressively freeze-dried samples 
from either 5% (wt/wt) sucrose (left picture) or 5% (wt/wt) trehalose solution (right pic-
ture). Both sugars showed a comparable, fully collapsed appearance, which can be de-
scribed as foam-like structure. The apparent volume of the foam-like structures equals 
the initial filling height. Observations of the appearance in the course of drying revealed 
that this foam-like structure is formed at the late stage of sublimative drying following a 
pronounced shrinkage of the drying product.  
The comparable structure of samples of either sugar is also reflected in the pictures 
attained by a digital microscope at a magnification of 100x (cf. Figure 5.2). As the samples 
could not be removed from the vial without destruction, the pictures show fragments of 
the freeze-dried material. However, despite of fragmentation, the original glassy struc-
ture of the samples could be displayed, showing that the sugars formed a transparent 
glass. The red scale bar represents 250 µm, which is about one magnitude larger than the 
range of typical pore sizes for non-collapsed samples.  
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Figure 5.2: Microscopic appearance (100x magnification) of aggressively freeze-dried samples  from 5% (wt/wt) 
sugar solutions (process settings: pc=1 mbar, Ts=45 °C). Left picture shows sucrose based samples, right picture 
trehalose based.  
Although the samples were subjected to a comparably long aggressive freeze-drying 
cycle of 24 h at 45 °C shelf temperature, the residual water content of samples from both 
sugars is still comparably high (cf. Figure 5.3, left graph).  
 
Figure 5.3: Physico-chemical characteristicss of samples aggressively freeze-dried from 5% (wt/wt) sucrose or 
5% (wt/wt) trehalose solution (process settings: pc=1 mbar, Ts=45 °C). Left graph shows residual water content 
(grey bars) and glass transition temperature (black squares), right graph shows specific surface area. 
While a residual water content of 1.5% was detected for sucrose based samples, tre-
halose based samples ended up at 2.2%. From conventional freeze-drying it is known that 
trehalose exhibits higher residual water contents if subjected to similar freeze-drying pro-
cesses. As especially drying by desorption within the secondary drying step is dependent 
from the available surface for desorption, specific surface of the collapsed lyophilizates 
was determined (cf. Figure 5.3, right graph). No apparent difference was detected for the 
different sugars. Both, sucrose as well as trehalose based samples showed a very low 
specific surface area compared to conventionally freeze-dried lyophilizates, which ex-
hibit SSA of around 1 to 2 m²/g (data not shown). Regarding glass transition temperature, 
the aggressively freeze-dried products showed glass transition temperature of 55.1 °C 
(sucrose) and 68.8 °C (trehalose), respectively (cf. Figure 5.3, left graph).  
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During aggressive freeze-drying of sucrose and trehalose solution, there is consider-
able mobility in the drying matrix resulting in collapsed appearance after the process. 
Therefore, also crystallization of the sugars seemed so be possible in the course of col-
lapse. To figure out, whether crystallization plays a role, the dried samples were analyzed 
using powder X-Ray diffraction (XRD). The absence of peaks in the diffractograms (cf. 
Figure 5.4) revealed the fully amorphous structure of samples from both sugars. This is 
further assisted by the absence of melting peaks in the DSC thermograms.  
 
Figure 5.4: XRD diffraction pattern of samples aggressively freeze-dried from 5% (wt/wt) sucrose or 5% (wt/wt) 
trehalose solution (process settings: pc=1 mbar, Ts=45 °C). 
Usually, freeze-drying of pharmaceutical formulations is designed to form highly po-
rous product structures, which then readily dissolves in a diluent. One major concern 
regarding collapsed lyophilizates is a prolonged reconstitution time due to the less po-
rous structure [18]. Therefore, the rehydration behavior of collapsed trehalose and su-
crose samples were checked by the addition of high-purified water. Despite the drasti-
cally reduced specific surface area compared to conventionally freeze-dried lyophilizates, 
trehalose based samples were fully rehydrated after 18 ± 3 s, sucrose based samples 
within 22 ± 5 s. The overall short rehydration can partly be assigned to the very good 
solubility of sucrose and trehalose in water. 
Summing up the influence of type of disaccharide on physico-chemical characteristics 
of aggressively freeze-dried lyophilizates, sucrose and trehalose resulted in comparable 
products with regard to appearance, crystallinity, and specific surface area. Small differ-
ences were detected for the glass transition temperatures as well as residual water con-
tent. In the context of potential protein stabilization, the fully amorphous nature as well 
as high glass transition temperature renders both sugars suitable excipients for aggres-
sive freeze-drying. In addition, the low specific surface area could improve the stabiliza-
tion of especially surface sensitive proteins. On the other hand, comparable high residual 
water contents could potentially foster for example degradation of incorporated biophar-
maceuticals. However, usually the addition of a protein to the amorphous sugar matrix 
results in sort of a bulking effect and therefore lower water content in protein containing 
lyophilizates.  
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3. ADDITION OF BULKING AGENT 
A common strategy of conventional freeze-drying to form a mechanical strong prod-
uct cake is to add excipients to a freeze-drying formulation that crystallizes during freez-
ing [17, 19]. Mannitol represents one of these bulking agents that is frequently used [15]. 
In addition, amino acids have been shown to act as bulking agent [20, 21]. While usually 
bulking agents are used in excess to amorphous stabilizers regarding weight to weight 
ratios [15], amino acids have been shown to act at lower weight to weight ratios [30]. In 
order to evaluate the influence of bulking agent on the physico-chemical characteristics, 
a number of different weight-to-weight ratios of mannitol or phenylalanine to sucrose or 
trehalose were subjected to aggressive freeze-drying in 2R vials with 1ml fill according 
to the protocol shown in Table 3.4 (page 55) by using a FTS LyoStar II freeze-drier. Table 
5.1 shows the formulations used within that study.  
Table 5.1: Formulations to characterize the influence of bulking agent on the physico-chemical characteristics of 
aggressively freeze-dried products. 
formulation lysozyme sucrose trehalose mannitol phenylalanine 
 mg/ml mg/ml mg/ml mg/ml mg/ml 
suc 1 50.0    
suc:man 10:2 1 41.7  8.3  
suc:man 1:1 1 25.0  25.0  
suc:man 2:10 1 8.3  41.7  
suc:phe 10:0.5 1 47.6   2.4 
suc:phe 10:1 1 45.5   4.5 
suc:phe 10:2 1 41.7   8.3 
suc:phe 10:3 1 38.5   11.5 
tre 1  50.0   
tre:man 10:2 1  41.7 8.3  
tre:man 1:1 1  25.0 25.0  
tre:man 2:10 1  8.3 41.7  
tre:phe 10:0.5 1  47.6  2.4 
tre:phe 10:1 1  45.5  4.5 
tre:phe 10:2 1  41.7  8.3 
tre:phe 10:3 1  38.5  11.5 
 
The ratio between sugar and either bulking agent was varied from low to high con-
tents. Due to differences in water solubility of mannitol and phenylalanine, high and low 
bulking agent content is represented by different absolute concentrations of either sub-
stance. In order not to compromise the evaluation by a potential additional effect of the 
solid content on the physico-chemical characteristics, the solid content was kept at 
51 mg/ml for all formulations. To account for the fact that generally a formulation is de-
signed to protect a protein in a pharmaceutical formulation, additionally lysozyme was 
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added to the formulation. As in this study the physico-chemical characteristics were of 
interest, no characterization of the stability of lysozyme was conducted.  
Product temperature 
In order to characterize the drying behavior of the different formulations regarding 
product temperature, thermocouples were placed in one vial of each formulation. It was 
of special interest, in which way the addition of bulking agent influences the product 
temperature especially during the primary drying stage. Figure 5.5 displays exemplary 
curves for trehalose based formulations containing both, low and high amount of man-
nitol or phenylalanine. Both formulation containing a low amount of either mannitol or 
phenylalanine showed a product temperature course comparable to the formulation con-
taining no bulking agent (tre), characterized by a clear plateau around -20 °C, which is 
reached after an overall process time of 5.5 h. After the end of sublimation at around 7 h 
process time, the product temperatures tended towards the shelf temperature of 45 °C. 
The product temperature of the formulation containing a low amount of phenylalanine 
(tre:phe 10:0.5) showed a smooth characteristic. Both, the formulation containing no bulk-
ing agent (tre) or a low amount of mannitol (tre:man 10:2) showed a somehow serrated 
characteristics towards the end of primary drying, which is attributed to the slightly dif-
ferent collapsing behavior of those formulations compared to tre:phe 10:0.5 (compare 
macroscopic appearance below).  
 
Figure 5.5: Product temperatures of trehalose-based formulations containing both, a high and low amount of 
mannitol or phenylalanine; primary drying section between 5 and 10 h drying time is shown (solid content 5% 
(wt/wt); 2R glass vials, 1 ml fill; process settings: pc=1 mbar, Ts=45 °C). 
The formulations containing a high amount of bulking agent (tre:phe 10:3 and 
tre:man 2:10) showed a somewhat different behavior regarding product temperature. 
Product temperatures of both formulations showed no clear plateau phase during pri-
mary drying phase, but a steady, slight increase in the overall smoothly shaped curves. 
Taking the macroscopic appearance and the specific surface area (see below) into consid-
eration, this steady increase in product temperature during primary drying can be at-
tributed to increasing product resistance due to growing dry layer that have to be passed 
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by the water vapor formed at the progressing sublimation front. Increasing resistance 
consequently lead to increasing pressure at the sublimation front resulting in increasing 
product temperature. Formulation of medium bulking agent content (e.g. tre:man 1:1, 
tre:phe 10:1) also showed a slight rise in product temperature during primary drying, 
however, less pronounced compared to the formulation containing a high amount of 
bulking agent. Sucrose based formulations showed similar product temperature course 
(data not shown). 
For all formulations, the mean product temperature during primary drying (cf. Table 
5.2) was calculated by average of the recorded product temperatures between 5.5 and 
6.75 h overall process time. For all formulations, an increase in bulking agent content 
resulted in an increase in mean product temperature during primary drying phase. The 
lack of a distinct plateau of product temperature of formulations containing a high 
amount of bulking agent is reflected in the higher standard deviation of the calculated 
mean product temperature, too. Comparing the mean product temperatures to the glass 
transition temperatures of the maximally freeze-concentrated solutions (Tg’, cf. Table 5.2) 
showed that product temperature were at least 15 °C higher than Tg’. Therefore, for all 
formulations some sort of collapse was expectable. Interestingly, increasing amount of 
mannitol result in a slight decrease in Tg’, while increasing amounts of phenylalanine 
resulted in slightly increasing Tg’.  
Table 5.2: Product temperatures during primary drying and glass transition temperatures of the maximally 
freeze-concentrated solution of bulking agent containing formulations.  
formulation Tg’ product temperature primary drying 
 mean SD mean SD 
 °C °C °C °C 
suc -33.8 0.2 -16.2 0.9 
suc:man 10:2 -35.4 0.1 -17.4 0.2 
suc:man 1:1 -38.2 0.4 -15.9 1.2 
suc:man 2:10 -40.6 0.1 -13.8 2.7 
suc:phe 10:0.5 -32.9 0.2 -17.4 0.3 
suc:phe 10:1 -32.3 0.0 -17.5 0.7 
suc:phe 10:2 -30.8 0.2 -14.9 2.0 
suc:phe 10:3 -30.1 0.2 -13.2 2.4 
tre -31.3 0.2 -16.3 1.2 
tre:man 10:2 -34.3 0.2 -17.2 0.5 
tre:man 1:1 -37.9 0.1 -16.7 1.5 
tre:man 2:10 -40.0 0.2 -13.7 2.8 
tre:phe 10:0.5 -31.0 0.1 -17.4 0.6 
tre:phe 10:1 -30.6 0.2 -16.6 1.6 
tre:phe 10:2 -29.5 0.2 -15.5 2.0 
tre:phe 10:3 -28.3 2.5 -12.8 2.3 
 
Macroscopic and microscopic appearance 
Figure 5.6 shows the macroscopic appearance of the aggressively freeze-dried formu-
lations. Regarding the sugar, on which the formulations were based on the appearance 
was overall comparable between sucrose and trehalose. Minor different appearance was 
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noticed for the formulation containing no bulking agent. Both samples were fully col-
lapsed. While the sucrose formulations showed a foamy appearance, as already shown 
above for samples containing no protein, the trehalose formulation exhibited a less foamy 
structure, but rather a flat layer at the bottom of the vial. All other formulations showed 
an appearance that was independent from the sugar they were based on. Hence, in the 
following descriptions it is not differentiated between samples from either sugar.   
 
Figure 5.6: Macroscopic appearance of aggressively freeze-dried formulations containing different amounts of 
bulking agents (mannitol or phenylalanine), showing an overall comparable appearance between sucrose and 
trehalose (see text for sample description; process settings: pc=1 mbar, Ts=45 °C). 
The addition of a low amount of mannitol to the sugar based formulations 
(suc:man 10:2 ≙ sm2 in Figure 5.6; tre:man 10:2 ≙ tm2) resulted in no change in appear-
ance compared to the pure sugar formulations. Although they also showed collapsed 
appearance, the formulations containing a low amount of phenylalanine (suc:phe10:0.5 
≙ sp0.5; tre:phe 10:0.5 ≙ tp0.5) exhibited a more spongy structure. The samples from for-
mulations containing a medium content of phenylalanine (suc:phe10:1 ≙ sp1; tre:phe 10:1 
≙ tp1) showed signs of pronounced micro-collapse expressed as macroscopically visible 
pores. In addition, they showed some shrinkage in cake height. A medium content of 
mannitol (suc:man10:10 ≙ sm10; tre:man 10:10 ≙ tm10) as well as a medium to high con-
tent of phenylalanine (suc:phe10:2 ≙ sp2; tre:phe 10:2 ≙ tp2) resulted in an acceptable 
product cake with slight shrinkage in height. The addition of a high amount of mannitol 
(suc:man10:50 ≙ sm50; tre:man 10:50 ≙ tm50) or phenylalanine (suc:phe10:3 ≙ sp3; 
tre:phe 10:3 ≙ tp3) resulted in an elegant cake with no signs of collapse or shrinkage.  
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Regarding the macroscopic appearance, mannitol and phenylalanine showed compa-
rable trends, however, the overall amounts in the formulations were quite different. Phe-
nylalanine forms a macroscopically non-collapsed product already at a much lower 
amount compared to mannitol. From a general perspective, the application of medium 
to high amount of bulking agent hinders macroscopically visible collapse even through-
out aggressive freeze-drying, which resulted in product temperatures considerably 
higher than the glass transition temperature of the maximally freeze-concentrated solu-
tion (Tg’). 
In order to have a closer look to the microscopic structure of the aggressively freeze-
dried samples, scanning electron microscopy (SEM) was utilized. Figure 5.7 and Figure 
5.8 show exemplarily the SEM pictures of the sucrose-based samples. The microscopic 
structure of the trehalose-based samples appeared similar. Both, the sample containing 
no or a low amount of mannitol exhibited a structure of huge flakes under the REM. The 
flake-like structure can be addressed to the brittle nature of the macroscopically foam-
like structure of the lyophilizates (compare Figure 5.6). For the preparation of the sample 
prior to REM the foam-like structure needed to be removed from the vial. During that 
procedure, the brittleness of the thin material layers made it impossible not to partly de-
stroy the structure. Nevertheless, both fully collapsed samples (suc, suc:man 10:2) did not 
show the typical highly porous structure of common lyophilizates. The addition of a low 
amount of mannitol did not result in a change of the structure observable by SEM.  
 
Figure 5.7 Exemplarily SEM pictures of the sucrose-based samples with the bulking agent suc:man; top left pic-
ture (suc) and top right picture (suc:man 10:2) are fully collapsed samples with huge flakes. Bottom left picture 
(suc:man 1:1) and bottom right picture (suc:man 2:10) display formulations containing a medium or high level of 
mannitol and exhibiting a porous structure. 
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An increase of the amount of mannitol to medium level resulted in a porous micro-
scopic structure. Compared to conventionally freeze-dried samples, this structure ap-
peared somehow denser. Larger magnification (not shown) revealed a structure, that can 
be described as sort of mixture of crystalline and smooth structures. This somehow 
coated appearance can be attributed to the mixture of (partly) crystalline mannitol and 
amorphous sucrose. Samples freeze-dried from the highest amount of mannitol 
(suc:man 2:10) exhibited a highly porous structure, which seems to be dominated by crys-
talline structures. 
While low amounts of mannitol did not result in a change in microscopic structure 
compared to the samples containing no bulking agent, already low amounts of phenylal-
anine (suc:phe 10:0.5) resulted in a dense but not flake-like structure, which best can be 
described as a dense macro-porous network (cf. Figure 5.8).  
 
Figure 5.8: Exemplarily SEM pictures of the sucrose-based samples containing phenylalanine as bulking agent. 
Top left picture low amount of phenylalanine (suc:phe 10:0.5), top-right suc:phe 10:1, bottom left suc:phe 10:2 , 
bottom right suc:phe 10:3. 
Increasing the phenylalanine content resulted in a stepwise reduction of pore sizes 
and formation of the micro-porous structure characteristic for lyophilizates. While for 
suc:phe 10:1 and 10:2 signs of micro-collapse can be distinguished (large pores with sur-
rounding massive “walls”), the addition of high amounts of phenylalanine did not show 
that phenomenon. Increasing amounts of phenylalanine – as well as mannitol – resulted 
in increased brittleness of the porous structure on a microscopic level. 
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Residual water content 
As already outlined above, aggressive freeze-drying of pure sugar formulations re-
sulted in residual water contents of 1.5% and above due to the dense structure of the 
collapsed lyophilizates, which hinders an effective secondary drying. As the addition of 
bulking agent changed the macroscopic appearance of aggressively freeze-dried formu-
lations dramatically, a closer look to the achieved residual water content is of interest. 
Figure 5.9 displays the residual water content of the lyophilizates aggressively freeze-
dried from the formulations shown in Table 5.1. Without the addition of a bulking agent, 
the samples exhibited comparable high residual water contents of 1.9% (suc) and 3.7% 
(tre). The addition of a low amount of mannitol did not result in a significant change 
compared to the samples with no bulking agent. In contrast, by adding low amounts of 
phenylalanine to the sugar based formulations, a residual water content of 0.8% 
(suc:phe 10:0.5) or even 0.2% (tre:phe 10:0.5) was achieved. Medium to high amounts of 
phenylalanine resulted in residual water contents of below 0.1%, while for medium and 
high amounts of mannitol, residual water contents of between 0.5% and 0.2% were 
achieved. In other words, the addition of either bulking agent drastically decreased the 
residual water content of the aggressively freeze-dried lyophilizates.  
 
Figure 5.9: Effect of bulking agent on the residual water content for sugar based aggressively freeze-dried lyoph-
ilizates (n=3). 
It is noteworthy that the samples, freeze-dried from the formulations containing a low 
amount of phenylalanine, exhibited low residual water contents, although they showed 
collapsed appearance. Overall, as phenylalanine decreased the residual water content al-
ready at comparable low concentrations, this bulking agent seems to be superior to man-
nitol in this case concerning decreasing residual water content. 
 
Specific surface area 
The desorptive drying mechanism, which governs the kinetics of secondary drying 
and therefore the final residual water content, are inherently dependent from the specific 
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surface. Higher SSA is expected to result in lower residual moisture and vice versa. Be-
yond the description of the appearance of lyophilizates subjected to aggressive freeze-
drying, SSA data allow to quantify the degree of collapse. Hence, the specific surface area 
of the aggressively freeze-dried lyophilizates was analyzed using BET gas adsorption. 
Figure 5.10 shows the determined specific surface areas. Overlooking all data for phenyl-
alanine containing lyophilizates, a slight tendency of higher SSA for trehalose based sam-
ples could be noticed. Very low SSA was detected for formulations containing no bulking 
agent (below 0.1 m²/g). While the addition of low amounts of mannitol had no effect on 
the SSA (still below 0.1 m²/g), low amounts of phenylalanine resulted in slightly increased 
SSA of 0.26 m²/g for the trehalose based lyophilizates. In contrast, the same amount of 
phenylalanine did not increase the SSA of the sucrose based formulation. A medium 
amount of mannitol resulted in increased SSA of 0.43 m²/g (suc:man 1:1) and 0.73m²/g 
(tre:man 1:1), respectively. A comparable effect was detected for the formulations, con-
taining a medium amount of phenylalanine (sugar:phe 10:1). Generally, increasing 
amounts of phenylalanine resulted in a stepwise increase in SSA up to 1.11 and 1.30 m²/g 
for the formulations containing phenylalanine at a ratio of 10:2. In contrast to mannitol, 
further increase of phenylalanine amount did not result in further increase in SSA. The 
formulations containing high amounts of mannitol ended up at 3.46 m²/g (suc:man 2:10) 
and 3.36 m²/g (tre:man 2:10).  
 
Figure 5.10: Effect of bulking agent on the specific surface area of sugar based aggressively freeze-dried lyophi-
lizates. 
Overall, the determined specific surface areas support the observations of the macro-
scopic appearance of the different formulations. Macroscopically collapsed samples 
showed very low specific surface areas. The addition of bulking agents resulted in a step-
wise increase of the specific surface area, which is also noticeable macroscopically. Sam-
ples containing a medium amount of bulking agent showed a non-collapsed appearance 
but shrinkage of the product cake (sugar:man 1:1; sugar:phe 10:1), which is detectable as 
distinct decrease of SSA compared to formulations containing high amounts of bulking 
agent. The latter showed shrinkage neither.  
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Glass transition temperature  
As freeze-drying of protein formulations is performed to achieve a sound stabilization 
of an embedded protein during an extended period of storage, the glass transition tem-
perature of the underlying excipient matrix is of importance. Usually, higher glass tran-
sition temperatures are regarded as superior for storage stability. Figure 5.11 shows the 
glass transition temperatures (Tg) determined by DSC. Trehalose is known to inherently 
exhibit higher glass transition temperatures at comparable residual water contents.   
The lyophilizates aggressively freeze-dried from the formulations containing no bulking 
agent exhibited glass transition temperatures of around 50 °C (suc 49.5 °C; tre 53.1 °C), 
which is regarded as high enough to provide considerably storage stability. The addition 
of even small amount of phenylalanine increased the glass transition temperature espe-
cially for trehalose based samples to above 80 °C (except tre:phe 10:1). In addition, the 
glass transition temperatures of sucrose were increased by the addition of phenylalanine, 
however, not in a similar manner compared to trehalose. The addition of mannitol re-
vealed unexpected results, since only the formulation containing a medium amount of 
mannitol showed an increase in glass transition temperature. For both formulations, con-
taining a high or a low amount of mannitol, a decrease in glass transition temperature 
was detected for formulations based on both, sucrose and trehalose. Possibly, a consid-
erable amount of mannitol remained amorphous and decreased the glass transition tem-
perature of the mixture, while for the formulation containing a medium amount of man-
nitol a larger amount of mannitol crystallized. Even the comparably low residual water 
content of sugar:man 2:10 did not result in increased Tg. Regarding the connection be-
tween glass transition temperature and residual water content, partly crystalline lyophi-
lizates are generally prone to a phenomenon which could minimize the effect of lower 
residual water contents towards higher Tg’s. Assuming that there is no water embedded 
in the crystalline structure of a bulking agent, the residual water content of a partly crys-
talline lyophilizates is predominantly present as part of the amorphous mixture [22]. 
Comparing an amorphous and a partly crystalline lyophilizate of the same residual water 
content and same solid content, in the partly crystalline lyophilizate the residual water 
content of the amorphous phase must be consequently higher as in this sample less amor-
phous material contains all the water. In turn, in a fully amorphous sample the water is 
distributed in a larger amount of material, i.e. the water “concentration” is lower, result-
ing in higher glass transition temperature.  
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Figure 5.11: Effect of bulking agent on the glass transition temperature of sugar based aggressively freeze-dried 
lyophilizates (n=3). 
Crystallinity 
To address the molecular structure of the samples aggressively freeze-dried from the 
formulations containing different amount of phenylalanine or mannitol (cf. Table 5.1), 
Powder X-Ray diffraction (XRD) was utilized. The resulting diffraction patterns are 
shown in Figure 5.12. The samples from both formulations containing no bulking agent 
(suc, tre) showed no distinct diffraction peaks. Therefore, they are regarded as fully amor-
phous. Also the addition of low to medium amounts of phenylalanine (sugar:phe 10:0.5 
and sugar:phe 10:1) did not result in discernible diffraction. Hence, these samples are 
considered fully amorphous, too. The addition of high amounts of phenylalanine in tre-
halose based formulations (10:2 and 10:3) resulted in small but discernible diffraction 
peaks. According to the International Centre for Diffraction Data (ICDD) database, those 
diffraction patterns could be identified as L-phenylalanine hydrate (especially based on 
the most distinct peak at 6.4° 2-theta). The peak around 38.8° 2-theta result from the cop-
per sample holder. While the addition of the highest amount of phenylalanine to the su-
crose based formulation (i.e. formulation suc:phe 10:3) resulted also in discernible peaks, 
XRD of formulation with the second highest content of phenylalanine (suc:phe 10:2) 
showed an amorphous pattern.  
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Figure 5.12: Effect of bulking agent on the diffraction pattern of sugar based aggressively freeze-dried lyophi-
lizates. 
While low amounts of mannitol resulted in fully amorphous structure for sucrose 
based samples, trehalose based samples showed small, but discernible diffraction peaks 
(cf. Figure 5.12). Independent from sugar, medium and high amounts of mannitol re-
sulted in clear diffraction pattern underlining the presence of considerable amounts of 
crystalline structures in those samples. According to literature (JCPDS database [23-25]), 
the diffraction pattern detected from the formulation containing medium to high manni-
tol amounts, can be attributed to the δ-polymorph of mannitol (characteristic peaks at 
9.7°, 20.4, and 24.6° 2-theta). Neither peaks characteristic for the α-polymorph (13.6°, 17.2° 
2-theta), nor for the β-polymorph (14.6°, 16.8°, 23.4° 2-theta), nor for the hydrate form 
(17.9° 2-theta) of mannitol were detectable. Therefore, solely the δ-polymorph is formed 
during aggressive freeze-drying of the formulation containing medium and high 
amounts of mannitol. 
 
Summary 
It was shown that the addition of bulking agent (mannitol or phenylalanine) to either 
sucrose or trehalose based formulations influence physico-chemical characteristics of ag-
gressively freeze-dried lyophilizates. As expected, increasing weight-to-weight ratios re-
sulted in increased influence of the respective bulking agent. It needs to be mentioned 
that the applied absolute amount of either mannitol or phenylalanine was quite different. 
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While phenylalanine act as suitable bulking agent already at weight-to-weight ratios of 
10:2, mannitol needs to be applied at least at weight-to-weight ratios of 1:1. 
With increasing amounts of bulking agent, the macroscopic appearance changed from 
collapsed for low amounts of mannitol and phenylalanine to no visible signs of collapsed 
for high amount of either bulking agent. Medium amounts of bulking agent resulted in 
some shrinkage and macroscopically discernible larger pores (esp. for phenylalanine).  
The observations regarding the influence of bulking agent on the macroscopic appear-
ance were supported by the determined specific surface areas. Increasing amounts of 
mannitol or phenylalanine resulted in increasing specific surface areas underlining the 
change in structure at a microscopic level. By increasing amounts of either bulking agent, 
the microscopic structure addressed by scanning electron microscopy tended from flake-
like structure towards the appearance known from conventionally freeze-dried, which is 
characterized by a highly porous structure composed of small pores and thin interstitial 
walls between the pores. Assessing the specific surface area had shown that changes in 
structure, which can be attributed to micro-collapse, can be clearly identified if present. 
Obviously, for increasing amounts of bulking agent the crystalline part of the matrix pre-
vents macro- or even micro-collapse. The evidence for the at least partly crystalline struc-
ture of the bulking agents at medium to high contents have been shown by powder X-
ray diffraction analysis. Mannitol gave a strong crystalline signal of the stable δ-poly-
morph while phenylalanine crystallized in the hydrate form. Overall, there seems to be a 
slight tendency of sucrose seeming to depress crystallization slightly more effective. 
An increase of the amount of bulking agent resulted in a decrease in residual water 
content. This effect can also be clearly ascribed to the increase in specific surface area with 
increasing bulking agent content, since increase in SSA makes secondary drying mecha-
nism more effective. Consequently, glass transition temperatures were increased for in-
creasing amounts of phenylalanine. Although, increasing amounts of mannitol resulted 
in decreased residual water contents, the glass transition temperatures did not show an 
increase as well. Mannitol was utilized in far higher weight-to-weight ratios (bulking 
agent to sugar) compared to phenylalanine to achieve comparable effects regarding phys-
ico-chemical characteristics. Therefore, it is reasonable that the glass transition tempera-
tures did not increase since the residual water content is distributed only in the amor-
phous phase. 
The product temperatures of all formulations were remarkably above the glass tran-
sition temperature of the maximally freeze-concentrated solution (Tg’). Therefore, at least 
micro-collapse necessarily occurred in all formulations during the primary drying stage. 
The differences in the microscopic structure (i.e. specific surface area), which are depend-
ing on the amount of bulking agent in the formulation, resulted in slightly different prod-
uct temperatures, too. Overall, higher amount of bulking agent resulted in slightly higher 
product temperatures. This effect can be attributed to the higher resistance of the non-
collapsed samples aggressively freeze-dried from high bulking agent containing formu-
lations.  
Comparing both bulking agents utilized in this study, phenylalanine resulted in prod-
ucts with superior characteristics compared to mannitol. For the stabilization of a phar-
maceutical API (e.g. a protein), usually an amorphous lyophilizate with low residual wa-
ter content and high glass transition temperature represents the aimed goal [17]. As pure 
sugar formulations result in time consuming freeze-drying cycles in order to achieve low 
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residual water contents and acceptable appearance of the product, bulking agents (most 
often mannitol) are included to improve the drying behavior. However, especially for 
very sensitive molecules, the formation of additional surfaces by crystallization of a bulk-
ing agent within the lyophilizates can be detrimental. A formulation, showing full amor-
phous structure, low residual moisture, high glass transition temperature, and that can 
be freeze-dried fast, would be worth striving for. Leaving out the macroscopic appear-
ance, aggressively freeze-dried formulations based on sucrose or trehalose and low 
amounts of phenylalanine provides all desired qualities. The addition of higher amounts 
of phenylalanine also results in macroscopic elegant cakes, however, at the costs of form-
ing crystalline material in the lyophilizate. 
4. AMINO ACIDS AS BULKING AGENTS 
Inspired by the efficient benefit of phenylalanine as bulking agent for aggressive 
freeze-drying of sugar-based formulations, a number of further amino acids were inves-
tigated regarding their suitability to act as bulking agent. Amongst the selection of amino 
acids, glycine is the most prominent representative, which is reported to be used as bulk-
ing agent in some formulations [15]. Based on either sucrose or trehalose, the formula-
tions shown in Table 5.3 were subjected to aggressive freeze-drying in 2R vials with 1ml 
fill according to the protocol shown in Table 3.4 (page 55) by using a FTS LyoStar II freeze-
drier. Since phenylalanine has shown favorable physico-chemical characteristics at a 
sugar to phenylalanine ratio of 10:0.5 (see previous section), this weight-to-weight ratio 
was also applied for the investigation of the further amino acids. The formulations were 
composed at a total solid content of 50 mg/ml.  
The resulting lyophilizates were characterized regarding macroscopic appearance, 
specific surface area, residual water content, glass transition temperature, and molecular 
structure. In addition, the drying behavior of the different formulations was followed by 
recording the product temperatures in order to check for potential differences in the 
product temperatures during the quasi steady state within the primary drying phase. 
Moreover, product temperature data allows for a rough determination of the endpoint of 
primary drying and therefore an estimate of drying kinetics. 
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Table 5.3: Formulations to characterize the physico-chemical characteristics of aggressively freeze-dried formu-
lations containing various amino acids. 
formulation sucrose trehalose arginine glycine histidine isoleucine leucine methionine tryp-
topha
n 
 mg/ml mg/ml mg/ml mg/ml mg/ml mg/ml mg/ml mg/ml mg/ml 
suc:arg 47.5  2.5       
suc:gly 47.5   2.5      
suc:his 47.5    2.5     
suc:iso 47.5     2.5    
suc:leu 47.5      2.5   
suc:met 47.5       2.5  
suc:trp 47.5        2.5 
tre:arg  47.5 2.5       
tre:gly  47.5  2.5      
tre:his  47.5   2.5     
tre:iso  47.5    2.5    
tre:leu  47.5     2.5   
tre:met  47.5      2.5  
tre:trp  47.5       2.5 
 
Product temperature 
Having a look at the product temperatures firstly, all formulations showed similar 
product temperatures during primary drying (cf. Table 5.4), which range around -17.5 °C. 
The mean product temperatures were calculated by average of the temperature during 
the plateau, which is characteristic for the sublimation phase of freeze-drying.  
Table 5.4: Product temperatures during primary drying of aggressive freeze-drying of sugar-based formulations 
containing different amino acids at a sugar to amino acid ratio of 10:0.5. 
 product temperature primary drying 
amino acid sucrose based trehalose based 
 mean SD mean SD 
 °C °C   
arginine -16.5 0.3 -17.0 0.5 
glycine -18.0 0.5 -17.4 0.4 
histidine -17.8 0.3 -17.2 0.9 
isoleucine -17.6 0.3 -16.7 1.2 
leucine -17.7 0.2 -17.1 0.9 
methionine -17.5 0.4 -17.6 0.5 
tryptophan -17.8 0.4 -17.1 0.5 
 
No apparent differences were detected for the different formulations. Product tem-
peratures were comparable to sucrose- and trehalose-based formulations that contain a 
low amount of bulking agent (mannitol or phenylalanine; compare Table 5.2). It needs to 
be mentioned that latter samples additionally contained 1 mg/ml lysozyme. Since also a 
5% (wt/wt) sucrose formulation, which contained no protein or bulking agent, exhibited 
a product temperature of -17.2 °C (compare Table 4.1, page 69) the addition of low 
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amounts of bulking agents or protein does apparently not influence the product temper-
ature. In addition, the endpoint of primary drying (characterized by the increase of the 
product temperature towards shelf temperature) is comparable for all formulations (data 
not shown). The progress of the product temperature during the aggressive freeze-drying 
process is similar but slightly different for the different formulations. While the formula-
tions containing arginine, glycine, histidine, and tryptophan showed the jagged progress 
comparable to aggressively freeze-drying of pure sugar solutions, the formulations con-
taining isoleucine, leucine, and methionine showed a smooth progress, which is charac-
teristic for formulations containing e.g. sugar and phenylalanine at a ratio of at least 
10:0.5.  
 
Macroscopic appearance 
The macroscopic appearance of the lyophilizates are displayed in Figure 5.13. The 
samples that were aggressively freeze-dried from formulations containing arginine, gly-
cine, histidine, and tryptophan exhibited a collapsed, foam-like appearance comparable 
to samples aggressively freeze-dried from pure sugar formulations.  
   
Figure 5.13: Macroscopic appearance of aggressively freeze-dried sugar-based formulations containing different 
amino acids at a sugar to amino acid ratio of 10:0.5 (upper row sucrose based, lower row trehalose based). For 
comparison suc:phe 10:0.5 (sp5) and tre:phe 10:0.5 (tp0.5) is shown. 
In contrast, lyophilizates containing isoleucine, leucine, and methionine showed a col-
lapsed but more structured, sponge-like appearance. Obviously, the addition of arginine, 
glycine, histidine, and tryptophan in low concentrations had no effect on the drying be-
havior (i.e. product temperature and macroscopic appearance), while isoleucine, leucine 
and methionine affected the drying behavior and result. Regarding macroscopic appear-
ance, latter samples were similar to the lyophilizates aggressively freeze-dried from 
sugar:phenylalanine (10:0.5) formulations.  
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Residual water content 
The residual water content of the aggressively freeze-dried samples was analyzed via 
Karl-Fischer titration. By analogy to macroscopic appearance, the residual water content 
of the samples containing arginine, glycine, histidine, and tryptophan exhibit high values 
comparable to the samples containing no amino acid (cf. Figure 5.14). Sucrose based sam-
ples showed residual water contents of around 2%, while trehalose based samples ended 
up at of 2.8% and above.  
 
Figure 5.14: Residual water content of aggressively freeze-dried sugar-based formulations containing different 
amino acids at a sugar to amino acid ratio of 10:0.5. 
The addition of isoleucine, leucine, and methionine on the contrary resulted in mark-
edly decreased residual water contents, most pronounced for the formulations contain-
ing leucine. Latter formulations exhibited residual water contents of 0.5% (sucrose based) 
and 0.4% (trehalose based). However, also the reduction to 1.3% / 0.9% by isoleucine and 
1.0% / 1.3% by methionine expresses a substantial potential of those amino acids to act as 
bulking agent in the capacity of drying enhancer. 
Glass transition temperature 
Since water acts as plasticizer of the amorphous matrix, glass transition temperatures 
are inherently linked to the residual water content. As expected, the group of samples 
exhibiting no reduction of residual water content did not alter the glass transition tem-
perature compared to the pure sugar formulations. Sucrose-based formulation showed 
glass transition temperatures of 47.2 °C to 50.2 °C, trehalose-based samples of 57.3 °C to 
61.3 °C (cf. Figure 5.15). Amino acids that showed an impact on the residual water content 
(iso, leu, met), resulted in an increase of glass transition temperatures. While there is only 
a slight increase for sucrose-based samples, trehalose-based samples exhibited a steep 
increase of larger 20 K to glass transitions to above 88 °C.  
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Figure 5.15: Glass transition temperature of aggressively freeze-dried sugar-based formulations containing dif-
ferent amino acids at a sugar to amino acid ratio of 10:0.5 (n=3; suc:trp missing due to failure during measure-
ment). 
 
Specific surface area 
In the previous section (3) it was shown that for increasing amounts of bulking agent 
the specific surface area was increased as well. Assisted by the link between higher SSA 
and lower residual water content it was concluded that higher SSA is the major determi-
nant for decreased residual water content. Therefore, the specific surface areas of the ag-
gressively freeze-dried lyophilizates containing different amino acids were evaluated.  
Figure 5.16 shows the results of BET gas adsorption analysis. Keeping in mind a SSA 
of around 1 m²/g of conventionally freeze-dried sugar formulations, low SSA of about 
0.1 m²/g were detected, underlining the collapsed nature of all samples. For trehalose-
based samples, a clear trend of slightly increased SSA (0.13 to 0.16 m²/g) of lyophilizates 
containing isoleucine, leucine, or methionine is detectable as expected. However, su-
crose-based samples did not show a similar clear trend. On the contrary, suc:arg exhib-
ited the overall higher SSA for sucrose based samples (0.16 m²/g), which is regarded as 
outlier, however. Although the macroscopic appearance was quite different, material of 
similar SSA was formed during aggressive freeze-drying.  
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Figure 5.16: Specific surface area of aggressively freeze-dried sugar-based formulations containing different 
amino acids at a sugar to amino acid ratio of 10:0.5. 
Crystallinity 
To complete the picture, samples of all aggressively freeze-dried formulations were 
analyzed utilizing powder X-ray diffraction (XRD). The resulting diffraction patterns are 
shown in Figure 5.17.  
  
Figure 5.17: Diffraction patterns of aggressively freeze-dried sugar-based formulations containing different 
amino acids at a sugar to amino acid ratio of 10:0.5 (A: sucrose-based formulations, B: trehalose-based formula-
tions). 
All samples show a predominantly amorphous structure expressed by an amorphous 
halo and the lack of pronounced diffraction peaks. However, by having a closer look, at 
least one characteristic diffraction peak can be observed and definitely identified for each 
of the amino acids L-isoleucine (6.4° 2-theta), L-leucine (6.1° 2-theta), and L-methionine 
(5.8° 2-theta). According to XRD, all other amino acid containing formulations showed 
purely amorphous structure.  
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Summary 
The investigation concerning the ability of different amino acids to act as bulking 
agent at low sugar to amino acid weight-to-weight ratio revealed that L-isoleucine, L-
leucine, and L-methionine are able to change the resulting physico-chemical characteris-
tics of aggressively freeze-dried model formulations based on either sucrose or trehalose. 
By the addition of either one of the before mentioned amino acids, the appearance and 
the residual water content could be influenced. Especially for trehalose-based samples, a 
remarkable increase of glass transition temperature was detected, as well. Although a 
remarkable change of the macroscopic appearance from foamy collapsed to sponge-like 
collapsed could be discerned, the specific surface areas were hardly increased. Compared 
to amino acids that did not show any effect on the physico-chemical characteristics (L-
arginine, L-glycine, L-histidine, L-tryptophan) at the investigated low concentrations, the 
above mentioned three amino acids at least partly crystallized during aggressive freeze-
drying. Hence, the most probable explanation for the effect on the physico-chemical char-
acteristics offers the crystalline state of these amino acids. Comparing the substance prop-
erties of all investigated amino acids, the combination of high hydrophobicity and low 
water solubility seems to result in crystallization of iso, leu, and met. Interestingly, alt-
hough having comparable substance properties like leucine and methionine, phenylala-
nine did not crystallize during aggressive freeze-drying as shown above. 
5. SOLID CONTENT OF THE FORMULATION 
The formulations investigated so far and shown above have been fixed to an overall 
solid content of 50mg/ml, which represents a solid content frequently used for protein 
formulations. Nevertheless, in general the solid content of a protein formulation can be 
varied due to various requirements (e.g. stabilization, tonicity). To account for the effect 
of different solid contents on the resulting product from aggressive freeze-drying, a range 
of formulations of solid contents of 25 mg/ml up to 150 mg/ml was aggressively freeze-
dried. Pure sugar (sucrose or trehalose) formulations or mixtures of sugar and phenylal-
anine (at a ratio of 10:0.5) were utilized, respectively. The formulations used for this study 
can be found in Table 5.5. 1 ml aliquots of the respective formulations were filled in 2R 
vials and subjected to the aggressive freeze-drying protocol shown in Table 3.5 (page 56) 
in a FTS LyostarII freeze-drier (process settings: pc=1 mbar, Ts=45 °C). The resulting ly-
ophilizates were analyzed regarding physico-chemical characteristics (macroscopic ap-
pearance, residual water content, glass transition temperature, specific surface area, mo-
lecular structure/crystallinity). 
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Table 5.5: Formulations to characterize the physico-chemical characteristics of aggressively freeze-dried formu-
lations of different solid contents. 
formulation sucrose trehalose phenylalanine solid content 
 mg/ml mg/ml mg/ml mg/ml 
suc_25 25   25 
suc_50 50   50 
suc_75 75   75 
suc_100 100   100 
suc_150 150   150 
tre_25  25  25 
tre_50  50  50 
tre_75  75  75 
tre_100  100  100 
tre_150  150  150 
suc:phe_25 23.81  1.19 25 
suc:phe_50 47.62  2.38 50 
suc:phe_75 71.43  3.57 75 
suc:phe_100 95.24  4.76 100 
suc:phe_150 142.86  7.14 150 
tre:phe_25  23.81 1.19 25 
tre:phe_50  47.62 2.38 50 
tre:phe_75  71.43 3.57 75 
tre:phe_100  95.24 4.76 100 
tre:phe_150  142.86 7.14 150 
 
Macroscopic appearance 
Figure 5.18 displays the macroscopic appearance of the samples aggressively freeze-
dried from various solid contents. As already experienced from other studies (compare 
above) both, sucrose and trehalose, showed a comparable, collapsed appearance, which 
best can be described as foamy matrix. For trehalose at a low solid content of 25 mg/ml 
the formation of a foamy matrix during aggressive freeze-drying seems to be hindered. 
This sample resulted in a flat rigid layer, still showing small solid bubbles on the surface 
of the dried material. Overall, trehalose seems to exhibit slightly less voluminous for-
mation of foamy structure. Independent from choice of sugar, increasing solid content 
resulted in increased apparent volume of the foamy matrix. Obviously, by increasing the 
amount of sugar, literally more material can participate in the formation of the interstitial 
walls of the matrix and therefore the volume of the whole matrix is increased. Figure 5.18 
also shows the macroscopic appearance of formulations containing phenylalanine at a 
sugar to phenylalanine weight-to-weight ratio of 10:0.5. In contrast to the formulations 
containing no phenylalanine, a change in solid content did not result in a massive change 
of the apparent volume of the aggressively freeze-dried sample.  
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Figure 5.18: Macroscopic appearance of formulations of different solid contents of the initial solution (solid con-
tent in mg/ml showed as numbers on the vial). Formulations contain either no bulking agent (left) or phenylala-
nine at a sugar to phenylalanine weight-to-weight ratio of 10:0.5 (right). 
However, especially for sucrose-based formulations a solid content of 25 and 
50 mg/ml resulted in sort of shrinkage of the samples expressed as less contact between 
the inner walls of the vial and the dried sample. This phenomenon can be observed for 
tre:phe_25, too. Independent from sugar or solid content, the samples exhibited a sponge-
like structure with macroscopically clearly visible pores. Lower solid contents seem to 
exhibit a somewhat more filigree structure compared to samples of higher solid contents. 
As all samples showed an appearance not comparable to conventionally freeze-dried 
samples, they are regarded as collapsed. 
Product temperature 
The product temperatures detected at the plateau during sublimation (primary dry-
ing) are listed in Table 5.6. Neither for sucrose formulations nor for sucrose-based formu-
lations containing phenylalanine, the variation of solid content resulted in a significant 
change of the product temperature. For all formulations the product temperatures were 
measured at around -18 °C. While the product temperature of trehalose formulation also 
ranged round -18 °C, tre:phe formulations exhibited slightly higher product tempera-
tures of about -16 °C (cf. Table 5.6). However, due to the limited number of thermocou-
ples available, only the product temperature of the lowest and highest solid content was 
monitored for trehalose and trehalose based samples. As shown above, increased re-
sistance of the already dry product matrix against passing water vapor can be accounted 
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for increased product temperatures. Since the resistance of the product matrix is con-
nected to the microscopic structure of the product, specific surface area data could sup-
port the idea outlined above.  
Table 5.6: Product temperatures during primary drying of aggressive freeze-drying of sugar-based formulations 
from various solid contents. 
 product temperature primary drying 
solid content sucrose suc:phe 10:0.5 trehalose tre:phe 10:0.5 
 mean SD mean SD mean SD mean SD 
mg/ml °C °C °C °C °C °C °C °C 
25 -18.1 0.2 -17.9 0.3 -18.7 0.2 -15.3 0.3 
50 -17.9 0.3 -17.2 0.3 * * * * 
75 -18.4 0.2 -17.8 0.3 * * * * 
100 -18.0 0.4 -17.2 0.2 * * * * 
150 -18.1 0.2 -17.9 0.3 -17.3 0.4 -16.7 0.2 
*not determined due to limited number of thermocouples 
 
Specific surface area 
Figure 5.19 shows the specific surface area data of the aggressively freeze-dried sam-
ples. Focusing first on the formulation that exhibited slightly higher product tempera-
tures (tre:phe), in fact, consistently higher SSA could be detected for the different samples 
of that formulation compared to all other samples at the respective solid content. Moreo-
ver, increasing solid content resulted in decreased specific surface area. Starting from 
0.34 m²/g for a solid content of 25 mg/ml, the SSA is stepwise decreased to 0.10 m²/g for 
a solid content of 150 mg/ml. This decrease in SSA for increasing solid contents would 
underline the slightly higher product temperature of tre:phe_25 compared to tre:phe_150. 
On the other hand, also markedly higher SSA of suc:phe_25 compared to all other sucrose 
or suc:phe samples did not affect the resulting product temperature.  
In contrast to the tre:phe samples, for suc:phe lyophilizates a steep decrease of the 
SSA (from 0.24 to 0.09 m²/g) was detected for an increase of solid content from 25 mg/ml 
to 50 mg/ml. A further increase to 150 mg/ml resulted in no further decrease in SSA.  
For sucrose and trehalose formulations, a change in solid content between 50 mg/ml 
and 150mg/ml did not result in a change of SSA. The available amount of suc_25 and 
tre_25 was not sufficient to result in a measurement that met the criteria for a BET fit. 
Therefore, data for these formulations are missing. 
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Figure 5.19: Specific surface area of aggressively freeze-dried sugar-based formulations of various solid content 
of the initial solution (sugar-based formulations with and without addition of phenylalanine at a ratio of 10:0.5 
are shown). 
Residual water content 
As shown in section 3 of this chapter, the addition of low amounts of phenylalanine 
to sucrose and trehalose resulted in drastically reduced residual water content for a solid 
content of 50 mg/ml. It was of interest, if the same effect can be observed for the investi-
gated range of solid contents from 25 to 150 mg/ml, which represents a typical range for 
pharmaceutical protein formulations [15].  
The results of Karl-Fischer titration of aggressively freeze-dried samples are shown in 
Figure 5.20. In this study, a comparably short aggressive freeze-drying protocol (overall 
8 h drying time) was used. Hence, the samples containing no phenylalanine exhibited 
high residual water contents. Independent from solid content, for sucrose samples a re-
sidual water content of around 3% was detected. In contrast, trehalose samples revealed 
a decrease of residual water content for increasing solid content. Starting from around 
6% residual water content for a solid content of 25 mg/ml and 50 mg/ml, a stepwise de-
crease to 3.6% (75 mg/ml), to 2.4% (100 mg/ml), and to 1.9% (150 mg/ml) was detected. 
Obviously, the water was removed more effectively for higher solid contents compared 
to lower solid contents.  
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Figure 5.20: Residual water content of aggressively freeze-dried sugar-based formulations of various solid con-
tent of the initial solution (sugar-based formulations with and without addition of phenylalanine at a ratio of 
10:0.5 are shown). 
As already observed in section 3, the addition of phenylalanine at a weight-to-weight 
ratio of 10:0.5 result in a steep decrease of residual water content. For sucrose-based sam-
ples (suc:phe) at a solid content of 25 mg/ml, the residual water content is decreased from 
3.2% to 0.9% for example. Remarkably, increasing solid content of suc:phe resulted in an 
increase in residual water content, ending up at residual water contents comparable to 
the samples without phenylalanine for the highest solid content (150 mg/ml). In contrast 
to suc:phe samples, independent from the solid content, the tre:phe samples showed a 
comparable residual water content of 0.7% to 1.1%.  
Overall, there is no clear trend regarding the influence of solid content on the residual 
water content. While the residual water content of aggressively freeze-dried sucrose ly-
ophilizates is unaffected by the solid content, higher solid contents resulted in lower re-
sidual water of aggressively freeze-dried trehalose lyophilizates. The addition of phenyl-
alanine to the sugar based formulations changed the picture. While for low solid content 
the residual water content is reduced drastically compared to the sugar formulations, 
sucrose-based lyophilizates containing phenylalanine exhibited an increase in residual 
water content for increasing solid content. On the other hand, trehalose-based samples 
exhibited comparable, low residual water contents for all solid contents investigated. 
Glass transition temperature 
The analysis of the glass transition temperatures (Tg) of the aggressively freeze-dried 
samples revealed trends, which fit to the results of the residual water content of the sam-
ples. Since water acts as plasticizer on the amorphous matrix, usually higher residual 
water contents are linked to lower glass transition temperatures and vice versa. Table 5.7 
lists the glass transition temperatures analyzed via DSC.  
As expected from the comparable residual water contents, DSC analysis showed no 
influence of solid content on Tg of aggressively freeze-dried sucrose samples. For su-
crose-based samples that contain phenylalanine, a decrease of Tg was noticed for increas-
ing solid contents. Aggressively freeze-dried trehalose lyophilizates, however, exhibited 
an increase of Tg for increasing solid contents. Independent from solid content, tre:phe 
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samples overall showed high glass transition temperatures of above 90°C. Only the ly-
ophilizates freeze-dried from 150 mg/ml solid content exhibited a lower glass transition, 
which can be attributed to the higher water content of these species.  
Overall, it can be summarized, that the inversely proportional link between (e.g. high) 
glass transition temperatures and (e.g. low) residual water content can be established for 
all analyzed samples. The addition of phenylalanine increased the glass transition tem-
perature pronouncedly. While for higher solid contents this effect vanished for sucrose-
based samples, for trehalose-based samples (containing phenylalanine) it still was at a 
solid content of 150 mg/ml the Tg is 25.7 K above the Tg of the trehalose samples.  
Table 5.7: Glass transition temperatures of aggressively freeze-dried sugar-based formulations from various 
solid contents analyzed by differential scanning calorimetry (DSC, n=3). 
 glass transition temperature 
solid con-
tent 
sucrose suc:phe 10:0.5 trehalose tre:phe 10:0.5 
 mean SD mean SD mean SD mean SD 
mg/ml °C °C °C °C °C °C °C °C 
25 41.3 0.8 62.4 0.6 36.6 0.6 94.3 0.2 
50 43.9 1.1 54.0 0.8 43.5 2.0 94.8 0.7 
75 43.8 1.0 56.1 1.1 48.8 1.0 97.3 0.8 
100 45.4 1.3 49.3 1.1 56.2 3.1 91.2 2.3 
150 43.2 0.8 48.8 0.0 51.1 0.4 76.8 0.7 
 
Crystallinity 
In order to characterize the morphology of the aggressively freeze-dried samples, they 
were analyzed using X-Ray powder diffraction (XRD). The resulting diffraction patterns 
are shown in Figure 5.21. Since for none of the samples any distinct diffraction peak could 
be observed (small peak at 38.95° 2-θ observed for suc_25 and tre_25 can be unequivo-
cally attributed to the background copper sample holder), all samples are regarded as 
fully amorphous. For sucrose and suc:phe, as well as tre and tre:phe, the characteristic 
amorphous halo of the respective sugar can be observed. Obviously, the variation of solid 
content did not result in a change of the morphology of the aggressively freeze-dried 
samples. 
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Table 5.8: Overview of physico-chemical characteristics of aggressively freeze-dried sugar-based formulations of 
various solid content of the initial solution (sugar-based formulations with and without addition of phenylala-
nine at a ratio of 10:0.5 are shown). 
 sucrose suc:phe 10:0.5 trehalose tre:phe 10:0.5 
solid 
con-
tent 
Tg  
(mean 
± SD) 
water 
con-
tent 
(mean  
± SD) 
SSA 
 
Tg  
mean 
± SD 
water 
con-
tent 
(mean  
± SD) 
SSA 
 
Tg  
(mean 
± SD) 
water 
con-
tent 
(mean  
± SD) 
SSA 
 
Tg  
(mean 
± SD) 
water 
con-
tent 
(mean 
± SD) 
SSA 
 
mg/ml °C % m²/g °C % m²/g °C % m²/g °C % m²/g 
25 
41.3  
± 0.8 
3 2 
± 0.3 
n.a. 
62.4 ± 
0.6 
0.9  
± 0.0 
0.24 
36.6  
± 0.6 
6.4  
± 0.1 
n.a. 
94.3  
± 0.2 
0.9  
± 0.1 
0 34 
50 
43.9  
± 1.1 
3.4  
± 0 3 
0 05 
54.0 ± 
0.8 
1.8  
± 0.6 
0.09 
43.5  ± 
2.0 
5.9  
± 0.3 
0.06 
94.8  
± 0.7 
0.8  
± 0.1 
0 27 
75 
43.8  
± 1.0 
3.0  
± 0.1 
0 07 
56.1 ± 
1.1 
1.5  
± 0.1 
0.08 
48.8  ± 
1.0 
3.6  
± 0.1 
0.05 
97.3  
± 0.8 
0.7  
± 0.1 
0.13 
100 
45.4  
± 1.3 
3.1  
± 0.0 
0 08 
49.3 ± 
1.1 
2.5  
± 0.2 
0.04 
56.2  ± 
3.1 
2.4  
± 0.7 
0.05 
91.2  
± 2.3 
0.8  
± 0 2 
0 20 
150 
43.2  
± 0.8 
3.1  
± 0.0 
0 08 
48.8 ± 
0.0 
2.9  
± 0.1 
0.07 
51.1  ± 
0.4 
1.9  
± 0.4 
0.04 
76.8  
± 0.7 
1.1  
± 0.1 
0.10 
n.a.: due to low amount of sample BET SSA analysis not possible  
 
Regarding the specific surface area, the aggressive freeze-dried samples exhibited low 
SSA compared to conventionally freeze-dried samples. While the SSA of sucrose and tre-
halose samples were not affected by the solid content, both, suc:phe as well as tre:phe 
showed a decrease in SSA for increasing solid content. Since the apparent volume of the 
“cake” did not increase, it is conclusive that the increase in solids (i.e. simply more mate-
rial) result in a structure possessing thicker interstitial structure between the large pores.  
As it is the native purpose of drying to reduce the water content, the residual water 
content is a key parameter also for aggressive freeze-drying. Both disaccharides used in 
this study represent the most frequently used stabilizers in freeze-dried pharmaceutical 
protein formulations. The residual water contents of the lyophilizates without phenylal-
anine are regarded as comparably high (> 2%) for freeze-dried products. This is owed to 
the short drying time of only 6 h at 45 °C shelf temperature. Although both sugars are 
closely related, the resulting lyophilizates showed quite different trends regarding the 
influence of solid content on the residual water content. All lyophilizates aggressively 
freeze-dried from sucrose formulations of various solid contents showed comparable re-
sidual water content. In contrast, trehalose lyophilizates exhibited decreased residual wa-
ter contents for higher solid contents. In general, the residual water content is linked to 
the specific surface area of a lyophilizate, since the surface area available for desorption 
directly influences the amount of water that is removed under comparable conditions 
(temperature, pressure). Surprisingly, the SSA data of trehalose samples did not show an 
increase in SSA for increasing solid content, which would explain the lower water content 
of samples of higher solid content. On the other hand, the macroscopic appearance of 
samples of lower solid content indicates a somewhat denser structure compared to higher 
solid contents (see Figure 5.18). However, the macroscopic structure seems not to offer a 
comprehensive explanation for the substantial decrease of the residual water content. The 
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formation of a crystalline (bulk) structure would offer a possible explanation for better 
drying. Though, neither XRD diffractions nor DSC melting endotherms were noticed, 
which would indicate the presence of crystalline trehalose.  
The addition of phenylalanine to the still sugar dominated formulations (phenylala-
nine added at a weight-to-weight ratio of 10:0.5) resulted in a substantial decrease of wa-
ter content of samples at low solid content. The addition of phenylalanine obviously re-
sulted in an effect within the excipient matrix, which is similar to the effect of a bulking 
agent. Nevertheless, XRD and DSC indicate the absence of crystalline material. Hence, at 
the low contents used in that study, phenylalanine did not crystallize, but act as a drying 
enhancer anyway. For increasing solid content, different trends of sucrose-based and tre-
halose-based samples were observed. The residual water content of trehalose-based sam-
ples remained low for the different solid contents, whereas the residual water content of 
sucrose-based samples was increased with increasing solid content. Apparently, for in-
creasing solid content the effect of phenylalanine as drying enhancer is diminished for 
sucrose-based lyophilizates. On the other hand, for trehalose-based samples the un-
known effect works over the whole range of investigated solid contents. 
The trends outlined for the residual water content are assisted by the glass transition 
temperatures of the lyophilizates (naturally inversely proportional). Especially the for-
mulations containing trehalose and phenylalanine exhibited high glass transition tem-
peratures. Based on DSC and XRD data, all aggressively freeze-dried lyophilizates for-
mulations are fully amorphous independently from solid content. 
Based on the physico-chemical characterization of the lyophilizates aggressively 
freeze-dried from formulations of different solid contents, the characteristics comparable 
to samples analyzed elsewhere (compare CHAPTER 4, page 95) (low residual water con-
tent, high glass transition temperature, low SSA, amorphous nature) give reason to ex-
pect good stabilizing properties for biopharmaceuticals over the whole range of solid 
contents analyzed. 
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6. PROTEIN CONCENTRATION 
Besides the composition of the excipient matrix, which is usually mainly based on 
stabilizers like disaccharides, and the freeze-drying process utilized, also the concentra-
tion of the molecule to be stabilized can potentially affect the characteristics of the result-
ing dried product. Therefore, in this study the effect of an increased protein concentration 
of 10 mg/ml compared to a protein concentration of 1 mg/ml was investigated. For this 
study, mab_T1 was utilized as model protein, which was added to a sugar-based excipi-
ent mixtures of a solid content of 50 mg/ml (cf. Table 5.9). 1ml aliquots of the respective 
formulations were filled in 2R vials and subjected to the aggressive freeze-drying proto-
col shown in Table 3.5 (page 56) in a FTS LyostarII freeze-drier. Besides the appearance 
of the aggressively freeze-dried samples, the resulting residual water content as key qual-
ity was investigated. In addition, glass transition temperatures and specific surface area 
of the lyophilizates were determined.  
Table 5.9: Formulations used to study the protein stabilization in aggressively freeze-dried formulations of dif-
ferent solid contents. 
formulation mab_T1 sucrose trehalose phenylalanine solid content 
 mg/ml mg/ml mg/ml mg/ml mg/ml 
suc_1 1 50   51 
suc_10 10 50   61 
tre_1 1 50   51 
tre_10 10 50   61 
suc:phe_1 1 47.62  2.38 51 
suc:phe_10 10 47.62  2.38 61 
tre:phe_1 1  47.62 2.38 51 
tre:phe_10 10  47.62 2.38 61 
 
Macroscopic appearance 
Figure 5.22 displays the macroscopic appearance of the aggressively freeze-dried 
samples. As already shown above, the addition of phenylalanine to formulations contain-
ing 1 mg/ml mab_T1 changed the macroscopic appearance from a foam-like to a rather 
sponge-like structure (left picture). The increased protein concentration of 10 mg/ml re-
sulted in a sponge-like structure for the sucrose and trehalose based samples, too (right 
picture). For the sucrose lyophilizate, still some foamy parts were observed. In addition, 
also the appearance of the sucrose sample containing phenylalanine was slightly changed 
to a somewhat less coherent structure. Overall, the increase in protein concentration from 
1 to 10 mg/ml resulted in minor changes in the appearance. Especially trehalose-based 
samples seem to exhibit similar appearance for both protein contents. Comparing the 
macroscopic appearance of trehalose samples containing 1 mg/ml or 10 mg/ml mab_T1 
to the appearance of samples without added protein, it is noticeable that the samples 
containing no protein exhibited a comparable foam-like structure very similar to the su-
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crose samples. Upon addition of only 1 mg/ml mab_T1 the appearance of trehalose sam-
ples exhibited a reduced volume and a less pronounced foamy structure compared to 
sucrose lyophilizates, which were sort of unaffected by the addition of protein.  
  
Figure 5.22: Macroscopic appearance of lyophilizates aggressively freeze-dried from sugar based formulations 
containing 1 mg/ml (left picture) or 10 mg/ml (right picture) mab_T1 (suc: sucrose; sp: sucrose:phenylalanine 
10:0.5; tre: trehalose; tp: trehalose:phenylalanine 10:0.5). 
Residual water content 
Since the addition of the higher amount of protein (10 mg/ml) showed an effect on the 
observed appearance of especially the sucrose lyophilizates, it can be expected that also 
other physico-chemical characteristics were changed by the increase of the protein con-
tent in the aggressively freeze-dried formulations. Figure 5.23 shows the residual water 
content of the analyzed samples, for comparison of sucrose and trehalose samples, also 
the residual water content of lyophilizates without protein is shown. While the residual 
water content of sucrose lyophilizates is hardly affected by the addition of 1 mg/ml pro-
tein, trehalose lyophilizates showed an increase in residual water content from 3.4% to 
5.7%. The increase in residual water content of the latter sample is attributed to a change 
in the lyophilizate structure. The sample without protein showed a foam-like structure 
of a certain volume, while the addition of 1 mg/ml mab_T1 resulted in a decrease in vol-
ume and a dense structure of reduced volume. Obviously, this dense nature of the lyoph-
ilizate renders the desorptive drying more difficult.  
A further increase of the protein concentration from 1 mg/ml to 10 mg/ml mab_T1, a 
significant increase in residual water content was detected. Only trehalose samples 
showed a slight decrease of water content (from 5.7% to 4.5%). The residual water content 
of tre:phe increased from 0.6% to 1.7%, and of suc:phe from 0.9% to 2.1%, respectively. In 
addition, the RWC of sucrose samples was increased from 2.8% to 5.2%.  
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In conventional freeze-drying, a higher protein concentration usually results in better 
drying (by a bulking effect of the protein). As shown above, by adding a higher concen-
tration of protein, the macroscopic appearance was changed. Hence, also the microscopic 
structure is likely to be different. To account of the structure on the microscopic level, the 
specific surface area of the aggressively freeze-dried lyophilizates was analyzed using 
BET gas adsorption.  
 
 
Figure 5.23: Residual water content of lyophilizates aggressively freeze-dried from sugar based formulations 
containing 1 mg/ml or 10 mg/ml mab_T1. For trehalose and sucrose lyophilizates also residual water content of 
samples containing no protein are shown. 
Specific surface area 
Figure 5.24 illustrates the determined SSA of the lyophilizates. Generally, the samples 
containing phenylalanine exhibited higher SSA compared to the samples aggressively 
freeze-dried from sugar formulations. However, the overall low SSA for all samples un-
derlines the collapsed nature of these lyophilizates. Besides the trehalose samples, which 
seems to represents sort of a specialty, all samples showed a decrease of SSA for increased 
protein content. Obviously, the addition of 1 mg/ml and 10 mg/ml mab_T1 changed the 
microscopic structure toward a structure of less specific surface. Since the residual water 
of the lyophilizates usually depends on the effectiveness of secondary drying, a reduced 
SSA conclusively explains the increased residual water content for samples of higher pro-
tein content. It is known, however, that for higher protein contents than 10 mg/ml the 
protein itself works as bulking agent, represented by higher SSA and lower residual 
moistures for high protein concentrations [6]. 
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Figure 5.24: Specific surface area of lyophilizates aggressively freeze-dried from sugar based formulations con-
taining no protein (only data for trehalose and sucrose available), 1 mg/ml or 10 mg/ml mab_T1.  
Glass transition temperature 
Figure 5.25 displays the glass transition temperatures of the aggressively freeze-dried 
samples containing 1 mg/ml or 10 mg/ml mab_T1 analyzed by DSC.  
 
Figure 5.25: Glass transition temperatures of lyophilizates aggressively freeze-dried from sugar based formula-
tions containing 1 mg/ml or 10 mg/ml mab_T1. 
For samples containing phenylalanine, higher glass transition temperatures were de-
tected compared to sugar lyophilizates. An increase of the protein content from 1 mg/ml 
to 10 mg/ml resulted in a decrease of the Tg for all samples, except the trehalose lyophi-
lizate. While both samples containing phenylalanine and 10 mg/ml mab_T1 still exhibited 
relatively high glass transition temperatures of 80.2 °C and 51.4 °C, respectively, Tg of 
sucrose and trehalose lyophilizates were detected at 46.7 °C and 25.6 °C. It is obvious that 
lower glass transition temperatures are connected to higher residual water content (com-
pare Figure 5.23). Generally, the Tg of lyophilizates containing 10 mg/ml protein and 
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phenylalanine are regarded as high enough for a considerable storage stability for incor-
porated sensitive molecules. On the other hand, lyophilizates aggressively freeze-dried 
from formulations containing no phenylalanine and 10 mg/ml mab_T1 exhibited rather 
low Tg. Therefore, the very short aggressive freeze-drying protocol would need to be 
prolonged in order to reach lower residual water contents and thus higher glass transi-
tion temperatures for the sugar formulations without phenylalanine. 
 
Summary 
To get an idea of the resulting physico-chemical characteristics of lyophilizates with 
moderately increased protein concentration (from 1 mg/ml to 10 mg/ml mab_T1), formu-
lations based on sucrose or trehalose were aggressively freeze-dried with the short pro-
tocol. With a drying time of 8 h (2 h ramp to 45 °C and 6 h at 45 °C shelf temperature), 
this protocol had been developed for 1 mg/ml protein concentration and led to dry prod-
ucts for sugar to phenylalanine weight-to-weight ratios of 10:0.5 with residual water con-
tents of 1% and below. The addition of higher amounts of protein revealed that the struc-
ture of the resulting collapsed lyophilizates was changed compared to a protein content 
of 1 mg/ml. This change in structure is partly macroscopically visible. Moreover, the anal-
ysis of the specific surface area of the resulting lyophilizates revealed a reduction of SSA, 
indicating a condensed microscopic structure. Since a denser structure renders secondary 
(desorptive) drying mechanisms less effective, the residual water contents are higher 
compared to samples of a protein content of 1 mg/ml. In consequence, the glass transition 
temperatures decreased. As protein itself is able to generate a bulking structure in lyoph-
ilizates [6], also samples containing no phenylalanine were included in the study. They 
exhibited no reduction of the (inherently high) residual water content, but rather an in-
crease. Glass transition temperature followed that trend in the opposite direction. Obvi-
ously, the amount of protein that was applied in this study was not high enough to enable 
the formation of a bulking structure by the protein. In order to achieve residual water 
levels of around 1%, the duration of the drying protocol would need to be prolonged. 
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7. SUMMARY AND CONCLUSIONS 
The present studies aimed to investigate the influence of formulation design on phys-
ico-chemical characteristics of aggressively freeze-dried lyophilizates. For this purpose, 
a range of freeze-drying formulations were selected, especially with respect to formula-
tions that contain bulking agents in different quantities. Since for the majority of sensitive 
molecules, which are intended to be stabilized by freeze-drying, the utilization of an 
amorphous excipient is inevitable for stabilization, the investigated formulations are 
based on the most common cryo-/lyo-protectans, namely sucrose and trehalose.  
 
In a first step, formulations comprising only sucrose or trehalose (in buffered aqueous 
solutions) were aggressively freeze-dried. The resulting lyophilizates from both sugars 
were amorphous and exhibited a foam-like collapsed appearance of low specific surface 
area. Due to the low SSA, the lyophilizates showed comparably high residual water con-
tent of above 1.5% (trehalose > sucrose) although freeze-dried at high shelf temperature 
(45 °C) for 24 h. Nevertheless, acceptable glass transition temperatures of above 50 °C 
were achieved (trehalose > sucrose). 
 
In addition to amorphous stabilizers, freeze-drying formulations frequently contain 
bulking agents to improve the appearance and decrease drying time. The stepwise addi-
tion of bulking agents (mannitol, phenylalanine) to aggressive freeze-dried formulations 
resulted in decreasing degree of collapse, both, visible as well as detected by SSA meas-
urements. Moreover, increasing amounts of bulking agents resulted in stepwise de-
creased residual water content and in case of phenylalanine also an increase of the glass 
transition temperature of the amorphous phase. XRD analysis revealed that the change 
in physico-chemical characteristics could be attributed to crystallization of the bulking 
agent.  
Despite exhibiting collapse (i.e. low SSA) and a fully amorphous structure, formula-
tions containing sugar and a low amount of phenylalanine (ratio 10:0.5) showed low re-
sidual water contents and high Tg. Since low SSA is reported to be potentially preferably 
for the stabilization of proteins in dried matrices [2, 26, 27], this special formulation are 
regarded as highly interesting for protein stabilization.  
 
Since phenylalanine has turned out as promising excipients for freeze-drying, the abil-
ity of other amino acids to improve drying at a low sugar to amino acid weight-to-weight 
ratio (10:0.5) was investigated. In this study arginine, glycine, histidine, isoleucine, leu-
cine, methionine, and tryptophan were used. Aggressive freeze-drying of the 
sugar/amino acid formulations revealed that isoleucine, leucine, and methionine are able 
to decrease the residual water content. Especially for trehalose-based samples, a remark-
able increase of glass transition temperature was detected, as well. Moreover, the samples 
collapsed to a sponge-like appearance, which was somewhat different to the foam-like 
appearance of collapsed pure sugar samples. Nevertheless, the specific surface areas 
were hardly increased. Lyophilizates that contain arginine, glycine, histidine, or trypto-
phan showed no effect of the amino acids on the physico-chemical characteristics com-
pared to pure sugar samples. XRD showed that isoleucine, leucine, and methionine crys-
tallized during aggressive freeze-drying. Hence, the crystalline state of these amino acids 
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offer the most probable explanation for the effect on the physico-chemical characteristics. 
Since the intended use of a bulking agent is the formation of a crystalline “backbone” of 
a lyophilizate, these amino acids are generally regarded as promising bulking agents. 
However, compared to phenylalanine, none of the investigated amino acids exhibited a 
comparable effect on the physico-chemical characteristics: Phenylalanine improved the 
physico-chemical characteristics but remained fully amorphous.  
 
In a separate study, the influence of different solid contents of the formulations 
(25 - 150 mg/ml) on the physico-chemical properties was evaluated. Both, sucrose and 
trehalose formulations were studied. Additionally, formulations that contain phenylala-
nine at a ratio of 10:0.5 (sugar:phe) were included in the study. All of the aggressively 
freeze-dried lyophilizates exhibited a fully amorphous structure regardless of solid con-
tent.  
To achieve low water content (and consequently high glass transition temperatures), 
the most promising results of a formulation without phenylalanine was achieved for the 
trehalose samples of 150 mg/ml, which showed low SSA and comparably low water con-
tent. However, to achieve water content of ≤ 1% and high Tg, the use of trehalose and a 
low amount of phenylalanine (10:0.5) is inevitable. The (low) residual water content of 
tre:phe samples hardly changed for the different solid contents, although the SSA was 
stepwise decreased for higher solid contents. As low SSA is preferable for protein stabi-
lization, higher solid contents are advisable. Regarding water content and SSA, for 
suc:phe 10:0.5 formulations the preferred solid content should be between 50 – 75 mg/ml.  
 
The addition of a higher amount of protein (10 mg/ml) to sucrose and trehalose for-
mulations with and without low amounts of phenylalanine was evaluated. Analysis of 
the specific surface area of the resulting lyophilizates revealed a reduction of SSA. Hence, 
the resulting residual water contents are higher compared to samples of a protein content 
of 1 mg/ml. Consequently, also the glass transition temperatures were lower. It is con-
cluded that the amount of protein influences the formation of the collapsed structure and 
was not high enough to enable the formation of a bulking structure by the protein. Nev-
ertheless, the formulations that contained phenylalanine (tre:phe 10:0.5, suc:phe 10:0.5) 
exhibited acceptable water content of ≤ 2%. Moreover, the tre:phe 10:0.5 samples exhib-
ited a Tg of ≥ 80 °C, indicating promising properties for storage stabilization of a protein. 
 
Finally, it can be summarized that aggressive freeze-drying is applicable to a wide 
range of sugar-based formulations. Both, sucrose and trehalose, which are the major ex-
cipients for protein stabilization, served as sound foundation of aggressively freeze-dried 
lyophilizates. Amongst all investigated lyophilizates, trehalose-based samples that con-
tain phenylalanine at a ratio of 10:0.5 exhibited superior potential for protein stabiliza-
tion: low water content, high Tg, low SSA, and fully amorphous structure.  
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CHAPTER 6 THE INFLUENCE OF FORMULATION COMPOSITION ON 
PROTEIN STABILITY IN AGGRESSIVELY FREEZE-DRIED 
LYOPHILIZATES 
1. INTRODUCTION 
The overall aim of freeze-drying is to stabilize sensitive molecules against degradation 
during storage. In pharmaceutical products, most often a protein is the molecule to be 
stabilized [1]. As recently shown by Schersch et al., structural collapse of a lyophilizate 
does not necessarily result in instability of incorporated proteins [2]. Moreover, they have 
shown that proteins in collapsed formulations can show a superior stability during stor-
age compared to samples freeze-dried conventionally [3, 4]. Overall, there is a growing 
interest in applying high product temperatures during freeze-drying [5-8] in order to 
save time and resources. Since high product temperatures can only be achieved by ag-
gressive freeze-drying, further investigation of the robustness and potentially universal 
use of aggressive freeze-drying to different types of protein formulations is of high inter-
est. In CHAPTER 5 of this thesis it was shown for a broad range of formulations that 
aggressive freeze-drying resulted in suitable physico-chemical characteristics for protein 
stabilization.  
The formulations studied in this chapter were based on an amorphous excipient (e.g. 
a disaccharide), which is obligatory for the stabilization of incorporated proteins (amor-
phous excipients act as water replacement in the dry state [9-12] and provide a vitrified 
glassy matrix of reduced mobility [13-15]). Since freeze-drying formulations often contain 
bulking agents [1], the impact of this usually crystalline components on protein stability 
in aggressively freeze-dried lyophilizates was examined. The major focus of the study 
was to evaluate aggressive freeze-drying for formulations of 50 mg/ml excipient concen-
tration and 1 mg/ml protein. However, also excipient concentrations of 25 mg/ml to 
150 mg/ml and 10 mg/ml protein concentration (the protein concentration in a biophar-
maceutical drug can cover a considerable range [16]) were investigated.  
The utmost goal of freeze-drying is the stabilization of a valuable molecule. Inher-
ently, the stability of this molecule is the major product quality. In order to cover a sig-
nificant range of marketed biopharmaceutical proteins [17], an recombinant monoclonal 
IgG1 antibody (mab_T1) was used as model protein. Mab_T1 is usually stored as refrig-
erated liquid bulk solution due to its susceptibility to freezing and drying stresses. 
Freeze-drying without proper stabilization in terms of suitable excipients and an appro-
priate freeze-drying process consequently result in substantial instability, ending up in 
the formation of considerable amounts of aggregates. Therefore, mab_T1 is considered as 
suitable model to reveal even minor changes towards non-ideal stabilization. 
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2. TYPE OF DISACCHARIDE 
Sucrose and trehalose have turned out as preferable choice for stabilizing incorpo-
rated proteins [18]. In order to evaluate, whether both sugars act as suitable stabilizers 
during aggressive freeze-drying, too, formulations containing 1 mg/ml mab_T1 and ei-
ther 50mg/ml sucrose or trehalose (compare Table 6.1) were subjected to aggressive 
freeze-drying. 1ml aliquots of the respective formulations were filled in 2R vials and sub-
jected to the aggressive freeze-drying protocol shown in Table 3.5 (page 56, pc=1 mbar, 
6 h at Ts=45 °C,) in a Martin Christ 2-12D freeze-drier.  
Table 6.1: Formulations to characterize the influence of type of disaccharide on the protein stability of mab_T1 
(formulations based on 10 mM potassium phosphate buffer pH 6.4). 
formulation mab_T1 sucrose trehalose 
 mg/ml mg/ml mg/ml 
suc 1 50  
tre 1  50 
 
Sub-visible particles and turbidity 
Figure 6.1 shows the subvisible particle counts ≥1 µm (assessed by LO) and the tur-
bidity of reconstituted samples. Before freeze-drying, the sucrose- or trehalose-based for-
mulation exhibited a subvisible particle content of below 4000 particles ≥ 1 µm per ml. 
The overall low amounts of subvisible particles were not changed during aggressive 
freeze-drying, neither for sucrose-based samples nor for trehalose-based ones. In addi-
tion, particles of ≥ 10 µm as well as ≥ 25 µm were not increased during aggressive freeze-
drying. The detected concentrations are far below the limit of the Ph. Eur. (6000 ≥ 10 µm 
and 600 ≥ 25 µm per container, in this case per ml, since filling volume was 1 ml). Per ml 
sucrose-based samples contained 20±8 particles ≥ 10 µm and 2±2 particles ≥ 25 µm, tre-
halose-based samples 27±26 particles ≥ 10 µm and 1±2 particles ≥ 25 µm (cf. Figure 6.1, 
right graph). The left graph in Figure 6.1 also displays the turbidity of the formulations 
before and after freeze-drying. While the turbidity of freeze-dried sucrose samples seems 
to be slightly increased to 1.30 ± 0.19 FNU compared to 0.96 ± 0.08  FNU before freeze-
drying, the turbidity of trehalose based samples were apparently unchanged (0.87 ± 
0.02 FNU before vs. 1.07 ± 0.33 FNU after freeze-drying).  
Overall, no substantial changes were detected for subvisible particles and turbidity be-
fore and after freeze-drying. It is concluded that both, sucrose and trehalose successfully 
stabilized mab_T1 against aggregation to non-soluble aggregates. For comparison, also a 
formulation containing mab_T1 without stabilizing disaccharide (i.e. mab_T1 in 10mM 
potassium phosphate buffer) was aggressively freeze-dried using the same aggressive 
freeze-drying protocol. The resulting products exhibited subvisible particle counts of 
around 50,000 particles ≥ 1µm per ml and a turbidity of about 30 FNU (data not shown). 
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Figure 6.1: Sub-visible particle count ≥1µm (bars) and turbidity (triangles) before and after aggressive freeze-
drying (sugar based formulations containing 1 mg/ml mab_T1).  
To account for soluble aggregates, the reconstituted samples were analyzed using HP-
SEC. The results are summarized in Table 6.2. Comparing samples regarding the amount 
of high molecular weight species (HMWS) or low molecular weight species (LMWS) to 
the formulations before freeze-drying, no substantial increase could be detected. Moreo-
ver, the monomer content was unchanged after aggressive freeze-drying. To account for 
a potential loss of protein, the detected monomer amount (integrated area under the 
curve) of freeze-dried samples were compared to the monomer amount prior to freeze-
drying. Since neither this monomer recovery was decreased, nor instability indicating 
HMWS or LMWS were increased, aggressive freeze-drying did not alter the samples re-
garding aggregation or fragmentation of mab_T1.  
Table 6.2: HP-SEC data to characterize the influence of type of disaccharide on the protein stability of mab_T1 
(formulations based on 10 mM potassium phosphate buffer pH 6.4). 
 HMWS content LMWS content monomer content monomer 
recovery 
 before 
freeze-dry-
ing 
after 
freeze-dry-
ing 
before 
freeze-dry-
ing 
after 
freeze-dry-
ing 
before 
freeze-dry-
ing 
after freeze-
drying 
 
formulation % % % % % % % 
suc 1.4 ± 0.1 1.7 ± 0.1 1.1 ± 0.2 0.8 ± 0.2 97.3 ± 0.3 97.6 ± 0.5 101.2 ± 0.4 
tre 1.3 ± 0.0 1.7 ± 0.1 1.3 ± 0.0 0.8 ± 0.1 97.6 ± 0.1 97.5 ± 1.3 100.4 ± 0.7 
 
 
The conformational stability of mab_T1 after aggressive freeze-drying was assessed 
by FT-IR spectroscopy. The secondary structure of mab_T1 was unaffected, since no 
change was detected in the FT-IR spectra after freeze-drying.  
Summing up the results concerning the influence of type of disaccharide on the sta-
bility of mab_T1 during aggressive freeze-drying, no difference could be noticed between 
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sucrose and trehalose. Both sugars are able to stabilize mab_T1 during aggressive freeze-
drying successfully.  
3. ADDITION OF BULKING AGENT 
As shown in CHAPTER 5, aggressive freeze-drying of formulations containing no 
bulking agent resulted in high residual water contents due to the reduced specific surface 
area (compare page 109). In order to reduce the residual water content without being 
forced to prolong the aggressive freeze-drying cycle, the addition of bulking agents like 
mannitol seemed to be feasible. In fact, it could be shown that the addition of a certain 
amount of bulking agent reduces the residual water content of the resulting lyophilizates 
dramatically (see page 113). In the previous section it was shown that formulations of 
sucrose and trehalose without containing a bulking agent stabilized mab_T1 successful 
during aggressive freeze-drying. Now, the influence of adding bulking agents to sugar 
based formulations on the stability of mab_T1 was studied. In a first step, each, low and 
high amounts of mannitol, glycine and phenylalanine were added to sugar-based formu-
lation according to the overview given in Table 6.3. Aliquots of 1ml of the formulations 
were filled into DIN 2R glass vials (type 1) and aggressively freeze-dried according to the 
protocol shown in Table 3.5 (page 56) in a Martin Christ 2-12D freeze-drier. For compar-
ison, the same formulations were subjected to a conventional / moderate freeze-drying 
cycle in the same configuration (vials, filling volume, freeze-drier). For freeze-drying of 
these samples, the protocol shown in Table 3.8 (page 57; pc=0.07 mbar, primary drying 
60 h at Ts=-30 °C, secondary drying 10 h at Ts=10 °C) was utilized. Since the focus of the 
investigation was set on the influence of formulation composition on the stability of in-
corporated mab_T1 of aggressively freeze-dried lyophilizates, not all results from the 
moderately freeze-dried samples are shown in the following. 
In a second step, the lyophilizates from aggressive freeze-drying, that exhibit a low 
residual water content and a glass transition of above 50 °C, were subjected to an indica-
tive stability study at 2-8 °C, 30 °C, and 50 °C for up to 6 months. In Table 6.3 the formu-
lations that were included in the stability study are highlighted by an asterisk. The same 
formulations were also moderately freeze-dried and stored. Mab_T1 was added to all 
formulations at a concentration of 1 mg/ml. Since mab_T1 was known to aggregate upon 
freeze-drying unless suitable stabilized, aggregation behavior was characterized investi-
gating subvisible particle counts, turbidity, and HP-SEC. In addition, the secondary 
structure of mab_T1 was monitored via FT-IR of selected reconstituted samples.  
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Table 6.3: Formulations used to study the influence of bulking agent on the protein stability of mab_T1 of ag-
gressively freeze-dried products (formulations based on 10 mM potassium phosphate buffer pH 6.4). 
formulation mab_T1 sucrose trehalose mannitol glycine phenylalanine 
 mg/ml mg/ml mg/ml mg/ml mg/ml mg/ml 
suc:man 10:3 1 38.46  11.54   
suc:man 10:30* 1 12.50  37.50   
suc:gly 10:3 1 38.46   11.54  
suc:gly 10:30* 1 12.50   37.50  
suc:phe 10:0.5* 1 47.62    2.38 
suc:phe 10:3* 1 38.46    11.54 
tre:man 10:3 1  38.46 11.54   
tre:man 10:30* 1  12.50 37.50   
tre:gly 10:3 1  38.46  11.54  
tre:gly 10:30* 1  12.50  37.50  
tre:phe 10:0.5* 1  47.62   2.38 
tre:phe 10:3* 1  38.46   11.54 
* subjected to indicative stability study 
 
3.1 PRODUCT CHARACTERISTICS AFTER AGGRESSIVE FREEZE-DRYING 
3.1.1 APPEARANCE AND RECONSTITUTION  
Prior to analysis, the samples were reconstituted. All of the aggressively freeze-dried 
lyophilizates were fully reconstituted within 35 second at the maximum (see Table 6.4). 
Besides tre:gly, all lyophilizates from moderate freeze-drying exhibited increased recon-
stitution times. Obviously, aggressive freeze-drying did not result in prolonged reconsti-
tution times. Contrary to the literature ([19]), even the samples exhibiting a collapsed ap-
pearance (marked by an asterisk in Table 6.4 and displayed in Figure 6.2) did rather show 
a decrease and not an increase of reconstitution time.  
Table 6.4: Reconstitution times of lyophilizates of bulking agent containing samples, subjected to aggressive or 
moderate freeze-drying.  
formulation aggressive freeze-drying moderate freeze-drying 
 sucrose trehalose sucrose trehalose 
 seconds seconds seconds seconds 
sugar:man 10:3 21 ± 1 * 27 ± 8 * 55 ± 5 55 ± 5 
sugar:man 10:30 17 ± 1 23 ± 6 35 ± 5 47 ± 7 
sugar:gly 10:3 14 ± 2 * 19 ± 4 * 39 ± 4 15 ± 4 
sugar:gly 10:30 15 ± 1 21 ± 3 46 ± 3 14 ± 1 
sugar:phe 10:0.5 29 ± 8 * 35 ± 1 * 32 ± 3 43 ± 8 
sugar:phe 10:3 29 ± 4 32 ± 2 57 ± 2 49 ± 4 
 *lyophilizates showed a collapsed appearance 
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Figure 6.3: HMWS of mab_T1 detected by HP-SEC of formulations containing bulking agent in different quanti-
ties. The results of samples analyzed before and after aggressive freeze-drying are shown.  
In addition to the amount of HMWS, the percentage recovery of mab_T1 monomer 
was calculated from the HP-SEC data (cf. Figure 6.4). Overall, a monomer recovery of > 
97% was detected. No clear trend could be established comparing the monomer recovery 
of the different lyophilizates. For trehalose-based samples, a somewhat reduced mono-
mer recovery was detected for samples containing a high amount of mannitol or phenyl-
alanine. In sucrose-based samples for the formulation containing a low amount of man-
nitol (suc:man 10:3) a slightly reduced monomer recovery was detected. Regarding solu-
ble aggregates (HMWS) the recovery of mab_T1 monomer, an overall good stabilization 
of mab_T1 during aggressive freeze-drying was achieved by the applied formulations.  
 
Figure 6.4: Monomer recovery of mab_T1 detected by HP-SEC. The monomer content (in term of area under the 
curve) of reconstituted aggressively freeze-dried samples was compared to the monomer content of the formula-
tions before freeze-drying. 
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Non-soluble aggregates 
The reconstituted lyophilizates were further analyzed regarding subvisible particle 
(svp) content and turbidity. While subvisible particles were detected in the range of ≥ 
1 µm, turbidity values also allow for quantification of smaller non-soluble aggregates. 
Figure 6.5 and Figure 6.6 show the svp counts and turbidity values of samples freeze-
dried aggressively or moderately, respectively. Aggressive freeze-drying of both formu-
lations containing a high amount of mannitol as bulking agent (suc:man 10:30 and 
tre:man 10:30) exhibited a drastic increase of subvisible particles (from around 3,000 par-
ticles/ml to above 80,000 particles/ml). In addition, the turbidity of those samples was 
increased from around 1 FNU before freeze-drying to 5.4 FNU and 2.7 FNU 
(suc:man 10:30 and tre:phe 10:30, respectively). It is concluded that suc:man 10:30 and 
tre:man 10:30 were not able to completely stabilize mab_T1 against aggregation during 
aggressive freeze-drying. Moderately freeze-dried samples of those formulations also 
showed an increase in subvisible particle level and turbidity (cf. Figure 6.6).  
Aggressive freeze-drying of all other formulations resulted in low subvisible particle 
counts of particles ≥ 1 µm (cf. Figure 6.5). A small increase of particles were observed for 
the formulations that contain a high amount of phenylalanine (suc:phe 10:3 and tre:phe 
10:3). Those samples exhibited an increased turbidity, too. Although the svp count of the 
formulations containing a high amount of glycine is unchanged, the turbidity is markedly 
increased (independent from sugar). The increase of turbidity indicates the formation of 
non-soluble aggregates smaller than 1 µm. 
 
Figure 6.5: Subvisible particle counts (particles ≥ 1µm) as well as turbidity of aggressively freeze-dried of formu-
lations containing bulking agent in different quantities. The subvisible particle counts of the formulations before 
freeze-drying ranged around 3,000 particles ≥ 1µm per ml. Turbidity values of the formulation before freeze-
drying ranged around 1 FNU. 
Summarizing, it was observed that formulations containing high amount of bulking 
agents (and were therefore macroscopically not collapsed) showed a tendency towards 
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instability, which is indicated by the formation of aggregates. On the other hand, lyoph-
ilizates that have been freeze-dried from formulations containing low amounts of bulking 
agents (sugar:man 10:3, sugar:gly 10:3, augar:phe 10:0.5) exhibited no signs of aggrega-
tion.  
Comparing the aggregation of mab_T1 (svp, turbidity) of aggressive versus moderate 
freeze-drying, samples containing a low amount of bulking agent showed comparable 
svp counts and turbidity (compare Figure 6.6). For lyophilizates that contained a low 
amount of phenylalanine, the samples from moderate freeze-drying even showed a 
slightly higher turbidity compared to the samples from aggressive freeze-drying.  
 
Figure 6.6: Subvisible particle counts (particles ≥ 1µm) as well as turbidity of moderately freeze-dried of formu-
lations containing bulking agent in different quantities. The subvisible particle counts of the formulations before 
freeze-drying ranged around 3,000 ≥ 1µm per ml. Turbidity values of the formulation before freeze-drying 
ranged around 1 FNU. 
Secondary structure 
The secondary structure of a protein is an important criterion to judge potential insta-
bility. To assess the secondary structure of mab_T1, second derivative FT-IR spectroscopy 
of the amide I region was utilized. Generally, the secondary structure of IgG proteins 
consist of around 70% β-sheet structures, while the remaining structures are of unordered 
nature [20, 21]. The 2nd derivative spectra of the formulations were checked for the ap-
pearance of additional bands at wavenumbers of 1620-1625 cm-1 and 1680-1700 cm-1, 
which are indicative for hydrogen bonded intermolecular β-sheet structures [22-24]. In 
addition, band broadening or shifts of peaks are regarded as (unwanted) changes in the 
secondary structure of mab_T1.  
Figure 6.7 displays the second derivative FT-IR spectra of bulking agent containing su-
crose- and trehalose-based formulations before and after aggressive freeze-drying. For-
mulations containing glycine could not be investigated due to interfering FT-IR spectra 
of mab_T1 and glycine. The major peak at 1639 cm-1 is indicative for intramolecular β-
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sheet structures [20]. A slightly more pronounced band at 1690 cm-1, indicating a ten-
dency towards unfolding, was identified for suc:man 10:3, suc:phe 10:3, tre:man 10:30. 
For tre:man 10:30 additionally a minute shift of the main peak towards lower wave-
numbers was noticed.  
  
  
Figure 6.7: 2nd derivative FT-IR spectra (amide I band) before and after aggressive freeze-drying. The sugar-
based formulations contain bulking agent in low and high quantities (A: suc:man; B: suc:phe; C: tre:man; D: 
tre:phe; arrows highlight small changes in the spectra). 
Overall, no drastic change in the FT-IR spectra was discernible. Formulations contain-
ing low and high amounts of bulking agents did not show a clear trend towards instabil-
ity. Hence, the influence of bulking agent on the stability of the secondary structure of 
mab_T1 is regarded as negligible. 
Summary 
As shown above, the addition of high amounts of bulking agents to either sucrose- or 
trehalose-based formulation subjected to aggressive freeze-drying resulted in increased 
aggregation of mab_T1. On the other hand, formulations containing low amounts of 
bulking agents showed excellent stabilization of mab_T1. In order to evaluate whether 
the differences in the ability to stabilize mab_T1 can be attributed to the physico-chemical 
characteristics of the lyophilizates, the residual water content, the specific surface area, 
and the crystallinity of the samples were analyzed. 
A 
C 
B 
D 
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3.1.3 PHYSICO-CHEMICAL CHARACTERISTICS 
Residual water content 
As shown in the precious chapter (compare page 113), the addition of increasing 
amounts of bulking agents decrease the residual water content of the resulting lyophi-
lizates. Figure 6.8 depicts the residual water content of samples from aggressive freeze-
drying of the formulations listed in Table 6.3. While formulations containing a high 
amount of bulking agent (mannitol, glycine, or phenylalanine) exhibit low residual water 
contents of below 0.5%, the lyophilizates containing a low amount of mannitol or glycine 
exhibited high residual water contents. The formulations containing a low amount of 
phenylalanine exhibited low to medium residual water content of 0.75 ± 0.05% for the 
trehalose-based formulations and 1.69 ± 0.47% for the sucrose-based formulations, re-
spectively. Besides the slight difference between suc:phe 10:0.5 and tre:phe 10:0.5, the re-
sidual water contents of sucrose- and trehalose- based lyophilizates were comparable.  
  
Figure 6.8: Residual water content of lyophilizates after aggressive or moderate freeze-drying (overall drying 
time: aggressive 8 h, moderate 77 h). The sugar-based formulations contain bulking agent in low and high quan-
tities.  
  
Figure 6.9: Specific surface area of lyophilizates after aggressive or moderate freeze-drying. The sugar-based 
formulations contain bulking agent in low and high quantities. 
Taking the macroscopic appearance (Figure 6.2) and the specific surface area (cf. Fig-
ure 6.9) into consideration, the collapsed nature and therefore drastically decreased SSA 
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hinders an effective secondary drying of the formulations containing mannitol or glycine 
at a low concentration. To reach comparable residual water contents for latter formula-
tions, it would have been necessary to extend the drying time of the aggressive freeze-
drying process. The process was designed to freeze-dry the trehalose-based formulation 
containing a low amount of phenylalanine to a residual water content of below 1%. The 
same target was set for the design of the moderate freeze-drying cycle. The residual water 
contents of the moderately freeze-dried lyophilizates are shown in Figure 6.8, they 
ranged from 0.49% (suc:phe 10:3) to 1.96% (suc:gly 10:3). No apparent difference could 
be detected between sucrose- and trehalose-based samples. For the trehalose-based for-
mulation containing a low amount of bulking agent, a residual water content of 0.81% 
was determined. Overall, the differences between the different formulations of low and 
high bulking agent content were less pronounced compared to aggressive freeze-drying. 
This can be attributed to less pronounced differences in the SSA of the different lyophi-
lizates resulting from moderate freeze-drying (cf. Figure 6.9). However, also for moder-
ately freeze-dried samples a higher SSA of samples containing higher amounts of bulking 
agent can be distinguished. Comparing sucrose- and trehalose-based lyophilizates, a mi-
nor tendency of lower SSA for sucrose-based samples could be noticed.  
Specific surface area and protein stability 
Since the SSA of dried products is known to play an important role for the stabiliza-
tion of incorporated molecules [25, 26], the SSA of aggressive freeze-dried samples is 
compared to the turbidity, which was identified as the most sensitive tool for instability 
of mab_T1. The left graph in Figure 6.10 depicts the relationship of SSA and turbidity of 
aggressively freeze-dried samples. Comparing the SSA and the turbidity, samples of 
higher SSA exhibit higher turbidity. In other words, aggressively freeze-dried samples of 
higher SSA resulted in more pronounced aggregation (=instability) of mab_T1 compared 
to samples of low SSA. Consequently, it can be stated that higher amounts of bulking 
agents result in inferior stabilization of mab_T1.  
      
Figure 6.10: Turbidity versus SSA of aggressively and moderately freeze-dried lyophilizates. Sucrose- and treha-
lose-based samples of different bulking agent contents are displayed. 
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Moderately freeze-dried samples of higher SSA exhibited higher turbidity values (cf. 
right graph in Figure 6.10), too. However, while for aggressively freeze-dried samples an 
increased turbidity was notice for a SSA of ≥ 0.5 m²/g, moderately freeze-dried lyophi-
lizates showed an increase only at a SSA of ≥ 1.5 m²/g. Hence, high specific surface area 
by itself does not necessarily result in aggregation of mab_T1 (=turbidity). Potentially, a 
combination of (high) SSA and (high) temperature during drying causes instability. 
Crystallinity 
Usually, the incorporation of a protein in an amorphous matrix is regarded as neces-
sary for successful stabilization [27]. The addition of bulking agents result in the for-
mation of at least partially crystalline structures, which potentially cause instability of the 
incorporated protein molecules. The crystallinity was analyzed using X-Ray powder dif-
fraction (XRD). Figure 6.11 displays the diffraction patterns from XRD analysis. In gen-
eral, no difference in the spectra of sucrose- or trehalose-based samples was noticed. The 
type of sugar did not affect the crystallinity.  
No distinct peaks were observable from the diffraction patterns of lyophilizates ag-
gressively freeze-dried from formulations containing low amounts of glycine or phenyl-
alanine (peak at 38.8° 2-θ originates from copper sample holder). These samples are re-
garded as fully amorphous according to the characterization by XRD.  
Samples that contain high amounts of glycine or phenylalanine formed crystalline 
structures during freeze-drying indicated by distinct peaks. The diffraction peaks of gly-
cine containing samples can be attributed to β-glycine [28]. As phenylalanine was used 
in a lower amount (10:3) compared to glycine (10:30), the peaks were smaller in those 
species. Reference diffraction patterns of the International Centre for Diffraction Data 
(ICDD, formerly JCPDS database) were utilized to identify the peaks detected for the 
formulations containing a high amount of phenylalanine. The peaks at 6.5°, 15.1°, 17.5°, 
and 21.6° 2-θ are characteristic for phenylalanine-hydrate.  
To avoid the formation of metastable mannitol polymorphs, formulations containing 
mannitol should be subjected to a thermal treatment after freezing (annealing). Since ag-
gressive freeze-drying aims for short process times, annealing was not included in the 
performed freeze-drying process. Hence, the potential formation of metastable mannitol 
hemihydrate was accepted. Samples containing a low amount of mannitol exhibited dif-
fraction peaks at 9.6° and 17.9° 2-θ that can be attributed to mannitol hemihydrate [29]. 
Moderately freeze-dried lyophilizates of the same formulation exhibited no diffraction 
peaks (Figure 6.11, right graphs). If high amounts of mannitol are used, a number of dif-
fraction peaks were observed. Besides mainly δ-mannitol, also mannitol hemihydrate 
was noticed. On the contrary, aggressive freeze-drying of formulations containing a high 
amount of mannitol resulted in lyophilizates containing no mannitol hemihydrate (ab-
sence of the characteristic peak at 17.9° 2-θ). As the freezing steps of both cycles, aggres-
sive as well as moderate, were identical, obviously a recrystallization (to the stable δ-
modification) of mannitol occurred during the drying phase of aggressive freeze-drying.  
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Figure 6.11: Diffraction patterns of lyophilizates after aggressive or moderate freeze-drying. The sugar-based 
formulations contain bulking agent in low and high quantities. 
Regarding the influence of bulking agents on the stability of mab_T1 in aggressively 
freeze-dried lyophilizates, the presence of crystalline material seems to increase the ag-
gregation of mab_T1. As shown above, the aggressively freeze-dried samples, which con-
tain a high amount of mannitol, glycine, or phenylalanine, showed increased subvisible 
particle counts and turbidity. As the formation of a crystalline bulking structure is ac-
companied by an increased SSA, instability of mab_T1 cannot be exclusively accounted 
to crystallinity in the lyophilizates. Most probably, the large SSA, which results from the 
crystallization of the bulking agent, is responsible for the slightly less successful stabili-
zation of mab_T1.  
3.1.4 SUMMARY 
Summing up, the results regarding the influence of bulking agents on the ability of 
aggressively freeze-dried formulations to stabilize mab_T1 have shown that most of the 
formulations exhibited an overall good preservation of mab_T1 stability. No difference 
could be noticed between the sugars utilized as main stabilizers, implicating that both are 
suitable candidates for freeze-drying formulations for aggressive freeze-drying. Three 
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bulking agents (mannitol, glycine, and phenylalanine) were added to sucrose- or treha-
lose-based formulations in low and high amounts. While all samples of the formulations 
containing a low amount of either bulking agent showed very good stabilization of 
mab_T1, the addition of higher amounts of bulking agent resulted in slightly worse sta-
bilization.   
Since aggressive freeze-drying of formulations that contain low amounts of mannitol or 
glycine resulted in high residual water contents, the use of higher amounts is recom-
mendable in order to reduce the residual water content. On the other hand, it has turned 
out that formulations applying high amounts of bulking agent resulted in partly crystal-
line lyophilizates, which exhibits high SSA und therefore somewhat higher risks for in-
stability. Therefore, either shorter drying time (i.e. higher residual water content) or a 
medium amount of glycine or mannitol (i.e. lower SSA) seems to be feasible for a good 
combination of low residual water content and sound protein stabilization.    
Phenylalanine was utilized as a third bulking agent in this investigation. For the formu-
lations containing a high amount of phenylalanine the same observation as for mannitol 
and glycine were made. The aggressively freeze-dried lyophilizates exhibit slightly less 
successful preservation of mab_T1 stability due to the facts outlined above. However, the 
formulations applying low amount of phenylalanine showed an excellent preservation 
of mab_T1 stability and low residual water content / fully amorphous structure. Overall, 
these lyophilizates (suc:phe 10:0.5 and tre:phe 10:0.5) have emerged as preferable choice 
for generating stable products of mab_T1. 
 
3.2 PRODUCT CHARACTERISTICS AFTER STORAGE  
3.2.1 PROTEIN STABILITY 
Some of the formulations investigated above were subjected to an indicative stability 
study under accelerated conditions. For that purpose, selected samples were stored at 2-
8 °C, 30 °C, and 50 °C for up to 6 months. Suitable formulations were selected by their 
glass transition temperature. A glass transition temperature of above 50 °C was regarded 
as necessary. Figure 6.12 depicts the glass transition temperatures of lyophilizates aggres-
sively freeze-dried from the formulations denoted in Table 6.3. Inherently, trehalose-
based samples exhibited higher glass transition temperatures compared to sucrose-based 
samples.  
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Figure 6.12: Glass transition temperatures of lyophilizates after aggressive freeze-drying. The sugar-based for-
mulations contain bulking agent in low and high quantities. 
Based on the threshold of 50 °C, the formulations containing a high amount of man-
nitol, glycine, or phenylalanine were chosen. Additionally, the formulations containing a 
low amount of phenylalanine fulfilled the criterion and were included in the storage sta-
bility study, too. In order to compare the aggressively freeze-dried samples to conven-
tionally freeze-dried ones, the identical formulations were moderately freeze-dried and 
subjected to the same storage conditions. Major focus was set on the aggregation indicat-
ing analytical methods. Besides soluble aggregates (HP-SEC) and non-soluble aggregates 
(subvisible particle counts, turbidity), also the secondary structure of mab_T1 (2nd deriv-
ative FT-IR) was assessed. To possibly track down potential instabilities of mab_T1 to 
physico-chemical changes, also residual water content (Karl-Fischer titration), specific 
surface area (BET gas adsorption), and crystallinity (XRD) were evaluated.  
Soluble aggregates  
Soluble aggregates of mab_T1 are represented by high molecular weight species 
(HMWS) that were quantified by HP-SEC. Figure 6.13 displays the HMWS of reconsti-
tuted samples after storage over 10 and 26 weeks at the different storage conditions. On 
the left-hand side, sucrose-based samples are shown and on the right-hand side treha-
lose-based samples.  
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Figure 6.13: High molecular weight species (HMWS) of mab_T1 after storage of aggressively freeze-dried sam-
ples at 2-8 °C, 30 °C, and 50 °C for up to 26 weeks. 
At refrigerated storage of 2-8 °C no increase of HMWS was noticed for all formula-
tions that contain phenylalanine as bulking agent. For the sucrose-based formulations, 
containing mannitol or glycine, a slight increase of HMWS from 1.7% to 2.2% (gly) and 
1.9% to 2.6% (man) was detected after 26 weeks of storage. The HMWS content of the 
trehalose-based formulation containing glycine was slightly increased, too, while tre:man 
did not show an increase.  
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During storage at 30 °C a similar behavior was observed. The lyophilizates composed 
of sucrose and glycine exhibited a slight increase of HMWS, while the lyophilizates com-
posed of sucrose and mannitol exhibited no increase. Both, trehalose-based glycine and 
mannitol lyophilizates showed a minor increase after 26 weeks at 30 °C. The samples 
containing phenylalanine exhibit no increase of the low HMWS content over the whole 
storage period of 26 weeks. 
At a storage temperature of 50 °C all sucrose-based samples showed an increase of 
HMWS of up to 7.1% indicating substantial aggregation of mab_T1. Only the formulation 
containing a high amount of phenylalanine exhibited just a minor increase. Although the 
increase of trehalose-based mannitol and glycine samples is slightly less pronounced 
compared to the sucrose-based formulations, both species exhibited a distinct increase of 
HMWS during storage at 50 °C. Trehalose-based lyophilizates containing phenylalanine 
and stored at 50 °C did not show any increase over the whole storage period of 26 weeks. 
Obviously, both formulations stabilized mab_T1 pretty well against formation of soluble 
aggregates.  
Overall, especially trehalose-based lyophilizates that contain phenylalanine as bulk-
ing agent showed excellent stabilization of mab_T1 during the indicative stability study. 
Samples of aggressive and moderate freeze-drying were compared for a storage tem-
perature of 50 °C (the HMWS of all moderately freeze-dried and stored samples can be 
found in Table 9.5 in the appendix). Figure 6.14 depicts HMWS of lyophilizates stored for 
26 weeks at 50 °C. Samples moderately freeze-dried from formulations containing man-
nitol and glycine showed substantial formation of HMWS. It is remarkable that all ag-
gressively freeze-dried samples exhibited a comparable or even lower HMWS content 
compared to moderately freeze-dried samples. Only the moderately freeze-dried 
suc:phe 10:0.5 formulation exhibited lower HMWS content than the aggressively freeze-
dried sample. Interestingly, the former sample was completely collapsed after storage 
(initially non-collapsed appearance).  
 
Figure 6.14: Comparison of high molecular weight species (HMWS) after storage over 26 weeks at 50 °C. Green 
bars represent aggressively freeze-dried samples and orange bars moderately freeze-dried samples, respec-
tively. The dotted line displays the average HMWS content after freeze-drying, i.e. before storing the samples.  
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Overall, the trehalose-based lyophilizates, which contain phenylalanine 
(tre:phe 10:0.5, tre:phe 10:3), were able to completely prevent the formation of HMWS. 
These formulations revealed an excellent stabilization of mab_T1. 
 
The recovery of mab_T1 monomer was calculated from the integrated HP-SEC chro-
matograms. The monomer content before aggressive freeze-drying was set as 100%. A 
decrease of monomer recovery is attributed to a loss in protein due to instability of 
mab_T1 (e.g. aggregation). The monomer recoveries of the different samples after storage 
at the different temperatures are summarized in Table 6.5.  
After freeze-drying, tre:man 10:30 and tre:phe 10:3 already showed a slight decrease 
of monomer recovery. While for tre:phe 10:3 no further decrease during storage for 26 
weeks was detected, the recovery of tre:man 10:30 further decreased for storage temper-
atures of 30 °C and 50 °C. Overall, the stored samples showed a monomer recovery of 
above 88%. As expected, lower recovery was detected after 26 weeks at 50 °C. Comparing 
the different formulations, aggressively freeze-dried and stored suc:gly 10:30, tre:gly 
10:30, tre:phe 10:0.5, and tre:phe 10:3 showed good monomer recovery of ≥ 95%. 
Table 6.5: Monomer recovery of aggressively freeze-dried samples after storage. 
aggressive HP-SEC monomer recovery (%) 
  2-8°C 30°C 50°C 
 after FD 10 weeks 26 weeks 10 weeks 26 weeks 10 weeks 26 weeks 
suc:man 10:30 99.4 ± 0.2 99.2 ± 0.2 105.1 ± 0.3 98.0 ± 0.4 98.2 ± 0.5 94.8 ± 0.5 89.0 ± 1.7 
suc:gly 10:30 99.8 ± 0.4 100.3 ± 0.2 107.1 ± 1.8 100.8 ± 0.4 100.1 ± 0.4 97.0 ± 0.3 96.7 ± 0.3 
suc:phe 10:0.5 100.8 ± 0.3 101.8 ± 0.6 96.9 ± 1.6 101.3 ± 0.6 95.5 ± 0.4 69.0 ± 23.2 90.3 ± 1.0 
suc:phe 10:3 100.3 ± 0.7 100.8 ± 1.0 94.7 ± 0.8 100.5 ± 0.7 95.9 ± 0.7 101.5 ± 2.1 92.8 ± 0.7 
tre:man 10:30 98.6 ± 0.3 97.8 ± 0.3 98.5 ± 0.3 96.5 ± 0.5 96.8 ± 0.4 92.4 ± 0.7 88.0 ± 0.5 
tre:gly 10:30 101.3 ± 0.5 101.7 ± 0.3 100.1 ± 0.3 100.4 ± 0.6 100.4 ± 0.4 98.4 ± 0.4 95.4 ± 0.4 
tre:phe 10:0.5 103.9 ± 1.1 103 ± 0.9 96.7 ± 0.7 102.7 ± 0.8 97.1 ± 0.3 101.8 ± 1.1 96.2 ± 0.2 
tre:phe 10:3 97.8 ± 0.6 98 ± 0.5 95.8 ± 0.7 97.6 ± 0.6 95.7 ± 0.3 95.3 ± 0.3 94.9 ± 0.2 
 
Again, the lyophilizates from aggressive freeze-drying were compared to the samples 
from moderate freeze-drying. In order to benchmark both species for the most challeng-
ing storage conditions, the monomer recovery after 26 weeks at 50 °C is compared (cf. 
Figure 6.15) (the monomer recovery of all moderately freeze-dried and stored samples 
can be found in Table 9.6 in the appendix). While the monomer recovery of all aggres-
sively freeze-dried samples ranged above 90%, the monomer recovery of several moder-
ately freeze-dried samples was drastically decreased. Sucrose-based formulations con-
taining mannitol or glycine exhibited a recovery of only 4% and 56%, respectively. The 
monomer recovery of moderately freeze-dried formulations containing mannitol (69%) 
or glycine (90%) was decreased, too. All formulations containing phenylalanine as bulk-
ing agent exhibited a monomer recovery of ≥ 98%.  
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As already observed for HMWS content, the trehalose-based formulations, which 
contain phenylalanine (tre:phe 10:0.5, tre:phe 10:3), exhibited excellent stabilization of 
mab_T1 also in terms of monomer recovery.  
 
Figure 6.15: Comparison of monomer recovery after storage for 26 weeks at 50 °C. Green bars represent aggres-
sively freeze-dried samples and orange bars moderately freeze-dried samples, respectively. 
Non-soluble aggregates 
The formation of non-soluble aggregates during storage of the aggressively freeze-
dried samples was monitored by analyzing the turbidity as well as the subvisible particle 
concentration. Figure 6.16 depicts the turbidity values for the different storage tempera-
ture over storage time. On the left-hand side, sucrose-based samples are shown and on 
the right-hand side trehalose-based samples.  
At a storage temperature of 2-8 °C, the sucrose- and trehalose-based lyophilizates con-
taining glycine or phenylalanine (low or high amount) showed no change in turbidity. 
As outlined above, the samples, which apply high amounts of bulking agent (sugar:gly 
10:30 and sugar:phe 10:3) exhibited a higher turbidity already right after aggressive 
freeze-drying. Because no increase in turbidity was detectable, it was concluded that 
mab_T1 was stabilized against further aggregation. Lyophilizates from both formulations 
that contain mannitol showed a slight increase in turbidity during storage at 2-8 °C. These 
samples exhibited the highest turbidity level already right after aggressive freeze-drying. 
Although stored at low temperature, in the course of storage, additional aggregation oc-
curred in theses lyophilizates.   
At a storage temperature of 30 °C the same trend could be observed for the formulations 
containing mannitol: a slight increase in turbidity compared to the value after aggressive 
freeze-drying. Evidently, the formulations containing mannitol did not protect mab_T1 
against aggregation. Storage of the sucrose-based formulation containing glycine re-
vealed a considerable increase of turbidity after 26 weeks at 30 °C, too. The trehalose-
based samples applying glycine as bulking agent only showed a minimal increase of tur-
bidity.  
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Figure 6.16: Turbidity after storage of aggressively freeze-dried samples at 2-8 °C, 30 °C, and 50 °C for up to 26 
weeks (the sugar-based formulations contain bulking agents and 1 mg/ml mab_T1). 
For sucrose- and trehalose-based lyophilizates, which contain a high amount of phe-
nylalanine, a minimal increase of turbidity could be noticed, too. Both formulations that 
contain a low amount of phenylalanine exhibited a low turbidity even after 26 weeks at 
30 °C. Apparently, these formulations were able to protect mab_T1 completely against 
aggregation.   
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Storage at 50 °C confirmed the trends already observed for a storage temperature of 
30 °C. Formulations based on sucrose and containing mannitol or glycine revealed a dra-
matic increase of turbidity to up to > 80 FNU (see inserted plot in the lower left graph in 
Figure 6.16). Obviously, at that storage temperature, these formulations were unable to 
stabilize mab_T1 against aggregation. The formulations containing phenylalanine 
showed a considerable increase of turbidity, too. The lyophilizates containing a low 
amount of phenylalanine showed an even more distinct increase compared to the formu-
lation applying a high amount of phenylalanine.  
Focusing on the trehalose based lyophilizates stored at 50 °C, the samples containing 
mannitol as bulking agent showed a dramatic increase of turbidity. No successful stabi-
lization of mab_T1 was achieved in these lyophilizates. Also the samples, which contain 
a high amount of phenylalanine (tre:phe 10:3) exhibited a considerable increase of tur-
bidity. Aggregation of mab_T1 was not completely prevented. Both, the formulation con-
taining glycine and a low amount of phenylalanine, respectively, only exhibited a slight 
increase in turbidity. Evidently, even during storage for 26 weeks at 50 °C, these formu-
lations were able to prevent aggregation almost completely.  
Overall, the sugar-based samples containing phenylalanine at low content 
(suc:phe 10:0.5, tre:phe 10:0.5) revealed exceptional stabilization of mab_T1. While su-
crose-based lyophilizates prevented aggregation upon storage at up to 30 °C, trehalose-
based samples exhibited excellent stability even at up to 50 °C.  
 
For comparison, the turbidity of moderately freeze-dried and subsequently stored 
samples was analyzed (cf Figure 6.17). Overall, for storage at 2-8 ° and 30 °C similar 
trends were observed as for aggressively freeze-dried samples. Storage of the moderately 
freeze-dried lyophilizates at 50 °C revealed a considerable increase of turbidity in all ly-
ophilizates. Amongst the utilized bulking agents, phenylalanine revealed the lowest in-
crease in turbidity. However, the excellent stabilization of mab_T1, as observed in ag-
gressively freeze-dried samples, was not achieved by any of the moderately freeze-
dried lyophilizates.  
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Figure 6.17: Turbidity after storage of moderately freeze-dried samples at 2-8 °C, 30 °C, and 50 °C for up to 26 
weeks (the sugar-based formulations contain bulking agents and 1 mg/ml mab_T1; asterisk marks a not fully 
dissolvable sample). 
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In addition to the turbidity, the subvisible particle concentration of the stored lyoph-
ilizates was assesed. While turbidity is rather indicative for non-soluble protein aggre-
gates, also in the size range below 1 µm subvisible particle counts reveals non-soluble 
aggregates of ≥ 1 µm. Figure 6.18 displays the svp counts of aggressively freeze-dried 
samples subjected to 26 weeks storage at 2-8 °C, 30 °C, or 50 °C. In general, comparable 
trends could be observed as delineated for the turbidity values shown above.  
The mannitol containing samples exhibited svp counts, which are around 10 times 
higher already after freeze-drying. As expected, in these samples the svp concentration 
increased upon storage at 30 °C and 50 °C. Interestingly, the suc:man 10:30 lyophilizates 
exhibited a decrease of svp count after storage at 30 °C. Since the turbidity of these ly-
ophilizates did not show a comparable decrease, the result of the samples after 26 weeks 
at 30 °C is regarded as outlier. 
Based on either sucrose or trehalose, the formulations containing glycine or phenylal-
anine exhibited a constantly low svp level for storage temperatures of 2-8 °C and 30 °C. 
Obviously, these lyophilizates completely prevented aggregation of mab_T1 to non-sol-
uble aggregates.  
Storing the samples at 50 °C revealed worse stabilization of mab_T1 in sucrose-based 
lyophilizates that contain glycine (suc:gly 10:30) or a low amount of phenylalanine 
(suc:phe 10:0.5). In contrast, the respective trehalose based lyophilizates (tre:gly 10:30, 
tre:phe 10:0.5) showed excellent stabilization. Evidently, these formulations were able to 
stabilize mab_T1 successfully against aggregation even if stored 26 weeks at 50 °C.  
 
CHAPTER 4 
175 
  
  
  
 
Figure 6.18: Sub-visible particle counts ≤1 µm after storage of aggressively freeze-dried samples at 2-8 °C, 30 °C, 
and 50 °C for up to 26 weeks (the sugar-based formulations contain bulking agents and 1 mg/ml mab_T1).  
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In addition to determining svp of ≥ 1 µm, larger species of ≥ 10 µm and ≥ 25 µm 
were assessed according to the guideline of the European Pharmacopeia (Ph.Eur. 2.9.19).  
The detected amounts of svp ≥ 10 µm and ≥ 25 µm are listed in Fehler! Verweisquelle 
konnte nicht gefunden werden.. Besides the trehalose-based sample containing manni-
tol stored at 50 °C for 26 weeks, none of the analyzed lyophilizates reached the limit of 
6,000 particles ≥ 10 µm. Overall, the svp counts of svp ≥ 25 µm was low (typically below 
10 particles per ml) and no sample reached 600 particles ≥ 25µm.  
Overall, the svp counts of particles ≥ 10µm underline the observations for turbidity 
and svp of ≥ 1µm. For a storage temperature of up to 30 °C no apparent increase in the 
svp counts ≥ 10 µm were noticed. Storing the samples at 50 °C revealed the formation of 
increase numbers of particles in the lyophilizates composed of sucrose and either manni-
tol, glycine, or a low amount of phenylalanine (suc:man 10:30, suc: gly 10:30, suc:phe 
10:0.5). It appears that in these samples comparably large mab_T1 aggregates were 
formed.  
In contrast to most of the sucrose-based lyophilizates, samples based on trehalose did 
not show an increase in the svp level of particles ≥ 10 µm. Although smaller particles (≥ 
1 µm) were increased in the samples containing mannitol and glycine, no increase in 
larger aggregates (≥ 10 µm) was detectable.  
In order to pin down the subvisible particle counts of aggressively freeze-dried sam-
ples after storage, moderately freeze-dried samples are subjected to the identical storage 
conditions and further, the svp counts were analyzed. Table 6.6 depicts the svp counts of 
particles ≥ 1 µm. The overall trends are comparable to those observed for the turbidity of 
stored moderately freeze-dried samples (compare Figure 6.17). 
Table 6.6: Subvisible particle counts of moderately freeze-dried lyophilizates. Subvisible particle of ≥1µm of 
samples stored at 2-8 °C, 30 °C, or 50 °C are listed. 
moderate subvisible particle counts ≥ 1µm (#/ml) 
  2-8°C 30°C 50°C 
 after FD 10 weeks 26 weeks 10 weeks 26 weeks 10 weeks 26 weeks 
suc:man 
10:30 
7,871 ± 
1,831 
45,627 ± 
21,378 
7,363 ± 
3,093 
100,757 ± 
32,951 
69,956 ± 
6,053 
n.d. 
31,625 ± 
16,885 
suc:gly 
10:30 
4,475 ± 
3,819 
3,144 ± 
1,087 
1,248 ±   776 
8,002 ± 
3,438 
2,832 ±   881 
386,5163 ± 
204,069 
173,250 ± 
24,968 
suc:phe 
10:0.5 
7,108 ± 
2,216 
2,736 ± 
1,265 
1,959 ±   760 
8,015 ± 
2,214 
3,051 ± 
1,502 
38,167 ± 
28,708 
256,346 ± 
5,609 
suc:phe 
10:3 
5,934 ± 
1,941 
6,584 ±   778 3,912 ±   971 7,617 ±   703 4,723 ±   939 
20,361 ± 
5,322 
35,419 ± 
2,659 
tre:man 
10:30 
37,097 ± 
3,397 
13,4582 ± 
5,123 
49,157 ± 
20,344 
458,222 ± 
103,443 
159,650 ± 
15,623 
2,908,793 ± 
254,374 
200,344 ± 
8,801 
tre:gly 
10:30 
4,435 ± 
1,107 
22,525 ± 
5,172 
2,900 ± 
1,106 
67,583 ± 
11,718 
1,841 ±   528 
109,483 ± 
7,572 
190,980 ± 
25,623 
tre:phe 
10:0.5 
4,551 ± 
2,551 
3,873 ± 
1,373 
3,272 ±   844 2,790 ±   704 
5,589 ± 
1,957 
9,545 ±   468 
11,863 ± 
1,658 
tre:phe 10:3 
9,179 ± 
3,169 
6,944 ± 
1,265 
6,130 ± 
1,819 
7,986 ± 
1,559 
13,468 ± 
2,705 
19,790 ± 
2,077 
15,861 ± 
1,246 
n.d.: not determined 
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Besides the formulations containing mannitol, all moderately freeze-dried lyophi-
lizates showed low svp contents for a storage temperature of up to 30 °C (and 26 weeks 
storage). For a storage temperature of 50 °C all moderately freeze-dried samples showed 
an increase in svp content ≥1 µm. While trehalose-based lyophilizates that contain phe-
nylalanine (tre:phe 10:0.5, tre:phe 10:30) showed a minor increase of svp level, all lyoph-
ilizates containing mannitol or glycine exhibited a tremendous increase of svp level after 
26 weeks at 50 °C.  
 
Summing up the results regarding aggregation in aggressively freeze-dried lyoph-
ilizates, the data have shown excellent stabilization of mab_T1 in trehalose-based sam-
ples, which contain phenylalanine (tre:phe). Especially the lyophilizates that contain 
a low amount of phe (tre:phe 10:0.5) revealed superior stabilization, even after six 
months storage at 50 °C. Also sucrose-based lyophilizates containing phenylalanine 
showed admirable stabilization for storage up to 30 °C. On the other hand, independ-
ent from sugar, diminished stability was observed for lyophilizates containing man-
nitol or glycine. Compared to moderate freeze-drying, equal or even better storage sta-
bility of mab_T1 was achieved by aggressive freeze-drying.  
 
Secondary Structure 
As already outlined above, the secondary structure of proteins is susceptive to 
changes if not properly stabilized. To assess the secondary structure of mab_T1 in the 
course of storage, the samples were analyzed, utilizing the 2nd derivative FT-IR spectra of 
reconstituted samples. Since the optical assessment of the spectra does not allow for 
quantitative comparison, the overlap of spectra was calculated as described by Prestrelski 
et al. [30] and expressed by a correlation coefficient. The 2nd derivative spectra of samples 
after freeze-drying and storage were compared to the spectra of the formulations before 
freeze-drying. A reference sample of mab_T1 solution, which was subjected to a heating 
ramp in the temperature controlled Bio-ATR cell of the FT-IR spectrometer, exhibited a 
correlation coefficient of 0.985 at 70 °C, 0.645 at 80 °C and 0.080 at 90 °C. While for a 
correlation coefficient of 0.985 optically still a good overlap of spectra was attested, a cor-
relation coefficient of 0.645 represent a clearly discernible change in the 2nd derivative FT-
IR spectra (spectra not shown).  
Figure 6.19 displays the correlation coefficients of aggressively and moderately 
freeze-dried samples after freeze-drying and storage. Overall, high correlation coeffi-
cients of > 0.985 were determined for aggressively freeze-dried samples (tre:man 10:30 is 
regarded as outlier since the stored samples of this formulation showed high correlation 
coefficients). Due to interfering absorbance of glycine, sample containing this bulking 
agent could not be assessed by FT-IR spectroscopy. Compared to 2-8 °C and 30 °C storage 
temperature, for all analyzed formulations it was noticed that a storage temperature of 
50°C resulted in a slight decrease of the correlation coefficient, indicating minor changes 
of the secondary structure in these lyophilizates. Comparing sucrose- and trehalose-
based formulations, no apparent difference could be observed. In contrast to the aggre-
gation to soluble and non-soluble aggregates (expressed as HWMS, turbidity and svp 
count), mannitol exhibited higher correlation coefficients compared to both formulations 
containing phenylalanine. It is reported that aggregation can occur without detectable 
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changes in the secondary structure [31, 32]. Comparing the lyophilizates from aggressive 
freeze-drying to those from moderate freeze-drying, the moderately freeze-dried su-
crose-based samples exhibited lower correlation coefficients, i.e. the protection of the sec-
ondary structure is less effective. While tre:man 10:30 also showed slightly worse preser-
vation of secondary structure, both formulations containing phenylalanine demonstrated 
well conservation of the secondary structure.  
  
Figure 6.19: Correlation coefficient of FT-IR spectra after freeze-drying and storage over 10 weeks at different 
temperatures. For calculation of the correlation coefficient, spectra derived from reconstituted samples were 
compared to the FT-IR spectra of the respective formulations before freeze-drying.  
 
3.2.2 PHYSICO-CHEMICAL CHARACTERISTICS AFTER STORAGE 
In order to evaluate, whether the trends observed for the stability of mab_T1 in for-
mulations containing bulking agents can be ascribed to physico-chemical characteristics 
of the respective lyophilizates, the residual water content, glass transition temperatures, 
specific surface area, and crystallinity were assessed.  
Macroscopic appearance 
The macroscopic appearance of the trehalose-based samples showed no change after 
storage over 26 weeks (cf. Figure 6.20). Sucrose-based samples exhibited no change of 
appearance at a storage temperature of up to 30 °C, too (cf. Figure 6.21). However, storage 
at 50 °C revealed a change in color from white to brown for the samples containing gly-
cine or a low amount of phenylalanine. In addition, the latter lyophilizates exhibited pro-
nounced shrinkage of the already initially collapsed material. Obviously, these samples 
underwent non-enzymatic browning via the Maillard reaction (brown pigments are 
formed by a multi-step reaction between reducing sugars and amino groups [33]).  
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Figure 6.20: Macroscopic appearance after storage of aggressively freeze-dried samples at 2-8 °C, 30 °C, and 
50 °C for up to 26 weeks (trehalose-based formulations contain bulking agents and 1 mg/ml mab_T1; tm30 ≙ 
tre:man 10:30, tg30 ≙ tre:gly 10:30, tp0.5 ≙ tre:phe 10:0.5, tp30 ≙ tre:phe 10:3). 
Freeze-dried sucrose is reported to be prone to non-enzymatic browning [34]. Sucrose 
itself has non-reducing characteristics and cannot participate in the Maillard reaction di-
rectly. Hence, prior to reacting with the amino groups of glycine or phenylalanine sucrose 
was obviously hydrolyzed to fructose and glucose. However, neither DSC thermograms 
exhibited melting endotherms at 150 °C (glucose, [35]) or 120 °C (fructose, [36]) nor XRD 
diffraction data showed a characteristic peak at 17.2 ° 2-θ (cf. Figure 6.24). Apparently, in 
terms of thermal properties and diffraction the excess of sucrose hides the rather minor 
amounts of glucose and fructose. 
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Figure 6.21: Macroscopic appearance after storage of aggressively freeze-dried samples at 2-8 °C, 30 °C, and 
50 °C for up to 26 weeks (sucrose-based formulations contain bulking agents and 1 mg/ml mab_T1; sm30 ≙ 
suc:man 10:30, sg30 ≙ suc:gly 10:30, sp0.5 ≙ suc:phe 10:0.5, sp30 ≙ suc:phe 10:3). 
The macroscopic appearance of moderately freeze-dried samples after storage at up 
to 30°C for 26 weeks revealed no change in the elegant cake structure compared to ini-
tially after freeze-drying (data not shown). Storing the samples at 50°C resulted in discol-
oration (browning) of the sucrose-based lyophilizates that contain glycine or a low 
amount of phenylalnine as bulking agent (cf. Figure 6.22). Obviously, non-enzymatic 
browning happened to these samples, too. The formulation containing sucrose and a low 
amount of phenylalanine (suc:phe 10:0.5) additionally exhibited pronounced shrinkage 
of the cake to a dense yellowish-brown puck.  
While the aggressively freeze-dried lyophilizates that contain sucrose and mannitol 
did not show any signs of discoloration after storage at 50°C, the same formulations mod-
erately freeze-dried revealed discoloration, too. No matter whether aggressively or mod-
erately freeze-dried, the formulation containing sucrose and a high amount of phenylal-
anine (suc:phe 10:3) remained unchanged regarding the color of the lyophilizates (com-
pare Figure 6.21 and Figure 6.22).  
Due to the difference in the bond energy of the disaccharide bond of sucrose (> 115 
kJ/mol) and trehalose (< 4 kJ/mol), sucrose is more prone to split into glucose and fructose 
[37]. As expected, aggressively as well as moderately freeze-dried trehalose-based sam-
ples showed no discoloration after storage at 50°C – with one exception. The moderately 
The Influence of Formulation Composition on Protein Stability in Aggressively Freeze-dried Lyophilizates 
182 
freeze-dried samples containing glycine as bulking agent exhibited a slight, but discern-
ible discoloration towards a shiny red-brown color. Apparently, although trehalose is 
comparable robust against hydrolysis, in these samples a certain degree of hydrolysis 
occurred, which is followed by non-enzymatic browning. 
 
 
 
Figure 6.22: Macroscopic appearance after storage of moderately freeze-dried samples at 50 °C for 26 weeks 
(sugar-based formulations contain bulking agents and 1 mg/ml mab_T1).  
Non-enzymatic browning is reported to be a diffusion controlled reaction, which is 
therefore related to the viscosity of the material [38]. As the viscosity drops dramatically 
at the glass transition, lyophilizates stored above their glass transition temperature are 
reported to show extensive non-enzymatic browning [38]. In the present study, the su-
crose-based samples showing browning when stored in the vicinity to the glass transition 
temperature (assessed by DSC, cf. Table 6.7). Hence, the necessary mobility for hydrolysis 
of sucrose and the reaction cascade resulting in non-enzymatic browning is plausible in 
these lyophilizates.  
The aggressively freeze-dried samples containing mannitol did not exhibit non-enzy-
matic browning upon storage, although they showed comparable glass transition tem-
peratures (close to the storage temperature of 50°C). Hence, the amino acids utilized as 
bulking agents (glycine, phenylalanine) are considered as main reaction partners of glu-
cose / fructose. The sucrose-based formulation that contain a high amount of phenylala-
nine (suc:phe 10:3) revealed no change in color. These samples showed considerably high 
glass transition temperatures throughout the stability study. Obviously, low mobility 
prevented a chemical reaction.  
 
Glass transition temperature 
Generally, the glass transition temperatures of all aggressively freeze-dried samples 
exhibited no substantial change when storing the samples at 2-8°C, 30°C, 50°C (cf. Table 
6.7). As expected, trehalose-based samples showed higher Tg than sucrose-based ones. 
Especially the lyophilizates that contain phenylalanine (tre:phe) exhibited considerably 
suc:man 10:30 suc:gly 10:30 suc:phe 10:0.5 suc:phe 10:3 
tre:man 10:30 tre:gly 10:30 tre:phe 10:0.5 tre:phe 10:3 
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high glass transition temperatures of ≥ 90 °C even after storage at 50 °C for 26 weeks (i.e. 
6 months). As shown above, these phe containing lyophilizates also offered superior sta-
bilization of mab_T1. Obviously, the high glass transition temperatures allow storage at 
high temperatures with full stabilization of mab_T1. 
Table 6.7: Glass transition temperatures after storage of aggressively freeze-dried samples at 2-8 °C, 30 °C, and 
50 °C for up to 26 weeks (the sugar-based formulations contain bulking agents and 1 mg/ml mab_T1). 
aggressive glass transition temperature (°C) 
  2-8°C 30°C 50°C 
 after FD 10 weeks 26 weeks 10 weeks 26 weeks 10 weeks 26 weeks 
suc:man 10:30 51.2 ± 0.8 47.8 ± 0.9 46.7 ± 1.9 49.0 ± 2.2 51.8 ± 1.3 51.6 ± 2.8 47.4 ± 0.1 
suc:gly 10:30 56.8 ± 0.8 58.4 ± 2.6 38.8 ± 0.4 57.1 ± 1.8 56.3 ± 2.2 49.4 ± 1.2 48.5 ± 1.4 
suc:phe 10:0.5 54 ± 0.8 50.9 ± 2.2 56.5 ± 4.3 62.6 ± 4.3 55.8 ± 1.2 58.3 ± 1.6 60.1 ± 1.6* 
suc:phe 10:3 75.6 ± 0.9 76.4 ± 1.1 71.5 ± 7.5 73.8 ± 2.0 68.8 ± 1.5  71.0 ± 0.8 71.0 ± 1.5 
tre:man 10:30 67 ± 0.2 65.3 ± 2.2 66.5 ± 1.7 66.2 ± 0.7 63.0 ± 4.4 63.7 ± 1.6 64.2 ± 0.1 
tre:gly 10:30 73 ± 0.7 73.6 ± 0.7 72.7 ± 2.5 70.7 ± 1.8 65.6 ± 1.9 69.7 ± 2.1 66.6 ± 0.4 
tre:phe 10:0.5 94.8 ± 0.7 98.7 ± 1.4 100.9 ± 0.4 96.2 ± 1.1 98.3 ± 0.2 96.2 ± 2 95.1 ± 2.4 
tre:phe 10:3 107.1 ± 1.4 105.7 ± 0.7 108.8 ± 1.3 102.2 ± 0.9 100.6 ± 5.2 99.2 ± 1.2 99.5 ± 0.1 
*only detectable in one of three analyzed samples, the other two samples showed melting of crystalline sucrose 
 
Also after moderate freeze-drying, the samples containing phenylalanine as bulking 
agent revealed considerably higher Tg compared to samples applying mannitol or gly-
cine as bulking agent (cf. Appendix, Table 9.2). 
The sucrose-based samples containing mannitol or glycine revealed low glass transi-
tion temperatures. Nevertheless, these samples were put to all storage conditions in order 
to compare moderately and aggressively freeze-dried lyophilizates of all formulations 
also at the highest storage temperature of 50°C. In contrast to the constant glass transition 
temperatures of aggressively freeze-dried samples throughout the storage study (com-
pare Table 6.7), the moderately freeze-dried lyophilizates revealed a considerable de-
crease of the glass transition temperatures for all formulations. As expected, storing the 
suc:man 10:30 lyophilizates roughly 20°C above their glass transition temperature re-
sulted in crystallization of sucrose. In the stored samples no glass transition was detecta-
ble. The DSC thermogram revealed melting of crystalline sucrose instead. In addition, 
XRD revealed the characteristic peaks of crystalline sucrose (compare Figure 9.2). Inter-
estingly, also the formation of α-mannitol was evidently in these samples.  
Residual water content 
It is a well-known phenomenon that under accelerated storage conditions (i.e. raised 
temperatures) the residual water content of the lyophilizates can show an increased over 
time, which is caused e.g. by water vapor permeability of the stopper [39, 40]. 
Overall, aggressively freeze-dried sucrose- and trehalose-based samples are compa-
rable (cf. Figure 6.23). By aggressive freeze-drying, low initial water content was 
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achieved. Only the sucrose-based lyophilizates that contain a low amount of phenylala-
nine showed slightly higher water contents. In addition, they exhibited high standard 
deviations, which are attributed to inhomogeneity of the water content within the batch. 
Trehalose-based samples containing phenylalanine have turned out as excellent stabilizer 
of mab_T1 (see 3.2.1). These lyophilizates exhibited low water content, too. Also the col-
lapsed tre:phe 10:0.5 samples could be dried to < 1%. 
The stored samples exhibited no increase of water content throughout the 26 weeks 
storage period. Even for storage at 50 °C, constant water content was observed (cf. Figure 
6.23). Hence, the aggressively freeze-dried lyophilizates provide a robust foundation for 
storage-stable products.  
    
    
    
 
Figure 6.23: Residual water content after storage of aggressively freeze-dried samples at 2-8 °C, 30 °C, and 50 °C 
for up to 26 weeks (the sugar-based formulations contain bulking agents and 1 mg/ml mab_T1). 
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The minor increase of water content, which is noticed for aggressively freeze-dried 
suc:man 10:30 samples, is ascribed to water consumption by chemical reactions. This the-
ory is underlined by the considerable decrease of RWC in moderately freeze-dried 
suc:man samples (compare Appendix, Figure 9.1). The decrease of water is accompanied 
by a drastic decrease of remaining monomer (i.e. recovery, compare Figure 6.15). Most 
probably, glycation of mab_T1 occurred in these samples.  
Overall, moderately freeze-dried samples exhibited a considerable increase of water 
content, which was manifested already after 10 weeks at 30°C or 50°C (compare Appen-
dix, Figure 9.1). No further change was noticed between 10 and 26 weeks of storage. 
Specific surface area 
It was shown in CHAPTER 5 (page 113 pp.) that the addition of substantial amounts 
of bulking agent resulted in macroscopically non-collapsed lyophilizates, even if aggres-
sive conditions were utilized for freeze-drying (i.e. 45 °C shelf temperature and 1 mbar 
chamber pressure). These results were underlined in this study. Depending on the nature 
and amount of bulking agent, a range of specific surface areas (SSA) was noticed after 
aggressive freeze-drying (see Table 6.8).  
Samples, that contain mannitol, glycine, or a high amount of phenylalanine (suc:phe 
10:3, tre:phe 10:3) exhibited an intact cake. However, compared to moderately freeze-
dried samples (cf. Table 6.9) substantial lower SSA was observed for aggressively freeze-
dried lyophilizates of the same formulation. Evidently, micro-collapse occurred during 
aggressive freeze-drying.  
The lyophilizates containing a low amount of phenylalanine (suc:phe 10:0.5, tre:phe 
10:0.5) showed very low SSA of 0.09 m²/g and 0.27m²/g. These samples collapsed during 
aggressive freeze-drying due to the high product temperature. 
Table 6.8: Specific surface area after storage of aggressively freeze-dried samples at 2-8 °C, 30 °C, and 50 °C for 
up to 26 weeks (macroscopically collapsed samples in bold). 
formulation specific surface area (m²/g) 
  2-8°C 30°C 50°C 
 after FD 10 weeks 26 weeks 10 weeks 26 weeks 10 weeks 26 weeks 
suc:man 10:30 2.29 2.32 2.31 2.28 2.28 2.46 2.38 
suc:gly 10:30 0.94 0.77 0.91 0.72 0.82 0.73 0.82 
suc:phe 10:0.5 0.09 0.08 0.10 0.12 0.09 0.07 0.06 
suc:phe 10:3 1.45 1.50 1.30 1.54 1.54 1.43 1.51 
tre:man 10:30 2.38 2.26 2.21 2.37 2.33 2.23 2.18 
tre:gly 10:30 0.83 0.79 0.79 0.88 0.95 0.81 0.90 
tre:phe 10:0.5 0.27 0.19 0.24 0.30 0.26 0.26 0.26 
tre:phe 10:3 1.62 1.51 1.64 1.46 1.63 1.57 1.79 
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Table 6.9: Specific surface area after storage of moderately freeze-dried samples at 2-8 °C, 30 °C, and 50 °C for 
up to 26 weeks (macroscopically collapsed samples in bold). 
formulation specific surface area (m²/g) 
  2-8°C 30°C 50°C 
 after FD 10 weeks 26 weeks 10 weeks 26 weeks 10 weeks 26 weeks 
suc:man 10:30 2.19 2.42 2.27 2.64 2.89 1.78 2.11 
suc:gly 10:30 2.12 2.45 2.26 2.34 2.10 0.91 1.00 
suc:phe 10:0.5 1.65 1.71 1.54 1.55 1.53 0.01 0.02 
suc:phe 10:3 2.54 2.73 2.56 2.57 2.85 2.40 2.38 
tre:man 10:30 2.54 2.56 2.94 2.77 3.47 1.99 2.19 
tre:gly 10:30 2.70 2.86 2.99 2.47 2.70 1.63 1.66 
tre:phe 10:0.5 2.09 1.89 1.92 2.01 1.90 1.92 2.14 
tre:phe 10:3 3.26 3.53 3.31 2.96 3.37 3.27 3.08 
 
Some of the lyophilizates that were moderately freeze-dried exhibited a considerable 
decrease of SSA indicating (micro-) collapse during storage (cf. Table 6.9). Both, the su-
crose- as well as trehalose-based lyophilizates containing glycine as bulking agent re-
vealed a distinct decrease of the SSA upon storage at 50°C. The SSA of the suc:phe 10:0.5 
samples stored at 50 °C were drastically decreased, too. These samples also exhibited a 
fully collapsed appearance (cf. Figure 6.22, p. 182). 
On the contrary, none of the aggressively freeze-dried samples exhibited a change 
of the SSA. Although the storage temperature of 50 °C was close to the glass transition 
temperature of some samples (compare Table 6.7), no changes of the microscopic struc-
ture was noticed after 6 months. This correlates well with the visual impression of the 
macroscopic appearance (compare Figure 6.20 and Figure 6.21, page 180). As expected 
from the high glass transition temperatures, the trehalose-based lyophilizates containing 
phenylalanine showed no change in SSA during storage (tre:phe 10:0.5, tre:phe 10:3).  
 
Crystallinity 
The crystallinity of aggressively freeze-dried samples was analyzed utilizing XRD. 
Figure 6.24 depicts the resulting diffractograms. The formulations containing glycine, 
mannitol, or a high amount of phenylalanine did not reveal any apparent alteration of 
the XRD pattern in the course of storage (independent from sugar or storage tempera-
ture). Indicated by distinct diffraction peaks, all of these samples revealed a partly crys-
talline structure, which remained unchanged during storage. 
Lyophilizates composed of sucrose or trehalose and a low content of phenylalanine 
exhibited a fully amorphous structure after aggressive freeze-drying. The trehalose-
based lyophilizates (tre:phe 10:0.5) remained fully amorphous for all storage condi-
tions after 26 weeks. For a storage temperature of 30°C, also the sucrose-based lyophi-
lizates (suc:phe 10:0.5) revealed a fully amorphous structure. However, upon storage at 
50°C for 26 weeks these samples exhibited a distinct diffraction pattern, which can be 
attributed to crystalline sucrose. Obviously, high mobility in these samples, which were 
stored close to the Tg, fostered crystallization of sucrose from the amorphous matrix.  
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Moderate freeze-drying of formulations that contain glycine or a high amount of phe-
nylalanine showed a partly crystalline structure comparable to samples from aggressive 
freeze-drying (data see appendix, Figure 9.2). Independent from temperature, no change 
of crystallinity was observed after 26 weeks storage. Lyophilizates, that contain a low 
amount of phenylalanine (suc:phe 10:0.5, tre:phe 10:0.5), remained fully amorphous 
throughout the storage period. 
In contrast, distinct alteration in the crystallinity and polymorphism upon storage was 
observed in the lyophilizates that contain mannitol as bulking agent. The different crys-
talline structures, which appeared for the different storage temperatures, suggest that in 
a first step α-mannitol is formed (characteristic peaks at 13.6°, 17.2°, and 18.7° 2-θ). Stor-
ing these samples at 50°C additionally resulted in crystallization of sucrose, indicated by 
characteristic peaks at 11.7° , 13.1°, 19.6°, and 31.9° 2-θ.  
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Figure 6.24: XRD diffraction patterns after storage of aggressively freeze-dried samples at 2-8 °C, 30 °C, and 
50 °C for 26 weeks (the sugar-based formulations contain bulking agents and 1 mg/ml mab_T1; diffraction pat-
terns marked by * were measured on an alternative device). 
CHAPTER 4 
189 
3.2.3 SUMMARY 
During the accelerated storage stability study (6 months at 2-8°C, 30°C and 50°C) of 
sugar-based lyophilizates that contain bulking agents, several trends were observed.  
Especially storage of samples at 50°C revealed pronounced differences of the formu-
lations in the ability to stabilize incorporated mab_T1. The formulations based on treha-
lose and utilizing phenylalanine as bulking agent, exhibited excellent stabilization of 
mab_T1 throughout the whole storage period. On the other hand, especially formula-
tions containing mannitol failed in protection of mab_T1 against aggregation. Insufficient 
stabilization of a mAb in mannitol containing lyophilizates from aggressive freeze-drying 
was already observed by Schersch et al. [3]. 
Already after aggressive freeze-drying both, the sucrose- as well as the trehalose-
based lyophilizates that contain mannitol, revealed aggregation of mab_T1. In the course 
of storing the samples at 30°C or above, further aggregation was detected, which can be 
probably attributed to the comparably low glass transition temperature. At a storage tem-
perature of 50°C the samples are stored in the vicinity of their Tg, allowing for increased 
mobility. The same phenomenon was observed for sucrose-based samples that contain 
only a low amount of phenylalanine. Finally, storage of these samples at 50°C (i.e. close 
to their initial Tg) resulted in substantial non-enzymatic browning. The pronounced for-
mation of soluble and non-soluble aggregates, detected for these samples, can be at-
tributed to chemical degradation to a serious extend. Non-enzymatic browning was ob-
served in the sucrose-based samples that contain glycine as well. The discoloration of 
these samples is accompanied by distinct increase of non-soluble aggregates. 
Comparing the data for a storage temperature of 30°C, which is at least 20 K below 
the initial glass transition temperatures of the aggressively freeze-dried lyophilizates, for-
mulations that contain glycine or phenylalanine revealed complete preservation of 
mab_T1 throughout the storage period of 6 months.  
 
Compared to the equivalents from moderate freeze-drying, the aggressively freeze-
dried samples performed at least equal in terms of protein stabilization. Considering 
the physico-chemical characteristics, the aggressively freeze-dried samples showed 
less change of important properties. While moderately freeze-dried samples showed an 
increase in residual water content and hence a decrease of glass transition temperatures 
over time, aggressive freeze-drying resulted in lyophilizates that remained unchanged 
even upon storage at 50°C. Moderately freeze-dried lyophilizates that contain mannitol 
or glycine showed low Tg, which potentially explains the worse performance in terms of 
protein stabilization of these samples especially if stored at 50°C. This underlines the im-
portance of high glass transition temperatures for sound storage stability. Low Tg allows 
for increased mobility, resulting in non-enzymatic browning. Instability in mannitol con-
taining samples is also indicated by crystallization (sucrose-based) or a change in manni-
tol polymorphism (sucrose- and trehalose-based). In addition, while overall the residual 
water content is rather increased during storage, the samples containing mannitol as 
bulking agent exhibited a decrease upon storage at 30°C and 50°C. This is considered as 
a further hint for chemical reactions in these lyophilizates.  
In the end, the study on the storage stability revealed that lyophilizates, which were 
aggressively freeze-dried from sugar-based formulations of high bulking agent content 
(mannitol, glycine, phenylalanine), exhibited a non-collapsed appearance, but were less 
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successful in stabilizing the sensitive model mab_T1. Due to the formation of a crystalline 
structure, these products were able to withstand macroscopic collapse. However, the 
macroscopic intact cake exhibits a large specific surface area, which diminishes the stabi-
lization. Less successful stabilization was also shown for the moderately freeze-dried ly-
ophilizates, all of which exhibited non-collapsed appearance and large SSA. Moreover, 
the correlation between SSA and stabilization was also shown for other dried products 
in the literature [41].  
On the other hand, outstanding storage stability of mab_T1 was achieved by ag-
gressively freeze-dried lyophilizates that contain trehalose and phenylalanine at a ra-
tio of 10:0.5. These samples showed a collapsed structure of low specific surface area. 
Moreover, they were fully amorphous and exhibited high glass transition temperature. 
Despite the low SSA, these samples could be dried to low water contents within 12 h 
by the aggressive protocol (i.e. 4 h freezing and 8 h drying).  
Considerations on the reason for differences in stabilization unveiled two facts: On 
the one hand, the formulations containing mannitol exhibited the highest SSA and worst 
stabilization. On the other hand, at high storage temperatures of 50°C trehalose-based 
samples of lower SSA (low amount of phenylalanine) performed better than tre:phe 10:3 
presenting higher SSA. Finally, this led to the conclusion that high SSA serves most prob-
ably as a key instability factor. Consequently, for most effective stabilization of proteins 
in lyophilizates, low SSA should by aspired by freeze-drying. 
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3.3 AMINO ACIDS AS BULKING AGENTS 
As outlined above, a number of amino acids have been evaluated regarding their po-
tential to act as bulking agent in sugar-based formulations intended for aggressive freeze-
drying. Based on either sucrose or trehalose, the formulations shown in Table 6.10 were 
subjected to aggressive freeze-drying in 2R vials with 1 ml fill according to the protocol 
shown in Table 3.4 (page 55) using a FTS LyoStar II freeze-drier. Since phenylalanine has 
shown favorable physico-chemical characteristics at a sugar to phenylalanine ratio of 
10:0.5 (see previous section), this weight-to-weight ratio was also applied for the investi-
gation of the further amino acids. To assess the ability to stabilize an incorporated protein, 
mab_T1 was added to the formulations at a concentration of 1 mg/ml. The formulations 
were composed at a total solid content of 51 mg/ml. Amongst the selection of amino acids, 
glycine is the most prominent representative, which is reported to be used as bulking 
agent in some formulations [18].  
The physico-chemical characteristics of the resulting lyophilizates were already de-
scribed (see CHAPTER 5, page 125pp.) regarding macroscopic appearance, specific sur-
face area, residual water content, glass transition temperature, and crystallinity. In this 
section, the integrity of mab_T1 is evaluated by HP-SEC, analyzing the samples regard-
ing their monomer/dimer content and recovery of monomer after aggressive freeze-dry-
ing. In addition, the potential formation of non-soluble aggregates is followed by the tur-
bidity and sub-visible particle concentration.  
Table 6.10: Formulations to characterize the ability of combinations of sugars and amino acids to stabilize 
mab_T1 during aggressive freeze-drying.  
formula-
tion 
mab_T1 su-
crose 
treha-
lose 
argi-
nine 
gly-
cine 
histi-
dine 
isoleu-
cine 
leu-
cine 
methio-
nine 
trypto-
phan 
 mg/ml mg/m
l 
mg/ml mg/ml mg/m
l 
mg/ml mg/ml mg/m
l 
mg/ml mg/ml 
suc:arg 1 47.5  2.5       
suc:gly 1 47.5   2.5      
suc:his 1 47.5    2.5     
suc:ile 1 47.5     2.5    
suc:leu 1 47.5      2.5   
suc:met 1 47.5       2.5  
suc:trp 1 47.5        2.5 
tre:arg 1  47.5 2.5       
tre:gly 1  47.5  2.5      
tre:his 1  47.5   2.5     
tre:ile 1  47.5    2.5    
tre:leu 1  47.5     2.5   
tre:met 1  47.5      2.5  
tre:trp 1  47.5       2.5 
 
 
Before analyzing the lyophilizates regarding protein integrity, the samples were re-
constituted with highly purified water and the reconstitution time was determined. Table 
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6.11 depicts the reconstitution times that were noticed for the different formulations. All 
samples were completely dissolved in less than 20 seconds. Sucrose-based samples seem 
to exhibit even slightly lower reconstitution times compared to trehalose-based samples. 
Except the lyophilizate containing isoleucine, all sucrose-based samples were reconsti-
tuted within 10 seconds. Taking the macroscopic appearance into consideration (compare 
Figure 6.25, all samples exhibited a collapsed appearance) the fact that these collapsed 
lyophilizates were readily reconstituted is remarkable and confounds the reports on gen-
erally prolonged reconstitution times, which were attributed to collapsed lyophilizates 
[19].  
   
Figure 6.25: Macroscopic appearance of aggressively freeze-dried sugar-based formulations containing different 
amino acids at a sugar to amino acid ratio of 10:0.5 (upper row sucrose based, lower row trehalose based). For 
comparison suc:phe 10:0.5 (sp5) and tre:phe 10:0.5 (tp0.5) is shown. 
 
Table 6.11: Reconstitution times (n=6) of sugar-based lyophilizates containing amino acids at a ratio of 10:0.5 and 
1 mg/ml mab_T1. 
amino acid sucrose trehalose 
 seconds seconds 
arginine 7 ± 1 18 ± 3 
glycine 9 ± 1 17 ± 2 
histidine 8 ± 1 15 ± 2 
isoleucine 17 ± 3 9 ± 1 
leucine 7 ± 1 10 ± 3 
methionine 7 ± 1 12 ± 3 
tryptophan 8 ± 1 14 ± 2 
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HP-SEC analysis of formulations prior to aggressive freeze-drying, revealed a mono-
mer content of 97.6%. The monomer content of the reconstituted samples was throughout 
comparable to the formulations prior to aggressive freeze-drying (cf. Table 6.12). Also the 
protein recovery of reconstituted samples was calculated. As shown in Table 6.12, no ap-
parent loss of monomer was noticed (overall high monomer recovery of > 98.5%). Alt-
hough trehalose-based samples seem to exhibit minimally less monomer recovery, due 
to overlapping standard deviations, no trend could be derived. Neither the formation of 
high molecular weight species (HMWS) nor loss in monomer could be noticed for the 
aggressively freeze-dried samples. Thus it it concluded that mab_T1 was stabilized 
against aggregation to soluble aggregates by all of the investigated formulations. Obvi-
ously, the excess amount of stabilizing amorphous disaccharide (sucrose or trehalose) 
renders the stabilization of mab_T1 highly effective.  
Table 6.12: Monomer content and recovery of mab_T1 (1 mg/ml) aggressively freeze-dried from sugar-based 
formulations containing amino acids at a ratio of 10:0.5. (n=3). 
 HP-SEC  
amino acid sucrose based trehalose based 
 monomer content monomer recovery monomer content monomer recovery 
 mean  ± SD mean  ± SD mean  ± SD mean  ± SD 
 % % % % 
arginine 97.64 ± 0.06 104.8 ± 4.2 97.56 ± 0.02 103.0 ± 1.8 
glycine 97.79 ± 0.04 100.5 ± 2.8 97.77 ± 0.02 98.8 ± 2.1 
histidine 97.80 ± 0.01 100.5 ± 1.6 97.57 ± 0.02 99.9 ± 1.7 
isoleucine 97.86 ± 0.01 100.8 ± 1.1 97.63 ± 0.01 98.7 ± 1.7 
leucine 97.77 ± 0.01 99.2 ± 1.3 97.63 ± 0.01 98.3 ± 1.3 
methionine 97.75 ± 0.01 98.5 ± 1.4 97.67 ± 0.00 99.5 ± 1.1 
phenylalanine 97.43 ± 0.50 100.8 ± 0.3 97.33 ± 0.55 100.6 ± 1.1 
tryptophan 97.90 ± 0.01 99.2 ± 1.2 97.65 ± 0.01 99.3 ± 1.6 
 
The formulations before freeze-drying exhibited low subvisible particle counts 
(around 2,000 to 3,000 particles ≥ 1 µm per ml) and low turbidity values (around 0.8 
FNU). Analysis of the reconstituted aggressively freeze-dried lyophilizates revealed com-
parably low svp content and turbidity for samples that contain arginine, glycine, histi-
dine, tryptophan, or phenylalanine. No increase was observed for sucrose-based (cf. Fig-
ure 6.26) or trehalose-based (Figure 6.27) samples. On the contrary, the samples contain-
ing isoleucine, leucine, or methionine exhibited an increase in turbidity and/or svp con-
tent, clearly indicating aggregation of mab_T1 in these formulations. The most pro-
nounced increase of aggregates was detected for the samples the contain isoleucine.  
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Figure 6.26: Subvisible particle counts (particles ≥ 1µm) and turbidity of lyophilizates aggressively freeze-dried 
from sucrose-based formulations containing amino acids at a ratio of 10:0.5 (subvisible particle counts before 
freeze-drying ranged around 3,000 particles ≥ 1µm per ml, turbidity values before freeze-drying around 0.8 
FNU). 
 
Figure 6.27: Subvisible particle counts (particles ≥ 1µm) and turbidity of lyophilizates aggressively freeze-dried 
from trehalose-based formulations containing amino acids at a ratio of 10:0.5 (subvisible particle counts before 
freeze-drying ranged around 3,000 particles ≥ 1µm per ml, turbidity values before freeze-drying around 0.8 
FNU). 
Taking the physico-chemical characteristics into consideration, the lyophilizates con-
taining isoleucine, leucine, methionine, or phenylalanine showed a number of character-
istics that differ from the other formulations. For comparison, the physico-chemical and 
integrity data of the trehalose-based samples are summarized in Table 6.13 (overall sim-
ilar trends were observed for sucrose-based samples).  
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Table 6.13: Summary amino acid screening. 
amino acid appear-
ance 
SSA crystallin-
ity 
water 
content 
Tg monomer 
content 
svp turbidity 
  m²/g  % °C % ≥1µm/ml FNU 
arginine collapsed 0.06 amorphous 3.8 57.5 97.6 1161 0.73 
glycine collapsed 0.08 amorphous 2.8 57.3 97.8 1755 0.64 
histidine collapsed 0.08 amorphous 3.5 57.9 97.6 3470 0.73 
isoleucine collapsed 0.17 partly crys-
talline 
0.9 94.7 97.6 9269 2.02 
leucine collapsed 0.13 partly crys-
talline 
0.4 91.1 97.6 3925 1.16 
methionine collapsed 0.15 partly crys-
talline 
1.3 88.3 97.7 5462 1.46 
phenylala-
nine 
collapsed 0.27 amorphous 0.8 94.8 97.3 2759 0.90 
tryptophan collapsed 0.09 amorphous 3.3 61.3 97.7 2114 0.90 
 
The appearance of these lyophilizates exhibited a different collapsed nature (see Fig-
ure 6.25) compared to the lyophilizates containing arginine, glycine, histidine, or trypto-
phan. The collapsed structure is underlined by the low specific surface area of all lyoph-
ilizates. Slightly higher SSA was noticed in the samples that contain isoleucine, leucine, 
methionine, and phenylalanine. As shown by XRD (compare also Figure 5.17), isoleucine, 
leucine and methionine formed crystalline structures (although they are utilized in low 
amounts compared to the amorphous sugar matrix). This increase of SSA is accompanied 
by crystallization of the incorporated amino acids in ile, leu, and met samples. As indi-
cated by an increase of subvisible particles and turbidity, in these partly crystalline sam-
ples the ability to stabilize incorporated mab_T1 was diminished.  
On the contrary, the phenylalanine containing lyophilizates remained fully amor-
phous. Although these samples exhibited a slightly higher SSA (compared to arg, gly, 
his, and trp), an excellent stabilization of mab_T1 was achieved.  
The lyophilizates containing arg, gly, his, and trp showed an excellent stabilization 
during aggressive freeze-drying, too. However, these amino acids had no (decreasing) 
effect on the high residual water content of aggressively freeze-dried lyophilizates. 
Hence, the glass transition temperatures were considerably lower. Due to the high water 
content and low Tg, a successful stabilization during storage is questionable. Neverthe-
less, it was shown that admixing non-crystallizing amino acids to formulations intended 
for aggressive freeze-drying did not cause instability of an embedded protein.  
In summary, only phenylalanine at low concentrations was able to decrease the 
water content of sugar-based lyophilizates, remain fully amorphous, and successfully 
stabilized embedded mab_T1. 
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4. SOLID CONTENT OF THE FORMULATION 
Most of the formulations investigated in this work were designed to contain a solid 
content of 50 mg/ml, which is representative for the range of commonly used freeze-dry-
ing formulations. Usually, the solid content is mainly composed of excipients (cryo-/ ly-
oprotectant, bulking agent).  However, depending on the requirements regarding the sta-
bility of the incorporated molecule of interest, a range of different solid contents are re-
ported for freeze-dried products [18].  
The effect of different solid contents on the resulting physico-chemical characteristics 
of lyophilizates from aggressive freeze-drying was already outlined in CHAPTER 5 (page 
131 pp.). To address additionally the influence of different solid contents on the ability to 
stabilize an incorporated protein, a set of formulations of solid contents bracketing the 
usual range of solid contents for sugar-based formulations (25 mg/ml and 150 mg/ml) 
was aggressively freeze-dried.  
The utilized formulations contain a disaccharide and phenylalanine (at a ratio of 
10:0.5). In other studies it was shown that at a solid content of 50 mg/ml the resulting in 
lyophilizates provide excellent preservation of protein stability (compare section 3.2.1). 
Since sucrose and trehalose are the most often used disaccharides in freeze-drying for-
mulations [18], both were employed. The formulations used for this study can be found 
in Table 6.14. 1 ml aliquots of the respective formulations were filled in 2R vials and sub-
jected to the aggressive freeze-drying protocol shown in Table 3.4 (page 55, Table 3.5) in 
a FTS LyostarIII freeze-drier. The resulting lyophilizates were analyzed regarding the 
ability to prevent aggregation of mab_T1 during aggressive freeze-drying.  
Table 6.14: Formulations to characterize the ability of aggressively freeze-dried formulations of different solid 
contents to stabilize incorporated mab_T1 (formulations were prepared in 10 mM potassium phosphate buffer, 
pH 6.4 ). 
formulation mab_T1 sucrose trehalose phenylalanine excipient con-
tent without 
buffer 
 mg/ml mg/ml mg/ml mg/ml mg/ml 
suc:phe_25 1 23.81  1.19 25 
suc:phe_150 1 142.86  7.14 150 
tre:phe_25 1  23.81 1.19 25 
tre:phe_150 1  142.86 7.14 150 
 
Although the samples exhibited a collapsed appearance (cf. Figure 6.28), they readily 
rehydrate and were fully reconstituted within less than 30 seconds. The time of reconsti-
tution is depicted in Table 6.15. Compared to the sucrose-based lyophilizates, which were 
reconstituted in less than 10 seconds, the trehalose-based samples showed slightly slower 
reconstitution. However, the influence of the sugar or the solid content on the reconsti-
tution time is regarded as negligible since the differences for the samples are in a narrow 
frame. 
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Figure 6.28: Macroscopic appearance of formulations of different solid contents of the formulation (solid content 
in mg/ml showed as numbers on the vial). Formulations contain either no bulking agent (left) or phenylalanine 
at a sugar to phenylalanine weight-to-weight ratio of 10:0.5 (right). 
Table 6.15: Reconstitution times (n=6) of sugar-based lyophilizates of low and high solid content (the formula-
tions contain a low amount of phenylalanine and 1 mg/ml mab_T1). 
formulation reconstitution time 
 seconds 
suc:phe_25 7 ± 1 
suc:phe_150 7 ± 1 
tre:phe_25 27 ± 3 
tre:phe_150 17 ± 3 
 
To account for soluble aggregates, the reconstituted samples were analyzed by HP-
SEC and compared to the formulations before aggressive freeze-drying. In all samples, 
three different species could be determined from the HP-SEC chromatograms. In the 
samples prior to freeze-drying, besides the dominant monomer peak (around 97.8%), also 
minor fractions of high molecular weight species (HMWS, around 1.6%) and low molec-
ular weight species (LMWS, around 0.6%) were detected. Figure 6.29 shows the monomer 
content of the formulations before and after freeze-drying.  
 
Figure 6.29: Monomer content of mab_T1 (1 mg/ml, n=3) in sugar-based lyophilizates of low and high solid con-
tent (the formulations contain a low amount of phenylalanine). 
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No considerable decrease of monomer was noticed. Thus, independent from sugar 
and solid content, the formulations were able to prevent formation of soluble aggregates 
(and fragments) of mab_T1. 
Figure 6.30 displays the monomer recovery. Both sucrose-based formulations showed 
a complete recovery of monomer (> 99%) independent from solid content. The trehalose-
based lyophilizates exhibited a slightly lower monomer recovery of > 90%. The samples 
of low solid content exhibited slightly lower monomer recovery. Since no formation of 
HMWS was detectable, the decrease in monomer is attributed to aggregation towards 
non-soluble aggregates. Hence, the concentration of subvisible particles (svp) and the 
turbidity was assessed.  
 
Figure 6.30: Monomer recovery of mab_T1 (n=3) in sugar-based lyophilizates of low and high solid content (the 
formulations contain a low amount of phenylalanine). 
 
Figure 6.31: Subvisible particle counts (particles ≥ 1µm) and turbidity of aggressively freeze-dried samples of 
low and high solid content containing 1 mg/ml mab_T1 (the turbidity of the formulations before freeze-drying 
ranged around 0.6 FNU). 
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The svp concentration was assessed by light obscuration. In addition, turbidity of re-
constituted samples was determined by static light scatting at 90°. Figure 6.31 depicts the 
svp concentrations of particles ≥ 1 µm per ml and the turbidity. The amount of particles 
of ≥ 10 µm and ≥ 25 µm are listed in Table 6.16.  
Compared to the formulations before freeze-drying, all of the reconstituted lyophi-
lizates exhibited an increase of the svp content. The samples of high solid content (150 
mg/ml) showed only a minor increase, which can be attributed to the lab environment. A 
more pronounced increase was observed for the lyophilizates of low solid content 
(25 mg/ml). Obviously, in these samples non-soluble aggregates of mab_T1 were formed 
due to insufficient stabilization. In contrast to the investigations on the influence of bulk-
ing agent on the stability of mab_T1 in aggressively freeze-dried lyophilizates (see section 
3.1.2, page 156 pp.), no increase of turbidity was detected in any of the samples (cf. Figure 
6.31). 
Table 6.16: Subvisible particle counts (particles ≥ 10 µm and ≥ 25 µm) of aggressively freeze-dried samples of 
low and high solid content containing 1 mg/ml mab_T1. 
formulation subvisible particles (#/ml) 
 before freeze-drying after freeze-drying 
 ≥ 10 µm ≥ 25 µm ≥ 10 µm ≥ 25 µm 
suc:phe_25 8 ± 8 2 ± 4 137 ± 21 17 ± 4 
suc:phe_150 16 ± 5 2 ± 0 47 ± 8 1 ± 1 
tre:phe_25 14 ± 8 3 ± 3 129 ± 20 12 ± 6 
tre:phe_150 6 ± 4 2 ± 2 46 ± 12 7 ± 2 
 
 
Summing up the findings concerning the influence of solid content of aggressively 
freeze-dried sugar-based formulations that contain phenylalanine (at a ratio of 10:0.5), 
lyophilizates of high solid content (150 mg/ml) were able to prevent aggregation of 
mab_T1 during aggressive freeze-drying. For a low solid content (25 mg/ml) mab_T1 was 
slightly less successful protected against aggregation. Overall, no difference between su-
crose and trehalose-based samples was observed.  
Considering the physico-chemical data (cf. Table 6.17, for details see section 5 of 
CHAPTER 5, page 131 pp.), the worse stabilization in lyophilizates of low solid content 
can be attributed to the larger specific surface area. Samples of 25 mg/ml exhibited a SSA 
of 0.34 m²/g, while for 150 mg/ml a SSA of 0.10 m²/g was determined.  
Based on the stability data for samples of 50 mg/ml and the comparable physico-
chemical characteristics of lyophilizates of solid contents between 50 and 150 mg/ml, a 
good storage stability is probable for tre:phe 10:0.5 formulations of ≥ 50 mg/ml solid con-
tent. 
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Table 6.17: Overview of physico-chemical characteristics of aggressively freeze-dried samples of low and high 
solid content containing 1 mg/ml mab_T1. 
formulation appearance SSA water content Tg crystallinity 
  m²/g % °C  
suc:phe_25 collapsed 0.24 0.91 ± 0.04 62.4 ± 0.6 amorphous 
suc:phe_150 collapsed 0.07 2.90 ± 0.15 48.8 ± 0.1 amorphous 
tre:phe_25 collapsed 0.34 0.93 ± 0.09 94.3 ± 0.2 amorphous 
tre:phe_150 collapsed 0.10 1.10 ± 0.12 76.8 ± 0.7 amorphous 
 
5. PROTEIN CONCENTRATION 
In order to get an insight, whether aggressive freeze-drying is applicable to protein 
formulations of higher protein concentration, selected formulations containing 10 mg/ml 
mab_T1 were aggressively freeze-dried. Either sucrose or trehalose was utilized as major 
excipient. Additionally, two sugar-based formulations that contain a low amount of phe-
nylalanine were selected. The utilized formulations are depicted in Table 6.18.  
For successful stabilization, a certain stabilizer to protein ratio is necessary [42]. It was 
shown above that for aggressive freeze-drying a sugar to protein ratio of 50 to 1 per-
formed well in protecting mab_T1. It was decided, to maintain the concentration of the 
excipients at 50 mg/ml, which consequently resulted in a reduction of the sugar to protein 
ratio of 5 to 1, which is recommended as lowest advisable ratio for stabilization[42].  
1 ml aliquots of the respective formulations were filled in 2R vials and subjected to 
the aggressive freeze-drying protocol shown in Table 3.4 (page 55 Table 3.5) in a FTS 
LyostarIII freeze-drier. The resulting lyophilizates were analyzed with regard to aggre-
gation of mab_T1. Soluble aggregates were assessed using HP-SEC, non-soluble aggre-
gates were evaluated utilizing subvisible particle detection by light obscuration and tur-
bidity by static light scattering. Additionally, the reconstitution time was monitored.  
Table 6.18: Formulations to characterize the ability to stabilize mab_T1 at protein concentration of 10 mg/ml dur-
ing aggressively freeze-drying (formulations were prepared in 10 mM potassium phosphate buffer, pH 6.4 ). 
formulation mab_T1 sucrose trehalose phenylalanine 
 mg/ml mg/ml mg/ml  mg/ml 
suc 10 50   
suc:phe 10 47.62  2.38 
tre 10  50  
tre:phe 10  47.62 2.38 
 
Despite the collapsed appearance (cf. Figure 6.32), the lyophilizates dissolved fast and 
were completely reconstituted with ≤ 20 seconds. Table 6.19 displays the reconstitution 
times of the samples. No apparent difference was noticed for the different formulations. 
Neither the type of disaccharide nor the addition of phenylalanine in low concentration 
imposed an influence on the reconstitution time.  
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Figure 6.32: Macroscopic appearance of lyophilizates aggressively freeze-dried from sugar based formulations 
containing 1 mg/ml (left picture) or 10 mg/ml (right picture) mab_T1 (suc: sucrose; sp: sucrose:phenylalanine 
10:0.5; tre: trehalose; tp: trehalose:phenylalanine 10:0.5). 
Table 6.19: Reconstitution time of sugar-based aggressively freeze-dried lyophilizates that contain 10mg/ml 
mab_T1 (suc:phe and tre:phe samples contain phenylylanine at a ratio of 10:0.5; n=6).  
formulation reconstitution time 
 seconds 
suc 18 ± 1 
suc:phe 15 ± 1 
tre 19 ± 2 
tre:phe 10 ± 3 
 
The monomer content was assessed by HP-SEC, and the recovery of monomer after 
aggressive freeze-drying was calculated (cf. Figure 6.33).  
 
Figure 6.33: Monomer content and monomer recovery of sugar-based lyophilizates containing 10mg/ml mab_T1 
(suc:phe and tre:phe samples contain phenylalanine at a ratio of 10:0.5; n=3). 
For none of the investigated formulations a decrease in monomer content could be 
determined. No change of high molecular weight species (HMWS, e.g. mab_T1 dimer or 
suc sp tre tp 
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oligomer) and low molecular weight species (LMWS, e.g. mab_T1 fragments) in the re-
constituted freeze-dried samples were observed (data not shown). A monomer recovery 
of around 100% was observed (cf. Figure 6.33). 
 
Figure 6.34: Subvisible particle counts (particles ≥ 1µm) and turbidity of aggressively freeze-dried samples con-
taining 10 mg/ml mab_T1 (suc:phe and tre:phe samples contain phenylalanine at a ratio of 10:0.5; n=3). 
Table 6.20: Subvisible particle counts (particles ≥ 10 µm and ≥ 25 µm) and turbidity of aggressively freeze-dried 
samples containing 10 mg/ml mab_T1 (suc:phe and tre:phe samples contain phenylalanine at a ratio of 10:0.5; 
n=3). 
formulation subvisible particles (#/ml) 
 before freeze-drying after freeze-drying 
 ≥ 10 µm ≥ 25 µm ≥ 10 µm ≥ 25 µm 
sucrose 14 ± 4 1 ± 2 276 ± 23 12 ± 5 
suc:phe 16 ± 13 8 ± 11 104 ± 12 5 ± 2 
trehalose 7 ± 2 1 ± 2 181 ± 18 7 ± 3 
tre:phe 8 ± 3 0 ± 0 148 ± 25 6 ± 4 
 
The svp content and the turbidity of the samples were monitored. Particles of ≥ 1 µm, 
≥ 10 µm, and ≥ 25 µm were investigated. As usual, the formulations were filtered 
(0.22µm PVDF membrane) prior to freeze-drying. Although the formulations were fil-
tered, the comparably high turbidity of the mab_T1 bulk material could not be signifi-
cantly reduced. Obviously, a certain population of the particles causing turbidity exhib-
ited a particle size allowing them to pass the 0.22 µm filter. Figure 6.34 depicts the svp 
content and the turbidity before and after aggressive freeze-drying. The particle content 
of particles ≥ 10 µm and ≥ 25 µm were listed in Table 6.20.  
Summary 
After aggressive freeze-drying, no distinct change of the turbidity values were de-
tected (cf. Figure 6.34). However, an increase of svp concentration, most pronounced for 
particles ≥ 1 µm, was detected for all formulations after aggressive freeze-drying. Nev-
ertheless, samples that showed substantial instability exhibited svp concentrations of 
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100,000 particles ≥1 µm/ml (compare e.g. section 3.2.1, page 165 pp.). Since for lyophi-
lizates at 10 mg/ml protein concentration below 20,000 particles ≥1 µm/ml were detected, 
still a good stabilization of mab_T1 could be achieved. While no difference was noticed 
between the formulations based on trehalose, the formulation applying sucrose as major 
excipient exhibited a slightly higher svp content compared to the sucrose-based formu-
lation containing a low amount of phenylalanine. However, no clear correlation can be 
established between stabilization and physico-chemical characteristics (compare Table 
6.21, details of physico-chemical characteristics see CHAPTER 5, page 141 pp.).  
Table 6.21: Overview of physico-chemical characteristics of aggressively freeze-dried samples containing 
10 mg/ml mab_T1 (suc:phe and tre:phe samples contain phenylalanine at a ratio of 10:0.5; water content and Tg 
n=3). 
formulation appearance SSA water content Tg crystallinity 
  m²/g % °C  
sucrose collapsed 0.01 5.19 ± 0.31 25.6 ± 2.7 amorphous 
suc:phe 10:0.5 collapsed 0.05 2.06 ± 0.10 51.4 ± 1.8 amorphous 
trehalose collapsed 0.03 4.48 ± 0.19 46.7 ± 2.1 amorphous 
tre:phe 10:0.5 collapsed 0.14 1.73 ± 0.15 80.2 ± 1.7 amorphous 
 
Comparing pure sucrose and trehalose lyophilizates, no distinct differences of resid-
ual water content or specific surface area were detected. Adding a low amount of phe-
nylalanine drastically reduced the water content and increased the Tg. Both formulations, 
which contain phenylalanine (suc:phe 10:0.5 vs. tre:phe 10:0.5) showed comparable water 
content and SSA. Hence, in terms of SSA, crystallinity, and water content sucrose-based 
and trehalose-based formulations resulted in comparable (collapsed) lyophilizates.  
Although the sucrose(-based) formulations exhibited a considerably lower glass tran-
sition temperature (Tg) compared to the trehalose(-based) samples, a connection to the 
slightly worse stabilization of mab_T1 in sucrose lyophilizates cannot be plausibly ex-
plained by that fact, since the samples were not stored at temperatures above the Tg.  
Summing up the results regarding the ability of aggressive freeze-drying to stabilize 
a protein at a concentration of 10 mg/ml, it was shown that the utilized model protein 
(mab_T1) could be stabilized against aggregation to soluble aggregates. Four different 
formulations, based on either trehalose or sucrose, have been demonstrated a full preser-
vation of monomer content and showed a complete recovery of monomer after aggres-
sive freeze-drying. Although the detection of subvisible particles revealed an increase of 
particle concentration after aggressive freeze-drying, pronounced aggregation of mab_T1 
to non-soluble aggregates was prevented. Obviously, the amount of mab_T1 monomers 
participating in aggregation to svp is too low to result in a detectable decrease in mono-
mer. Moreover, assuming that a certain (very low) percentage of mab_T1 aggregates dur-
ing freeze-drying, for samples of higher protein concentration, a higher svp concentration 
is expectable. Therefore, aggressive freeze-drying of protein formulations at a sugar to 
protein ratio of 5 to 1 is regarded as feasible.  
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6. SUMMARY AND CONCLUSIONS 
In the present study, the influence of the formulation design on the protein stabiliza-
tion in aggressively freeze-dried lyophilizates was investigated. The recombinant mono-
clonal IgG1 antibody mab_T1, which is sensitive to freezing and drying stresses, was 
used as model protein. For the majority of sensitive molecules, which are intended to be 
stabilized by freeze-drying, using an amorphous excipient is necessary for stabilization. 
Thus, the investigated formulations are based on the most common cryo-/lyo-protectants 
sucrose and trehalose.  
 
As a first step, formulations without bulking agents were studied. Despite the col-
lapsed appearance and rather high water content, the samples of trehalose and sucrose 
(at 50 mg/ml) completely stabilized mab_T1 during aggressive freeze-drying.  
 
It was shown in the previous chapter that adding bulking agents to aggressively 
freeze-dried lyophilizates can improve the physico-chemical characteristics (water con-
tent, Tg). Now, the impact of adding bulking agents on the protein stability was investi-
gated.  
Three bulking agents (mannitol, glycine, or phenylalanine) were added to sucrose- or 
trehalose-based formulations in low and high amounts. Previous test have shown that 
bulking agents allow extremely short aggressive freeze-drying cycles of 12 h (including 
freezing). Hence, the formulations were aggressively freeze-dried utilizing such a short 
protocol. All samples containing a low amount of either bulking agent showed very good 
stabilization of mab_T1. However, neither a low amount of mannitol nor glycine was able 
to reduce the residual water content to a satisfactory degree. On the other hand, the ap-
plication of high amounts of bulking agents successfully decreases the residual water 
content. However, the addition of higher amounts of bulking agent resulted in slightly 
worse stabilization of mab_T1 especially mannitol deteriorated the stability. Most prob-
ably, the high SSA of these lyophilizates imposed substantial stress to the protein. Again, 
the formulations containing a low amount of phenylalanine (tre:phe 10:0.5, suc:phe 
10:0.5) stand out by excellent stabilization and low residual water content.  
Due to their promising qualities, the lyophilizates composed of sucrose/trehalose and 
high amounts of glycine, mannitol, or phenylalanine, were subjected to a storage stability 
study at 30°C and 50°C (and a control at 2-8°C) for up to 6 months. Additionally, lyoph-
ilizates that contain a low amount of phenylalanine were included in this study. As a 
control, moderately freeze-dried samples of the respective formulations were stored at 
identical conditions, too. In contrast to moderately freeze-dried samples, the lyophi-
lizates from aggressive freeze-drying containing glycine or phenylalanine revealed no 
relevant change in any of the physico-chemical characteristics upon storage at 30°C. 
However, storage of sucrose-based mannitol samples revealed physico-chemical insta-
bility by the formation of α-mannitol.  
Regarding the preservation of protein stability, the aggressive freeze-dried samples 
exhibited better stabilization of mab_T1 during 6 months storage. Sugar-based formula-
tions with glycine and phenylalanine exhibited sound stabilization of mab_T1. Lyophi-
lizates that contain mannitol exhibited worst stabilization, even if stored at 2-8°C. In gen-
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eral, the sucrose-based lyophilizates with glycine and phenylalanine showed good stabi-
lization of mab_T1, if stored not higher than 30°C. At 50 °C storage, also these samples 
showed some aggregation after 6 months. In contrast, even if stored at 50°C, mab_T1 was 
well stabilized for 6 months by the trehalose-based formulations containing glycine or 
phenylalanine. Especially the formulations that contain a low amount of phenylalanine 
(tre:phe 10:0.5) completely prevented aggregation of mab_T1. The superior stabiliza-
tion in theses samples is ascribed to the unique physico-chemical properties: Fully 
amorphous structure despite adding phenylalanine, low SSA due to collapse during 
aggressive freeze-drying and low water content / high glass transition temperature de-
spite the collapsed appearance.  
 
Based on the remarkable stability achieved by the addition of low amounts of phenyl-
alanine to collapsed sugar-based lyophilizates, other amino acids were evaluated, too. 
Arginine, glycine, histidine, isoleucine, leucine, methionine, or tryptophan were added 
to sucrose- or trehalose-based formulations and aggressively freeze-dried. As shown in 
CHAPTER 5, isoleucine, leucine, and methionine are able to reduce the residual water 
content due to crystallization and increase of SSA. Now, the evaluation of the ability to 
protect mab_T1 against aggregation revealed increased aggregation in the formulations 
that contain isoleucine, leucine, or methionine. It is concluded that the increased SSA, 
due to crystallization of the amino acids, diminishes the ability to stabilize incorporated 
mab_T1 in aggressive freeze-dried lyophilizates. The other amino acids which were used 
(arg, gly, his, trp) exhibited good stabilization of mab_T1, however did no show an im-
provement of water content and Tg compared to pure sugar lyophilizates. Thus, phenyl-
alanine stands out by combining suitable physico-chemical properties and excellent pro-
tein stabilization upon combination with trehalose or sucrose. 
 
In a further study, the effect of low or high solid content on the ability to stabilize 
mab_T1 was investigated. Since suc:phe 10:0.5 and tre:phe 10:0.5 have shown superior 
stabilization, the solid content of these formulation was varied from 25 mg/ml to 
150 mg/ml. While for samples of ≥ 50 mg/ml aggregation of mab_T1 was prevented, 
slightly less successful stabilization was observed for low solid contents (25 mg/ml). 
Worse stabilization can be attributed to larger SSA of latter samples. 
A supplementary investigation aimed to evaluate the capability to stabilize mab_T1 
at 10 mg/ml. Besides sucrose and trehalose, also suc:phe 10:0.5 and tre:phe 10:0.5 were 
utilized at 50 mg/ml excipient concentration. Although especially the lyophilizates from 
sucrose and trehalose showed rather high water content, mab_T1 was effectively pro-
tected. As already observed for formulations of 1 mg/ml mab_T1 concentration, adding 
phenylalanine considerably decreased the water content without increasing the SSA. This 
phenomenon was observed for a protein concentration of 10 mg/ml, too. The sugar-based 
lyophilizates containing phenylalanine revealed excellent stabilization. Therefore, it is 
concluded that proteins can be stabilized by aggressive freeze-drying also at concentra-
tions at least up to 10 mg/ml. 
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CHAPTER 7 APPLICABILITY OF AGGRESSIVE FREEZE-DRYING FOR 
STABILIZATION OF VARIOUS PROTEINS 
1. INTRODUCTION 
The systematical investigations of Schersch e.t al concerning the influence of collapse 
of lyophilizates on the product quality has shown that even sensitive model proteins are 
not affected by collapse during freeze-drying [1]. Furthermore, the same authors showed 
that collapsed lyophilizates exhibited an admirable stability during storage at accelerated 
conditions (i.e. elevated temperatures) and even have advantage over conventionally 
freeze-dried lyophilizates of comparable residual water level upon storage [2, 3]. How-
ever, due to the collapsed nature, and therefore drastic reduced specific surface area of 
the lyophilizates, secondary drying mechanisms are slowed down dramatically [4], re-
sulting in the necessity to keep the collapsed samples prolonged times at high tempera-
tures to achieve acceptable residual water level [1]. This fact holds true especially for ly-
ophilizates “collapse-dried” from freeze-drying formulations that contain disaccharides 
like sucrose or trehalose without further excipients like bulking agents. Supporting the 
findings of Schersch et al [1] in chapter 5 of this thesis was shown, that the addition of 
substantial amounts of bulking agents like mannitol or glycine prevents the occurrence 
of macroscopic collapse even if aggressive protocols are utilized to freeze-dry the sam-
ples. Phenylalanine has turned out as high potential bulking agent especially for aggres-
sively freeze-dried lyophilizates containing a model antibody (mab_T1). Finally, it was 
shown that aggressive freeze-drying resulted in lyophilizates of excellent stabilization 
properties. Although major stabilization concepts of freeze-drying, namely water re-
placement [5-8] and vitrification [9-11], are considered as aunique concept to stabilize 
embedded proteins, the considerable number of different freeze-dried formulations [12] 
emphasizes (slightly) different requirements for stabilization of different molecules / pro-
teins. Hence, it is of substantial interest to evaluate, whether promising results obtained 
from aggressive freeze-drying of the model antibody mab_T1 can be extended to other 
proteins. In order to explore the potential of aggressive freeze-drying to be no longer an 
unwanted aberration during freeze-drying, but become a suitable alternative to conven-
tional freeze-drying, a number of further proteins were included in sugar based formu-
lations and subjected to aggressive freeze-drying. Besides a second recombinant mono-
clonal IgG antibody (mab_T2), a recombinant human granulocyte colony-stimulating fac-
tor (GCSF) was studied. Furthermore, L-lactic dehydrogenase was used as supplemen-
tary model protein due to its well-documented susceptibility to freeze-drying stresses 
[13-24]. 
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2. MAB_T2 
As shown in CHAPTER 5, aggressive freeze-drying of sucrose- and treahalose-based 
formulations containing no bulking agent resulted in high residual water contents (com-
pare page 109). The addition of a certain amount of bulking agent reduced the residual 
water content of the resulting lyophilizates dramatically (see page 113). In CHAPTER 6 
it was shown that formulations of sucrose and trehalose, that contain a low amount of 
phenylalanine, provided excellent stabilization of mab_T1 successful during aggressive 
freeze-drying and storage. Other bulking agents (mannitol, glycine) exhibited less suc-
cessful stabilization. Larger specific surface area in combination with crystallization of 
the bulking agents has turned out as major cause for instability of mab_T1. For the actual 
study, the investigated formulations contained polysorbate 20 to account for surface 
stress. Mab_T2 was chosen as model protein, which was aggressively freeze-dried in for-
mulations with and without bulking agents (cf. Table 7.1). Mannitol, glycine, or phenyl-
alanine were utilized at a low or high sugar (sucrose or trehalose) to bulking agent 
weight-to-weight ratio.   
Aliquots of 1ml of the formulations were filled into DIN 2R glass vials (type 1) and 
aggressively freeze-dried according to the protocol shown in Table 3.5 (page 56) in a Mar-
tin Christ 2-12D freeze-drier. The focus of the investigation was set on the influence of 
formulation composition on the stability of incorporated mab_T2 in aggressively freeze-
dried lyophilizates. Aggregation of mab_T2 was characterized by subvisible particle 
counts, turbidity, and HP-SEC. In addition, the secondary structure of selected reconsti-
tuted samples was monitored via FT-IR. 
Table 7.1: Formulations to evaluate the ability to stabilize mab_T2 during aggressive freeze-drying (formula-
tions based on 10 mM sodium citrate buffer pH 5.4). 
formulation mab_T2 sucrose trehalose mannitol glycine phenylala-
nine 
polysorb-
ate 20 
 mg/ml mg/ml mg/ml mg/ml mg/ml mg/ml % 
suc 1 50.00     0.004 
suc:man 10:3 1 38.46  11.54   0.004 
suc:man 10:30 1 12.50  37.50   0.004 
suc:gly 10:3 1 38.46   11.54  0.004 
suc:gly 10:30 1 12.50   37.50  0.004 
suc:phe 10:0.5 1 47.62    2.38 0.004 
suc:phe 10:3 1 38.46    11.54 0.004 
tre 1  50.00    0.004 
tre:man 10:3 1  38.46 11.54   0.004 
tre:man 10:30 1  12.50 37.50   0.004 
tre:gly 10:3 1  38.46  11.54  0.004 
tre:gly 10:30 1  12.50  37.50  0.004 
tre:phe 10:0.5 1  47.62   2.38 0.004 
tre:phe 10:3 1  38.46   11.54 0.004 
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As expected, the lyophilizates containing no or a low amount of bulking agent 
showed a collapsed appearance (see appendix, Figure 9.3). The samples that contain a 
high amount of bulking agent showed an elegant cake appearance. All lyophilizates read-
ily rehydrated within one minute (cf. Table 7.2). 
Table 7.2: Reconstitution time of aggressively freeze-dried lyophilizates containing 1 mg/ml mab_T2 and differ-
ent amounts of bulking agents (n=3). 
formulation  reconstitution time 
 sucrose trehalose 
 seconds seconds 
sugar 16 ± 1 37 ± 3 
sugar:man 10:3 35 ± 6 26 ± 3 
sugar:man 10:30 13 ± 1 13 ± 2 
sugar:gly 10:3 17 ± 2 16 ± 1 
sugar:gly 10:30 10 ± 0 16 ± 4 
sugar:phe 10:0.5 48 ± 8 32 ± 2 
sugar:phe 10:3 35 ± 2 27 ± 3 
 
The results of the size exclusion chromatography are summarized in Figure 7.1. In the 
formulations before freeze-drying low amounts of HMWS (≤ 0.4%) were observed. After 
aggressive freeze-drying, a low, but significant increase of aggregates was observed for 
the samples that contain a high amount of mannitol. These samples also exhibited a de-
creased monomer recovery. Besides the tre:man 10:3 lyophilizates, all collapsed samples 
revealed no increase of HMWS or decrease of monomer recovery. Also the elegant sam-
ples containing a high amount of glycine or phenylalanine showed good stabilization of 
mab_T2. 
 
Figure 7.1: HMWS and monomer recovery of mab_T2 determined by HP-SEC of formulations containing bulk-
ing agent in different quantities. The results of samples analyzed before and after aggressive freeze-drying are 
shown (collapsed samples are marked by an asterisk). 
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The subvisible particle count (particles ≥ 1µm/ml) and turbidity values of all lyophi-
lizates revealed no increase after aggressive freeze-drying (cf. Figure 7.2). Collapsed and 
non-collapsed samples completely prevented the formation of non-soluble aggregates of 
mab_T2.  
 
    
Figure 7.2: Subvisible particles ≥ 1µm/ml and turbidity of formulations containing 1 mg/ml mab_T2 and bulking 
agent in different quantities. The results of samples analyzed before and after aggressive freeze-drying are shown 
(A: sucrose-based samples, B: trehalose-based samples; bars represent svp, squares and triangles represent tur-
bidity; collapsed samples are marked by an asterisk). 
The secondary structure of mab_T2 was analyzed utilizing the 2nd derivative FT-IR 
spectra of reconstituted samples. The optical assessment of the spectra does not allow for 
quantitative comparison (exemplary suc:phe and tre:phe spectra see Figure 7.3). Hence, 
the overlap of spectra was calculated as described by Prestrelski et al. [25] and expressed 
by a correlation coefficient (a correlation coefficient of 1 represents complete overlap, for 
a correlation coefficient of 0.985 optically still a good overlap of spectra was observed). 
Overall, high correlation coefficients of ≥ 0.985 were determined for aggressively freeze-
dried samples (cf. Figure 7.4). Sucrose-based samples revealed slightly better correlation 
of the spectra than trehalose-based ones. Apparently, the secondary structure of mab_T2 
was slightly changed after aggressive freeze-drying in most of the trehalose-based lyoph-
ilizates. Only the samples that contain a low amount of phenylalanine (tre:phe 10:0.5) 
exhibited a high correlation coefficient of ≥ 0.995 indicating no change.  
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Figure 7.3: 2nd derivative FT-IR spectra (amide I band) before and after aggressive freeze-drying. The sugar-
based formulations contain phenylalanine at low and high quantities (A: sucrose-based; B: trehalose-based; for 
comparison the spectrum of a heat stressed mab_T2 sample is shown). 
 
Figure 7.4: Correlation coefficient of 2nd derivative FT-IR spectra of aggressively freeze-dried formulations con-
taining 1 mg/ml mab_T2 and bulking agent in different quantities. For calculation of the correlation coefficient, 
spectra derived from reconstituted samples were compared to the respective formulations before freeze-drying 
(corr. coefficient of a heat stressed samples was 0.682).  
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Summarizing, the results determined for the stabilization of mab_T2 in aggressively 
freeze-dried lyophilizates have shown that collapsed samples exhibited better stabiliza-
tion than non-collapsed samples. The non-collapsed samples resulted from formulations 
of high bulking agent content. As already observed for the stabilization of mab_T1 (com-
pare CHAPTER 6), the formation of partly crystalline samples of high SSA reduces the 
ability to protect a protein. The overall slightly worse stabilization of mab_T2 is attributed 
to the same mechanism, too. However, for mab_T2 overall less aggregation compared to 
mab_T1 was noticed. This is ascribed to the presence of polysorbate 20 in all formulations. 
Also for the stabilization of mab_T2, the combination of sucrose/trehalose and a low 
amount of phenylalanine (at a ratio of 10:0.5) revealed superior potential.  
3. GRANULOCYTE COLONY-STIMULATING FACTOR (GCSF) 
In CHAPTER 6 and the section above it was shown that monoclonal antibodies can 
be successfully stabilized by aggressive freeze-drying. To investigate the potential of ag-
gressive freeze-drying also for smaller proteins, Granulocyte Colony-Stimulating Factor 
(GCSF) was used as model. Non-glycosylated GSCF is marketed mainly as liquid formu-
lation (several Filgrastim products), while glycosylated GCSF is available as a freeze-
dried product (Lenograstim in Granocyte®). In Granocyte® GSCF is formulated with ar-
ginine, mannitol, phenylalanine, methionine, and polysorbate 20 [26]. Since sugar-based 
formulations have revealed high potential for excellent stabilization, GCSF was aggres-
sively freeze-dried in the formulations listed in Table 7.3. The formulations were based 
on a 10 mM sodium citrate buffer at pH 4.0. 
Table 7.3: Formulations to evaluate the ability to stabilize GCSF during aggressively freeze-drying (formulations 
based on 10 mM sodium citrate buffer pH 4.0). 
formulation GCSF sucrose trehalose mannitol glycine phenylala-
nine 
polysorb-
ate 20 
 mg/ml mg/ml mg/ml mg/ml mg/ml mg/ml % 
suc 1 50.00     0.004 
suc:man 10:3 1 38.46  11.54   0.004 
suc:man 10:30 1 12.50  37.50   0.004 
suc:gly 10:3 1 38.46   11.54  0.004 
suc:gly 10:30 1 12.50   37.50  0.004 
suc:phe 10:0.5 1 47.62    2.38 0.004 
suc:phe 10:3 1 38.46    11.54 0.004 
tre 1  50.00    0.004 
tre:man 10:3 1  38.46 11.54   0.004 
tre:man 10:30 1  12.50 37.50   0.004 
tre:gly 10:3 1  38.46  11.54  0.004 
tre:gly 10:30 1  12.50  37.50  0.004 
tre:phe 10:0.5 1  47.62   2.38 0.004 
tre:phe 10:3 1  38.46   11.54 0.004 
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Aliquots of 1 ml of the formulations were filled into DIN 2R glass vials (type 1) and 
aggressively freeze-dried according to the protocol shown in Table 3.5 (page 56) in a Mar-
tin Christ 2-12D freeze-drier. The focus of the investigation was set on on the stability of 
incorporated GCSF in aggressively freeze-dried lyophilizates. Aggregation was charac-
terized by subvisible particle counts, turbidity, and HP-SEC. In addition, the secondary 
structure of selected reconstituted samples was monitored via FT-IR.  
For formulations that contain a high amount of bulking agent (suc:man 10:30, 
suc:gly 10:30, suc:phe 10:3, tre:man 10:30, tre:gly 10:30, tre:phe 10:3), aggressive freeze-
drying resulted in non-collapsed lyophilizates, whereas samples with no or a low amount 
of bulking agent showed a collapsed appearance (suc, suc:man 10:3, suc:gly 10:3, 
suc:phe 10:0.5, tre, tre:man 10:3, tre:gly 10:3, tre:phe 10:0.5; pictures see appendix, Figure 
9.5). Nevertheless, all samples were reconstituted within less than one minute (see ap-
pendix for details, Table 9.5).  
Size exclusion chromatography revealed overall low HMWS of less than 1%. How-
ever, the aggressively freeze-dried samples exhibited some increase of HMWS indicating 
aggregation of GSCF. Interestingly, the non-collapsed samples showed a higher content 
of HWMS compared to collapsed samples. Regarding monomer recovery, no relevant 
difference was observed between the samples. However, the monomer recovery of only 
90 - 95% indicates a loss, which is not only reflected in the HMWS.  
 
Figure 7.5: HMWS and monomer recovery of GCSF determined by HP-SEC of formulations containing bulking 
agent in different quantities. The results of samples analyzed before and after aggressive freeze-drying are 
shown (collapsed samples are indicated by an asterisk in the axis annotation, non-collapse samples are marked 
by a triangle in the axis annotation). 
Analyzing the lyophilizates regarding their subvisible particle concentration 
(≥ 1 µm/ml) and turbidity revealed comparably high particle concentration already be-
fore freeze-drying (cf. Figure 7.6). After aggressive freeze-drying, especially the non-col-
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lapsed samples exhibited a considerable increase of svp concentration, indicating aggre-
gation of GCSF. Besides the samples containing a low amount of glycine, the collapsed 
samples showed no increase of svp content. However, the turbidity of most of the col-
lapsed samples was increased. Although the increase of turbidity was less pronounced 
for non-collapsed samples, GCSF was not completely stabilized against aggregation. The 
sucrose-based samples exhibited slightly better stabilization than the trehalose-based 
samples. Best stabilization of GCSF was achieved by the sucrose-based samples contain-
ing a low amount of mannitol or phenylalanine (suc:man 10:3, suc:phe 10:0.5). 
 
Figure 7.6: Subvisible particles ≥ 1µm/ml and turbidity of formulations containing 1 mg/ml GCSF and bulking 
agent in different quantities. The results of samples analyzed before and after aggressive freeze-drying are 
shown (A: sucrose-based samples, B: trehalose-based samples; bars represent svp, squares and triangles repre-
sent turbidity; collapsed samples are indicated by an asterisk in the axis annotation, non-collapse samples are 
marked by a triangle in the axis annotation). 
The secondary structure of GCSF was analyzed by 2nd derivative FT-IR spectra. The 
overlap of spectra was calculated as described by Prestrelski et al. [25] and expressed by 
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a correlation coefficient. A correlation coefficient of 1 would indicate a comparable sec-
ondary structure. For a heat stressed solution of GSCF (at 10 mg/ml), a correlation coeffi-
cient of 0.921 was determined.  
Figure 7.7 displays the correlation coefficients of the analyzed samples (due to infer-
ring spectra, glycine could not be analyzed). The trehalose-based samples showed overall 
high correlation coefficients. Good preservation of secondary structure was determined 
for the collapsed samples without bulking agent or with a low content of phenylalanine. 
Sucrose-based samples exhibited slightly lower correlation coefficients. Especially the ly-
ophilizates containing a low amount of phenylalanine exhibited less successful preserva-
tion of the secondary structure.  
 
Figure 7.7: Correlation coefficient of 2nd derivative FT-IR spectra of aggressively freeze-dried formulations con-
taining 1 mg/ml GCSF and bulking agent in different quantities. For calculation of the correlation coefficient, 
spectra derived from reconstituted samples were compared to the respective formulations before freeze-drying 
(corr. coefficient of a heat stressed samples was 0.921). 
Summarizing, aggressive freeze-drying of sugar-based formulations resulted in ac-
ceptable stabilization of GCSF. Comparing non-collapsed and collapsed samples, the lat-
ter were superior in preventing aggregation. Overall, best stabilization was achieved by 
formulations without a bulking agent (50mg/ml sucrose or trehalose), which had a col-
lapsed structure after aggressive freeze-drying. Also the collapsed tre:phe 10:0.5 lyophi-
lizates revealed good stabilization. Nevertheless, also in collapsed samples, no complete 
stabilization of GCSF was achieved. However, the comparably high subvisible particle 
concentration before freeze-drying indicate a potential instability of GCSF already in the 
initial formulations, which could be caused by a non-ideal buffer system. As this study 
highlighted the potential of collapsed lyophilizates to stabilize GCSF, further investiga-
tions are advised, which take the buffer into consideration. 
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4. L-LACTIC DEHYDROGENASE (LDH) 
During the studies on the stabilization of antibodies during aggressive freeze-drying 
(mab_T1, see CHAPTER 6; mab_T2, see section 2 in this chapter) sugar-based formula-
tions that contain phenylalanine had shown excellent stabilization. Hence, it was conclu-
sive to evaluate the ability of these formulations to stabilize also a further sensitive model. 
L-lactic dehydrogenase (LDH) represents one of the most frequently utilized models to 
evaluate the impact of freeze-drying on protein stability. Although LDH is not a pharma-
ceutical for therapeutic use, it is able to reveal also minor insufficient stabilization during 
freeze-drying [13-24]. As the trehalose-based formulations have shown superior stabili-
zation during storage also at elevated temperatures, these formulations were chosen for 
the actual study (cf. Table 7.4). Phenylalanine was added at a low (10:0.5) and high (10:3) 
weight-to-weight ratio.  
Table 7.4: Formulations to evaluate the ability to stabilize L-lactic dehydrogenase during aggressively freeze-
drying (formulations based on 10 mM sodium phosphate buffer pH 7.5). 
formulation LDH trehalose phenylalanine 
 mg/ml mg/ml mg/ml 
tre:phe 10:0.5 0.75 47.62 2.38 
tre:phe 10:3 0.75 38.46 11.54 
 
To benchmark aggressive freeze-drying to the conventional technique, the same for-
mulations were moderately freeze-dried (using the protocol shown in Table 3.7, page 57; 
chamber pressure 0.04 mbar, shelf temperature primary drying at -40 °C/-20 °C, second-
ary drying at 10 °C). Since the impact of drying time was of interest, two aggressive 
freeze-drying protocols were used. The first protocol applies a hold time of 24 h at 45 °C 
(overall process time 30 h 20 min, for details see Table 3.4, page 55), the second protocol 
operates a hold time of only 6 h at 45 °C (overall process time 12 h 20 min, details in Table 
3.5, page 56). A chamber pressure of 1 mbar is used in both cycles. Aliquots of 1 ml of the 
formulations were filled into DIN 2R glass vials (type 1) and freeze-dried in a FTS LyoStar 
II freeze-drier.  
The samples were analyzed after freeze-drying and subjected to an indicative stability 
study at 50 °C for 6 months (for comparison samples were stored at 2-8 °C, too). Key 
physico-chemical characteristics of the lyophilizates were monitored (water content, 
glass transition temperature, crystallinity, specific surface area). The characterization of 
the protein stability was focused on the aggregation of LDH. The samples were charac-
terized by subvisible particle counts, turbidity, and HMWS (HP-SEC). Additionally, the 
catalytic activity of selected reconstituted samples was monitored via an enzymatic assay. 
 
 
4.1 PHYSICO-CHEMICAL CHARACTERISTICS 
Aggressively freeze-dried samples (by either protocol) containing a low amount of 
phenylalanine (tre:phe 10:0.5) had a collapsed appearance (data not shown, compare e.g. 
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CHAPTER 6, Figure 6.2, page 156). Samples containing a high amount of phenylalanine 
(tre:phe 10:3) exhibited an elegant appearance.  
The residual water content after freeze-drying and after 6 months storage was deter-
mined by Karl-Fischer titration (cf. Figure 7.8). As expected, the collapsed samples 
(tre:phe 10:0.5), aggressively freeze-dried by the short protocol, initially exhibited the 
highest water content. Nevertheless, the water content of 1.1% is considered as suffi-
ciently low as starting point for a storage stability study. The non-collapsed samples 
(tre:ph 10:3) reached water contents of < 0.2% regardless, which protocol was used. As 
expected, after storage over 6 months a (moderate) increase was observed for all samples 
(caused e.g. by diffusion of water through the stopper), which is more pronounced at 
50 °C storage. Only the tre:phe 10:0.5 lyophilizates, aggressively freeze-dried by the short 
protocol, exhibited an apparent decrease, which potentially could be explained by con-
sumption of water due to crystallization of amorphous phenylalanine to phenylalanine 
hydrate. However, neither the DSC thermogram nor the XRD diffraction pattern revealed 
the presence of crystalline phenylalanine hydrate in these samples. Hence, the reason for 
a decrease of water content remained unclear and the data must be considered as an out-
lier. 
    
Figure 7.8: Residual water content after freeze-drying and storage of lyophilizates at 2-8 °C and 50 °C for 6 
months (the trehalose-based formulations contain a low or high amount of phenylalanine and 0.75 mg/ml LDH; 
the sample marked by an asterisk is regarded as aberration). 
Table 7.5 lists the glass transition temperatures (Tg) detected by DSC measurements. 
Collapsed samples (tre:phe 10:0.5) exhibited a high Tg of > 90 °C, non-collapsed samples 
of even > 100 °C. The initially high Tg of collapsed and non-collapsed lyophilizates were 
only slightly decreased after storage (in accordance with the increase of water content). 
Based on the high Tg, good preservation of protein stability is expected. 
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Table 7.5: Glass transition temperatures after freeze-drying and storage of lyophilizates at 2-8 °C and 50 °C for 6 
months (the trehalose-based formulations contain a low or high amount of phenylalanine and 0.75 mg/ml LDH). 
 tre:phe 10:0.5 tre:phe 10:3 
 after FD 26 weeks stored after FD 26 weeks stored 
storage temperature n.a. 2-8°C 50°C n.a. 2-8°C 50°C 
 Tg ± SD [°C] Tg ± SD [°C] Tg ± SD [°C] Tg ± SD [°C] Tg ± SD [°C] Tg ± SD [°C] 
moderate 116.0 ± 0.9 100.6 ± 0.6 96.0 ± 1.9 113.4 ± 1.1 104.2 ± 1.0 98.7 ± 0.3 
aggressive 114.7 ± 0.2 112.4 ± 0.3 100.4 ± 1.0 116.5 ± 1.3 106.1 ± 1.2 92.9 ± 1.0 
short aggressive 90.1 ± 5.9 103.1 ± 0.4 87.1 ± 2.0 114.3 ± 4.2 104.4 ± 7.8 99.2 ± 1.2 
n.a. not applicable 
 
Analysis of the crystallinity (by XRD) after freeze-drying revealed fully amorphous 
structure of all tre:phe 10:0.5 lyophilizates (cf. Figure 7.9 A). Figure 7.9 depicts the diffrac-
tion pattern after storing the lyophilizates for 6 months at 2-8 °C or 50 °C. Both, the non-
collapsed samples from moderate freeze-drying and the collapsed samples from the ag-
gressive cycles retained their fully amorphous structure (cf. Figure 7.9 C).  
   
   
Figure 7.9: Diffraction patterns (by XRD) of moderately or aggressively freeze-dried lyophilizates. Samples after 
freeze-drying (A, B) and storage at 2-8 °C or 50 °C for 6 months (C, D) are shown. The trehalose-based formula-
tions contain a low (tre:phe 10:0.5) or high (tre:phe 10:3) amount of phenylalanine and 0.75 mg/ml LDH (the 
peak at 38.8° 2-theta results from the copper sample holder). 
C D 
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All of the samples containing a high amount of phenylalanine exhibited a partly crys-
talline structure after freeze-drying (cf. Figure 7.9 B).  
The diffraction pattern that was identified as crystalline L-phenylalanine hydrate us-
ing reference spectra of the International Centre for Diffraction Data (ICDD) database 
(characteristic peaks at 6.4°, 14.7°, 17.4°, and 21.3° 2-theta; cf. Figure 7.9 D). Also for these 
lyophilizates, no change (e.g. recrystallization) was observed throughout storage over 6 
months.  
 
The specific surface area (SSA) of the lyophilizates was determined by krypton gas 
adsorption (according to Brunauer-Emmett-Teller, BET). As expected, the tre:phe 10:0.5 
samples, which were aggressively freeze-dried and exhibited a collapsed appearance, 
showed a drastically reduced SSA compared to non-collapsed moderately freeze-dried 
samples (cf. Figure 7.10 A). No change was noticed after storing samples at 2-8 °C or 50 °C 
for 6 months. Hence, no (further) collapse occurred during storage.  
Comparing samples of low phenylalanine content to samples of high phenylalanine 
content, latter samples showed higher SSA without exception (cf. Figure 7.10 A vs. B). 
Although all tre:phe 10:3 samples (moderate/aggressive/short aggressive) exhibited a 
comparable macroscopic appearance, a reduced SSA was noticed for the aggressively 
freeze-dried samples (cf. Figure 7.10 B). Obviously, aggressive freeze-drying resulted in 
micro-collapse, which is macroscopically not observable. Comparing samples of the ag-
gressive and short aggressive cycle, slightly lower SSA was noticed for former samples. 
As the aggressive cycle utilized a hold time of 24 h at 45 °C (compared to 6 h in the short 
cycle), ongoing micro-collapse would offer a reasonable explanation. On the other hand, 
after storing the samples for 6 months, a comparable SSA was observed for both species. 
 
Figure 7.10: Specific surface area of lyophilizates after freeze-drying and storage of lyophilizates at 2-8 °C and 
50 °C for 6 months (the trehalose-based formulations contain a low or high amount of phenylalanine and 
0.75 mg/ml LDH). 
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4.2 PROTEIN STABILITY 
HP-SEC was utilized to assess high molecular weight species (HWMS) of LDH in 
samples after freeze-drying and storage (cf. Figure 7.11). Before freeze-drying a HWMS 
content of 0.6 ± 0.09% (tre:phe 10:0.5) and 0.90 ± 0.01% (tre:phe 10:3) was determined. 
Independent from drying cycle (moderate, aggressive, short aggressive), a minor increase 
was noticed for the tre:phe 10:0.5 samples after freeze-drying. No increase was detected 
for tre:phe 10:3 samples.  
After storing the samples for 6 months only a minimal increase was observed all sam-
ples of the three different cycles, even in case the samples were stored at 50 °C. No dif-
ference was noticed between collapsed and non-collapsed samples. Obviously, also in 
collapsed lyophilizates, which were generated by aggressive freeze-drying of the 
tre:phe 10:0.5 formulation, good stabilization of LDH against aggregation to HMWS was 
achieved.  
 
 
Figure 7.11: HP-SEC high molecular weight species of LDH in lyophilizates after freeze-drying and storage at 
2-8 °C and 50 °C for 6 months(the trehalose-based formulations contain a low (A) or high amount (B) of phenyl-
alanine and 0.75 mg/ml LDH; before freeze-drying a HWMS content of 0.6 ± 0.09% (tre:phe 10:0.5) and 
0.90 ± 0.01% (tre:phe 10:3) was determined; initially collapsed samples are marked by an asterisk). 
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The concentration of subvisible particles, which represents non-soluble LDH aggre-
gates, was assessed by light obscuration (cf. Figure 7.12). Before freeze-drying concentra-
tions of ≤ 2000 particles ≥ 1 µm/ml were detected for both formulations.  
After freeze-drying for all samples containing a high amount of phenylalanine a dras-
tic increase of svp was observed (cf. Figure 7.12 B). Moderate and aggressive freeze-dry-
ing resulted in pronounced aggregation in these non-collapsed samples. During storage 
at 2-8 °C or 50 °C, no further increase of the svp concentration ≥ 1 µm was observed. In 
contrast, the svp of ≥ 10 µm and ≥ 25 µm exhibited a considerable increase during storage 
(see appendix, Table 9.7) indicating ongoing aggregation toward larger aggregates. 
The lyophilizates that contain a low amount of phenylalanine showed a two-sided 
result (cf. Figure 7.12 A): While the moderately freeze-dried (non-collapsed) samples also 
exhibited severe aggregation, the aggressively freeze-dried (collapsed) samples showed 
no substantial increase. Apparently, in the collapsed samples aggregation during 
freeze-drying was prevented. During storage, the collapsed lyophilizates showed a mi-
nor increase of svp concentration, which is slightly more pronounced for 50 °C storage 
temperature. Comparing lyophilizates of the two aggressive cycles, upon storage at 50 °C 
samples of the short cycle showed a slightly higher svp concentration after 6 months. 
However, a svp concentration < 30,000 particles ≥ 1 µm/ml is regarded as suitable level 
for samples stored at 50°C. Regarding svp of ≥ 10 µm and ≥ 25 µm  a comparable, slight 
increase was noticed for samples of both cycles (see appendix, Table 9.6).  
 
The trends concerning aggregation to non-soluble aggregates were underlined by the 
turbidity of reconstituted samples (see Figure 9.7 in the appendix for details). After 
freeze-drying, non-collapsed samples, regardless whether produced by moderate freeze-
drying of tre:phe 10:0.5 or aggressive/moderate freeze-drying of tre:phe 10:3, exhibited 
an increase of turbidity from < 1 FNU to > 5 FNU. For the collapsed tre:phe 10:0.5 lyoph-
ilizates no change of turbidity was observed after aggressive freeze-drying.  
After storage of the samples for 6 months, moderately freeze-dried samples exhibited 
no further increase of the turbidity (i.e. no further aggregation occurred). In contrast, the 
aggressively freeze-dried tre:phe 10:3 samples revealed a further increase of turbidity, 
more pronounced in case stored at 50 °C. Obviously, the aggressive conditions during 
drying fostered further aggregation of LDH in non-collapsed lyophilizates during stor-
age. On the other hand, tre:phe 10:0.5 samples showed no increase after storage of 6 
months at 50°C, underlining the conclusion that aggregation of LDH was prevented in 
these collapsed lyophilizates.  
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Figure 7.12: Subvisible particle (svp) concentration of LDH in lyophilizates after freeze-drying and storage at 
2-8 °C and 50 °C for 6 months(the trehalose-based formulations contain a low (A) or high amount (B) of phenyl-
alanine and 0.75 mg/ml LDH; initially collapsed samples are marked by an asterisk). 
The enzymatic activity of LDH was tested before and after freeze-drying, and after 
storing samples for 6 months at 2-8 °C or 50 °C (cf. Figure 7.13). Despite their collapsed 
structure, aggressively freeze-dried tre:phe 10:0.5 samples showed comparable recovery 
of activity to non-collapsed samples. The collapsed lyophilizates produced by the short 
cycle exhibited a slightly lower recovery. However, analysis at the end of the storage 
study of 6 months revealed > 90% recovery of activity for the latter samples. Hence, ap-
parently lower activity after freeze-drying is ascribed to an experimental aberration in 
the enzymatic assay. Overall, excellent preservation of LDH activity was noticed for 
collapsed tre:phe 10:0.5 samples stored at 50 °C for 6 months. 
Although the high svp concentration of non-collapsed samples indicates instability of 
LDH, the enzymatic activity was not affected. The tre:phe 10:3 samples from moderate 
and aggressive freeze-drying revealed > 90% recovery of activity at the end of the storage 
study at 50°C. Also the non-collapsed lyophilizates were able to preserve LDH activity. 
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Figure 7.13: Enzymatic activity of LDH in lyophilizates after freeze-drying and storage at 2-8 °C and 50 °C for 6 
months(the trehalose-based formulations contain a low (A) or high amount (B) of phenylalanine and 0.75 mg/ml 
LDH; initially collapsed samples are marked by an asterisk). 
The data outlined above have shown superior stabilization of LDH in aggressively 
freeze-dried lyophilizates, which collapsed during drying. These lyophilizates were gen-
erated from a trehalose-based formulation that contained a low amount of phenylalanine 
(tre:phe 10:0.5). Most remarkably, the collapsed samples showed excellent preservation 
of LDH stability even after 6 months at 50°C. Lyophilizates of non-collapsed appearance, 
regardless whether produced by moderate freeze-drying of tre:phe 10:0.5 or moder-
ate/aggressive freeze-drying of the formulation with high phenylalanine content 
(tre:phe 10:3), revealed less successful stabilization especially against aggregation.  
Comparing the results from protein stability and physico-chemical evaluation of the 
lyophilizates produced by either moderate or aggressive freeze-drying, no correlation 
was found between residual water content and protein stability. Usually, higher water 
content is regarded as inferior for protein stabilization [27]. However, the collapsed sam-
ples from aggressive freeze-drying, which exhibited higher water contents (compare Fig-
ure 7.8), did not show inferior but superior stabilization of LDH. Also very low water 
content would be a conceivable scenario for worse stabilization [28, 29]. However, the 
aggressively freeze-dried tre:phe 10:0.5 samples, which exhibited a lower water content 
than the moderately freeze-dried ones, showed better stabilization. Hence, it is concluded 
that water content did not play the major role for the differences observed in protein 
stabilization. No correlation between glass transition temperatures and stability was ob-
servable, too. 
All lyophilizates based on the tre:phe 10:0.5 formulation showed a fully amorphous 
structure (compare Figure 7.9), but the non-collapsed samples from moderate freeze-dry-
ing exhibited as poor stabilization as the partly crystalline samples based on tre:phe 10:3. 
Hence, a fully amorphous structure by itself did not guarantee good protein stabilization.  
 
Since LDH is reported to be a surface sensitive protein [16] a correlation of instability 
and SSA seemed reasonable. Relating aggregation of LDH (i.e. turbidity) to the specific 
surface area of the lyophilizates uncovered that aggregation was observed in all non-
collapsed samples, which had a high SSA (cf. Figure 7.14). Even if moderate conditions 
were used, the high SSA of non-collapsed tre:phe 10:0.5 samples caused aggregation. 
Compared to the moderately freeze-dried tre:phe 10:3 samples, the SSA was considerably 
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lower in the aggressively freeze-dried non-collapsed samples. However, similar turbidity 
was observed. It is concluded that in case of non-collapsed lyophilizates aggressive con-
ditions result in instability at lower SSA compared to moderate conditions.  
 
Figure 7.14: Comparison of turbidity and specific surface area of after freeze-drying. The trehalose-based formu-
lations contain a low (tre:phe 10:0.5) or high amount (tre:phe 10:3) of phenylalanine and 0.75 mg/ml LDH (col-
lapsed lyophilizates are marked by an arrow). 
In contrast to the non-collapsed lyophilizates, the aggressively freeze-dried 
tre:phe 10:0.5 samples, which exhibited low SSA due to collapse, showed no increase of 
aggregation after freeze-drying (cf. Figure 7.14). These collapsed samples also showed 
excellent stabilization of LDH during storage at 50°C. The superior stability of LDH in 
collapsed lyophilizates, which was found in this study, supports the findings of Schersch 
et al [1, 2]. Low SSA is concluded to be the major prerequisite for successful stabilization.  
 
5. SUMMARY AND CONCLUSIONS 
In this chapter, the investigation on the applicability of aggressive freeze-drying to 
three different model proteins was investigated. Mab_T2 (IgG antibody), GCSF, and LDH 
(from rabbit muscle) were utilized to evaluate the stabilization of proteins in aggressively 
freeze-dried lyophilizates. As a benchmark, moderately freeze-dried samples were inves-
tigated, too.  
Aggressive freeze-drying of formulations that contain no or only a low amount of 
bulking agent resulted in collapsed samples. Non-collapsed samples were achieved ei-
ther by adding larger amounts of bulking agents to the formulations, or by moderate 
freeze-drying. The addition of larger amounts of bulking agents resulted in partially crys-
talline lyophilizates, which were able to withstand structural collapse. Consequently, 
these samples exhibit a large surface area.  
Since LDH is known as surface sensitive model protein [16] it was expected that a 
possible correlation between stabilization and SSA would be disclosed by investigating 
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samples of high and low SSA. In fact, for non-collapsed samples of large SSA worst sta-
bilization of LDH after freeze-drying and storage was observed. Collapsed samples of 
low SSA, however, revealed excellent stabilization. These samples could be stored for 6 
months at 50 °C without drastic sings of instability. Thus, it is concluded, that the combi-
nation of high SSA and aggressive drying conditions is the major stress for incorporated 
LDH.  
Overall, mab_T2 was well stabilized in all aggressively freeze-dried lyophilizates. 
Collapsed samples even showed slightly superior prevention of aggregation. The overall 
good stabilization also in non-collapsed samples is ascribed to the presence of polysorb-
ate 20 in all formulations. The combination of high SSA and aggressive drying conditions 
was shown to be the major stress for incorporated LDH (compare above). Hence, due to 
the partly crystalline structure and large SSA of non-collapsed maa_T2 samples, worse 
stabilization of mab_T2 is probable if no polysorbate would be used in the formulation. 
On the other hand, during formulation development for aggressive freeze-drying the ad-
dition of polysorbate or other surfactants could be a promising strategy to counteract 
surface stress.  
Comparing non-collapsed and collapsed samples of GCSF, the latter were superior in 
preventing aggregation. However, also in collapsed samples no complete stabilization of 
GCSF was achieved (indicated by aggregation). As already in the initial formulations ag-
gregation was observed, incomplete stabilization is partly attributed to a non-ideal 
buffer. It was beyond the scope of this investigation to screen for another buffer. Never-
theless, this study highlighted the potential of collapsed lyophilizates to stabilize GCSF.  
 
Overall, the most remarkable finding was that all of the three proteins were better 
stabilized in collapsed than in non-collapsed lyophilizates. Obviously, the high SSA 
of non-collapsed samples affected the stability of incorporated protein. The im-
portance of low SSA for dried protein formulations was already highlighted by Abdul-
Fattah et al [30, 31]. In the present studies, it was shown that collapsed lyophilizates, 
which had a low SSA, are the preferred choice for stabilization of incorporated pro-
teins. Especially lyophilizates that were composed of trehalose and phenylalanine at a 
weight-to-weight ratio of 10:0.5 presented superior ability to stabilize various proteins. 
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CHAPTER 8 FINAL SUMMARY AND CONCLUSION 
 
The objective of this thesis was to investigate whether aggressive freeze-drying can 
catch up with conventional freeze-drying as a robust and reliable drying technique for 
sensitive biopharmaceuticals. In previous work it was shown that collapse of lyophi-
lizates does not have a negative effect on protein stability during freeze-drying [1], but 
even revealed better stabilization during storage [2]. This was taken as a starting point 
for a sound investigation on aggressive freeze-drying. In order to broaden knowledge on 
how to apply aggressive freeze-drying, the potential design space for major process pa-
rameters (temperature, pressure, and time) was investigated. The drying kinetics of sub-
limation (primary drying) and desorption (secondary drying) were closely monitored to 
gain understanding on how to perform and potentially optimize aggressive freeze-dry-
ing. To account for the main strategies in formulation design for freeze-dried products, 
lyophilizates of sugar-based formulations with or without bulking agents were inten-
sively characterized after aggressive freeze-drying. As for the first time a systematic char-
acterization of the design space of aggressive freeze-drying was performed, key physico-
chemical parameters (e.g. water content, crystallinity) were precisely inspected. The re-
sulting samples were judged regarding the potential to ensure protein stabilization based 
on the concepts of water replacement [3-6] and vitrification [7-9]. Beyond the physico-
chemical characteristics of lyophilizates, the ability to stabilize incorporated proteins was 
the major determinant to assess aggressive freeze-drying. 
 
In CHAPTER 1, a comprehensive introduction is given. CHAPTER 2 summarizes the 
objectives of the thesis, the utilized materials and methods are outlined in CHAPTER 3.  
 
The influence of process parameters (shelf temperature, chamber pressure, process 
time) on drying kinetics, physico-chemical characteristics, and protein stabilization of ag-
gressively freeze-dried lyophilizates was studied in CHAPTER 4. The monoclonal IgG1 
antibody mab_T1 was utilized as model protein, which represents the currently most im-
portant class of protein pharmaceuticals. Additionally, mab_T1 is susceptive to freeze-
drying stresses if not suitably stabilized. Formulations were based on either sucrose or 
trehalose, which are superior cryo-and lyoprotectants for proteins [10, 11]. The selection 
of formulations was completed by two formulations containing phenylalanine as bulking 
agent (low and high concentration). 
Chamber pressures of 0.1 mbar to 4 mbar and shelf temperatures of 30 °C to 60 °C 
were investigated. The drying time was varied from 8 h to 24 h. For all conditions, very 
high sublimation rates were observed. Within maximum 6 h sublimation was completed.  
The lyophilizates of high phenylalanine content revealed a non-collapsed appearance 
regardless of the process parameters. If a chamber pressure of 0.1 mbar was used, also 
the formulations without bulking agent exhibited a non-collapsed appearance even if 
60 °C shelf temperature were utilized. This is caused by the considerable influence of the 
chamber pressure on the product temperature (during sublimation). For pressures of 
0.1 mbar to 4 mbar the product temperature ranged from -28.8 °C to -1.7 °C, respectively. 
The lyophilizates containing no or a low amount of a bulking agent collapsed during the 
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primary drying if a chamber pressure of ≥ 1 mbar was utilized. No increase of the prod-
uct temperature was observed, Hence, collapse did not result in restriction of water vapor 
flow (flow hindrance would result in an increase of Tp). Obviously, the high mobility of 
the collapsing matrix allows unimpeded water vapor flow. At chamber pressures of 
4 mbar, the samples that contain no or a low amount of bulking agent partly spattered to 
the stopper/out of the vials. Although this behavior is regarded as unacceptable/uncon-
trollable, they were characterized as well. 
For conventional freeze-drying a correlation of sublimation rate and product temper-
ature has been described [12]. For aggressive conditions, which were studied in this work, 
a higher sublimation rates was observed for higher product temperature in the range 
between -28 °C to -15 °C. However, above -15 °C no further increase of sublimation rate 
was noticed. 
All samples that contain no bulking agent revealed a fully amorphous structure for 
either process condition. The formulations containing a low amount of phenylalanine re-
vealed a fully amorphous structure in case freeze-dried at ≤ 2 mbar. For 4 mbar chamber 
pressure, a small fraction of crystalline phenylalanine hydrate was found in these lyoph-
ilizates (also detected in samples of high bulking agent content). Most probably, the high 
mobility (due to high product temperature) in the collapsing lyophilizates allowed for 
crystallization.  
Our investigations revealed that chamber pressure is the major determinant for the 
product temperature and therefore for collapse behavior and final structure. Neverthe-
less, as expected, higher shelf temperatures between 30 °C and 60 °C resulted in higher 
sublimation rates due to higher energy input. Interestingly, the product temperatures 
were hardly affected by shelf temperature. Despite high temperatures were used, also 
collapsed samples (which contained no bulking agent) showed comparably high water 
contents after 24 h (i.e. around 18 h secondary drying). If a low amount of phenylalanine 
was added to the sugar based formulation (10:0.5 wt:wt ratio), regardless of the collapsed 
structure, low water content of <1% was achieved already after 8 h drying.  
Summarizing the influence of process conditions of aggressive freeze-drying on pro-
tein stabilization, an overall good to excellent stabilization of mab_T1 (recombinant mon-
oclonal IgG1 antibody) was observed. Evaluating the stability in the collapsed and non-
collapsed samples revealed that collapsed samples consistently showed superior stabili-
zation. Non-collapsed lyophilizates, which resulted from either low chamber pressure or 
high bulking agent content, revealed an increase of aggregated species. Comparing the 
physico-chemical properties of these lyophilizates to non-collapsed ones, the major dif-
ference was the considerably higher specific surface of latter samples. In case of high 
bulking agent content, additionally the partly crystalline structure seems to be detri-
mental to mab_T1 stability. As collapsed lyophilizates were produced by medium to high 
chamber pressure, it is concluded that values of ≥ 1 mbar are preferable for stabilization. 
As for 4 mbar the collapse behavior was not controllable (spattering), the chamber pres-
sure is advised to be in the range between 1 and 2 mbar for aggressive freeze-drying. In 
addition, also higher shelf temperatures resulted in slightly better stabilization, indicat-
ing a possible annealing effect, which is described to improve stabilization of embedded 
proteins [13-15]. As high shelf temperatures also caused lower water content, a shelf tem-
perature of ≥ 45 °C is desirable for aggressive freeze-drying. Overall, an optimum level 
of stabilization was achieved by samples of low specific surface area and fully amorphous 
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structure. Monitoring of the stability of mab_T1 over drying time revealed slightly less 
successful stabilization for longer drying time. Hence, aggressive cycles should by as 
short as possible. To produce fully amorphous lyophilizates of sufficiently low resid-
ual water content and low specific surface area by short drying cycles, the addition of 
low amounts of phenylalanine to sugar-based formulations (ratio 10:0.5) is the key to 
success.  
 
In CHAPTER 5 and CHAPTER 6 the influence of formulation composition on phys-
ico-chemical characteristics (chapter 5) and protein stability (chapter 6) of aggressively 
freeze-dried lyophilizates were studied. The recombinant monoclonal IgG1 antibody 
mab_T1, which is sensitive to freezing and drying stresses, was used as model protein.  
As non-reducing disaccharides are effective cryo-and lyoprotectants, the majority of 
freeze-dried antibody drugs are based on either sucrose or trehalose [16]. Hence, these 
sugars were chosen as backbone of the investigated formulations. A range of freeze-dry-
ing formulations was selected, especially with respect to formulations that contain bulk-
ing agents (mannitol, glycine or phenylalanine) in different quantities. In a first step, for-
mulations without bulking agents were studied. Despite the collapsed appearance and 
high water content, the samples of trehalose and sucrose (at 50 mg/ml) completely stabi-
lized mab_T1 during aggressive freeze-drying. 
Previous test have shown that bulking agents allow extremely short aggressive freeze-
drying cycles of 12 h (including freezing). Such a short cycle was now utilized for drying 
the formulations that contain bulking agents. All samples containing a low amount of 
either bulking agent showed very good stabilization of mab_T1. However, neither a low 
amount of mannitol nor glycine was able to reduce the residual water content to a satis-
factory degree.  
As already observed by Schersch at al [1], a stepwise addition of mannitol to aggres-
sive freeze-dried formulations resulted in a decreasing degree of collapse, both, visible as 
well as detected by SSA measurements. The non-collapsed appearance was reflected by 
comparably high specific surface areas. In the present work, a similar effect was shown 
in case phenylalanine or glycine was used as bulking agent. Remarkably, a comparable 
bulking effect (in terms of appearance and SSA) was observed at a ten times lower sugar 
to phenylalanine ratio (i.e. at 10:3 instead of 10:30 for mannitol or glycine). The bulking 
effect of glycine (10:30) and phenylalanine (10:3) could be attributed to crystallization 
(detected by XRD). Although improving especially the drying towards low water con-
tents, the addition of higher amounts of bulking agent resulted in slightly worse stabili-
zation of mab_T1, especially mannitol deteriorated the stability. Obviously, the partly 
crystalline structure and the high SSA of these lyophilizates imposed some stress to the 
protein. 
Formulations containing sugar and a low amount of phenylalanine (tre:phe 10:0.5, 
suc:phe 10:0.5) revealed a collapsed structure. Intriguingly, despite these samples exhib-
ited collapse (i.e. low SSA) and were fully amorphous, they could be dried to low residual 
water contents and high Tg. Moreover, these lyophilizates stood out by excellent stabili-
zation of mab_T1. 
Consequently, these collapsed lyophilizates composed of sucrose/trehalose and a low 
amount of phenylalanine were subjected to a storage stability study at 30°C and 50°C 
(and a control at 2-8°C) for up to 6 months. Additionally, aggressively freeze-dried non-
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collapsed lyophilizates that contain high amounts of glycine, mannitol, or phenylalanine 
were included in this study. For comparison, moderately freeze-dried samples of the re-
spective formulations were stored at identical conditions. Summarizing, it was found that 
even if stored at 50°C, mab_T1 was completely stabilized for 6 months by the trehalose-
based lyophilizates that contain a low amount of phenylalanine (tre:phe 10:0.5). In case 
samples of suc:phe 10:0.5 were stored, excellent preservation was achieved for storage up 
to 30 °C. The glass transition temperatures of the sucrose-based lyophilizates were in the 
vicinity of 50 °C. Hence, high mobility reduced the ability for stabilization. Although ac-
ceptable stabilization was achieved, none of the moderately freeze-dried samples reached 
a comparable stability as the collapsed lyophilizates. In addition, the aggressively freeze-
dried non-collapsed samples (due to high bulking agent content) revealed ongoing ag-
gregation of mab_T1 in the course of storage. Obviously, the high SSA of non-collapsed 
resulted in inferior storage stability. 
The superior stabilization of suc:phe 10:5 and tre:phe 10:0.5 samples is ascribed to the 
unique physico-chemical properties: Fully amorphous structure despite adding phenyl-
alanine, low SSA due to collapse during aggressive freeze-drying and low water content 
/ high glass transition temperature despite the collapsed appearance. In the light of liter-
ature, the superior protein stabilization by amorphous matrices of low SSA [2, 17, 18] is 
reasonable. Based on the data, even room temperature storage is feasible. Hence, these 
special formulations are regarded as first choice for protein stabilization in aggressively 
freeze-dried lyophilizates.  
In order to evaluate, whether other amino acids feature a comparable potential as 
phenylalanine, arginine, glycine, histidine, isoleucine, leucine, methionine, and trypto-
phan were added to sugar-based formulations at a weight-to-weight ratio of 10:0.5. Ag-
gressive freeze-drying of the sugar/amino acid formulations resulted in collapsed lyoph-
ilizates with low SSA. Compared to lyophilizates containing no amino acid, a decrease of 
water content was observed for isoleucine, leucine, and methionine. For trehalose-based 
samples also a remarkable increase of glass transition temperature was detected. XRD 
revealed that contrary to phenylalanine, isoleucine, leucine, and methionine crystallized 
during freeze-drying. Evaluating of the ability to protect mab_T1 against aggregation re-
vealed increased aggregation in the formulations that contain isoleucine, leucine, or me-
thionine. It is concluded that crystallization of the amino acids diminishes the ability to 
stabilize incorporated mab_T1 in aggressive freeze-dried lyophilizates. The other amino 
acids used (arg, gly, his, trp) exhibited good stabilization of mab_T1, however no im-
provement of water content and Tg compared to pure sugar lyophilizates was achieved. 
Isoleucine, leucine, and methionine exhibit a negative hydropathy index [19]. Hence, the 
effect on the physico-chemical lyophilizate characteristics is ascribed to the hydrophobic 
nature of the side chains of these amino acids, which fosters crystallization in aqueous 
solutions. Although a negative hydropathy index is also reported for phenylalanine [19], 
no crystallization was detectable. It is concluded that phenylalanine exhibits a unique 
effect on the physico-chemical lyophilizate characteristics: It drastically improves the 
drying of collapsed lyophilizates and remains fully amorphous. Thus, phenylalanine 
stands out by combining suitable physico-chemical properties and excellent protein 
stabilization upon combination with trehalose or sucrose. 
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In a separate study it was shown that in the range between 25 and 150 mg/ml sucrose 
and trehalose formulation with and without phenylalanine (ratio 10:0.5) resulted in col-
lapsed lyophilizates of low SSA and fully amorphous structure. For pure sugar lyophi-
lizates, a slight tendency of lower water content was observed for higher solid contents. 
For samples that contain phenylalanine, a decrease of SSA with increasing solid content 
was noticed. While for samples of ≥ 50 mg/ml aggregation of mab_T1 was prevented, 
slightly less successful stabilization was observed for low solid contents (25 mg/ml). 
Worse stabilization is attributed to larger SSA of latter samples. 
The addition of a higher amount of protein (10 mg/ml mab_T1) resulted in a reduction 
of the specific surface area and a slight increase of residual water contents (compared to 
lyophilizates of 1 mg/ml). Although especially the lyophilizates from sucrose and treha-
lose showed rather high water content, mab_T1 was effectively protected. As already ob-
served for formulations of 1 mg/ml mab_T1 concentration, adding phenylalanine consid-
erably decreased the water content without increasing the SSA. The sugar-based lyophi-
lizates containing phenylalanine revealed excellent stabilization. Therefore, it is con-
cluded that proteins can be stabilized by aggressive freeze-drying also at concentrations 
at least up to 10 mg/ml. 
 
In CHAPTER 7, the applicability of aggressive freeze-drying to three different model 
proteins was investigated. Mab_T2 (monoclonal IgG1 antibody), GCSF, and LDH was 
utilized to evaluate the stabilization of proteins in aggressively freeze-dried lyophilizates.  
LDH is known as a surface sensitive model [20]. Thus, it was expected that a possible 
correlation between stabilization and the specific surface area, which was found for 
mab_T1, would be substantiated. The first choice formulation of the mab_T1 investiga-
tions (tre:phe 10:0.5) was chosen and compared to the formulation containing a high 
amount of phenylalanine(tre:phe 10:3), which did not collapse during aggressive freeze-
drying. In fact, for non-collapsed samples of large SSA insufficient stabilization of LDH 
after freeze-drying and storage was observed. Collapsed tre:phe 10:0.5 samples of low 
SSA, however, revealed excellent stabilization. These lyophilizates could be stored for 6 
months at 50 °C without showing instability. It is concluded that the combination of high 
SSA and aggressive drying conditions is the major stress for incorporated proteins.  
For the investigation on mab_T2 and GCSF stabilization sucrose/trehalose-based for-
mulations with low and high amounts of mannitol, glycine, and phenylalanine were ag-
gressively freeze-dried (12 h protocol). Independent, whether embedded in collapsed or 
non-collapsed lyophilizates, mab_T2 was well stabilized in all aggressively freeze-dried 
lyophilizates. The combination of high SSA and aggressive drying conditions in non-col-
lapsed lyophilizates did not cause major instability. Collapsed samples even showed 
slightly superior prevention of aggregation. The good stabilization also in non-collapse 
samples is ascribed to the presence of polysorbate 20 in all formulations. The addition of 
polysorbate or other surfactants could be a promising strategy for a formulation devel-
opment also for aggressive freeze-drying.  
Comparing non-collapsed and collapsed samples of GCSF, the latter were superior in 
preventing aggregation. However, also in collapsed samples, no complete stabilization 
of GCSF was achieved. As already in the initial formulations aggregation was observed, 
incomplete stabilization is partly attributed to a non-ideal buffer system. It was beyond 
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the scope of this investigation to screen for another buffer. Nevertheless, this study high-
lighted the potential of collapsed lyophilizates to stabilize GCSF.  
Overall it was found that LDH, mab_T2, and GCSF were better stabilized in collapsed 
than in non-collapsed lyophilizates. Obviously, the low SSA of collapsed samples is pref-
erable for a whole range of proteins supporting the observations on the importance of 
low SSA for dried protein formulations [17, 21]. In the present studies, it was show that 
collapsed lyophilizates of low SSA are the preferred choice for stabilization of incorpo-
rated proteins. Especially lyophilizates that were composed of trehalose and phenylala-
nine at a weight-to-weight ratio of 10:0.5 presented superior ability to stabilize various 
proteins. 
 
 
Having an overall look on the results of this thesis, aggressive freeze-drying turned 
out as controllable, reproducible, and very fast technique to generate lyophilizates. By 
selecting appropriate process conditions, elegant or collapsed lyophilizates can be pro-
duced by aggressive freeze-drying of common protein formulations – even if no bulking 
agents are used. Despite beeing usually regarded as not acceptable, compared to elegant 
samples, collapsed lyophilizates have shown superior potential to stabilize sensitive pro-
teins during storage. It has turned out that the low specific surface area of collapsed sam-
ples (in combination with a fully amorphous structure) can result in excellent stability. 
However, collapsed lyophilizates (of formulations that contain no bulking agent) were 
difficult to dry to low water contents within the short time of aggressive protocols (typi-
cally ≤ 24 h). The use of small amounts of phenylalanine, which were added to sucrose- 
or trehalose-based formulations at a weight-to-weight ratio of 10:0.5 (sugar:phe) emerged 
as a superior formulation strategy for aggressive freeze-drying. These formulations could 
by aggressively freeze-dried to fully amorphous, collapsed lyophilizates within 12 h and 
were able to stabilize therapeutics monoclonal antibodies (IgG1) for 6 months even at 
50°C storage. 
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CHAPTER 9 APPENDIX 
1. ADDITIONAL TABLES AND FIGURES  
Table 9.1: HP-SEC data to characterize the influence of type of disaccharide on the protein stability of mab_T1 
(formulations based on 10 mM potassium phosphate buffer pH 6.4) 
 HMWS content LMWS content monomer content monomer 
recovery 
 before 
freeze-
drying 
after 
freeze-dry-
ing 
before 
freeze-dry-
ing 
after 
freeze-dry-
ing 
before 
freeze-dry-
ing 
after freeze-
drying 
 
formulation % % % % % % % 
suc:man 10:3 1.36±0.04 1.66±0.12 1.30±0.08 0.95±0.22 97.34±0.35 97.39±0.21 100.58±0.27 
suc:man 10:30 1.35±0.06 1.87±0.05 1.46±0.25 0.8±0.03 97.19±0.32 97.32±0.08 99.37±0.2 
suc:gly 10:3 1.35±0.08 1.58±0.07 1.29±0.05 0.79±0.13 97.36±0.04 97.63±0.08 101.97±0.05 
suc:gly 10:30 1.28±0.15 1.69±0.06 1.24±0.00 0.8±0.08 97.49±0.08 97.51±0.71 99.83±0.39 
suc:phe 10:0.5 1.34±0.04 1.57±0.05 1.23±0.05 0.73±0.08 97.43±0.49 97.7±0.21 100.77±0.34 
suc:phe 10:3 1.33±0.07 1.64±0.07 1.23±0.06 0.84±0.15 97.44±1.12 97.53±0.25 100.3±0.67 
tre:man 10:3 1.37±0.08 1.68±0.03 1.14±0.05 0.93±0.04 97.49±0.26 97.39±0.63 101.77±0.44 
tre:man 10:30 1.41±0.08 2.05±0.04 1.23±0.01 0.94±0.06 97.36±0.32 97.01±0.32 98.63±0.31 
tre:gly 10:3 1.30±0.03 1.62±0.06 0.93±0.24 0.92±0.03 97.77±0.37 97.46±0.5 101.77±0.43 
tre:gly 10:30 1.34±0.00 1.79±0.04 1.14±0.16 1±0.05 97.52±0.39 97.22±0.59 101.27±0.48 
tre:phe 10:0.5 1.28±0.00 1.71±0.04 1.21±0.19 0.95±0.09 97.44±0.33 97.33±0.55 103.86±1.07 
tre:phe 10:3 1.37±0.00 1.73±0.07 1.02±0.18 0.94±0.11 97.60±0.02 97.33±1.15 97.79±0.55 
 
Table 9.2: Glass transition temperatures after storage of moderately freeze-dried samples at 2-8 °C, 30 °C, and 
50 °C for up to 26 weeks (the sugar-based formulations contain bulking agents and 1 mg/ml mab_T1) 
moderate glass transition temperature (°C) 
  2-8°C 30°C 50°C 
 after FD 10 weeks 26 weeks 10 weeks 26 weeks 10 weeks 26 weeks 
suc:man 10:30 30.5 ± 6.4 22.3 ± 2.2 20.2 ± 2 19.6 ± 0.1 17.1 ± 0.4 n.d. n.d. 
suc:gly 10:30 40.3 ± 3.5 40.8 ± 1.7 38.9 ± 1.3 36.3 ± 0.8 33.8 ± 0.4 31.4 ± 2.7 31.8 ± 2 
suc:phe 10:0.5 67.5 ± 0.3 64.6 ± 1 60.1 ± 2.6 59.7 ± 1.9 64.6 ± 0.6 58.8 ± 0.4 55.1 ± 0.7 
suc:phe 10:3 73.7 ± 0.6 66.6 ± 3.5 70.4 ± 0.1 59.5 ± 1.5 46.3 ± 6.2 56.4 ± 7.9 56.8 ± 3.1 
tre:man 10:30 50.3 ± 2.7 45.4 ± 2.6 34.3 ± 3.8 37.9 ± 2.2 32.8 ± 4.8 37.7 ± 1.1 40.6 ± 0.6 
tre:gly 10:30 59 ± 0.1 57.6 ± 0.3 53.2 ± 0.8 51.4 ± 0.6 77.1 ± 10 46 ± 0.9 46.9 ± 0.4 
tre:phe 10:0.5 96.7 ± 1.1 94.6 ± 0.6 95.5 ± 0.7 87.6 ± 0.9 84.4 ± 0.4 82 ± 0.5 83.7 ± 1.2 
tre:phe 10:3 103.1 ± 1.2 99.7 ± 0.8 100.2 ± 0.9 92.6 ± 1.1 74.9 ± 7 85.6 ± 2 83.1 ± 0.5 
n.d.: no glass transition detected 
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Figure 9.1: Residual water content after storage of moderately freeze-dried samples at 2-8 °C, 30 °C, and 50 °C 
for up to 26 weeks (the sugar-based formulations contain bulking agents and 1 mg/ml mab_T1). 
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Figure 9.2: XRD diffraction patterns after storage of moderately freeze-dried samples at 2-8 °C, 30 °C, and 50 °C 
for 26 weeks (the sugar-based formulations contain bulking agents and 1 mg/ml mab_T1; # indicates diffractions 
of α-mannitol, diffractions of sucrose are highlighted by arrows; diffraction patterns marked by * were measured 
on an alternative device) 
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Table 9.3: HMWS detected by HP-SEC of moderately freeze-dried lyophilizates after storage for 26 weeks at 2-
8 °C, 30 °C, or 50 °C. For comparison, HWMS before and after freeze-drying are shown. The sugar-based formu-
lations contain bulking agents and 1.0 mg/ml mab_T1 (n=3). 
formulation before FD after FD after 26 weeks 
   2-8 °C 30 °C 50 °C 
suc:man 10:30 1.3 ± 0.2 1.8 ± 0.1 1.7 ± 0.0 2.4 ± 0.0 71.1 ± 58.1 
suc:gly 10:30 1.3 ± 0.2 1.8 ± 0.1 1.8 ± 0.0 2.6 ± 0.4 7.5 ± 2.5 
suc:phe 10:0.5 1.3 ± 0.2 1.8 ± 0.1 1.7 ± 0.0 1.9 ± 0.4 3.0 ± 0.1 
suc:phe 10:3 1.3 ± 0.1 1.7 ± 0.1 1.7 ± 0.1 1.6 ± 0.0 6.8 ± 0.8 
tre:man 10:30 1.4 ± 0.1 1.9 ± 0.0 1.7 ± 0.0 2.9 ± 0.0 13.0 ± 0.2 
tre:gly 10:30 1.4 ± 0.1 1.9 ± 0.1 2.0 ± 0.1 2.9 ± 0.1 6.6 ± 1.3 
tre:phe 10:0.5 1.4 ± 0.1 1.8 ± 0.1 1.6 ± 0.0 1.8 ± 0.1 1.8 ± 0.1 
tre:phe 10:3 1.5 ± 0.1 1.8 ± 0.1 1.7 ± 0.0 1.7 ± 0.0 1.7 ± 0.1 
 
 
Table 9.4: Monomer recovery (detected by HP-SEC) of moderately freeze-dried lyophilizates after storage for 26 
weeks at 2-8 °C, 30 °C, or 50 °C compared to monomer content after freeze-drying. The sugar-based formula-
tions contain bulking agents and 1.0 mg/ml mab_T1 (n=3). 
formulation after 26 weeks 
 2-8 °C 30 °C 50 °C 
suc:man 10:30 100.9 ± 0.6 99.9 ± 0.4 3.7 ± 1.8 
suc:gly 10:30 101.3 ± 0.5 99.9 ± 0.2 56.5 ± 5.6 
suc:phe 10:0.5 101.6 ± 0.5 101.5 ± 0.5 68.2 ± 2.5 
suc:phe 10:3 101.3 ± 0.6 101.4 ± 0.6 100.0 ± 1.0 
tre:man 10:30 100.7 ± 0.5 98.2 ± 0.2 69.0 ± 1.4 
tre:gly 10:30 101.2 ± 0.4 100.7 ± 0.4 90.8 ± 0.6 
tre:phe 10:0.5 101.7 ± 0.6 101.2 ± 0.5 99.8 ± 1.0 
tre:phe 10:3 100.6 ± 1.3 100.8 ± 1.3 98.0 ± 1.4 
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Table 9.5 Reconstitution time of sugar-based aggressively freeze-dried lyophilizates containing 1 mg/ml GCSF 
and different amounts of bulking agents (n=3). 
formulation reconstitution time 
 sucrose trehalose 
 seconds seconds 
sugar 27 ± 7 43 ± 2 
sugar:man 10:3 24 ± 3 23 ± 2 
sugar:man 10:30 14 ± 4 14 ± 2 
sugar:gly 10:3 17 ± 2 17 ± 3 
sugar:gly 10:30 10 ± 2 18 ± 1 
sugar:phe 10:0.5 30 ± 5 26 ± 6 
sugar:phe 10:3 33 ± 5 29 ± 4 
 
Table 9.6: Subvisible particle (svp) concentration of LDH in lyophilizates after freeze-drying and storage at 
2-8 °C and 50 °C for 6 months. The trehalose-based formulations contain a low amount of phenylalanine (tre:phe 
10:0.5) and 0.75 mg/ml LDH (n=3; before freeze-drying 7 ± 0 ≥ 10 µm and 0 ± 0 ≥ 10 µm svp per ml) 
 moderate aggressive* short aggressive* 
 2-8°C storage 50°C storage 2-8°C storage 50°C storage 2-8°C storage 50°C storage 
 
≥ 10 
µm 
≥ 25 
µm 
≥ 10 
µm 
≥ 25 
µm 
≥ 10 
µm 
≥ 25 
µm 
≥ 10 
µm 
≥ 25 
µm 
≥ 10 
µm 
≥ 25 
µm 
≥ 10 
µm 
≥ 25 
µm 
after FD 47 ± 27 2 ± 1 47 ± 27 2 ± 1 10 ± 0 3 ± 1 10 ± 0 3 ± 1 10 ± 4 2 ± 1 10 ± 4 2 ± 1 
8 weeks 
2903 ± 
180 
10 ± 7 
3036 ± 
155 
9 ± 2 44 ± 1 4 ± 1 66 ± 1 2 ± 2 75 ± 2 2 ± 2 55 ± 5 6 ± 2 
26 weeks 
4891 ± 
113 
14 ± 4 
1303 ± 
71 
10 ± 5 
149 ± 
25 
9 ± 4 
192 ± 
10 
7 ± 3 
129 ± 
15 
3 ± 3 
189 ± 
18 
6 ± 2 
 
 
Table 9.7: Subvisible particle (svp) concentration of LDH in lyophilizates after freeze-drying and storage at 
2-8 °C and 50 °C for 6 months. The trehalose-based formulations contain a low amount of phenylalanine (tre:phe 
10:0.5) and 0.75 mg/ml LDH (n=3; before freeze-drying 13 ± 5 ≥ 10 µm and 2 ± 3 ≥ 10 µm svp per ml)  
 moderate aggressive short aggressive 
 2-8°C storage 50°C storage 2-8°C storage 50°C storage 2-8°C storage 50°C storage 
 
≥ 10 
µm 
≥ 25 
µm 
≥ 10 
µm 
≥ 25 
µm 
≥ 10 
µm 
≥ 25 
µm 
≥ 10 
µm 
≥ 25 
µm 
≥ 10 
µm 
≥ 25 
µm 
≥ 10 
µm 
≥ 25 
µm 
after FD 21 ± 2 0 ± 1 21 ± 2 0 ± 1 51 ± 22 0 ± 0 51 ± 22 0 ± 0 24 ± 4 2 ± 2 24 ± 4 2 ± 2 
8 weeks 
2207 ± 
144 
6 ± 4 
2188 ± 
987 
10 ± 3 
1503 ± 
55 
72 ± 3 
854 ± 
34 
37 ± 3 
1328 ± 
68 
76 ± 
16 
167 ± 
17 
2 ± 2 
26 weeks 
1602 ± 
57 
13 ± 3 
1170 ± 
41 
17 ± 
10 
1736 ± 
44 
21 ± 
11 
1866 ± 
77 
46 ± 
13 
1866 ± 
20 
13 ± 0 
1140 ± 
50 
51 ± 8 
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Figure 9.7: Turbidity of lyophilizates after freeze-drying and storage at 2-8 °C and 50 °C for 6 months(the treha-
lose-based formulations contain a low (A) or high amount (B) of phenylalanine and 0.75 mg/ml LDH). 
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